TW202330556A - Boron-containing cyclic emissive compounds and color conversion film containing the same - Google Patents

Boron-containing cyclic emissive compounds and color conversion film containing the same Download PDF

Info

Publication number
TW202330556A
TW202330556A TW111136536A TW111136536A TW202330556A TW 202330556 A TW202330556 A TW 202330556A TW 111136536 A TW111136536 A TW 111136536A TW 111136536 A TW111136536 A TW 111136536A TW 202330556 A TW202330556 A TW 202330556A
Authority
TW
Taiwan
Prior art keywords
mmol
plc
compound
dcm
apci
Prior art date
Application number
TW111136536A
Other languages
Chinese (zh)
Inventor
郑世俊
傑弗瑞 漢默克
丁新亮
王鵬
蔡潔
協 劉
𦭑莎 姚
Original Assignee
日商日東電工股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日東電工股份有限公司 filed Critical 日商日東電工股份有限公司
Publication of TW202330556A publication Critical patent/TW202330556A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D7/00Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
    • C09D7/40Additives
    • C09D7/41Organic pigments; Organic dyes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/55Boron-containing compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1022Heterocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1033Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1037Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1055Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with other heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1096Heterocyclic compounds characterised by ligands containing other heteroatoms
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L33/00Semiconductor devices having potential barriers specially adapted for light emission; Processes or apparatus specially adapted for the manufacture or treatment thereof or of parts thereof; Details thereof
    • H01L33/48Semiconductor devices having potential barriers specially adapted for light emission; Processes or apparatus specially adapted for the manufacture or treatment thereof or of parts thereof; Details thereof characterised by the semiconductor body packages
    • H01L33/50Wavelength conversion elements
    • H01L33/501Wavelength conversion elements characterised by the materials, e.g. binder
    • H01L33/502Wavelength conversion materials
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L33/00Semiconductor devices having potential barriers specially adapted for light emission; Processes or apparatus specially adapted for the manufacture or treatment thereof or of parts thereof; Details thereof
    • H01L33/48Semiconductor devices having potential barriers specially adapted for light emission; Processes or apparatus specially adapted for the manufacture or treatment thereof or of parts thereof; Details thereof characterised by the semiconductor body packages
    • H01L33/50Wavelength conversion elements
    • H01L33/507Wavelength conversion elements the elements being in intimate contact with parts other than the semiconductor body or integrated with parts other than the semiconductor body

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Manufacturing & Machinery (AREA)
  • Computer Hardware Design (AREA)
  • Power Engineering (AREA)
  • Electroluminescent Light Sources (AREA)
  • Optical Filters (AREA)

Abstract

The present disclosure relates to novel photoluminescent complexes comprising a BODIPY moiety, a blue light absorbing moiety, and a linker complex, wherein the linker complex covalently bonds the blue light absorbing moiety to the ring-locked BODIPY moiety, a color conversion film comprising the photoluminescent complex, and a back-light unit using the same.

Description

含硼環狀發光化合物和含有該含硼環狀發光化合物的色轉換膜Boron-containing cyclic light-emitting compound and color conversion film containing the boron-containing cyclic light-emitting compound

除非本發明另有指定,否則本發明中所述之細節非本申請案之申請專利範圍之先前技術且不承認為藉由納入此節中之先前技術。Unless otherwise indicated herein, the details described in this disclosure are not prior art to the claims of this application and are not admitted to be prior art by inclusion in this section.

於顏色再現中,域或色域為在裝置(諸如電視或監視器)上可得之顏色之某個完全子集。例如,開發Adobe TM紅綠藍(RGB),藉由使用純光譜原色達成之寬域顏色空間以提供更寬色域及提供透過顯示器觀察到之可見色之更真實表現。據信,可提供更寬域之裝置可使顯示器能描繪更鮮艷色彩。 In color reproduction, a gamut or gamut is some complete subset of the colors available on a device such as a television or monitor. For example, Adobe red-green-blue (RGB) was developed to provide a wider color gamut and a more realistic representation of visible colors viewed through a display through a wide-gamut color space achieved by using pure spectral primaries. It is believed that devices that provide a wider gamut will enable displays to depict more vivid colors.

因為高定義大螢幕顯示器變得更常見,所以對更高性能、更精簡及高度功能化顯示器之需求已增加。目前發光二極體(LED)藉由激發綠色磷光體、紅色磷光體或黃色磷光體以獲得白色光源之藍色光源獲得。然而,目前藍色及紅色磷光體之發射峰之全半寬最大值(FWHM)係非常大,通常大於40 nm,從而導致綠色及紅色光譜重疊且致使顏色不可彼此充分區分。此重疊導致差的顯色及色域之劣化。As high-definition large-screen displays have become more common, the demand for higher performance, more compact and highly functional displays has increased. Currently light emitting diodes (LEDs) are obtained by a blue light source that excites a green phosphor, a red phosphor or a yellow phosphor to obtain a white light source. However, the full-width-half-maximum (FWHM) of the emission peaks of current blue and red phosphors is very large, typically greater than 40 nm, causing the green and red spectra to overlap and rendering the colors not sufficiently distinguishable from each other. This overlap results in poor color rendering and degradation of color gamut.

為校正色域之劣化,已開發使用含有量子點之膜與LED組合之方法。然而,量子點遭受各種缺點,包括毒性、低效率、昂貴封裝過程及尺寸均勻性。To correct the degradation of color gamut, methods have been developed using films containing quantum dots in combination with LEDs. However, quantum dots suffer from various disadvantages, including toxicity, low efficiency, expensive packaging process, and dimensional uniformity.

因此,對提高色轉換膜、背光單元及顯示裝置之性能存在需求。Therefore, there is a need to improve the performance of color conversion films, backlight units and display devices.

本文中所述之光致發光複合物可用於提高電視、電腦監視器、智慧裝置及利用顏色顯示器之任何其他裝置中之可區分色之間的對比度。本發明之光致發光複合物包含具有良好藍光吸光度及窄發射帶寬之色轉換染料複合物,其中發射帶之全半寬最大值[FWHM]小於40 nm。於一些實施例中,光致發光複合物吸收第一波長之光及發射第二較第一波長更長之波長之光。本文中所揭示之光致發光複合物可與色轉換膜一起使用用於發光裝置。本發明之色轉換膜藉由減少顏色光譜內之重疊來減少顏色劣化,從而導致高品質顯色。The photoluminescent composites described herein can be used to increase the contrast between distinguishable colors in televisions, computer monitors, smart devices, and any other device that utilizes a color display. The photoluminescent complex of the present invention comprises a color conversion dye complex with good blue light absorbance and narrow emission bandwidth, wherein the full half width maximum [FWHM] of the emission band is less than 40 nm. In some embodiments, the photoluminescent composite absorbs light at a first wavelength and emits light at a second wavelength longer than the first wavelength. The photoluminescent composites disclosed herein can be used with color conversion films for light emitting devices. The color conversion film of the present invention reduces color degradation by reducing overlap within the color spectrum, resulting in high quality color rendering.

一些實施例包含光致發光複合物,其中該光致發光複合物可包含:藍光吸收萘醯亞胺衍生物;包括未經取代之酯、經取代之酯、未經取代之醚或經取代之醚之連接子複合物;及環鎖定之硼-二吡咯甲烷(BODIPY)部分。於一些實施例中,該連接子複合物可將該萘醯亞胺衍生物共價連接至該環鎖定之BODIPY部分。於許多實施例中,該環鎖定之BODIPY部分吸收來自該萘醯亞胺衍生物之第一激發波長之能量及發射第二更高波長之光能量。於各種實施例中,該光致發光複合物具有大於80%之發射量子產率。Some embodiments comprise photoluminescent complexes, wherein the photoluminescent complexes may comprise: blue light absorbing naphthyl imide derivatives; including unsubstituted esters, substituted esters, unsubstituted ethers or substituted a linker complex of ethers; and a ring-locked boron-dipyrromethene (BODIPY) moiety. In some embodiments, the linker complex can covalently link the naphthylimide derivative to the ring-locked BODIPY moiety. In many embodiments, the ring-locked BODIPY moiety absorbs energy from a first excitation wavelength of the naphthylimide derivative and emits light energy at a second, higher wavelength. In various embodiments, the photoluminescent composite has an emission quantum yield greater than 80%.

於一些實施例中,該光致發光複合物可具有具有至多40 nm之全半寬最大值[FWHM]之發射帶。In some embodiments, the photoluminescent composite can have an emission band with a full width half width maximum [FWHM] of at most 40 nm.

於許多實施例中,該光致發光複合物可具有等於或大於45 nm之斯托克斯(Stokes)位移,在藍光吸收部分之激發峰與BODIPY部分之發射峰之間之差異。In many embodiments, the photoluminescent complex can have a Stokes shift equal to or greater than 45 nm, the difference between the excitation peak of the blue light absorbing moiety and the emission peak of the BODIPY moiety.

許多實施例包含色轉換膜,其中該色轉換膜可包含:透明基板層;色轉換層,其中該色轉換層包含樹脂基質;及分散於該樹脂基質內之至少一種如本文中所述之光致發光複合物。於一些實施例中,該色轉換膜可具有1 µm至約200 µm之厚度。於許多實施例中,本發明之色轉換膜可吸收400 nm至約480 nm範圍內之藍光及發射510 nm至約560 nm波長範圍內之光。另一實施例包含色轉換膜,其可吸收400 nm至約480 nm範圍內之藍光及發射580 nm至約670 nm波長範圍內之光。於各種實施例中,該色轉換膜可進一步包含透明基板層。於一些實施例中,該透明基板層可包含兩個相對表面,其中該色轉換層在相對表面中之一者上安置。Many embodiments include a color converting film, wherein the color converting film may comprise: a transparent substrate layer; a color converting layer, wherein the color converting layer comprises a resin matrix; and at least one light as described herein dispersed within the resin matrix Luminescent compound. In some embodiments, the color conversion film may have a thickness of 1 μm to about 200 μm. In many embodiments, the color conversion films of the present invention can absorb blue light in the range of 400 nm to about 480 nm and emit light in the wavelength range of 510 nm to about 560 nm. Another embodiment includes a color conversion film that absorbs blue light in the range of 400 nm to about 480 nm and emits light in the wavelength range of 580 nm to about 670 nm. In various embodiments, the color conversion film may further include a transparent substrate layer. In some embodiments, the transparent substrate layer may include two opposing surfaces, wherein the color converting layer is disposed on one of the opposing surfaces.

於一些實施例中,該色轉換膜可進一步包含單態氧淬滅劑。於一些實施例中,該色轉換膜可進一步包含自由基清除劑。In some embodiments, the color conversion film may further include a singlet oxygen quencher. In some embodiments, the color conversion film may further include a free radical scavenger.

許多實施例包含一種製備色轉換膜之方法,該方法包括:將如本文中所述之光致發光複合物及黏結劑樹脂溶解於溶劑中;及將該混合物施覆至透明基板之相對表面中之一者上。Many embodiments include a method of making a color conversion film, the method comprising: dissolving a photoluminescent composite as described herein and a binder resin in a solvent; and applying the mixture to opposing surfaces of a transparent substrate One of them goes up.

一些實施例包含包含本文中所述之色轉換膜之背光單元。Some embodiments include a backlight unit that includes the color conversion film described herein.

一些實施例包含包含本文中所述之背光單元之顯示裝置。Some embodiments include display devices that include the backlight units described herein.

本申請案提供具有優異色域及發光性質之光致發光複合物;使用光致發光複合物製造色轉換膜之方法,及包含該色轉換膜之背光單元。以下更詳細描述此等及其他實施例。The present application provides a photoluminescent composite having excellent color gamut and luminous properties; a method of manufacturing a color conversion film using the photoluminescent composite, and a backlight unit including the color conversion film. These and other embodiments are described in more detail below.

目前發明係關於用於色轉換膜之光致發光複合物、背光單元及包含該背光單元之顯示裝置。光致發光複合物可用於提高及增強色轉換膜內之一或多個所需發射帶寬之透射。於一些實施例中,該光致發光複合物可增強所需第一發射帶寬之透射及減少第二發射帶寬之透射二者。於一些實施例中,本發明描述可增強兩個顏色之間之對比度或強度,增加其彼此區分之光致發光複合物。The present invention relates to a photoluminescent composite for a color conversion film, a backlight unit and a display device comprising the backlight unit. Photoluminescent composites can be used to increase and enhance the transmission of one or more desired emission bandwidths within the color conversion film. In some embodiments, the photoluminescent composite can both enhance transmission of a desired first emission bandwidth and reduce transmission of a second emission bandwidth. In some embodiments, the present disclosure describes photoluminescent composites that can enhance the contrast or intensity between two colors, increasing their differentiation from each other.

於一些實施例中,硼-二吡咯甲烷(BODIPY)化合物係用作發射材料以替代量子點之使用。BODIPY複合物可具有窄FWHM、高螢光效率、對水分及氧二者之穩定性、及低生產成本。目前BODPY策略具有一些缺點,諸如藍色LED光之低吸收,例如,450 nm,其導致藍色LED光至綠光及紅光之低效轉換,及當用於色轉換膜中時寬FWHM。於一些實施例中,本文中所揭示之BODIPY化合物克服此等限制。In some embodiments, boron-dipyrromethene (BODIPY) compounds are used as emissive materials instead of quantum dots. BODIPY complexes can have narrow FWHMs, high fluorescence efficiency, stability to both moisture and oxygen, and low production costs. Current BODPY strategies have some disadvantages, such as low absorption of blue LED light, eg, 450 nm, which results in inefficient conversion of blue LED light to green and red light, and wide FWHM when used in color conversion films. In some embodiments, the BODIPY compounds disclosed herein overcome these limitations.

如本文中所用,當將化合物或化學結構稱作「經取代」時,該化合物或結構可包含一或多個取代基。經取代之基團衍生自未經取代之母體結構,其中母體結構上之一或多個氫原子獨立地經一或多個取代基置換。於一些實施例中,該等取代基可獨立地為F、Cl、Br、I、C 0-7H 1-15O 1-2N 0-2、C 0-7H 1-15O 0-2N 1-2、視情況經取代之烷基(包括未經取代之烷基,諸如甲基、乙基、C 3烷基、C 4烷基等,氟烷基,例如,CF 3等)、烯基或C 3-7雜烷基。 As used herein, when a compound or chemical structure is referred to as being "substituted," the compound or structure may contain one or more substituents. A substituted group is derived from an unsubstituted parent structure wherein one or more hydrogen atoms on the parent structure are independently replaced by one or more substituents. In some embodiments, the substituents can be independently F, Cl, Br, I, C 0-7 H 1-15 O 1-2 N 0-2 , C 0-7 H 1-15 O 0- 2 N 1-2 , optionally substituted alkyl (including unsubstituted alkyl, such as methyl, ethyl, C 3 alkyl, C 4 alkyl, etc., fluoroalkyl, for example, CF 3 , etc.) , alkenyl or C 3-7 heteroalkyl.

如本文中所用,術語「烷基」係指烴基,其不包含碳-碳雙鍵或三鍵,及包含直鏈、分支鏈或環狀烷基。As used herein, the term "alkyl" refers to a hydrocarbon group that does not contain carbon-carbon double or triple bonds, and that includes linear, branched or cyclic alkyl groups.

「烯烴」部分係指具有至少一個碳-碳雙鍵(-C=C-)及包含直鏈、分支鏈或環狀烯烴部分之基團。An "olefinic" moiety refers to a group having at least one carbon-carbon double bond (-C=C-) and comprising a linear, branched or cyclic olefinic moiety.

「炔烴」部分係指具有至少一個碳-碳三鍵(-C≡C-)及包含直鏈、分支鏈或環狀炔烴部分之基團。An "alkyne" moiety refers to a group having at least one carbon-carbon triple bond (-C≡C-) and comprising a linear, branched or cyclic alkyne moiety.

於一些實施例中,該烷基部分可具有1至6個碳原子(無論其於本文中是否出現),諸如「1至6」之數字範圍係指給定範圍內之各整數:例如,「1至6個碳原子」意指可具有1個碳原子、2個碳原子、3個碳原子等,至多及包含6個碳原子之烷基,雖然本定義亦覆蓋術語「烷基」之出現,其中不指定數字範圍。本文中指定之化合物之烷基可經指定為「C 1-6烷基」或相似指定。僅舉例而言,「C 1-6烷基」指示於烷基鏈中存在1至6個碳原子,即,該烷基鏈為甲基、乙基、丙基、異丙基、正丁基、異丁基、第二丁基或第三丁基等。因此,C 1-6烷基包括(例如) C 1-2烷基、C 3-4烷基、C 4-5烷基或C 5-6烷基。烷基可經取代或未經取代。典型烷基包括(但絕不限於):甲基、乙基、丙基、異丙基、丁基、異丁基、第三丁基、戊基、己基、乙烯基、丙烯基、丁烯基、環丙基、環丁基、環戊基、環己基及類似者。 In some embodiments, the alkyl moiety may have from 1 to 6 carbon atoms (whether or not they appear herein), numerical ranges such as "1 to 6" refer to each integer within the given range: for example, " 1 to 6 carbon atoms" means an alkyl group which may have 1 carbon atom, 2 carbon atoms, 3 carbon atoms, etc., up to and including 6 carbon atoms, although this definition also covers occurrences of the term "alkyl" , where no range of numbers is specified. Alkyl groups of compounds designated herein may be designated as "C 1-6 alkyl" or similar designations. By way of example only, "C 1-6 alkyl" indicates the presence of 1 to 6 carbon atoms in the alkyl chain, i.e., the alkyl chain is methyl, ethyl, propyl, isopropyl, n-butyl , isobutyl, second butyl or third butyl, etc. Thus, C 1-6 alkyl includes, for example, C 1-2 alkyl, C 3-4 alkyl, C 4-5 alkyl or C 5-6 alkyl. Alkyl groups can be substituted or unsubstituted. Typical alkyl groups include (but are by no means limited to): methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, hexyl, vinyl, propenyl, butenyl , cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and the like.

典型烯基包括(但不限於)乙烯基、丙烯基、丁烯基等。Typical alkenyl groups include, but are not limited to, ethenyl, propenyl, butenyl, and the like.

如本文中所用,術語「雜烷基」係指如本文中所定義之烷基,其中構成碳及/或氫原子中之一或多者已經氮、氧或硫置換。實例包括(但不限於) -CH 2-O-CH 3、-CH 2-CH 2-O-CH 3、-CH 2-N(CH 3)-CH 3、-CH 2-CH 2-NH-CH 3、-CH 2-CH 2-N(CH 3)-CH 3、-CH 2-S- CH 2-CH 3、-CH 2-NH-O-CH 3等。 As used herein, the term "heteroalkyl" refers to an alkyl group as defined herein in which one or more of the constituent carbon and/or hydrogen atoms have been replaced by nitrogen, oxygen or sulfur. Examples include, but are not limited to, -CH 2 -O-CH 3 , -CH 2 -CH 2 -O-CH 3 , -CH 2 -N(CH 3 )-CH 3 , -CH 2 -CH 2 -NH- CH 3 , -CH 2 -CH 2 -N(CH 3 )-CH 3 , -CH 2 -S-CH 2 -CH 3 , -CH 2 -NH-O-CH 3 , etc.

術語「芳族」係指具有含有4n+2個π電子之離域π-電子體系之平面環,其中n為整數。芳族環可自五個、六個、七個、八個、九個或超過九個原子形成。芳族環可視情況經取代。術語「芳族」包含碳環芳基(例如,苯基)及雜環芳基(或「雜芳基」或「雜芳族」)基團(例如,吡啶)二者。該術語包含單環或稠合環多環(即,共用相鄰碳原子對之環)基團。The term "aromatic" refers to a planar ring having a delocalized π-electron system containing 4n+2 π electrons, where n is an integer. Aromatic rings can be formed from five, six, seven, eight, nine or more than nine atoms. Aromatic rings can be optionally substituted. The term "aromatic" includes both carbocyclic aryl (eg, phenyl) and heterocyclic aryl (or "heteroaryl" or "heteroaromatic") groups (eg, pyridine). The term includes monocyclic or fused-ring polycyclic (ie, rings that share adjacent pairs of carbon atoms) groups.

術語「烴環」係指含有僅碳及氫及可係飽和之單環或多環環體系。單環碳環包含具有3至12個碳原子之基團。單環基團之說明性實例包括下列部分: 及類似者。 The term "hydrocarbon ring" refers to a monocyclic or polycyclic ring system containing only carbon and hydrogen and which may be saturated. Monocyclic carbocycles include groups having 3 to 12 carbon atoms. Illustrative examples of monocyclic groups include the following moieties: and the like.

多環基團之說明性實例包括下列部分: [雙環辛烷]、 [雙環戊烷]、 [雙環庚烷]、 [雙環庚烷]、 [雙環癸烷]、 [十氫萘]、 [八氫戊烯]、 [八氫茚]、 [六氫茚]、 [1,2,3,4-四氫萘]、 [2,3-二氫-1 H-茚]、 [2’,3’-二氫螺[環戊烷-1,1’-茚]或 [1,2,3,3a-四氫戊烯]。 Illustrative examples of polycyclic groups include the following moieties: [bicyclooctane], [Dicyclopentane], [bicycloheptane], [bicycloheptane], [bicyclodecane], [decalin], [octahydropentene], [octahydroindene], [hexahydroindene], [1,2,3,4-tetrahydronaphthalene], [2,3-dihydro-1 H -indene], [2',3'-Dihydrospiro[cyclopentane-1,1'-indene] or [1,2,3,3a-Tetrahydropentene].

如本文中所用,術語「芳基」意指芳族環,其中形成該環之原子各者為碳原子。芳基環可由五個、六個、七個、八個或超過八個碳原子形成。芳基可經取代或未經取代。芳基之實例包括(但不限於)苯基、萘基、菲基等。As used herein, the term "aryl" means an aromatic ring wherein each of the atoms forming the ring is a carbon atom. Aryl rings can be formed by five, six, seven, eight or more than eight carbon atoms. Aryl groups can be substituted or unsubstituted. Examples of aryl groups include, but are not limited to, phenyl, naphthyl, phenanthrenyl, and the like.

術語「雜芳基」係指包含一或多個選自氮、氧、硫或其組合之環雜原子之芳基,其中該雜芳基於其環體系中具有4至10個原子且限制條件為該基團之環不含有兩個相鄰氮、氧或硫原子。應瞭解,雜芳基環可於環中具有另外雜原子。於具有兩個或更多個雜原子之雜芳基中,彼等兩個或更多個雜原子可係彼此相同或不同。雜芳基可視情況經取代。含N雜芳基部分係指芳基,其中環之骨架原子中之至少一者為氮原子。雜芳基之說明性實例包括下列部分:吡咯、咪唑等。The term "heteroaryl" refers to an aryl group containing one or more ring heteroatoms selected from nitrogen, oxygen, sulfur, or combinations thereof, wherein the heteroaryl has 4 to 10 atoms in its ring system with the proviso that The ring of this group does not contain two adjacent nitrogen, oxygen or sulfur atoms. It is understood that heteroaryl rings may have additional heteroatoms in the ring. In a heteroaryl group having two or more heteroatoms, those two or more heteroatoms may be the same or different from each other. Heteroaryl groups can be optionally substituted. An N-containing heteroaryl moiety refers to an aryl group in which at least one of the skeletal atoms of the ring is a nitrogen atom. Illustrative examples of heteroaryl include the moieties: pyrrole, imidazole, and the like.

如本文中所用,術語「鹵素」意指氟、氯、溴及碘。As used herein, the term "halogen" means fluorine, chlorine, bromine and iodine.

如本文中所用,術語「鍵」、「鍵結」、「直接鍵」或「單鍵」意指兩個原子之間之化學鍵。As used herein, the terms "bond", "bond", "direct bond" or "single bond" mean a chemical bond between two atoms.

如本文中所用,術語「部分」係指分子之特定部分或官能基。化學部分通常經識別為嵌入或附接於分子之化學實體。As used herein, the term "moiety" refers to a specific part or functional group of a molecule. Chemical moieties are generally recognized as chemical entities embedded or attached to molecules.

如本文中所用,術語「氰基」或「腈」係指含有-CN官能基之任何有機化合物。As used herein, the term "cyano" or "nitrile" refers to any organic compound containing a -CN functional group.

術語「酯」係指具有式-COOR之化學部分,其中R為烷基、環烷基、芳基、雜芳基(透過環碳鍵結)或雜環(透過環碳鍵結)。本文中所述化合物上之任何羥基或羧基側鏈可經酯化。製備此酯之程序及特定基團可為任何適宜方法及可於參考資源中容易見到。The term "ester" refers to a chemical moiety having the formula -COOR, where R is alkyl, cycloalkyl, aryl, heteroaryl (bonded through a ring carbon), or heterocycle (bonded through a ring carbon). Any hydroxyl or carboxyl side chains on the compounds described herein may be esterified. Procedures and specific groups for preparing such esters can be by any suitable method and can be readily found in reference sources.

如本文中所用,術語「醚」係指含有連接至兩個烷基或芳基之氧原子之具有R-O-R’之通式的化學部分,其中術語烷基及芳基係如本文中所定義。As used herein, the term "ether" refers to a chemical moiety having the general formula R-O-R' containing an oxygen atom attached to two alkyl or aryl groups, wherein the terms alkyl and aryl are as defined herein .

如本文中所用,術語「酮」係指含有連接至兩個烷基或芳基之羰基(碳-氧雙鍵)之具有RC(=O)R’之通式的化學部分,其中術語烷基及芳基係本文中所定義。As used herein, the term "ketone" refers to a chemical moiety having the general formula RC(=O)R' containing a carbonyl group (carbon-oxygen double bond) attached to two alkyl or aryl groups, where the term alkyl and aryl are as defined herein.

如本文中所用,術語「環鎖定」係指其中化合物中之一或多個系列之原子經連接以形成環的化學結構。環可大小自三個至許多個原子變化(例如,芳族環、碳環環)。As used herein, the term "ring-locked" refers to a chemical structure in which one or more series of atoms in a compound are linked to form a ring. Rings can vary in size from three to many atoms (eg, aromatic rings, carbocyclic rings).

如本文中所用,術語「BODIPY」係指具有下式之化學部分: As used herein, the term "BODIPY" refers to a chemical moiety having the formula: .

BODIPY可由與經二取代之硼原子,通常BF 2單元複合之二吡咯甲烷組成。BODIPY之IUPAC名稱為4,4-二氟-4-硼雜-3a,4a-二氮雜-s-二環戊二烯并苯(indacene)。 BODIPY may consist of dipyrromethane complexed with a disubstituted boron atom, typically a BF2 unit. The IUPAC name of BODIPY is 4,4-difluoro-4-bora-3a,4a-diaza-s-dicyclopentadieneindacene.

如本文中所用,術語「萘醯亞胺」或「萘醯亞胺衍生物」係指具有下式之化學部分: As used herein, the term "naphthyl imide" or "naphthyl imide derivative" refers to a chemical moiety having the formula: .

本發明係關於光致發光複合物,其吸收第一波長之光能量及發射第二更高波長之光能量。本發明之光致發光複合物包含透過連接子偶合之吸收發光部分及發射發光部分使得針對吸收發光部分調整其距離以將其能量轉移至受體發光部分,其中該受體發光部分然後在大於吸收第一波長之第二波長下發射出來。The present invention relates to photoluminescent composites that absorb light energy at a first wavelength and emit light energy at a second, higher wavelength. The photoluminescent complex of the present invention comprises an absorbing luminescent moiety and an emitting luminescent moiety coupled through a linker such that its distance is adjusted for the absorbing luminescent moiety to transfer its energy to the acceptor luminescent moiety, wherein the acceptor luminescent moiety then reacts at a greater than the absorbing luminescent moiety. The first wavelength is emitted at the second wavelength.

一些實施例包含光致發光複合物。於一些實例中,該複合物包含:藍光吸收供體發色團(其中該供體發色團包括萘醯亞胺衍生物)、連接子複合物、及環鎖定之硼-二吡咯甲烷(BODIPY)部分。於一些實施例中,該連接子複合物可將萘醯亞胺衍生物共價連接至環鎖定之BODIPY部分。於一些實例中,該萘醯亞胺衍生物吸收第一激發波長之光及將能量轉移至環鎖定之BODIPY部分,其中該環鎖定之BODIPY部分然後發射第二波長之光能量。據信自激發之萘醯亞胺衍生物至環鎖定之BODIPY部分之能量轉移透過弗爾斯特(Förster)共振能量轉移(FRET)發生。此相信係由於光致發光複合物之吸收/發射光譜,其中存在兩個主要吸收帶,藍光吸收帶(萘醯亞胺衍生物)上之一者及環鎖定之BODIPY吸收帶上之一者,及僅一個發射帶位元於BODIPY部分之發射波長處(參見 12)。 Some embodiments comprise photoluminescent complexes. In some examples, the complex comprises: a blue light-absorbing donor chromophore (wherein the donor chromophore comprises a naphthylimide derivative), a linker complex, and a ring-locked boron-dipyrromethane (BODIPY )part. In some embodiments, the linker complex can covalently link the naphthylimide derivative to the ring-locked BODIPY moiety. In some examples, the naphthyl imide derivative absorbs light at a first excitation wavelength and transfers energy to a ring-locked BODIPY moiety, wherein the ring-locked BODIPY moiety then emits light energy at a second wavelength. It is believed that energy transfer from the excited naphthyl imide derivative to the ring-locked BODIPY moiety occurs via Förster resonance energy transfer (FRET). This is believed to be due to the absorption/emission spectrum of the photoluminescent complex, in which there are two main absorption bands, one on the blue light absorption band (naphthalimide derivative) and one on the ring-locked BODIPY absorption band, and only one emission band bit at the emission wavelength of the BODIPY portion (see Figures 1 and 2 ).

於一個實施例中,該光致發光複合物可具有高發射量子產率。於一些實施例中,該發射量子產率可大於50%、60%、70%、80%及/或90%。於許多實施例中,該發射量子產率可大於50%、或55%、或60%、或65%、或70%、或75%、或80%、或85%、或90%、或95%。發射量子產率可藉由將發射之光子數除以吸收之光子數來量測,其等於發光部分之發射效率。於各種實施例中,吸收發光部分可具有大於80%之發射量子產率。於一些實施例中,該量子產率可大於0.8 (80%)、0.81 (81%)、0.82 (82%)、0.83 (83%)、0.84 (84%)、0.85 (85%)、0.86 (86%)、0.87 (87%)、0.88 (88%)、0.89 (89%)、0.9 (90%)、0.91 (91%)、0.92 (92%)、0.93 (93%)、0.94 (94%)、0.95 (95%)、0.96 (96%)、0.97 (97%)、0.98 (98%),及可上至幾乎100%。膜之量子量測可藉由分光光度計,例如,Quantaurus-QY分光光度計(Hamamatsu, Inc., Campbell, CA, USA)進行。In one embodiment, the photoluminescent composite can have a high emission quantum yield. In some embodiments, the emission quantum yield may be greater than 50%, 60%, 70%, 80%, and/or 90%. In many embodiments, the emission quantum yield may be greater than 50%, or 55%, or 60%, or 65%, or 70%, or 75%, or 80%, or 85%, or 90%, or 95% %. The emission quantum yield can be measured by dividing the number of photons emitted by the number of photons absorbed, which is equal to the emission efficiency of the light-emitting moiety. In various embodiments, the absorbing light-emitting moiety can have an emission quantum yield of greater than 80%. In some embodiments, the quantum yield can be greater than 0.8 (80%), 0.81 (81%), 0.82 (82%), 0.83 (83%), 0.84 (84%), 0.85 (85%), 0.86 ( 86%), 0.87 (87%), 0.88 (88%), 0.89 (89%), 0.9 (90%), 0.91 (91%), 0.92 (92%), 0.93 (93%), 0.94 (94%) ), 0.95 (95%), 0.96 (96%), 0.97 (97%), 0.98 (98%), and can go up to almost 100%. Quantum measurements of films can be performed by a spectrophotometer, eg, Quantaurus-QY spectrophotometer (Hamamatsu, Inc., Campbell, CA, USA).

於一些實施例中,該光致發光複合物具有發射帶,其中該發射帶可具有小於40 nm之全半寬最大值(FWHM)。FWHM為在發射帶之最大發射強度一半之發射強度下之發射帶的寬度,單位奈米。於一些實施例中,該光致發光複合物具有小於或等於約35 nm、小於或等於約30 nm、小於或等於約25 nm、或小於或等於約20 nm之發射帶FWHM值。於一些實施例中,該FWHM為約40 nm至約35 nm、約35 nm至約30 nm、約30 nm至約25 nm、約25 nm至約20 nm、或小於約20 nm。In some embodiments, the photoluminescent composite has an emission band, wherein the emission band can have a full width half width maximum (FWHM) of less than 40 nm. FWHM is the width of the emission band at an emission intensity half of the maximum emission intensity of the emission band, in nanometers. In some embodiments, the photoluminescent composite has an emission band FWHM value of less than or equal to about 35 nm, less than or equal to about 30 nm, less than or equal to about 25 nm, or less than or equal to about 20 nm. In some embodiments, the FWHM is about 40 nm to about 35 nm, about 35 nm to about 30 nm, about 30 nm to about 25 nm, about 25 nm to about 20 nm, or less than about 20 nm.

於一些實施例中,該光致發光複合物可具有等於或大於45 nm之斯托克斯位移。如本文中所用,術語「斯托克斯位移」意指在藍光吸收部分之激發峰與BODIPY部分之發射峰之間之距離。於一些實施例中,斯托克斯位移為至少45 nm。於一些實施例中,光致發光複合物之斯托克斯位移可為約45至50 nm、約50至55 nm、約55至60 nm、約60至65 nm、約65至70 nm、約70至75 nm、約75至80 nm、約80至85 nm、約85至90 nm、約90至95 nm、約95至100 nm、或大於約100 nm,或由此等值中之任一者約束之範圍內的任何數值。In some embodiments, the photoluminescent composite can have a Stokes shift equal to or greater than 45 nm. As used herein, the term "Stokes shift" means the distance between the excitation peak of the blue light absorbing moiety and the emission peak of the BODIPY moiety. In some embodiments, the Stokes shift is at least 45 nm. In some embodiments, the Stokes shift of the photoluminescent complex can be about 45 to 50 nm, about 50 to 55 nm, about 55 to 60 nm, about 60 to 65 nm, about 65 to 70 nm, about 70 to 75 nm, about 75 to 80 nm, about 80 to 85 nm, about 85 to 90 nm, about 90 to 95 nm, about 95 to 100 nm, or greater than about 100 nm, or any of these equivalents Any value within the bounds of those constraints.

於一些實施例中,藍光吸收部分可具有介於約400 nm至約480 nm波長之間之峰吸收最大值。於一些實施例中,該峰吸收波長可介於約400 nm至約405 nm、約405至410 nm、約410至415 nm、約415至420 nm、約420至425 nm、約425至430 nm、約430至435 nm、約435至440 nm、約440至445 nm、約445至450 nm、約450至455 nm、約455至460 nm、約460至465 nm、約465至470 nm、約470至475 nm、約475至480 nm之間,或由此等值中之任一者約束之範圍內的任何波長。In some embodiments, the blue light absorbing moiety can have a peak absorption maximum between a wavelength of about 400 nm to about 480 nm. In some embodiments, the peak absorption wavelength can be between about 400 nm to about 405 nm, about 405 to 410 nm, about 410 to 415 nm, about 415 to 420 nm, about 420 to 425 nm, about 425 to 430 nm , about 430 to 435 nm, about 435 to 440 nm, about 440 to 445 nm, about 445 to 450 nm, about 450 to 455 nm, about 455 to 460 nm, about 460 to 465 nm, about 465 to 470 nm, about Between 470 and 475 nm, between about 475 and 480 nm, or any wavelength within the range bounded by any of these equivalents.

於一些實施例中,藍光吸收部分可具有具有介於約580 nm至約650 nm波長之間之峰吸收最大值之紅色/橙色吸收。於許多實施例中,該峰吸收可於約580 nm至約585 nm、約585至590 nm、約590至595 nm、約595至600 nm、約600至605 nm、約605至610 nm、約610至615 nm、約615至620 nm、約620至625 nm、約625至630 nm、約630至635 nm、約635至640 nm、約640至645 nm、約645至650 nm之範圍內,或由此等值中之任一者約束之範圍內的任何波長。In some embodiments, the blue light absorbing moiety can have red/orange absorption with a peak absorption maximum between wavelengths of about 580 nm to about 650 nm. In many embodiments, the peak absorption can be at about 580 nm to about 585 nm, about 585 to 590 nm, about 590 to 595 nm, about 595 to 600 nm, about 600 to 605 nm, about 605 to 610 nm, about 610 to 615 nm, about 615 to 620 nm, about 620 to 625 nm, about 625 to 630 nm, about 630 to 635 nm, about 635 to 640 nm, about 640 to 645 nm, about 645 to 650 nm, or any wavelength within the range bounded by any of these equivalents.

於一些實施例中,該光致發光複合物可具有介於約590 nm與約660 nm之間之發射峰。於許多實施例中,該發射峰可介於約590 nm至約595 nm、約595至600 nm、約600至605 nm、約605至610 nm、約610至615 nm、約615至620 nm、約620至625 nm、約625至630 nm、約630至635 nm、約635至640 nm、約640至645 nm、約645至650 nm、約650至655 nm、約655至660 nm之間,或由此等值中之任一者約束之範圍內的任何波長。In some embodiments, the photoluminescent complex can have an emission peak between about 590 nm and about 660 nm. In many embodiments, the emission peak can be between about 590 nm to about 595 nm, about 595 to 600 nm, about 600 to 605 nm, about 605 to 610 nm, about 610 to 615 nm, about 615 to 620 nm, Between about 620 to 625 nm, about 625 to 630 nm, about 630 to 635 nm, about 635 to 640 nm, about 640 to 645 nm, about 645 to 650 nm, about 650 to 655 nm, about 655 to 660 nm, or any wavelength within the range bounded by any of these equivalents.

其他實施例包括光致發光複合物,其中透過連接子複合物調整該藍光吸收萘醯亞胺衍生物及BODIPY部分之空間距離用於藍光吸收萘醯亞胺衍生物之能量至BODIPY部分之提高之轉移。Other embodiments include photoluminescent complexes in which the spatial distance between the blue light-absorbing naphthyl imide derivative and the BODIPY moiety is adjusted through a linker complex for the transfer of energy from the blue light absorbing naphthyl imide derivative to the BODIPY moiety transfer.

本發明描述光致發光複合物(PLC),其包含藍光吸收萘醯亞胺衍生物、連接子複合物及環鎖定之BODIPY部分。該連接子複合物將藍光吸收萘醯亞胺衍生物及環鎖定之BODIPY部分共價連接。於一些實施例中,該萘醯亞胺衍生物吸收第一激發波長之光能量及將能量轉移至環鎖定之BODIPY部分,其中該環鎖定之BODIPY部分吸收來自萘醯亞胺衍生物之能量及發射第二更高波長之光能量。於此等實施例中,該光致發光複合物具有大於80%之發射量子產率。The present invention describes a photoluminescent complex (PLC) comprising a blue-light absorbing naphthyl imide derivative, a linker complex, and a ring-locked BODIPY moiety. The linker complex covalently links the blue light absorbing naphthyl imide derivative and the ring-locked BODIPY moiety. In some embodiments, the naphthyl imide derivative absorbs light energy at the first excitation wavelength and transfers the energy to a ring-locked BODIPY moiety, wherein the ring-locked BODIPY moiety absorbs energy from the naphthyl imide derivative and Light energy of a second higher wavelength is emitted. In these embodiments, the photoluminescent composite has an emission quantum yield greater than 80%.

該連接子複合物將藍光吸收萘醯亞胺衍生物與環鎖定之BODIPY部分共價連接。可調整該連接子複合物以調整藍光吸收萘醯亞胺衍生物與環鎖定之BODIPY部分之空間距離。藉由調整環鎖定之萘醯亞胺衍生物與環鎖定之BODIPY之空間距離,可調整量子產率。於一些實施例中,分離藍光吸收萘醯亞胺衍生物及環鎖定之BODIPY部分之距離可為約8 Å或更少。該連接子複合物可維持藍光吸收萘醯亞胺衍生物與環鎖定之BODIPY部分之間之距離。This linker complex covalently links the blue light absorbing naphthyl imide derivative to the ring-locked BODIPY moiety. This linker complex can be tuned to adjust the spatial distance of the blue light absorbing naphthyl imide derivative and the ring-locked BODIPY moiety. The quantum yield can be tuned by adjusting the spatial distance between the ring-locked naphthyl imide derivative and the ring-locked BODIPY. In some embodiments, the distance separating the blue-absorbing naphthimide derivative and the ring-locked BODIPY moiety can be about 8 Å or less. This linker complex maintains the distance between the blue-light absorbing naphthyl imide derivative and the ring-locked BODIPY moiety.

於一些實施例中,該光致發光複合物包含連接子複合物(L),其中該連接子複合物將藍光吸收萘醯亞胺衍生物共價連接至環鎖定之BODIPY部分。於一些實施例中,該連接子複合物可包括萘醯亞胺衍生物與環鎖定之BODIPY部分之間之單鍵。In some embodiments, the photoluminescent complex comprises a linker complex (L), wherein the linker complex covalently links the blue light absorbing naphthyl imide derivative to the ring-locked BODIPY moiety. In some embodiments, the linker complex can include a single bond between the naphthylimide derivative and the ring-locked BODIPY moiety.

於一些實施例中,該連接子複合物可包括未經取代之酯、經取代之酯、未經取代之醚或經取代之醚。於一些實施例中,該連接子複合物可包括視情況經取代之C 2-7酯基。 In some embodiments, the linker complex can include unsubstituted esters, substituted esters, unsubstituted ethers, or substituted ethers. In some embodiments, the linker complex can include optionally substituted C2-7 ester groups.

一些實例包括包含經取代之酯基之連接子複合物,其中該連接子複合物可選自下列結構中之一者: Some examples include linker complexes comprising substituted ester groups, wherein the linker complexes can be selected from one of the following structures: , or .

於一些實施例中,該連接子複合物可包含未經取代之酯基。當連接子複合物包含未經取代之酯基時,該連接子複合物包含下列結構中之一者: In some embodiments, the linker complex can comprise unsubstituted ester groups. When the linker complex comprises an unsubstituted ester group, the linker complex comprises one of the following structures:

於一些實施例中,該連接子複合物可包含未經取代及/或經取代之醚。當連接子複合物包含未經取代及/或經取代之醚時,該連接子複合物包含下列結構中之一者: In some embodiments, the linker complex can comprise unsubstituted and/or substituted ethers. When the linker complex comprises unsubstituted and/or substituted ethers, the linker complex comprises one of the following structures:

目前發明之光致發光複合物可包含環鎖定之BODIPY部分。該環鎖定之BODIPY部分可具有下列通式: 。於一些實施例中,R 1及R 2可為H或C 1-3烷基。於一些實施例中,R 1及R 2可為經取代之芳基部分,其中該芳基部分上之取代基可為C 1-6烷基。於一些實施例中,R 3及R 4可為H、F、Br或-CF 3。於一些實施例中,R 5及R 6可為H、鹵化物(例如,-F、-Cl及/或-Br)、C 1-C 3烷基(例如,-CH 3)、C 1-C 3烷氧基(例如,-OCH 3)。於一些實施例中,X可為C 1-C 3烷基,例如,-CH 2-、-CH 2CH 2-、-CH 2CH 2CH 2-或螺環烷基。 The photoluminescent complexes of the present invention may comprise a ring-locked BODIPY moiety. The BODIPY portion of the ring lock may have the general formula: . In some embodiments, R 1 and R 2 can be H or C 1-3 alkyl. In some embodiments, R and R can be substituted aryl moieties, wherein the substituents on the aryl moiety can be C 1-6 alkyl. In some embodiments, R 3 and R 4 can be H, F, Br or -CF 3 . In some embodiments, R 5 and R 6 can be H, halide (eg, -F, -Cl and/or -Br), C 1 -C 3 alkyl (eg, -CH 3 ), C 1 - C 3 alkoxy (eg, -OCH 3 ). In some embodiments, X can be C 1 -C 3 alkyl, for example, -CH 2 -, -CH 2 CH 2 -, -CH 2 CH 2 CH 2 -, or spirocycloalkyl.

於一些實施例中,R 1為H。 In some embodiments, R 1 is H.

於一些實施例中,R 1為C 1-3烷基。 In some embodiments, R 1 is C 1-3 alkyl.

於一些實施例中,R 2為H。 In some embodiments, R 2 is H.

於一些實施例中,R 2為C 1-3烷基。 In some embodiments, R 2 is C 1-3 alkyl.

於一些實施例中,R 1及R 2為H。 In some embodiments, R 1 and R 2 are H.

於一些實施例中,R 1及R 2為C 1-3烷基。 In some embodiments, R 1 and R 2 are C 1-3 alkyl.

於一些實施例中,R 1為經取代之芳基部分,例如,苯基,其中該芳基部分(例如,苯基)上之取代基可為C 1-6烷基。 In some embodiments, R 1 is a substituted aryl moiety, eg, phenyl, wherein the substituent on the aryl moiety (eg, phenyl) can be C 1-6 alkyl.

於一些實施例中,R 2為經取代之芳基部分,例如,苯基,其中該芳基部分(例如,苯基)上之取代基可為C 1-6烷基。 In some embodiments, R is a substituted aryl moiety, eg, phenyl, wherein the substituent on the aryl moiety (eg, phenyl) can be C 1-6 alkyl.

於一些實施例中,R 1及R 2為經取代之芳基部分,例如,苯基,其中該芳基部分(例如,苯基)上之取代基可為C 1-6烷基。 In some embodiments, R and R are substituted aryl moieties, eg, phenyl, wherein the substituents on the aryl moiety (eg, phenyl) can be C 1-6 alkyl.

於一些實施例中,R 3為H。 In some embodiments, R 3 is H.

於一些實施例中,R 3為F。 In some embodiments, R 3 is F.

於一些實施例中,R 3為Br。 In some embodiments, R 3 is Br.

於一些實施例中,R 3為-CF 3In some embodiments, R 3 is -CF 3 .

於一些實施例中,R 4為H。 In some embodiments, R4 is H.

於一些實施例中,R 4為F。 In some embodiments, R 4 is F.

於一些實施例中,R 4為Br。 In some embodiments, R 4 is Br.

於一些實施例中,R 4為-CF 3In some embodiments, R 4 is -CF 3 .

於一些實施例中,R 3及R 4為H。 In some embodiments, R3 and R4 are H.

於一些實施例中,R 3及R 4為F。 In some embodiments, R3 and R4 are F.

於一些實施例中,R 3及R 4為Br。 In some embodiments, R 3 and R 4 are Br.

於一些實施例中,R 3及R 4為-CF 3In some embodiments, R 3 and R 4 are -CF 3 .

於一些實施例中,R 5為H。 In some embodiments, R 5 is H.

於一些實施例中,R 5為-F。 In some embodiments, R 5 is -F.

於一些實施例中,R 5為-Cl。 In some embodiments, R 5 is -Cl.

於一些實施例中,R 5為-Br。 In some embodiments, R 5 is -Br.

於一些實施例中,R 5為C 1-C 3烷基。 In some embodiments, R 5 is C 1 -C 3 alkyl.

於一些實施例中,R 5為-CH 3In some embodiments, R 5 is -CH 3 .

於一些實施例中,R 5為C 1-C 3烷氧基。 In some embodiments, R 5 is C 1 -C 3 alkoxy.

於一些實施例中,R 5為-OCH 3In some embodiments, R 5 is -OCH 3 .

於一些實施例中,R 6為H。 In some embodiments, R 6 is H.

於一些實施例中,R 6為-F。 In some embodiments, R 6 is -F.

於一些實施例中,R 6為-Cl。 In some embodiments, R 6 is -Cl.

於一些實施例中,R 6為-Br。 In some embodiments, R 6 is -Br.

於一些實施例中,R 6為C 1-C 3烷基。 In some embodiments, R 6 is C 1 -C 3 alkyl.

於一些實施例中,R 6為-CH 3In some embodiments, R 6 is -CH 3 .

於一些實施例中,R 6為C 1-C 3烷氧基。 In some embodiments, R 6 is C 1 -C 3 alkoxy.

於一些實施例中,R 6為-OCH 3In some embodiments, R 6 is -OCH 3 .

於一些實施例中,R 5及R 6為H。 In some embodiments, R 5 and R 6 are H.

於一些實施例中,R 5及R 6為-F。 In some embodiments, R5 and R6 are -F.

於一些實施例中,R 5及R 6為-Cl。 In some embodiments, R5 and R6 are -Cl.

於一些實施例中,R 5及R 6為-Br。 In some embodiments, R 5 and R 6 are -Br.

於一些實施例中,R 5及R 6為C 1-C 3烷基。 In some embodiments, R 5 and R 6 are C 1 -C 3 alkyl.

於一些實施例中,R 5及R 6為-CH 3In some embodiments, R 5 and R 6 are -CH 3 .

於一些實施例中,R 5及R 6為C 1-C 3烷氧基。 In some embodiments, R 5 and R 6 are C 1 -C 3 alkoxy.

於一些實施例中,R 5及R 6為-OCH 3In some embodiments, R 5 and R 6 are -OCH 3 .

於一些實施例中,R 5及R 6可為H、-CH 3、Cl、F或OCH 3In some embodiments, R 5 and R 6 can be H, —CH 3 , Cl, F, or OCH 3 .

於一些實施例中,X為C 1-C 3烷基。 In some embodiments, X is C 1 -C 3 alkyl.

於一些實施例中,X為-CH 2In some embodiments, X is -CH 2 .

於一些實施例中,X為-CH 2CH 2-。 In some embodiments, X is -CH 2 CH 2 -.

於一些實施例中,X為-CH 2CH 2CH 2-。 In some embodiments, X is -CH 2 CH 2 CH 2 -.

於一些實施例中,X為螺環烷基。In some embodiments, X is spirocycloalkyl.

於一些實施例中,L為未經取代之酯。In some embodiments, L is an unsubstituted ester.

於一些實施例中,L為經取代之酯。In some embodiments, L is a substituted ester.

於一些實施例中,L為未經取代之醚。In some embodiments, L is an unsubstituted ether.

於一些實施例中,L為經取代之醚。In some embodiments, L is a substituted ether.

許多實施例包含藍光吸收萘醯亞胺衍生物(Z),其中該藍光吸收萘醯亞胺衍生物可具有下列通式: ,其中Y可為氧(O)或硫(S)。於一些實施例中,R 7及/或R 8可為氫(H)、經取代或未經取代之芳基、或-CF 3。於一些實施例中,R 9可為H、經取代或未經取代之芳基、C 1- 5烷基芳基、經取代或未經取代之芳基羧酸(諸如對CO 2-第三丁基-苯基),或針對R 9不存在取代。 Many embodiments comprise blue light absorbing naphthyl imide derivatives (Z), wherein the blue light absorbing naphthyl imide derivatives may have the following general formula: , where Y can be oxygen (O) or sulfur (S). In some embodiments, R 7 and/or R 8 can be hydrogen (H), substituted or unsubstituted aryl, or -CF 3 . In some embodiments, R 9 can be H, substituted or unsubstituted aryl, C 1-5 alkylaryl, substituted or unsubstituted aryl carboxylic acid (such as for CO 2 -third Butyl-phenyl), or there is no substitution for R9 .

於一些實施例中,Y為氧(O)。In some embodiments, Y is oxygen (O).

於一些實施例中,Y為硫(S)。In some embodiments, Y is sulfur (S).

於一些實施例中,R 7為H。 In some embodiments, R 7 is H.

於一些實施例中,R 7為經取代之芳基。 In some embodiments, R 7 is substituted aryl.

於一些實施例中,R 7為未經取代之芳基。 In some embodiments, R 7 is unsubstituted aryl.

於一些實施例中,R 7為-CF 3In some embodiments, R 7 is -CF 3 .

於一些實施例中,R 8為H。 In some embodiments, R 8 is H.

於一些實施例中,R 8為經取代之芳基。 In some embodiments, R 8 is substituted aryl.

於一些實施例中,R 8為未經取代之芳基。 In some embodiments, R 8 is unsubstituted aryl.

於一些實施例中,R 8為-CF 3In some embodiments, R 8 is -CF 3 .

於一些實施例中,R 7及R 8為H。 In some embodiments, R7 and R8 are H.

於一些實施例中,R 7及R 8為經取代之芳基。 In some embodiments, R7 and R8 are substituted aryl.

於一些實施例中,R 7及R 8為未經取代之芳基。 In some embodiments, R7 and R8 are unsubstituted aryl.

於一些實施例中,R 7及R 8為-CF 3In some embodiments, R 7 and R 8 are -CF 3 .

於一些實施例中,R 9為H。 In some embodiments, R9 is H.

於一些實施例中,R 9為經取代之芳基。 In some embodiments, R 9 is substituted aryl.

於一些實施例中,R 9為未經取代之芳基。 In some embodiments, R 9 is unsubstituted aryl.

於一些實施例中,R 9為C 1- 5烷基芳基。 In some embodiments, R 9 is C 1-5 alkylaryl .

於一些實施例中,R 9為經取代之芳基羧酸。 In some embodiments, R 9 is a substituted arylcarboxylic acid.

於一些實施例中,R 9為未經取代之芳基羧酸。 In some embodiments, R 9 is an unsubstituted arylcarboxylic acid.

於一些實施例中,R 9為對CO 2-第三丁基-苯基。 In some embodiments, R 9 is p-CO 2 -tert-butyl-phenyl.

本發明之光致發光複合物可由下列結構表示,其僅出於說明目的提供,且絕不應解釋為限制: 、或其組合。 The photoluminescent complexes of the present invention can be represented by the following structures, which are provided for illustrative purposes only and should in no way be construed as limiting: , or a combination thereof.

於一些實施例中,該光致發光複合物包含藍光吸收萘醯亞胺衍生物。於一些實例中,該藍光吸收萘醯亞胺衍生物可包含有機發光團。於許多實施例中,該藍光吸收部分可具有約400 nm至約480 nm波長之間之峰吸收最大值。於一些實施例中,該峰吸收可為至少約400 nm、410 nm、420 nm、430 nm、440 nm、450 nm或460 nm。於一些實施例中,該峰吸收可小於約410 nm、420 nm、430 nm、440 nm、450 nm、及460 nm、470 nm或480 nm。於許多實施例中,該光致發光複合物可具有約450 nm之最大峰值吸收。於一些實施例中,該藍光吸收萘醯亞胺衍生物可具有約410 nm之最大峰值吸收及約400 nm之最低最大峰值吸收。仍於許多實施例中,該藍光吸收萘醯亞胺衍生物可具有約480 nm之最大峰值吸收。In some embodiments, the photoluminescent compound comprises a blue light absorbing naphthyl imide derivative. In some examples, the blue light-absorbing naphthyl imide derivative may include an organic luminescent group. In many embodiments, the blue light absorbing moiety can have a peak absorption maximum between a wavelength of about 400 nm to about 480 nm. In some embodiments, the peak absorption can be at least about 400 nm, 410 nm, 420 nm, 430 nm, 440 nm, 450 nm, or 460 nm. In some embodiments, the peak absorption can be less than about 410 nm, 420 nm, 430 nm, 440 nm, 450 nm, and 460 nm, 470 nm, or 480 nm. In many embodiments, the photoluminescent complex can have a peak absorption maximum at about 450 nm. In some embodiments, the blue light-absorbing naphthyl imide derivative may have a maximum peak absorption at about 410 nm and a lowest maximum peak absorption at about 400 nm. Still in many embodiments, the blue light absorbing naphthyl imide derivative can have a maximum peak absorption at about 480 nm.

一些實施例包含色轉換膜,其中該色轉換膜包含:色轉換層,其中該色轉換層包含樹脂基質及分散於該樹脂基質內之上述光致發光複合物。於許多實施例中,該色轉換膜可包含本文中所述之光致發光複合物中之一或多者。Some embodiments include a color conversion film, wherein the color conversion film comprises: a color conversion layer, wherein the color conversion layer comprises a resin matrix and the aforementioned photoluminescent composite dispersed within the resin matrix. In many embodiments, the color conversion film can comprise one or more of the photoluminescent composites described herein.

一些實施例包含色轉換膜,其可為約1 µm至約200 µm厚。於許多實施例中,該色轉換膜可經描述為約1 µm至約5 µm厚、約5 µm至約10 µm厚、約10 µm至約15 µm厚、約15 µm至約20 µm厚、約20 µm至約40 µm厚、約40 µm至約80 µm厚、約80 µm至約120 µm厚、約120 µm至約160 µm厚、約160 µm至約200 µm厚,或由以上範圍約束之任何厚度。Some embodiments include a color conversion film, which can be from about 1 μm to about 200 μm thick. In many embodiments, the color conversion film can be described as about 1 µm to about 5 µm thick, about 5 µm to about 10 µm thick, about 10 µm to about 15 µm thick, about 15 µm to about 20 µm thick, About 20 µm to about 40 µm thick, about 40 µm to about 80 µm thick, about 80 µm to about 120 µm thick, about 120 µm to about 160 µm thick, about 160 µm to about 200 µm thick, or bound by the above range of any thickness.

於一些實施例中,該色轉換膜可吸收約400 nm至約480 nm波長之範圍內之光及可發射約590 nm至約660 nm之範圍內之光。In some embodiments, the color conversion film can absorb light in a wavelength range from about 400 nm to about 480 nm and can emit light in a wavelength range from about 590 nm to about 660 nm.

於一些實施例中,該色轉換膜可進一步包含透明基板層。該透明基板層具有兩個相對表面,其中該色轉換層可在鄰近發光源之透明層表面上及與之物理接觸安置。該透明基板不受特別限制及熟習此項技術者能自用於此項技術中之彼等選擇透明基板。透明基板之一些非限制性實例包括PE (聚乙烯)、PP (聚丙烯)、PEN (聚萘二甲酸乙二醇酯)、PC (聚碳酸酯)、PMA (聚丙烯酸甲酯)、PMMA (聚甲基丙烯酸甲酯)、CAB (乙酸丁酸纖維素)、PVC (聚氯乙烯)、PET (聚對苯二甲酸乙二醇酯)、PETG (經乙二醇修飾之聚對苯二甲酸乙二醇酯)、PDMS (聚二甲基矽氧烷)、COC (環烯烴共聚物)、PGA (聚甘醇酸或聚乙醇酸)、PLA (聚乳酸)、PCL (聚己內酯)、PEA (聚己二酸乙二醇酯)、PHA (聚羥基烷酸酯)、PHBV (聚(3-羥基丁酸酯共聚3-羥基戊酸酯))、PBE (聚對苯二甲酸丁二醇酯)、PTT (聚對苯二甲酸三亞甲基酯)。以上提及之樹脂中之任一者可為對應各自單體及/或聚合物。In some embodiments, the color conversion film may further include a transparent substrate layer. The transparent substrate layer has two opposing surfaces, wherein the color conversion layer can be disposed on and in physical contact with the surface of the transparent layer adjacent to the light emitting source. The transparent substrate is not particularly limited and those skilled in the art can select the transparent substrate from those used in the art. Some non-limiting examples of transparent substrates include PE (polyethylene), PP (polypropylene), PEN (polyethylene naphthalate), PC (polycarbonate), PMA (polymethyl acrylate), PMMA ( Polymethyl methacrylate), CAB (cellulose acetate butyrate), PVC (polyvinyl chloride), PET (polyethylene terephthalate), PETG (polyethylene terephthalate modified with ethylene glycol) glycol ester), PDMS (polydimethylsiloxane), COC (cycloolefin copolymer), PGA (polyglycolic acid or polyglycolic acid), PLA (polylactic acid), PCL (polycaprolactone) , PEA (polyethylene adipate), PHA (polyhydroxyalkanoate), PHBV (poly(3-hydroxybutyrate copolymer 3-hydroxyvalerate)), PBE (polybutylene terephthalate glycol esters), PTT (polytrimethylene terephthalate). Any of the above-mentioned resins may be the corresponding respective monomers and/or polymers.

於一些實施例中,該透明基板可具有兩個相對表面。於許多實施例中,該色轉換膜可在相對表面中之一者上及與之物理接觸安置。於一些實施例中,其上未安置色轉換膜之透明基板之側可鄰近光源。基板可在製備色轉換膜之材料期間作為支撐物起作用。所用基板之類型不受特別限制,及材料及/或厚度不受限制,只要其係透明且能作為支撐物起作用。熟習此項技術者可確定哪種材料及厚度用作支撐基板。In some embodiments, the transparent substrate may have two opposite surfaces. In many embodiments, the color converting film can be disposed on and in physical contact with one of the opposing surfaces. In some embodiments, the side of the transparent substrate on which the color conversion film is not disposed may be adjacent to the light source. The substrate can function as a support during the preparation of the material for the color conversion film. The type of substrate used is not particularly limited, and the material and/or thickness are not limited as long as it is transparent and functions as a support. Those skilled in the art can determine which material and thickness to use for the support substrate.

一些實施例包含一種製備色轉換膜之方法,其中該方法包括:將本文中所述之光致發光化合物及黏結劑樹脂溶解於溶劑中;及將該混合物施覆至透明基板表面。Some embodiments include a method of making a color conversion film, wherein the method includes: dissolving a photoluminescent compound and a binder resin described herein in a solvent; and applying the mixture to a surface of a transparent substrate.

可與該(等)光致發光複合物一起使用之黏結劑樹脂包括樹脂,諸如丙烯酸樹脂、聚碳酸酯樹脂、乙烯-乙烯基醇共聚物樹脂、乙烯-乙酸乙烯酯共聚物樹脂及其皂化產物、AS樹脂、聚酯樹脂、氯乙烯-乙酸乙烯酯共聚物樹脂、聚乙烯基丁縮醛樹脂、聚乙烯基磷酸(PVPA)、聚苯乙烯樹脂、酚醛樹脂、苯氧基樹脂、聚碸、尼龍、纖維素樹脂及乙酸纖維素樹脂。於一些實施例中,該黏結劑樹脂可為聚酯樹脂及/或丙烯酸樹脂。Binder resins that can be used with the photoluminescent composite(s) include resins such as acrylic resins, polycarbonate resins, ethylene-vinyl alcohol copolymer resins, ethylene-vinyl acetate copolymer resins, and saponified products thereof , AS resin, polyester resin, vinyl chloride-vinyl acetate copolymer resin, polyvinyl butyral resin, polyvinyl phosphonic acid (PVPA), polystyrene resin, phenolic resin, phenoxy resin, polystyrene, Nylon, cellulose resin and cellulose acetate resin. In some embodiments, the binder resin may be polyester resin and/or acrylic resin.

可用於溶解或分散複合物及樹脂之溶劑可包括烷烴,諸如丁烷、戊烷、己烷、庚烷及辛烷;環烷烴,諸如環戊烷、環己烷、環庚烷及環辛烷;醇,諸如乙醇、丙醇、丁醇、戊醇、己醇、庚醇、辛醇、癸醇、十一醇、二丙酮醇及呋喃醇;Cellosolves TM,諸如甲基Cellosolve TM、乙基Cellosolve TM、丁基Cellosolve TM、甲基Cellosolve TM乙酸酯及乙基Cellosolve TM乙酸酯;丙二醇及其衍生物,諸如丙二醇單甲醚、丙二醇單乙醚乙酸酯、丙二醇單乙醚乙酸酯、丙二醇單丁醚乙酸酯、及二丙二醇二甲醚;酮,諸如丙酮、甲基戊基酮、環己酮及苯乙酮;醚,諸如二噁烷及四氫呋喃;酯,諸如乙酸丁酯、乙酸戊酯、丁酸乙酯、丁酸丁酯、草酸二乙酯、丙酮酸乙酯、2-羥基丁酸乙酯、乙醯乙酸乙酯、乳酸甲酯、乳酸乙酯及3-甲氧基丙酸甲酯;鹵代烴,諸如氯仿、氯甲烷及四氯乙烷;芳族烴,諸如苯、甲苯、二甲苯及甲酚;及高極性溶劑,諸如二甲基甲醯胺、二甲基乙醯胺及N-甲基吡咯啶酮。 Solvents that can be used to dissolve or disperse the compound and resin can include alkanes such as butane, pentane, hexane, heptane, and octane; cycloalkanes such as cyclopentane, cyclohexane, cycloheptane, and cyclooctane ; Alcohols, such as ethanol, propanol, butanol, pentanol, hexanol, heptanol, octanol, decyl alcohol, undecyl alcohol, diacetone alcohol and furyl alcohol; Cellosolves TM , such as methyl Cellosolve TM , ethyl Cellosolve TM , Butyl Cellosolve TM , Methyl Cellosolve TM Acetate and Ethyl Cellosolve TM Acetate; Propylene Glycol and its derivatives such as Propylene Glycol Monomethyl Ether, Propylene Glycol Monoethyl Ether Acetate, Propylene Glycol Monoethyl Ether Acetate, Propylene Glycol Monobutyl ether acetate, and dipropylene glycol dimethyl ether; ketones, such as acetone, methyl amyl ketone, cyclohexanone, and acetophenone; ethers, such as dioxane and tetrahydrofuran; esters, such as butyl acetate, acetic acid Amyl Butyrate, Butyl Butyrate, Diethyl Oxalate, Ethyl Pyruvate, Ethyl 2-Hydroxybutyrate, Ethyl Acetate, Methyl Lactate, Ethyl Lactate and 3-Methoxy methyl propionate; halogenated hydrocarbons such as chloroform, methyl chloride and tetrachloroethane; aromatic hydrocarbons such as benzene, toluene, xylene and cresol; and highly polar solvents such as dimethylformamide, dimethyl Acetamide and N-methylpyrrolidone.

一些實施例包含背光單元。於一些實例中,該背光單元可包含以上提及之色轉換膜,該色轉換膜包含本文中所述之該(等)光致發光複合物。Some embodiments include a backlight unit. In some examples, the backlight unit may comprise the above-mentioned color conversion film comprising the photoluminescent composite(s) described herein.

其他實施例可包含顯示裝置,其中該裝置可包含本文中所述之背光單元。Other embodiments may include a display device, where the device may include a backlight unit as described herein.

除非另有指定,否則用於本說明書及實施例中之表述成分、性質(諸如分子量)、反應條件等等之數量之所有數字應理解為於所有實例中經術語「約」修飾。因此,除非相反指定,否則本說明書及附接實施例中闡述之數字參數為近似值,其可取決於尋求獲得之所需性質變化。至少及不作為限制等效物之教條至實施例之範圍之應用的嘗試,各數位參數應至少根據報告之有效數字之數位及藉由應用習知及普通圓整技術解釋。Unless otherwise specified, all numbers expressing quantities of ingredients, properties (such as molecular weights), reaction conditions, etc. used in the specification and examples are to be understood as modified by the term "about" in all instances. Accordingly, unless specified to the contrary, the numerical parameters set forth in the specification and accompanying examples are approximations that may vary depending upon the desired properties sought to be obtained. At least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the embodiments, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying commonly known and ordinary rounding techniques.

針對所揭示之製程及/或方法,於製程及方法中進行之功能可以不同順序實施,如可由上下文指示。此外,概述之步驟及操作僅作為實例提供及該等步驟及操作中之一些可係視情況可選,經組合至幾個步驟及操作,或擴展至另外步驟及操作。For the disclosed processes and/or methods, the functions performed in the processes and methods may be performed in a different order, as may be dictated by the context. Furthermore, the steps and operations outlined are provided as examples only and some of these steps and operations may be optionally combined into several steps and operations, or extended to additional steps and operations.

本發明有時可說明其他不同組分內包含或與其他不同組分關聯之不同組分。此等描述之架構僅為實例,及可實施許多其他架構以達成相同或相似功能。The invention may sometimes describe different components contained within or associated with other different components. These described architectures are examples only, and many other architectures can be implemented to achieve the same or similar functionality.

用於本發明及隨附實施例(例如,隨附實施例之體)中之術語一般意欲作為「開放」術語(例如,術語「包含(including)」應解釋為「包括但不限於」,術語「具有」應解釋為「具有至少」,術語「包含(includes)」應解釋為「包括但不限於」等),此外,若引入要素之特定數目,則此可解釋為意指至少詳述數字,如可由上下文指示(例如,「兩個詳述」而無其他修飾之光禿詳述意指至少兩個詳述或兩個或更多個詳述)。如本發明中所用,表示兩個或更多個替代術語之任何轉折性詞語及/或短語應理解為考慮包含彼等術語中之一者、該等術語中之任一者或兩個術語之可能性。例如,短語「A或B」應理解為包含「A」或「B」或「A及B」之可能性。相似地,短語「A及/或B」應理解為包含「A」或「B」或「A及B」之可能性。The terms used in this disclosure and in the accompanying examples (eg, body of the accompanying examples) are generally intended as "open" terms (eg, the term "including" should be interpreted as "including but not limited to", the term "Has" should be interpreted as "having at least", the term "includes" should be interpreted as "including but not limited to", etc.), and furthermore, if a specific number of elements is introduced, this can be interpreted as meaning at least the recited number , as may be dictated by the context (eg, "two recitations" without other modifications of a bare recitation means at least two recitations or two or more recitations). As used herein, any transitional word and/or phrase denoting two or more alternative terms should be understood to include one of those terms, either of those terms, or both terms possibility. For example, the phrase "A or B" should be understood to include the possibilities of "A" or "B" or "A and B." Similarly, the phrase "A and/or B" should be understood to include the possibilities of "A" or "B" or "A and B".

除非本文中另有指定或由上下文明確反駁,否則用於描述本發明之背景下(尤其於下列實施例之背景下)之術語「一(a/an)」及「該」及相似提及物應解釋為覆蓋單數及複數二者。本文中提供之任何及所有實例或代表性語言(例如,「諸如」或「例如」)之使用僅意欲更好說明本發明且不對任何實施例之範圍施加限制。本文中本說明書中之語言不應解釋為指示對實踐本發明必不可少之任何未具體化之要素。Unless otherwise specified herein or clearly contradicted by context, the terms "a/an" and "the" and similar references are used to describe the context of the invention, especially in the context of the following examples It should be construed to cover both the singular and the plural. The use of any and all examples, or representative language (eg, "such as" or "such as") provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of any embodiment. No language in the specification herein should be construed as indicating any non-specified element as essential to the practice of the invention.

本文中所揭示之替代要素或實施例之分組不應解釋為限制。各組成員可個別或以與該組之其他成員或本文中見到之其他要素之任何組合提及及具體化。出於方便及/或可專利性之原因,期望組之一或多個成員可包含於組中或自組刪除。當任何此納入或刪除發生時,認為本說明書含有所修改之組,因此滿足用於隨附實施例中之所有馬庫什(Markush)組之書面描述。Groupings of alternative elements or embodiments disclosed herein should not be construed as limitations. Each group member may be referred to and embodied individually or in any combination with other members of the group or other elements found herein. It is contemplated that one or more members of a group may be included in or deleted from the group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is deemed to contain the group as modified, thus satisfying the written description for all Markush groups in the accompanying examples.

本文中描述某些實施例,包含為發明者已知之用於進行本發明之最佳模式。當然,此等所述實施例之變型將在閱讀上述描述後對一般技術者變得顯然。本發明者期望熟習技工酌情採用此等變型,及本發明者意欲實踐本發明,除非本文中特定描述。因此,該等實施例由適用法律預許可。此外,除非本文中另有指定或上下文另有明確反駁,否則考慮上述要素於其所有可能變型中之任何組合。最後,應瞭解本文中所揭示之實施例說明該等實施例之原則。因此,舉例而言,但非限制性,可根據本文中教示利用替代實施例。因此,該等實施例不限於如本文中精確所示及所述之實施例。Certain embodiments are described herein, including the best mode known to the inventors for carrying out the invention. Of course, variations of those described embodiments will become apparent to those of ordinary skill upon reading the foregoing description. The inventors expect skilled artisans to employ such modifications as appropriate, and the inventors intend for the invention to be practiced unless specifically described herein. Accordingly, these examples are pre-licensed by applicable law. Moreover, unless otherwise indicated herein or otherwise clearly contradicted by context, any combination of the above-described elements in all possible variations thereof is contemplated. In conclusion, it should be understood that the embodiments disclosed herein illustrate the principles of such embodiments. Thus, by way of example, and not limitation, alternative embodiments may be utilized in light of the teachings herein. Accordingly, the embodiments are not limited to what is precisely shown and described herein.

實施例實施例1. 一種光致發光複合物,其包含: 藍光吸收供體發色團,其中該供體發色團包含萘醯亞胺衍生物; 連接子複合物;及 環鎖定之硼-二吡咯甲烷(BODIPY)部分; 其中該連接子複合物將具有該萘醯亞胺衍生物之該供體發色團及該環鎖定之BODIPY部分共價連接,其中該萘醯亞胺衍生物吸收第一激發波長之藍光能量及將能量轉移至該環鎖定之BODIPY部分,其中該環鎖定之BODIPY部分吸收來自該萘醯亞胺衍生物之能量及發射第二更高波長之光能量,且其中該光致發光複合物具有大於80%之發射量子產率。 EXAMPLES Example 1. A photoluminescent complex comprising: a blue light absorbing donor chromophore, wherein the donor chromophore comprises a naphthyl imide derivative; a linker complex; and a ring-locked boron- Dipyrromethane (BODIPY) moiety; wherein the linker complex covalently links the donor chromophore with the naphthyl imide derivative and the ring-locked BODIPY moiety, wherein the naphthyl imide derivative absorbs Excite blue light energy at a first wavelength and transfer energy to the ring-locked BODIPY moiety, wherein the ring-locked BODIPY moiety absorbs energy from the naphthylimide derivative and emits light energy at a second higher wavelength, and wherein The photoluminescent composite has an emission quantum yield greater than 80%.

實施例2. 如實施例1之光致發光複合物,其中該供體發色團之該萘醯亞胺衍生物具有以下通式: ,其中Y選自氧(O)或硫(S);其中R 7及R 8獨立地選自氫(H)、經取代或未經取代之芳基、或-CF 3;且其中R 9獨立地選自氫(H)、經取代或未經取代之芳基、C 1-C 5烷基,或針對R 9不存在取代。 Embodiment 2. The photoluminescent complex as in embodiment 1, wherein the naphthyl imide derivative of the donor chromophore has the following general formula: , wherein Y is selected from oxygen (O) or sulfur (S); wherein R 7 and R 8 are independently selected from hydrogen (H), substituted or unsubstituted aryl, or -CF 3 ; and wherein R 9 is independently is selected from hydrogen (H), substituted or unsubstituted aryl, C 1 -C 5 alkyl, or there is no substitution for R 9 .

實施例3. 如實施例1之光致發光複合物,其中該環鎖定之BODIPY部分具有以下通式: ,其中R 1及R 2獨立地選自H或C 1-C 3烷基;其中R 3及R 4獨立地選自H、F、Br、-CF 3或連接至L-Z之鍵;其中R 5及R 6獨立地選自H、C 1-C 3烷基、鹵化物或C 1-C 3烷氧基;且其中X獨立地選自C 1-C 3烷基、-CH 2CH 2-、-CH 2CH 2CH 2-或螺環烷基。 Embodiment 3. The photoluminescent complex as in embodiment 1, wherein the ring-locked BODIPY moiety has the general formula: , wherein R 1 and R 2 are independently selected from H or C 1 -C 3 alkyl; wherein R 3 and R 4 are independently selected from H, F, Br, -CF 3 or a bond connected to LZ; wherein R 5 and R 6 is independently selected from H, C 1 -C 3 alkyl, halide or C 1 -C 3 alkoxy; and wherein X is independently selected from C 1 -C 3 alkyl, -CH 2 CH 2 - , -CH 2 CH 2 CH 2 - or spirocycloalkyl.

實施例4. 如實施例3之光致發光複合物,其中L為連接子複合物,其可為經取代之酯、未經取代之酯、經取代之醚或未經取代之醚。 Example 4. As in the photoluminescent complex of Example 3, wherein L is a linker complex, which can be a substituted ester, an unsubstituted ester, a substituted ether or an unsubstituted ether.

實施例5. 如實施例3之光致發光複合物,其中Z為包含萘醯亞胺衍生物之供體發色團。 Example 5. The photoluminescent complex as in Example 3, wherein Z is a donor chromophore comprising a naphthylimide derivative.

實施例6. 如實施例1或4之光致發光複合物,其中該連接子複合物為未經取代之酯;其中該未經取代之酯包括下列結構中之一者: Embodiment 6. The photoluminescent complex as in embodiment 1 or 4, wherein the linker complex is an unsubstituted ester; wherein the unsubstituted ester includes one of the following structures:

實施例7. 如實施例1或4之光致發光複合物,其中該連接子複合物為經取代之酯;其中該經取代之酯包括下列結構中之一者: Embodiment 7. The photoluminescent complex as in embodiment 1 or 4, wherein the linker complex is a substituted ester; wherein the substituted ester comprises one of the following structures: , or .

實施例8. 如實施例1或4之光致發光複合物,其中該連接子複合物為未經取代及/或經取代之醚;其中該未經取代及/或經取代之醚包括下列結構中之一者: Embodiment 8. The photoluminescent complex as in embodiment 1 or 4, wherein the linker complex is an unsubstituted and/or substituted ether; wherein the unsubstituted and/or substituted ether includes the following structure one of:

實施例9. 如請求項1、2、3、4、5、6、7或8之光致發光複合物,其中該光致發光複合物包括下列結構中之一者: 、或其任何組合。 Embodiment 9. The photoluminescent compound according to claim 1, 2, 3, 4, 5, 6, 7 or 8, wherein the photoluminescent compound comprises one of the following structures: , or any combination thereof.

實施例10. 一種色轉換膜,其包含: 透明基板層; 色轉換層,其中該色轉換層包含樹脂基質;及 分散於該樹脂基質內之至少一種光致發光複合物,其中該至少一種光致發光複合物包含如實施例1、2、3、4、5、6、7、8或9中之光致發光複合物。 Example 10. A color conversion film comprising: Transparent substrate layer; a color conversion layer, wherein the color conversion layer comprises a resin matrix; and At least one photoluminescent compound dispersed in the resin matrix, wherein the at least one photoluminescent compound comprises the photoluminescent compound as in embodiment 1, 2, 3, 4, 5, 6, 7, 8 or 9 Complex.

實施例11. 如實施例10之色轉換膜,其進一步包含單態氧淬滅劑。 Example 11. As in the color conversion film of Embodiment 10, it further comprises a singlet oxygen quencher.

實施例12. 如實施例10之色轉換膜,其進一步包含自由基清除劑。 Example 12. As in the color conversion film of Example 10, it further comprises a free radical scavenger.

實施例13. 如實施例10之色轉換膜,其中該膜具有介於10 µm與200 µm之間之厚度。 Example 13. The color conversion film of embodiment 10, wherein the film has a thickness between 10 μm and 200 μm.

實施例14. 如實施例10之色轉換膜,其中該膜吸收約400 nm至約480 nm波長範圍內之光及發射約590 nm至約650 nm波長範圍內之光。 Example 14. The color conversion film of Example 10, wherein the film absorbs light within a wavelength range of about 400 nm to about 480 nm and emits light within a wavelength range of about 590 nm to about 650 nm.

實施例15. 一種製備如實施例10、11、12、13或14之色轉換膜之方法,該方法包括: 將如實施例1、2、3、4、5、6、7、8或9之光致發光複合物及黏結劑樹脂溶解於溶劑中;及 將該混合物施覆至透明基板相對表面中之一者。 Example 15. A method for preparing a color conversion film as in embodiment 10, 11, 12, 13 or 14, the method comprising: Dissolving the photoluminescent composite and binder resin as in Example 1, 2, 3, 4, 5, 6, 7, 8 or 9 in a solvent; and The mixture is applied to one of the opposing surfaces of the transparent substrate.

實施例16. 一種背光單元,其包含如實施例10、11、12、13或14之色轉換膜。 Example 16. A backlight unit comprising the color conversion film of Embodiment 10, 11, 12, 13 or 14.

實施例17. 一種顯示裝置,其包含如實施例16之背光單元。 Example 17. A display device comprising the backlight unit of Embodiment 16.

實例已發現本文中所述之光致發光複合物之實施例如與用於色轉換膜中之其他形式之染料相比具有改善之性能。此等效益藉由下列實例進一步證實,該等實例意欲說明本發明但是不意欲以任何方式限制範圍或潛在原則。 EXAMPLES Embodiments of the photoluminescent composites described herein have been found to have improved performance, for example, compared to other forms of dyes used in color conversion films. These benefits are further demonstrated by the following examples, which are intended to illustrate the invention but are not intended to limit the scope or underlying principles in any way.

下列實例為如本文中所述之萘醯亞胺衍生物(即,藍光吸收中間體)之許多實施例之合成程序:The following examples are synthetic procedures for many embodiments of naphthyl imide derivatives (ie, blue light absorbing intermediates) as described herein:

實例 1 (Ex-1) Ex-1.1:將2-硝基苯酚(6.6 g,48 mmol)、KOH粉末(2.4 g,43 mmol)之混合物混合及在真空下攪拌30分鐘,然後添加銅粉(0.4 g),接著100 mL無水DMF。將混合物攪拌5分鐘,然後添加4-氯酞酸酐(5.1g,22 mmol)。將整體脫氣,然後在回流下加熱1.5小時。於冷卻至室溫後,將100 mL 20%鹽酸逐滴添加至所得反應混合物中,允許將其靜置2小時。藉由過濾收集沉澱物,然後在真空下乾燥過夜,以得到黃棕色固體(4.6 g)。將其藉由於回流乙酸(50 mL)中攪拌1小時,然後冷卻至室溫來進一步純化。過濾及於空氣中乾燥,得到黃色固體(3.0 g,41%產率)。藉由LCMS (APCI)證實:針對C 18H 10NO 6(M+H)計算值:336.0;實測值:336。 1H NMR (400 MHz,氯仿- d) δ 8.80 (dd, J= 8.5, 1.2 Hz, 1H), 8.72 (dd, J= 7.3, 1.2 Hz, 1H), 8.50 (d, J= 8.2 Hz, 1H), 8.19 (dd, J= 8.2, 1.7 Hz, 1H), 7.90 (dd, J= 8.5, 7.3 Hz, 1H), 7.79 (td, J= 7.9, 1.7 Hz, 1H), 7.54 (td, J= 8.0, 1.3 Hz, 1H), 7.39 (dd, J= 8.3, 1.2 Hz, 1H), 6.89 (d, J= 8.2 Hz, 1H)。 Example 1 (Ex-1) : Ex-1.1 : A mixture of 2-nitrophenol (6.6 g, 48 mmol), KOH powder (2.4 g, 43 mmol) was mixed and stirred under vacuum for 30 minutes, then copper powder (0.4 g) was added, followed by 100 mL Anhydrous DMF. The mixture was stirred for 5 minutes, then 4-chlorophthalic anhydride (5.1 g, 22 mmol) was added. The whole was degassed and then heated at reflux for 1.5 hours. After cooling to room temperature, 100 mL of 20% hydrochloric acid was added dropwise to the resulting reaction mixture, which was allowed to stand for 2 hours. The precipitate was collected by filtration, then dried under vacuum overnight to give a yellow-brown solid (4.6 g). It was further purified by stirring in refluxing acetic acid (50 mL) for 1 hour, then cooled to room temperature. Filtration and air drying afforded a yellow solid (3.0 g, 41% yield). Confirmed by LCMS (APCI): Calcd. for C18H10NO6 (M+H): 336.0; found: 336 . 1 H NMR (400 MHz, chloroform- d ) δ 8.80 (dd, J = 8.5, 1.2 Hz, 1H), 8.72 (dd, J = 7.3, 1.2 Hz, 1H), 8.50 (d, J = 8.2 Hz, 1H ), 8.19 (dd, J = 8.2, 1.7 Hz, 1H), 7.90 (dd, J = 8.5, 7.3 Hz, 1H), 7.79 (td, J = 7.9, 1.7 Hz, 1H), 7.54 (td, J = 8.0, 1.3 Hz, 1H), 7.39 (dd, J = 8.3, 1.2 Hz, 1H), 6.89 (d, J = 8.2 Hz, 1H).

Ex-1.2 將含於乙酸(75 mL)中之4-(2-硝基苯氧基)-1,8-萘酸酐(2.0 g,6 mmol)及鐵粉(<10 μm,0.91 g,16 mmol)之混合物加熱至回流持續30分鐘。將所得溶液倒入水(220 mL)中。藉由過濾收集所得沉澱物,然後用水洗滌及於空氣中徹底乾燥,然後放在真空下,以得到黃色固體(1.65 g,90%產率)。藉由LCMS (APCI)證實:針對C 18H 12NO 4(M+H)計算值:306.1;實測值:306。 Ex-1.2 : 4-(2-nitrophenoxy)-1,8-naphthoic anhydride (2.0 g, 6 mmol) and iron powder (<10 μm, 0.91 g, 16 mmol) of the mixture was heated to reflux for 30 minutes. The resulting solution was poured into water (220 mL). The resulting precipitate was collected by filtration, washed with water and dried thoroughly in air, then placed under vacuum to give a yellow solid (1.65 g, 90% yield). Confirmed by LCMS (APCI): Calcd. for C18H12NO4 (M+H): 306.1 ; found: 306.

Ex-1.3 將化合物4-(2-胺基苯氧基)-1,8-萘酸酐(1.5 g,4.9 mmol)分散於乙酸(35 mL)中及冷卻至0℃。當攪拌時,添加經預冷卻之鹽酸(3 mL,37 mmol),然後在0℃下逐滴添加含於12 mL水中之亞硝酸鈉溶液(3.29 g,46 mmol)。將整體在0℃下攪拌一小時,然後轉移至添加漏斗中,及歷時1小時時間滴入回流硫酸銅溶液(5.08 g,20 mmol,於50 mL水中)中。於冷卻至室溫後,藉由過濾收集沉澱物,用水及丙酮洗滌,然後於空氣中乾燥,然後於真空中乾燥,以得到黃色固體(0.92 g,65%產率)。藉由LCMS (APCI)證實:針對C 18H 8O 4(M-)計算值:288.0;實測值:288。 1H NMR (400 MHz,氯仿- d) δ 8.61 (dd, J= 17.1, 8.1 Hz, 2H), 8.09 (d, J= 8.0 Hz, 1H), 7.97 (d, J= 7.9 Hz, 1H), 7.59 (t, J= 7.7 Hz, 1H), 7.40 (t, J= 8.1 Hz, 2H), 7.33 (d, J= 8.4 Hz, 1H)。 Ex-1.3 : Compound 4-(2-aminophenoxy)-1,8-naphthoic anhydride (1.5 g, 4.9 mmol) was dispersed in acetic acid (35 mL) and cooled to 0°C. While stirring, pre-cooled hydrochloric acid (3 mL, 37 mmol) was added, followed by a solution of sodium nitrite in 12 mL of water (3.29 g, 46 mmol) dropwise at 0 °C. The whole was stirred at 0 °C for one hour, then transferred to an addition funnel, and dropped into refluxing copper sulfate solution (5.08 g, 20 mmol, in 50 mL of water) over a period of 1 hour. After cooling to room temperature, the precipitate was collected by filtration, washed with water and acetone, then dried in air and then in vacuo to give a yellow solid (0.92 g, 65% yield). Confirmed by LCMS ( APCI ): Calcd. for C18H8O4 (M-): 288.0; found: 288 . 1 H NMR (400 MHz, chloroform- d ) δ 8.61 (dd, J = 17.1, 8.1 Hz, 2H), 8.09 (d, J = 8.0 Hz, 1H), 7.97 (d, J = 7.9 Hz, 1H), 7.59 (t, J = 7.7 Hz, 1H), 7.40 (t, J = 8.1 Hz, 2H), 7.33 (d, J = 8.4 Hz, 1H).

Ex-1 將含於5 mL DMF中之1H,3H-異𠳭唏[6,5,4-mna]𠮿-1,3-二酮(100 mg,0.347 mmol)、2-(4-胺基苯基)乙酸(135 mg,0.9 mmol)之混合物於微波反應器中在165℃下加熱2小時。於冷卻至50℃後,向所得溶液中逐滴添加1.5 mL丙酮以形成黃色沉澱物,藉由過濾收集該沉澱物及用丙酮洗滌,於空氣中乾燥,以得到黃色固體(88 mg,61%產率)。藉由LCMS (APCI)證實:針對C 26H 15NO 5(M-)計算值:421.1;實測值:421。 1H NMR (400 MHz, DMSO- d 6) δ 8.27 (d, J= 45.1 Hz, 4H), 7.67 - 7.00 (m, 8H), 3.58 (s, 2H)。 Ex-1 : 1H,3H-iso[6,5,4-mna][6,5,4-mna] in 5 mL DMF - A mixture of 1,3-dione (100 mg, 0.347 mmol), 2-(4-aminophenyl)acetic acid (135 mg, 0.9 mmol) was heated in a microwave reactor at 165°C for 2 hours. After cooling to 50 °C, 1.5 mL of acetone was added dropwise to the resulting solution to form a yellow precipitate, which was collected by filtration and washed with acetone, dried in air to give a yellow solid (88 mg, 61% Yield). Confirmed by LCMS (APCI): Calcd. for C26H15NO5 (M-): 421.1; found: 421 . 1 H NMR (400 MHz, DMSO- d 6 ) δ 8.27 (d, J = 45.1 Hz, 4H), 7.67 - 7.00 (m, 8H), 3.58 (s, 2H).

實例 2 (Ex-2): Ex-2 將含於5 mL DMF中之1H,3H-異𠳭唏[6,5,4-mna]𠮿-1,3-二酮(100 mg,0.347 mmol)、4-(4-胺基苯基)丁酸(125 mg,0.7 mmol)之混合物於微波反應器中在165℃下加熱2.5小時。向混合物中添加15 mL丙酮,藉由過濾收集所得沉澱物及於空氣中乾燥,然後於真空烘箱中在100℃下乾燥1小時,以得到黃色固體(120 mg,77%產率)。藉由LCMS (APCI)證實:針對C 28H 19NO 5(M-)計算值:449.1;實測值:449。 1H NMR (400 MHz, DMSO- d 6) δ 8.38 (d, J= 41.6 Hz, 4H), 7.81 - 6.97 (m, 8H), 2.69 - 2.64 (m, 2H), 2.26 (t, J= 7.2 Hz, 2H), 1.87 (p, J= 7.2 Hz, 2H)。 Example 2 (Ex-2): Ex-2 : 1H,3H-iso[6,5,4-mna][6,5,4-mna]𠮿 contained in 5 mL of DMF - A mixture of 1,3-dione (100 mg, 0.347 mmol), 4-(4-aminophenyl)butanoic acid (125 mg, 0.7 mmol) was heated in a microwave reactor at 165°C for 2.5 hours. 15 mL of acetone was added to the mixture, and the resulting precipitate was collected by filtration and dried in air, then in a vacuum oven at 100 °C for 1 hour to give a yellow solid (120 mg, 77% yield). Confirmed by LCMS (APCI): Calcd. for C28H19NO5 (M-): 449.1; found: 449 . 1 H NMR (400 MHz, DMSO- d 6 ) δ 8.38 (d, J = 41.6 Hz, 4H), 7.81 - 6.97 (m, 8H), 2.69 - 2.64 (m, 2H), 2.26 (t, J = 7.2 Hz, 2H), 1.87 (p, J = 7.2 Hz, 2H).

實例 3 (Ex-3) Ex -3.1 向含於正二氯苯(30 mL)中之化合物 Ex-1.3(290 mg,1.0 mmol)之混合物中添加溴(1.98 g,12 mmol)。將混合物在75℃下加熱30小時。於冷卻至室溫後,藉由過濾收集固體,於空氣中乾燥,以得到290 mg黃色固體作為所需產物。將濾液裝載在矽膠上及藉由急驟層析法使用己烷/二氯甲烷(50% à 100%二氯甲烷)之溶離劑純化。收集所需溶離份及移除溶劑,以得到110 mg黃色固體。獲得400 mg之總產物,產率89.7%。LCMS (APCI-):針對C 18H 6Br 2O 4計算值:443.9;實測值:444。 1H NMR (400 MHz, d 2-TCE) δ 9.40 (dd, J= 8.5, 1.5 Hz, 1H), 8.71 (s, 1H), 8.67 (s, 1H), 7.60 (ddd, J= 8.4, 7.1, 1.5 Hz, 1H), 7.48 (dd, J= 8.3, 1.4 Hz, 1H), 7.38 (ddd, J= 8.5, 7.1, 1.4 Hz, 1H)。 Example 3 (Ex-3) : Ex -3.1 : To a mixture of compound Ex-1.3 (290 mg, 1.0 mmol) in n-dichlorobenzene (30 mL) was added bromine (1.98 g, 12 mmol). The mixture was heated at 75°C for 30 hours. After cooling to room temperature, the solid was collected by filtration and dried in air to give 290 mg of yellow solid as the desired product. The filtrate was loaded onto silica gel and purified by flash chromatography using the eluent of hexane/dichloromethane (50% à 100% dichloromethane). The desired fractions were collected and the solvent was removed to give 110 mg of a yellow solid. 400 mg of total product were obtained, yield 89.7%. LCMS (APCI-): Calcd. for Ci8H6Br2O4 : 443.9 ; found: 444. 1 H NMR (400 MHz, d 2 -TCE) δ 9.40 (dd, J = 8.5, 1.5 Hz, 1H), 8.71 (s, 1H), 8.67 (s, 1H), 7.60 (ddd, J = 8.4, 7.1 , 1.5 Hz, 1H), 7.48 (dd, J = 8.3, 1.4 Hz, 1H), 7.38 (ddd, J = 8.5, 7.1, 1.4 Hz, 1H).

Ex-3.2 將含於無水N,N-二甲基甲醯胺(DMF) (4 mL)中之化合物 Ex -3.1(190 mg,0.426 mmol)、4-(4-胺基苯基)丁酸(180 mg,0.64 mmol)、4-(N,N-二甲胺基)-吡啶(4 mg)之混合物在165℃下加熱2.5小時。於將混合物冷卻至室溫及靜置過夜後,藉由過濾收集固體,將該固體用丙酮洗滌及於真空烘箱中在90℃下乾燥1小時,以得到黃色固體(220 mg,84.5%產率)。LCMS (APCI-):針對C 28H 17Br 2NO 5計算值:604.95;實測值:605。 1H NMR (400 MHz, DMSO- d 6) δ 9.42 (dd, J= 8.6, 1.5 Hz, 1H), 8.57 (d, J= 4.6 Hz, 2H), 7.83 - 7.68 (m, 1H), 7.63 - 7.44 (m, 2H), 7.34 (d, J= 8.3 Hz, 2H), 7.31 - 7.16 (m, 2H), 2.67 (dd, J= 4.8, 2.8 Hz, 2H), 2.28 (t, J= 7.4 Hz, 2H), 1.95 - 1.80 (m, 2H)。 Ex-3.2 : Compound Ex -3.1 (190 mg, 0.426 mmol), 4-(4-aminophenyl)butyl in anhydrous N,N-dimethylformamide (DMF) (4 mL) A mixture of acid (180 mg, 0.64 mmol), 4-(N,N-dimethylamino)-pyridine (4 mg) was heated at 165°C for 2.5 hours. After cooling the mixture to room temperature and standing overnight, the solid was collected by filtration, washed with acetone and dried in a vacuum oven at 90 °C for 1 hour to give a yellow solid (220 mg, 84.5% yield ). LCMS ( APCI-): Calcd. for C28H17Br2NO5 : 604.95 ; found: 605. 1 H NMR (400 MHz, DMSO- d 6 ) δ 9.42 (dd, J = 8.6, 1.5 Hz, 1H), 8.57 (d, J = 4.6 Hz, 2H), 7.83 - 7.68 (m, 1H), 7.63 - 7.44 (m, 2H), 7.34 (d, J = 8.3 Hz, 2H), 7.31 - 7.16 (m, 2H), 2.67 (dd, J = 4.8, 2.8 Hz, 2H), 2.28 (t, J = 7.4 Hz , 2H), 1.95 - 1.80 (m, 2H).

Ex-3 將含於THF/水(5 mL/0.5 mL)中之化合物 Ex -3.2(100 mg,0.165 mmol)、(3,5-雙(三氟甲基)苯基)硼酸(170 mg,0.66 mmol)、Pd(dppf)Cl2 (20 mg,0.027 mmol)及碳酸鉀(138 mg,1 mmol)之混合物脫氣,然後在80℃下加熱2小時。於冷卻至室溫後,藉由過濾收集沉澱物,用丙酮洗滌,然後於真空烘箱中在90℃下乾燥2小時。獲得黃色固體(142 mg,94%產率)。LCMS (APCI-):針對C 44H 23F 12NO 5計算值:873.14;實測值:873。 1H NMR (400 MHz, d 2-TCE) δ 8.65 (s, 1H), 8.40 (s, 1H), 8.17 (s, 2H), 7.96 (d, J= 19.3 Hz, 4H), 7.38 (d, J= 8.4 Hz, 1H), 7.33 (d, J= 8.0 Hz, 2H), 7.18 (d, J= 8.0 Hz, 3H), 6.90 (d, J= 6.3 Hz, 2H), 2.72 (t, J= 7.6 Hz, 2H), 2.38 (t, J= 7.4 Hz, 2H), 2.03 - 1.93 (m, 2H)。 Ex-3 : Compound Ex -3.2 (100 mg, 0.165 mmol), (3,5-bis(trifluoromethyl)phenyl)boronic acid (170 mg) contained in THF/water (5 mL/0.5 mL) , 0.66 mmol), Pd(dppf)Cl2 (20 mg, 0.027 mmol) and potassium carbonate (138 mg, 1 mmol) was degassed and then heated at 80°C for 2 hours. After cooling to room temperature, the precipitate was collected by filtration, washed with acetone, and then dried in a vacuum oven at 90° C. for 2 hours. A yellow solid was obtained (142 mg, 94% yield). LCMS ( APCI- ): Calcd. for C44H23F12NO5 : 873.14; found: 873. 1 H NMR (400 MHz, d 2 -TCE) δ 8.65 (s, 1H), 8.40 (s, 1H), 8.17 (s, 2H), 7.96 (d, J = 19.3 Hz, 4H), 7.38 (d, J = 8.4 Hz, 1H), 7.33 (d, J = 8.0 Hz, 2H), 7.18 (d, J = 8.0 Hz, 3H), 6.90 (d, J = 6.3 Hz, 2H), 2.72 (t, J = 7.6 Hz, 2H), 2.38 (t, J = 7.4 Hz, 2H), 2.03 - 1.93 (m, 2H).

實例 4 (Ex-4) Ex-4.1:將4-溴-1,8-萘酸酐(2.77 g,10 mmol)、4-溴-2-硝基苯酚(3.27 g,15 mmol)之混合物在真空下脫氣30分鐘,然後添加無水NMP (50 mL),接著添加氫氧化鈉(0.2 g,5 mmol)及銅粉(0.318 g,5 mmol)。將混合物用氬氣噴射20分鐘,然後在180℃下在氬氣氛圍下加熱過夜。於將混合物冷卻降至室溫後,向溶液中逐滴添加50 mL 20%鹽酸水溶液,然後添加50 mL水。允許將所得混合物靜置3小時,然後過濾以收集沉澱物,將該沉澱物於真空中乾燥,以得到4.6 g粗產物。將粗產物分散於30 mL丙酮中及在室溫下攪拌過夜以溶解雜質。過濾及於真空中乾燥,得到棕黃色固體作為所需產物(3.3 g,80%產率)。LCMS (APCI+):針對C 18H 9BrNO 6(M+H)計算值= 413.95;實測值:414。 1H NMR (400 MHz, TCE-d 2) δ 8.70 (dd, J= 8.4, 1.2 Hz, 1H), 8.63 (dd, J= 7.3, 1.2 Hz, 1H), 8.41 (d, J= 8.3 Hz, 1H), 8.24 (d, J= 2.4 Hz, 1H), 7.89 - 7.79 (m, 2H), 7.20 (d, J= 8.7 Hz, 1H), 6.82 (d, J= 8.3 Hz, 1H)。 Example 4 (Ex-4) : Ex-4.1 : A mixture of 4-bromo-1,8-naphthoic anhydride (2.77 g, 10 mmol), 4-bromo-2-nitrophenol (3.27 g, 15 mmol) was degassed under vacuum for 30 minutes, then Anhydrous NMP (50 mL) was added, followed by sodium hydroxide (0.2 g, 5 mmol) and copper powder (0.318 g, 5 mmol). The mixture was sparged with argon for 20 minutes, then heated at 180 °C overnight under an atmosphere of argon. After the mixture was cooled down to room temperature, 50 mL of 20% aqueous hydrochloric acid was added dropwise to the solution, followed by 50 mL of water. The resulting mixture was allowed to stand for 3 hours, then filtered to collect the precipitate, which was dried in vacuo to afford 4.6 g of crude product. The crude product was dispersed in 30 mL of acetone and stirred overnight at room temperature to dissolve impurities. Filtration and drying in vacuo afforded a tan solid as the desired product (3.3 g, 80% yield). LCMS ( APCI+): Calcd. for Ci8H9BrNO6 (M+H) = 413.95; found: 414 . 1 H NMR (400 MHz, TCE-d 2 ) δ 8.70 (dd, J = 8.4, 1.2 Hz, 1H), 8.63 (dd, J = 7.3, 1.2 Hz, 1H), 8.41 (d, J = 8.3 Hz, 1H), 8.24 (d, J = 2.4 Hz, 1H), 7.89 - 7.79 (m, 2H), 7.20 (d, J = 8.7 Hz, 1H), 6.82 (d, J = 8.3 Hz, 1H).

Ex-4.2:將含於乙酸(50 mL)中之化合物Ex-4.1 (1.5 g,3.6 mmol)、鐵粉(0.60 g,10.8 mmol)之混合物在125℃下加熱30分鐘。於冷卻至室溫後,向混合物中添加100 mL水,同時攪拌。將所得混合物過濾及用水洗滌,於空氣及真空中乾燥,以得到固體(1.35 g,82%產率)。LCMS (APCI-):針對C 18H 10BrNO 4計算值= 382.98;實測值:383。 1H NMR (400 MHz, DMSO- d 6) δ 9.01 - 8.26 (m, 3H), 7.96 (s, 1H), 6.93 (dd, J= 85.2, 36.5 Hz, 4H), 5.54 (s, 2H)。 Ex-4.2: A mixture of compound Ex-4.1 (1.5 g, 3.6 mmol), iron powder (0.60 g, 10.8 mmol) in acetic acid (50 mL) was heated at 125°C for 30 minutes. After cooling to room temperature, 100 mL of water was added to the mixture while stirring. The resulting mixture was filtered and washed with water, dried in air and vacuum to give a solid (1.35 g, 82% yield). LCMS (APCI-): Calcd. for C18H10BrNO4 = 382.98 ; found: 383 . 1 H NMR (400 MHz, DMSO- d 6 ) δ 9.01 - 8.26 (m, 3H), 7.96 (s, 1H), 6.93 (dd, J = 85.2, 36.5 Hz, 4H), 5.54 (s, 2H).

Ex-4.3:將化合物 Ex-4.2(2.65 g,6.9 mmol)分散於乙酸(50 mL)/水(10 mL)中及冷卻至0℃。當攪拌時,添加預冷卻之鹽酸(2.8 mL,34.5 mmol),然後在0℃下逐滴添加含於15 mL水中之亞硝酸鈉溶液(3.57 g,52 mmol)。將整體在0℃下攪拌一小時,然後轉移至添加漏斗中,及歷時1小時時間在130℃下滴入硫酸銅溶液(12 g,47 mmol,於140 mL水中)中。於冷卻至室溫後,藉由過濾收集沉澱物,用水(100 mL × 3)洗滌,然後於50 mL丙酮中在40℃下攪拌30分鐘。過濾,於空氣中然後於真空中乾燥,得到棕黃色固體(1.76 g,70%產率)。LCMS (APCI+):針對C 18H 8BrO 4(M+H)計算值= 366.95;實測值:367。 1H NMR (400 MHz, d 2-TCE) δ 8.51 (dd, J= 12.3, 8.1 Hz, 2H), 8.12 (d, J= 2.3 Hz, 1H), 7.86 (d, J= 7.9 Hz, 1H), 7.60 (dd, J= 8.8, 2.3 Hz, 1H), 7.28 (d, J= 8.3 Hz, 1H), 7.23 (d, J= 8.8 Hz, 1H)。 Ex-4.3 : Compound Ex-4.2 (2.65 g, 6.9 mmol) was dispersed in acetic acid (50 mL)/water (10 mL) and cooled to 0°C. While stirring, pre-cooled hydrochloric acid (2.8 mL, 34.5 mmol) was added, followed by a solution of sodium nitrite (3.57 g, 52 mmol) in 15 mL of water at 0 °C dropwise. The whole was stirred at 0 °C for one hour, then transferred to an addition funnel and added dropwise to a copper sulfate solution (12 g, 47 mmol, in 140 mL of water) at 130 °C over a period of 1 hour. After cooling to room temperature, the precipitate was collected by filtration, washed with water (100 mL×3), and then stirred in 50 mL of acetone at 40° C. for 30 minutes. Filtration, air and then vacuum drying afforded a tan solid (1.76 g, 70% yield). LCMS ( APCI+): Calcd for Ci8H8BrO4 (M+H) = 366.95 ; found: 367. 1 H NMR (400 MHz, d 2 -TCE) δ 8.51 (dd, J = 12.3, 8.1 Hz, 2H), 8.12 (d, J = 2.3 Hz, 1H), 7.86 (d, J = 7.9 Hz, 1H) , 7.60 (dd, J = 8.8, 2.3 Hz, 1H), 7.28 (d, J = 8.3 Hz, 1H), 7.23 (d, J = 8.8 Hz, 1H).

Ex-4.4:將含於10 mL DMF中之化合物 Ex-4.3(550 mg,1.5 mmol)、4-(4-胺基苯基)丁酸(537 mg,3 mmol)及DMAP (12.2 mg,0.1 mmol)之混合物於微波反應器中在165℃下加熱2.5小時。將所得溶液滴入50 mL丙酮中,同時攪拌。形成沉澱物及過濾及於真空烘箱中在60℃下乾燥過夜,以得到呈棕黃色固體之所需產物(0.49 g,62%產率)。LCMS (APCI-):針對C 28H 18BrNO 5計算值= 527.04;實測值:527。 1H NMR (400 MHz, DMSO- d 6) δ 8.54 (d, J= 2.3 Hz, 1H), 8.41 (dd, J= 9.9, 8.0 Hz, 2H), 8.33 (d, J= 7.9 Hz, 1H), 7.71 (dd, J= 8.8, 2.3 Hz, 1H), 7.39 (dd, J= 8.6, 4.2 Hz, 2H), 7.25 (d, J= 8.0 Hz, 2H), 7.17 (d, J= 7.9 Hz, 2H), 2.63 - 2.55 (m, 2H), 2.27 - 2.15 (m, 2H), 1.87 - 1.73 (m, 2H)。 Ex-4.4 : Compound Ex-4.3 (550 mg, 1.5 mmol), 4-(4-aminophenyl) butanoic acid (537 mg, 3 mmol) and DMAP (12.2 mg, 0.1 mmol) was heated in a microwave reactor at 165°C for 2.5 hours. The resulting solution was dropped into 50 mL of acetone while stirring. A precipitate formed and was filtered and dried in a vacuum oven at 60°C overnight to give the desired product (0.49 g, 62% yield) as a tan solid. LCMS (APCI-): Calcd . for C28H18BrNO5 = 527.04 ; found: 527. 1 H NMR (400 MHz, DMSO- d 6 ) δ 8.54 (d, J = 2.3 Hz, 1H), 8.41 (dd, J = 9.9, 8.0 Hz, 2H), 8.33 (d, J = 7.9 Hz, 1H) , 7.71 (dd, J = 8.8, 2.3 Hz, 1H), 7.39 (dd, J = 8.6, 4.2 Hz, 2H), 7.25 (d, J = 8.0 Hz, 2H), 7.17 (d, J = 7.9 Hz, 2H), 2.63 - 2.55 (m, 2H), 2.27 - 2.15 (m, 2H), 1.87 - 1.73 (m, 2H).

Ex-4:將含於THF/DMF/水(20L/4 mL/2 mL)之共溶劑中之化合物 Ex-4.4(385 mg,0.729 mmol)、苯基硼酸(178 mg,1.45 mmol)、Pd(dppf)Cl 2(36 mg,0.05 mmol)、碳酸鉀(276 mg,2 mmol)之混合物脫氣,然後在80℃下加熱過夜。將混合物用200 mL乙酸乙酯及50 mL 0.6 N鹽酸水溶液處理。將水相用乙酸乙酯(100 mL x 2)萃取。收集有機相及用鹽水(100 mL x 2)洗滌,經硫酸鈉乾燥,然後乾裝載在矽膠上及藉由急驟層析法使用DCM/EA (0%至40% EA與0.1% TFA)之溶離劑純化。收集主要所需溶離份,在減壓下移除溶劑,得到黃色固體(250 mg,65%產率)。LCMS (APCI-):針對C 34H 23NO 5計算值= 525.16;實測值:525。 1H NMR (400 MHz, TCE-d 2) δ 8.55 (dd, J= 19.5, 8.1 Hz, 2H), 8.20 (d, J= 2.1 Hz, 1H), 8.01 (d, J= 8.1 Hz, 1H), 7.72 (dd, J= 8.6, 2.1 Hz, 1H), 7.62 (d, J= 7.3 Hz, 2H), 7.51 - 7.28 (m, 7H), 7.17 (d, J= 8.2 Hz, 2H), 2.72 (t, J= 7.7 Hz, 2H), 2.39 (t, J= 7.3 Hz, 2H), 1.99 (q, J= 7.2 Hz, 2H)。 Ex-4 : Compound Ex-4.4 (385 mg, 0.729 mmol), phenylboronic acid (178 mg, 1.45 mmol), Pd in a co-solvent of THF/DMF/water (20L/4 mL/2 mL) A mixture of (dppf) Cl2 (36 mg, 0.05 mmol), potassium carbonate (276 mg, 2 mmol) was degassed and then heated at 80 °C overnight. The mixture was treated with 200 mL of ethyl acetate and 50 mL of 0.6 N aqueous hydrochloric acid. The aqueous phase was extracted with ethyl acetate (100 mL x 2). The organic phase was collected and washed with brine (100 mL x 2), dried over sodium sulfate, then dry loaded onto silica gel and eluted by flash chromatography using DCM/EA (0% to 40% EA with 0.1% TFA) Reagent purification. The main desired fractions were collected and the solvent was removed under reduced pressure to give a yellow solid (250 mg, 65% yield). LCMS (APCI-): Calcd. for C34H23NO5 = 525.16 ; found: 525 . 1 H NMR (400 MHz, TCE-d 2 ) δ 8.55 (dd, J = 19.5, 8.1 Hz, 2H), 8.20 (d, J = 2.1 Hz, 1H), 8.01 (d, J = 8.1 Hz, 1H) , 7.72 (dd, J = 8.6, 2.1 Hz, 1H), 7.62 (d, J = 7.3 Hz, 2H), 7.51 - 7.28 (m, 7H), 7.17 (d, J = 8.2 Hz, 2H), 2.72 ( t, J = 7.7 Hz, 2H), 2.39 (t, J = 7.3 Hz, 2H), 1.99 (q, J = 7.2 Hz, 2H).

實例 5 (Ex-5) Ex-5:將含於THF/DMF/水(20L/4 mL/2 mL)之共溶劑中之化合物 Ex-4.4(385 mg,0.729 mmol)、3,5-雙(三氟甲基)苯基硼酸(374 mg,1.45 mmol)、Pd(dppf)Cl 2(36 mg,0.05 mmol)、碳酸鉀(276 mg,2 mmol)之混合物脫氣,然後在80℃下加熱過夜。將混合物用200 mL乙酸乙酯及50 mL 0.6N鹽酸水溶液處理。將水相用乙酸乙酯(100 mL x 2)萃取。收集有機相及用鹽水(100 mL x 2)洗滌,經硫酸鈉乾燥,然後乾裝載在矽膠上及藉由急驟層析法使用DCM/EA (0%至40% EA與0.1% TFA)之溶離劑純化。收集主要所需溶離份,在減壓下移除溶劑,得到黃色固體(340 mg,70.5%產率)。LCMS (APCI-):針對C 36H 21F 6NO 5計算值= 661.13;實測值:661。 1H NMR (400 MHz, d 2-TCE) δ 8.57 (dd, J= 19.2, 8.1 Hz, 2H), 8.18 (d, J= 2.2 Hz, 1H), 8.05 (d, J= 8.0 Hz, 1H), 8.03 - 7.98 (m, 2H), 7.87 (s, 1H), 7.72 (dd, J= 8.6, 2.2 Hz, 1H), 7.48 (d, J= 8.6 Hz, 1H), 7.33 (d, J= 8.3 Hz, 3H), 7.21 - 7.12 (m, 2H), 2.72 (t, J= 7.6 Hz, 2H), 2.39 (t, J= 7.3 Hz, 2H), 2.04 - 1.97 (m, 2H)。 Example 5 (Ex-5) Ex-5 : Compound Ex-4.4 (385 mg, 0.729 mmol), 3,5-bis(trifluoromethyl)benzene in a co-solvent of THF/DMF/water (20L/4 mL/2 mL) A mixture of boronic acid (374 mg, 1.45 mmol), Pd(dppf)Cl 2 (36 mg, 0.05 mmol), potassium carbonate (276 mg, 2 mmol) was degassed and then heated at 80°C overnight. The mixture was treated with 200 mL of ethyl acetate and 50 mL of 0.6N aqueous hydrochloric acid. The aqueous phase was extracted with ethyl acetate (100 mL x 2). The organic phase was collected and washed with brine (100 mL x 2), dried over sodium sulfate, then dry loaded onto silica gel and eluted by flash chromatography using DCM/EA (0% to 40% EA with 0.1% TFA) Reagent purification. The main desired fractions were collected and the solvent was removed under reduced pressure to give a yellow solid (340 mg, 70.5% yield). LCMS ( APCI-): Calcd. for C36H21F6NO5 = 661.13 ; found: 661. 1 H NMR (400 MHz, d 2 -TCE) δ 8.57 (dd, J = 19.2, 8.1 Hz, 2H), 8.18 (d, J = 2.2 Hz, 1H), 8.05 (d, J = 8.0 Hz, 1H) , 8.03 - 7.98 (m, 2H), 7.87 (s, 1H), 7.72 (dd, J = 8.6, 2.2 Hz, 1H), 7.48 (d, J = 8.6 Hz, 1H), 7.33 (d, J = 8.3 Hz, 3H), 7.21 - 7.12 (m, 2H), 2.72 (t, J = 7.6 Hz, 2H), 2.39 (t, J = 7.3 Hz, 2H), 2.04 - 1.97 (m, 2H).

實例 6 (Ex-6) Ex-6:將含於10 mL DMF中之1H,3H-硫𠮿[2,1,9-def]異𠳭唏-1,3-二酮(458 mg,1.5 mmol)、4-(4-胺基苯基)丁酸(537 mg,3 mmol)及DMAP (14 mg,0.11 mmol)之混合物於微波反應器中在165℃下加熱2.5小時。將所得溶液滴入60 mL丙酮中,同時攪拌。形成橙色沉澱物,及過濾及用乙醚洗滌,於空氣中乾燥,以得到橙色固體(546 mg),將其於真空烘箱中在100℃下進一步乾燥3小時,以得到呈橙色固體之所需產物(500 mg,71.7%產率)。藉由LCMS (APCI-)證實:針對C 28H 19NO 4S計算值= 465.10;實測值:465。 1H NMR (400 MHz, DMSO- d 6) δ 8.55 (d, J= 8.4 Hz, 1H), 8.52 - 8.46 (m, 2H), 8.32 (d, J= 8.0 Hz, 1H), 7.78 (d, J= 8.0 Hz, 1H), 7.65 - 7.58 (m, 1H), 7.52 (tt, J= 7.2, 5.5 Hz, 2H), 7.37 - 7.30 (m, 2H), 7.30 - 7.23 (m, 2H), 2.69 (t, J= 7.4 Hz, 2H), 2.29 (t, J= 7.3 Hz, 2H), 1.88 (p, J= 7.5 Hz, 2H)。 Example 6 (Ex-6) Ex-6 : 1H,3H-sulfur 𠮿 contained in 10 mL DMF [2,1,9-def]iso-1,3-dione (458 mg, 1.5 mmol), 4-(4-aminophenyl)butanoic acid (537 mg, 3 mmol) and DMAP (14 mg, 0.11 mmol) was heated in a microwave reactor at 165°C for 2.5 hours. The resulting solution was dropped into 60 mL of acetone while stirring. An orange precipitate formed and was filtered and washed with ether, dried in air to give an orange solid (546 mg), which was further dried in a vacuum oven at 100 °C for 3 hours to give the desired product as an orange solid (500 mg, 71.7% yield). Confirmed by LCMS (APCI-): calcd for C28H19NO4S = 465.10 ; found: 465. 1 H NMR (400 MHz, DMSO- d 6 ) δ 8.55 (d, J = 8.4 Hz, 1H), 8.52 - 8.46 (m, 2H), 8.32 (d, J = 8.0 Hz, 1H), 7.78 (d, J = 8.0 Hz, 1H), 7.65 - 7.58 (m, 1H), 7.52 (tt, J = 7.2, 5.5 Hz, 2H), 7.37 - 7.30 (m, 2H), 7.30 - 7.23 (m, 2H), 2.69 (t, J = 7.4 Hz, 2H), 2.29 (t, J = 7.3 Hz, 2H), 1.88 (p, J = 7.5 Hz, 2H).

下列實例為如本文中所述之吡咯中間體之許多實施例之合成程序: 實例 7 (Ex-7.3) Ex-7.2 – 化合物 Ex-7.2 (E)-6,7,8,9- 四氫 -5H- 苯并 [7] 輪烯 -5- 酮肟之一般合成程序:將含於EtOH/H 2O (45 mL/150 mL)中之化合物 Ex-7.1(10.0 g,62.0 mmol)、NH 2OH•HCl (6.50 g,93.0 mmol)及NaOAc (12.7 g,155.0 mmol)之混合物放入500 mL具有回流冷凝器之二頸圓底燒瓶中。將溶液加熱上至115℃以回流及在此溫度下保持1小時。TLC (50% EtOAc/己烷)顯示反應完全。於冷卻降至0℃及過濾後,獲得呈淺白色固體之化合物 Ex-7.2用於下個步驟無需進一步純化,定量產率。MS (APCI):針對C 11H 14NO ([M+H] +)計算值= 176實測值:176。 1H NMR (400 MHz, CDCl 3) δ 7.98 (bs, 1H), 7.39 (dd, J= 7.6 Hz, 1.6 Hz, 1H), 7.30 (td, J= 7.6 Hz, 1.6 Hz, 1H), 7.23 (td, J= 7.6 Hz, 1.6 Hz, 1H), 7.13 (d, J= 7.6 Hz, 1H), 2.74 (m, 4H), 1.78 (ddd, J= 13.2 Hz, 6.0 Hz, 6.0 Hz, 2H), 1.65 (ddd, J= 12.4 Hz, 6.0 Hz, 6.0 Hz, 2H)。 The following example is a synthetic procedure for a number of embodiments of pyrrole intermediates as described herein: Example 7 (Ex-7.3) : Ex-7.2 - General synthetic procedure for compound Ex-7.2 , (E)-6,7,8,9- tetrahydro -5H- benzo [7] annulene -5- one oxime: will be contained in EtOH/H 2 A mixture of compound Ex-7.1 (10.0 g, 62.0 mmol), NH 2 OH•HCl (6.50 g, 93.0 mmol) and NaOAc (12.7 g, 155.0 mmol) in O (45 mL/150 mL) was put into 500 mL with In a two-neck round bottom flask with a reflux condenser. The solution was heated up to 115°C to reflux and held at this temperature for 1 hour. TLC (50% EtOAc/hexanes) showed the reaction was complete. After cooling down to 0° C. and filtration, compound Ex-7.2 was obtained as an off-white solid and used in the next step without further purification, quantitative yield. MS (APCI): Calcd. for C11H14NO ([M+H] + ) = 176 Found: 176 . 1 H NMR (400 MHz, CDCl 3 ) δ 7.98 (bs, 1H), 7.39 (dd, J = 7.6 Hz, 1.6 Hz, 1H), 7.30 (td, J = 7.6 Hz, 1.6 Hz, 1H), 7.23 ( td, J = 7.6 Hz, 1.6 Hz, 1H), 7.13 (d, J = 7.6 Hz, 1H), 2.74 (m, 4H), 1.78 (ddd, J = 13.2 Hz, 6.0 Hz, 6.0 Hz, 2H), 1.65 (ddd, J = 12.4 Hz, 6.0 Hz, 6.0 Hz, 2H).

Ex-7.3 – 化合物 Ex-7.3 1,4,5,6- 四氫苯并 [6,7] 環庚 [1,2-b] 吡咯之一般合成程序:將含於DMSO (50 mL)中之化合物 Ex-7.2(8.8 g,50.0 mmol)及KOH (10.1 g,180.0 mmol)之溶液放入250 mL具有回流冷凝器之二頸圓底燒瓶中。將溶液在室溫下脫氣及加熱上至140℃。透過注射器泵歷時5.5小時向此溶液中逐滴添加含於DMSO (50 mL)中之DCE (12.4 g,125 mmol)之另外溶液。於完成DCE溶液之添加後,將反應冷卻降至室溫,接著倒入飽和NH 4Cl溶液(500 mL)中。使用EtOAc (500 mL*3)自處理溶液萃取所需產物。將合併之有機層經無水Na 2SO 4乾燥,在真空下濃縮及藉由矽膠急驟層析法使用含DCM之己烷(0至30%)作為溶離劑純化,以得到呈淺白色固體之化合物 Ex-7.3,4.6 g,50%產率。MS (APCI):針對C 13H 14N ([M+H] +)計算值= 184實測值:184。 1H NMR (400 MHz, CDCl 3) δ 8.19 (bs, 1H), 7.34 (dd, J= 8.0 Hz, 1.6 Hz, 1H), 7.22 (td, J= 7.6 Hz, 1.6 Hz, 1H), 7.16 (dd, J= 7.6 Hz, 1.6 Hz, 1H), 7.09 (td, J= 7.6 Hz, 1.6 Hz, 1H), 6.84 (t, J= 2.8 Hz, 1H), 6.16 (t, J= 2.8 Hz, 1H), 2.90 (t, J= 6.8 Hz, 2H), 2.83 (m, 2H), 2.02 (m, 2H)。 Ex-7.3 - General Synthetic Procedure for Compound Ex-7.3 , 1,4,5,6- Tetrahydrobenzo [6,7] cyclohepta [1,2-b] pyrrole: In DMSO (50 mL) A solution of compound Ex-7.2 (8.8 g, 50.0 mmol) and KOH (10.1 g, 180.0 mmol) was put into a 250 mL two-neck round bottom flask with a reflux condenser. The solution was degassed at room temperature and heated up to 140°C. To this solution was added dropwise via syringe pump an additional solution of DCE (12.4 g, 125 mmol) in DMSO (50 mL) over 5.5 hours. After the addition of the DCE solution was complete, the reaction was cooled to room temperature, then poured into saturated NH4Cl solution (500 mL). The desired product was extracted from the work-up solution using EtOAc (500 mL*3). The combined organic layers were dried over anhydrous Na2SO4 , concentrated in vacuo and purified by silica gel flash chromatography using DCM in hexane (0 to 30%) as eluent to give the compound as off-white solid Ex-7.3 , 4.6 g, 50% yield. MS (APCI): Calcd. for C13H14N ([M+H] + ) = 184 Found: 184 . 1 H NMR (400 MHz, CDCl 3 ) δ 8.19 (bs, 1H), 7.34 (dd, J = 8.0 Hz, 1.6 Hz, 1H), 7.22 (td, J = 7.6 Hz, 1.6 Hz, 1H), 7.16 ( dd, J = 7.6 Hz, 1.6 Hz, 1H), 7.09 (td, J = 7.6 Hz, 1.6 Hz, 1H), 6.84 (t, J = 2.8 Hz, 1H), 6.16 (t, J = 2.8 Hz, 1H ), 2.90 (t, J = 6.8 Hz, 2H), 2.83 (m, 2H), 2.02 (m, 2H).

實例 8 (Ex-8.2) 化合物 Ex-8.2 4,5- 二氫 -1H- 苯并 [g] 吲哚之一般合成程序:將含於DMSO (50 mL)中之NH 2OH•HCl (4.2 g,60.0 mmol)及KOH (3.4 g,60.0 mmol)之混合物放入500 mL具有回流冷凝器之二頸圓底燒瓶中。將溶液在室溫下攪拌30分鐘。然後添加含於DMSO (25 mL)中之化合物 Ex-8.1(7.3 g,50.0 mmol)。將溶液加熱上至70℃及在此溫度下保持30分鐘。然後,將另一部分之KOH (8.4 g,150.0 mmol)添加至溶液中,接著將該溶液加熱上至140℃。透過注射器泵歷時4小時向此溶液中逐滴添加含於DMSO (25 mL)中之DCE (9.9 g,100.0 mmol)之另外溶液。於完成DCE溶液之添加後,將反應冷卻降至室溫,接著倒入飽和NH 4Cl溶液(200 mL)中。使用EtOAc (200 mL*3)自處理溶液萃取所需產物。將合併之有機層經無水Na 2SO 4乾燥,在真空下濃縮及藉由矽膠急驟層析法使用含DCM之己烷(0至30%)作為溶離劑純化,以得到呈淺白色固體之化合物 Ex-8.2,3.7 g,43%產率。MS (APCI):針對C 12H 12N ([M+H] +)計算值= 170實測值:170。 1H NMR (400 MHz, CDCl 3) δ 8.28 (bs, 1H), 7.22 (ddd, J= 17.6 Hz, 10.4 Hz, 10.4 Hz, 2H), 7.16 (t, J= 7.2 Hz, 1H), 7.08 (td, J= 7.2, 1.6 Hz, 1H), 6.76 (m, 1H), 6.15 (m, 1H), 2.96 (t, J= 7.2 Hz, 2H), 2.78 (t, J= 7.2 Hz, 2H)。 Example 8 (Ex-8.2) : Compound Ex-8.2 , the general synthesis procedure of 4,5- dihydro -1H- benzo [g] indole: NH 2 OH·HCl (4.2 g, 60.0 mmol) and KOH in DMSO (50 mL) (3.4 g, 60.0 mmol) of the mixture was placed in a 500 mL two necked round bottom flask with a reflux condenser. The solution was stirred at room temperature for 30 minutes. Compound Ex-8.1 (7.3 g, 50.0 mmol) in DMSO (25 mL) was then added. The solution was heated up to 70°C and held at this temperature for 30 minutes. Then, another portion of KOH (8.4 g, 150.0 mmol) was added to the solution, and the solution was heated up to 140°C. To this solution was added dropwise via syringe pump an additional solution of DCE (9.9 g, 100.0 mmol) in DMSO (25 mL) over 4 hours. After the addition of the DCE solution was complete, the reaction was cooled to room temperature, then poured into saturated NH4Cl solution (200 mL). The desired product was extracted from the work-up solution using EtOAc (200 mL*3). The combined organic layers were dried over anhydrous Na2SO4 , concentrated in vacuo and purified by silica gel flash chromatography using DCM in hexane (0 to 30%) as eluent to give the compound as off-white solid Ex-8.2 , 3.7 g, 43% yield. MS (APCI): Calcd. for C12H12N ([M+H] + ) = 170 Found: 170 . 1 H NMR (400 MHz, CDCl 3 ) δ 8.28 (bs, 1H), 7.22 (ddd, J = 17.6 Hz, 10.4 Hz, 10.4 Hz, 2H), 7.16 (t, J = 7.2 Hz, 1H), 7.08 ( td, J = 7.2, 1.6 Hz, 1H), 6.76 (m, 1H), 6.15 (m, 1H), 2.96 (t, J = 7.2 Hz, 2H), 2.78 (t, J = 7.2 Hz, 2H).

實例 9 – 光致發光複合物 (PLC) 之合成:下列實例為如本文中所述之RL-萘醯亞胺-BODIPY之許多實施例之合成程序: 合成 PLC-1 化合物 PLC-1.3 之一般程序:將100 mL 2頸圓底燒瓶安裝空氣冷凝器及攪拌棒。向該燒瓶中添加化合物1,4,5,6-四氫苯并[6,7]環庚[1,2-b]吡咯 PLC-1.1(813.1 mg,4.4 mmol)及4-羥基-2,6-二氯苯甲醛 PLC-1.2(424.3 mg,2.2 mmol),接著添加無水二氯乙烷(55 ml)。將反應混合物用Ar噴射30分鐘,然後添加TFA (4滴)。將反應溶液在室溫下攪拌過夜。於將反應於冰水浴中冷卻降至0℃後,添加對氯醌(731.8 mg,2.98 mmol)。將反應在0℃下保持30分鐘。然後在0℃下添加BF 3•OEt 2(3.0 mL,24.1 mmol)及Et 3N (1.9 mL,13.3 mmol)。將反應混合物加熱上至50℃持續3小時。將反應混合物用矽膠裝載及藉由急驟層析法,使用含DCM之己烷(0至80%至90%)作為溶離劑純化,以得到呈棕金色固體之純BODIPY PLC-1.3,476.0 mg,36%產率。MS (APCI):針對C 33H 24BCl 2F 2N 2O ([M-H] -)計算值= 584實測值:584。 1H NMR (400 MHz, CDCl 3) 8.09 (dd, J= 4.0 Hz, 2.0 Hz, 2H), 7.32 (dddd, J= 13.2 Hz, 7.2 Hz, 7.2 Hz, 2.0 Hz, 4H), 7.22 (dd, J= 6.4 Hz, 2.0 Hz, 2H), 6.99 (s, 2H), 6.43 (s, 2H), 5.77 (bs, 1H), 2.63 (dd, J= 6.8 Hz, 6.8 Hz, 4H), 2.32 (bs, 4H), 2.03 (ddd, J= 14.0 Hz, 6.8 Hz, 6.8 Hz, 4H)。 Example 9 - Synthesis of Photoluminescent Complex (PLC) : The following example is a synthetic procedure for a number of embodiments of RL-naphthylimide-BODIPY as described herein: Synthesis of PLC-1 : General procedure for compound PLC-1.3 : A 100 mL 2-neck round bottom flask was equipped with an air condenser and a stirring bar. To this flask was added compound 1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-b]pyrrole PLC-1.1 (813.1 mg, 4.4 mmol) and 4-hydroxy-2, 6-Dichlorobenzaldehyde PLC-1.2 (424.3 mg, 2.2 mmol) followed by addition of anhydrous dichloroethane (55 ml). The reaction mixture was sparged with Ar for 30 min, then TFA (4 drops) was added. The reaction solution was stirred overnight at room temperature. After cooling the reaction down to 0 °C in an ice-water bath, p-chloranil (731.8 mg, 2.98 mmol) was added. The reaction was maintained at 0°C for 30 minutes. Then BF 3 •OEt 2 (3.0 mL, 24.1 mmol) and Et 3 N (1.9 mL, 13.3 mmol) were added at 0°C. The reaction mixture was heated up to 50 °C for 3 hours. The reaction mixture was loaded on silica gel and purified by flash chromatography using DCM in hexane (0 to 80% to 90%) as eluent to give pure BODIPY PLC-1.3 as a brown-golden solid, 476.0 mg, 36% yield. MS ( APCI ) : Calcd . for C33H24BCl2F2N2O ([MH] - ) = 584 Found: 584. 1 H NMR (400 MHz, CDCl 3 ) 8.09 (dd, J = 4.0 Hz, 2.0 Hz, 2H), 7.32 (dddd, J = 13.2 Hz, 7.2 Hz, 7.2 Hz, 2.0 Hz, 4H), 7.22 (dd, J = 6.4 Hz, 2.0 Hz, 2H), 6.99 (s, 2H), 6.43 (s, 2H), 5.77 (bs, 1H), 2.63 (dd, J = 6.8 Hz, 6.8 Hz, 4H), 2.32 (bs , 4H), 2.03 (ddd, J = 14.0 Hz, 6.8 Hz, 6.8 Hz, 4H).

化合物 PLC-1 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-1.3(25.0 mg,0.043 mmol)、 PLC-1.4(24.0 mg,0.053 mmol)、EDC•HCl (40.9 mg,0.21 mmol)及DMAP•TsOH (25.6 mg,0.085 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物用矽膠裝載及藉由急驟層析法,使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗紫色固體之純RL-萘醯亞胺-BODIPY PLC-1。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-1,21.0 mg,48%產率。MS (APCI):針對C 61H 41Cl 2F 2N 3O 5([M-H] -)計算值= 1015實測值:1015。 1H NMR (400 MHz, CDCl 3) 8.66 (dd, J= 18.4 Hz, 7.6 Hz, 2H), 8.10 (m, 3H), 7.99 (d, J=8.0 Hz, 1H), 7.56 (ddd, J= 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.36 (m, 13H), 7.22 (dd, J= 6.8 Hz, 2.0 Hz, 2H), 6.45 (s, 2H) 2.88 (t, J= 7.6 Hz, 2H), 2.72 (t, J= 7.2 Hz, 2H), 2.63 (m, 4H), 2.20 (m, 6H), 2.04 (ddd, J= 6.8 Hz, 6.8 Hz, 6.8 Hz, 4H)。 General procedure for compound PLC-1 : A 10 mL vial was fitted with a stir bar. Add compound PLC-1.3 (25.0 mg, 0.043 mmol), PLC-1.4 (24.0 mg, 0.053 mmol), EDC·HCl (40.9 mg, 0.21 mmol) and DMAP·TsOH (25.6 mg, 0.085 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc (0 to 5%) with DCM as eluent to give pure RL-naphthalene as a dark purple solid Amide-BODIPY PLC-1 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-1 , 21.0 mg, 48% yield. MS ( APCI ) : Calcd . for C61H41Cl2F2N3O5 ([MH] - ) = 1015 Found: 1015. 1 H NMR (400 MHz, CDCl 3 ) 8.66 (dd, J = 18.4 Hz, 7.6 Hz, 2H), 8.10 (m, 3H), 7.99 (d, J =8.0 Hz, 1H), 7.56 (ddd, J = 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.36 (m, 13H), 7.22 (dd, J = 6.8 Hz, 2.0 Hz, 2H), 6.45 (s, 2H) 2.88 (t, J = 7.6 Hz, 2H ), 2.72 (t, J = 7.2 Hz, 2H), 2.63 (m, 4H), 2.20 (m, 6H), 2.04 (ddd, J = 6.8 Hz, 6.8 Hz, 6.8 Hz, 4H).

合成 PLC-2 化合物 PLC-2 之一般程序:將含於DCM (8 mL)中之化合物 PLC-2.1(31 mg,0.053 mmol)、化合物 PLC-2.2(43 mg,0.082 mmol)、EDC•HCl (100 mg,0.52 mmol)及DMAP/p-TsOH (16 mg,0.054 mmol)之混合物在室溫下攪拌過夜。然後將所得混合物裝載在矽膠上,藉由急驟層析法使用DCM/乙酸乙酯(0% à 5%乙酸乙酯)之溶離劑純化。收集主紅色溶離份及在減壓下濃縮至約1 mL,然後添加10 mL甲醇。將所得沉澱物過濾及於空氣中乾燥,以得到暗紅色固體(41 mg,70.8%產率)。LCMS (APCI-):針對C 67H 46BCl 2F 2N 3O 5(M-)計算值= 1091.29;實測值:1091。 1H NMR (400 MHz, d 2-TCE) δ 8.56 (dd, J= 19.3, 8.1 Hz, 2H), 8.21 (d, J= 2.2 Hz, 1H), 8.02 (d, J= 8.1 Hz, 1H), 7.97 (t, J= 4.7 Hz, 2H), 7.73 (dd, J= 8.6, 2.1 Hz, 1H), 7.63 (dd, J= 7.2, 1.7 Hz, 2H), 7.50 - 7.41 (m, 3H), 7.38 (dd, J= 8.0, 2.2 Hz, 3H), 7.34 - 7.25 (m, 7H), 7.25 - 7.18 (m, 4H), 6.40 (s, 2H), 2.82 (t, J= 7.5 Hz, 2H), 2.67 (t, J= 7.4 Hz, 2H), 2.60 - 2.49 (m, 4H), 2.24 (s, 4H), 2.18 - 2.07 (m, 2H), 2.03 - 1.90 (m, 4H)。 Synthesis of PLC-2 : General procedure for compound PLC-2 : Compound PLC-2.1 (31 mg, 0.053 mmol), compound PLC-2.2 (43 mg, 0.082 mmol), EDC·HCl (100 mg, 0.52 mmol) and DMAP/p-TsOH (16 mg, 0.054 mmol) was stirred overnight at room temperature. The resulting mixture was then loaded onto silica gel and purified by flash chromatography using the eluent of DCM/ethyl acetate (0%→5% ethyl acetate). The main red fractions were collected and concentrated under reduced pressure to about 1 mL, then 10 mL of methanol was added. The resulting precipitate was filtered and air dried to give a dark red solid (41 mg, 70.8% yield). LCMS (APCI-) : Calcd . for C67H46BCl2F2N3O5 (M-) = 1091.29 ; found: 1091. 1 H NMR (400 MHz, d 2 -TCE) δ 8.56 (dd, J = 19.3, 8.1 Hz, 2H), 8.21 (d, J = 2.2 Hz, 1H), 8.02 (d, J = 8.1 Hz, 1H) , 7.97 (t, J = 4.7 Hz, 2H), 7.73 (dd, J = 8.6, 2.1 Hz, 1H), 7.63 (dd, J = 7.2, 1.7 Hz, 2H), 7.50 - 7.41 (m, 3H), 7.38 (dd, J = 8.0, 2.2 Hz, 3H), 7.34 - 7.25 (m, 7H), 7.25 - 7.18 (m, 4H), 6.40 (s, 2H), 2.82 (t, J = 7.5 Hz, 2H) , 2.67 (t, J = 7.4 Hz, 2H), 2.60 - 2.49 (m, 4H), 2.24 (s, 4H), 2.18 - 2.07 (m, 2H), 2.03 - 1.90 (m, 4H).

合成 PLC-3 化合物 PLC-3 之一般程序:將含於無水二氯甲烷(5 mL)中之化合物 PLC-3.1(28 mg,0.048 mmol)、化合物 PLC-2.1(70 mg,0.08 mmol)、DIC (0.1 mL,0.63 mmol)、DMAP/TsOH鹽(29 mg,0.1 mmol)之混合物在室溫下攪拌40小時。將所得混合物裝載在矽膠上及藉由急驟層析法使用己烷/二氯甲烷(50% à 100%二氯甲烷)之溶離劑純化。收集所需溶離份。於移除溶劑及用甲醇洗滌後,於過濾及於空氣中乾燥後獲得暗紅色固體(45 mg,65%產率)。LCMS (APCI-):針對C 77H 46BCl 2F 14N 3O 5(M-)計算值= 1439.27;實測值:1439。 1H NMR (400 MHz, d 2-TCE) δ 8.66 (s, 1H), 8.41 (s, 1H), 8.18 (d, J= 1.5 Hz, 2H), 7.96 (d, J= 18.4 Hz, 6H), 7.39 (dd, J= 8.3, 2.4 Hz, 3H), 7.34 - 7.12 (m, 11H), 6.98 - 6.85 (m, 2H), 6.39 (s, 2H), 2.82 (t, J= 7.6 Hz, 2H), 2.66 (t, J= 7.4 Hz, 2H), 2.54 (d, J= 6.1 Hz, 4H), 2.24 (m, 4H), 2.15 - 2.06 (m, 2H), 1.96 (m, 4H)。 Synthesis of PLC-3 : General procedure for Compound PLC-3 : Compound PLC-3.1 (28 mg, 0.048 mmol), Compound PLC-2.1 (70 mg, 0.08 mmol), DIC (0.1 mL, 0.63 mmol), a mixture of DMAP/TsOH salt (29 mg, 0.1 mmol) was stirred at room temperature for 40 hours. The resulting mixture was loaded onto silica gel and purified by flash chromatography using the eluent of hexane/dichloromethane (50%→100% dichloromethane). Collect the desired fractions. After removing the solvent and washing with methanol, a dark red solid (45 mg, 65% yield) was obtained after filtration and air drying. LCMS ( APCI- ): Calcd . for C77H46BCl2F14N3O5 (M-) = 1439.27 ; found: 1439. 1 H NMR (400 MHz, d 2 -TCE) δ 8.66 (s, 1H), 8.41 (s, 1H), 8.18 (d, J = 1.5 Hz, 2H), 7.96 (d, J = 18.4 Hz, 6H) , 7.39 (dd, J = 8.3, 2.4 Hz, 3H), 7.34 - 7.12 (m, 11H), 6.98 - 6.85 (m, 2H), 6.39 (s, 2H), 2.82 (t, J = 7.6 Hz, 2H ), 2.66 (t, J = 7.4 Hz, 2H), 2.54 (d, J = 6.1 Hz, 4H), 2.24 (m, 4H), 2.15 - 2.06 (m, 2H), 1.96 (m, 4H).

合成 PLC-4 化合物 PLC-4.3 之一般程序:將100 mL 2頸圓底燒瓶安裝空氣冷凝器及攪拌棒。向該燒瓶中添加化合物4,5-二氫-1H-苯并[g]吲哚 PLC-4.1(203.1 mg,1.2 mmol)及4-羥基-2,6-二甲基苯甲醛 PLC-4.2(90.0 mg,0.6 mmol),接著添加無水二氯乙烷(15 ml)。將反應混合物用Ar噴射30分鐘,然後添加TFA (3滴)。將反應溶液加熱上至40℃及在40℃下攪拌過夜。於將反應於冰水浴中冷卻降至0℃後,添加對氯醌(200.0 mg,0.8 mmol)。將反應在0℃下保持30分鐘。然後在0℃下添加BF 3•OEt 2(0.8 mL,6.5 mmol)及Et 3N (0.5 mL,3.6 mmol)。將反應混合物加熱上至50℃持續2小時。將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之己烷(0至80%至90%)作為溶離劑純化,以得到呈暗紫金色固體之純BODIPY PLC-4.3,242.2 mg,78%產率。MS (APCI):針對C 33H 28BF 2N 2O ([M+H] +)計算值= 517實測值:517。 1H NMR (400 MHz, CDCl 3) 8.80 (d, J= 8.0 Hz, 2H), 7.44 (td, J= 7.2 Hz, 1.6 Hz, 2H), 7.31 (td, J= 7.6 Hz, 1.2 Hz, 2H), 7.25 (m, 2H), 6.63 (s, 2H), 6.33 (s, 2H), 4.82 (s, 1H), 2.91 (t, J= 6.4 Hz, 4H), 2.65 (t, J= 6.4 Hz, 4H), 2.18 (s, 6H)。 Synthesis of PLC-4 : General procedure for compound PLC-4.3 : A 100 mL 2-neck round bottom flask was equipped with an air condenser and a stirring bar. To this flask was added compound 4,5-dihydro-1H-benzo[g]indole PLC-4.1 (203.1 mg, 1.2 mmol) and 4-hydroxy-2,6-dimethylbenzaldehyde PLC-4.2 ( 90.0 mg, 0.6 mmol), followed by the addition of anhydrous dichloroethane (15 ml). The reaction mixture was sparged with Ar for 30 min, then TFA (3 drops) was added. The reaction solution was heated up to 40°C and stirred overnight at 40°C. After cooling the reaction down to 0 °C in an ice-water bath, p-chloranil (200.0 mg, 0.8 mmol) was added. The reaction was maintained at 0°C for 30 minutes. Then BF 3 •OEt 2 (0.8 mL, 6.5 mmol) and Et 3 N (0.5 mL, 3.6 mmol) were added at 0°C. The reaction mixture was heated up to 50 °C for 2 hours. The reaction mixture was loaded on silica gel and purified by flash chromatography using DCM in hexane (0 to 80% to 90%) as eluent to give pure BODIPY PLC-4.3 as a dark purple gold solid, 242.2 mg, 78 %Yield. MS ( APCI) : Calcd. for C33H28BF2N2O ([M+H] + ) = 517 Found : 517. 1 H NMR (400 MHz, CDCl 3 ) 8.80 (d, J = 8.0 Hz, 2H), 7.44 (td, J = 7.2 Hz, 1.6 Hz, 2H), 7.31 (td, J = 7.6 Hz, 1.2 Hz, 2H ), 7.25 (m, 2H), 6.63 (s, 2H), 6.33 (s, 2H), 4.82 (s, 1H), 2.91 (t, J = 6.4 Hz, 4H), 2.65 (t, J = 6.4 Hz , 4H), 2.18 (s, 6H).

化合物 PLC-4 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-4.3(25.0 mg,0.048 mmol)、 PLC-4.4(27.2 mg,0.061 mmol)、EDC•HCl (46.4 mg,0.24 mmol)及DMAP•TsOH (29.0 mg,0.097 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈藍綠色固體之純RL-萘醯亞胺-BODIPY PLC-4。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-4,20.1 mg,44%產率。MS (APCI):針對C 61H 43BF 2N 3O 5([M-H] -)計算值= 947實測值:947。 1H NMR (400 MHz, CDCl 3) 8.80 (d, J= 8.4 Hz, 2H), 8.66 (dd, J= 18.4 Hz, 8.0 Hz, 2H), 8.11 (dd, J= 8.0 Hz, 1.6 Hz, 1H), 7.99 (d, J= 8.0 Hz, 1H), 7.56 (ddd, J= 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.37 (m, 11H), 7.25 (m, 2H), 6.93 (s, 2H), 6.35 (s, 2H), 2.90 (m, 6H), 2.68 (m, 6H), 2.24 (s, 6H), 2.20 (m, 2H)。 General procedure for compound PLC-4 : A 10 mL vial was fitted with a stir bar. Add compound PLC-4.3 (25.0 mg, 0.048 mmol), PLC-4.4 (27.2 mg, 0.061 mmol), EDC·HCl (46.4 mg, 0.24 mmol) and DMAP·TsOH (29.0 mg, 0.097 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc (0 to 5%) with DCM as eluent to give pure RL-naphthoyl as a blue-green solid Imine-BODIPY PLC-4 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-4 , 20.1 mg, 44% yield. MS ( APCI) : Calcd. for C6iH43BF2N3O5 ([MH] - ) = 947 Found: 947 . 1 H NMR (400 MHz, CDCl 3 ) 8.80 (d, J = 8.4 Hz, 2H), 8.66 (dd, J = 18.4 Hz, 8.0 Hz, 2H), 8.11 (dd, J = 8.0 Hz, 1.6 Hz, 1H ), 7.99 (d, J = 8.0 Hz, 1H), 7.56 (ddd, J = 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.37 (m, 11H), 7.25 (m, 2H), 6.93 (s, 2H), 6.35 (s, 2H), 2.90 (m, 6H), 2.68 (m, 6H), 2.24 (s, 6H), 2.20 (m, 2H).

合成 PLC-5 化合物 PLC-5.3 之一般程序:將100 mL 2頸圓底燒瓶安裝空氣冷凝器及攪拌棒。向該燒瓶中添加化合物4,5-二氫-1H-苯并[g]吲哚 PLC-5.1(203.1 mg,1.2 mmol)及4-羥基-2,6-二氯苯甲醛 PLC-5.2(114.6 mg,0.6 mmol),接著添加無水二氯乙烷(15 ml)。將反應混合物用Ar噴射30分鐘,然後添加TFA (3滴)。將反應溶液在室溫下攪拌過夜。於將反應於冰水浴中冷卻降至0℃後,添加對氯醌(200.0 mg,0.8 mmol)。將反應在0℃下保持30分鐘。然後在0℃下添加BF 3•OEt 2(0.8 mL,6.5 mmol)及Et 3N (0.5 mL,3.6 mmol)。將反應混合物加熱上至50℃持續2小時。將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之己烷(0至80%至90%)作為溶離劑純化,以得到呈暗紫金色固體之純BODIPY PLC-5.3,200.3 mg,57%產率。MS (APCI):針對C 31H 20BCl 2F 2N 2O ([M-H] -)計算值= 556實測值:556。 1H NMR (400 MHz, CDCl 3) 8.80 (d, J= 8.0 Hz, 2H), 7.44 (td, J= 7.6 Hz, 1.6 Hz, 2H), 7.32 (td, J= 7.6 Hz, 1.2 Hz, 2H), 7.25 (m, 2H), 6.99 (s, 2H), 6.35 (s, 2H), 5.68 (bs, 1H), 2.93 (t, J= 7.6 Hz, 4H), 2.68 (t, J= 7.6 Hz, 4H)。 Synthesis of PLC-5 : General procedure for compound PLC-5.3 : A 100 mL 2-neck round bottom flask was equipped with an air condenser and a stirring bar. To this flask was added compound 4,5-dihydro-1H-benzo[g]indole PLC-5.1 (203.1 mg, 1.2 mmol) and 4-hydroxy-2,6-dichlorobenzaldehyde PLC-5.2 (114.6 mg, 0.6 mmol), followed by addition of anhydrous dichloroethane (15 ml). The reaction mixture was sparged with Ar for 30 min, then TFA (3 drops) was added. The reaction solution was stirred overnight at room temperature. After cooling the reaction down to 0 °C in an ice-water bath, p-chloranil (200.0 mg, 0.8 mmol) was added. The reaction was maintained at 0°C for 30 minutes. Then BF 3 •OEt 2 (0.8 mL, 6.5 mmol) and Et 3 N (0.5 mL, 3.6 mmol) were added at 0°C. The reaction mixture was heated up to 50 °C for 2 hours. The reaction mixture was loaded on silica gel and purified by flash chromatography using DCM in hexane (0 to 80% to 90%) as eluent to give pure BODIPY PLC-5.3 as a dark purple gold solid, 200.3 mg, 57 %Yield. MS ( APCI ): Calcd. for C31H20BCl2F2N2O ([MH] ) = 556 Found : 556. 1 H NMR (400 MHz, CDCl 3 ) 8.80 (d, J = 8.0 Hz, 2H), 7.44 (td, J = 7.6 Hz, 1.6 Hz, 2H), 7.32 (td, J = 7.6 Hz, 1.2 Hz, 2H ), 7.25 (m, 2H), 6.99 (s, 2H), 6.35 (s, 2H), 5.68 (bs, 1H), 2.93 (t, J = 7.6 Hz, 4H), 2.68 (t, J = 7.6 Hz , 4H).

化合物 PLC-5 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-5.3(25.0 mg,0.045 mmol)、 PLC-5.4(25.2 mg,0.056 mmol)、EDC•HCl (43.0 mg,0.22 mmol)及DMAP•TsOH (26.9 mg,0.089 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈綠色固體之純RL-萘醯亞胺-BODIPY PLC-5。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-5,16.0 mg,36%產率。MS (APCI):針對C 59H 37BCl 2F 2N 3O 5([M-H] -)計算值= 986實測值:986。 1H NMR (400 MHz, CDCl 3) 8.80 (d, J= 8.4 Hz, 2H), 8.66 (dd, J= 18.0 Hz, 8.0 Hz, 2H), 8.11 (dd, J= 8.0 Hz, 1.6 Hz, 1H), 7.99 (d, J= 8.0 Hz, 1H), 7.56 (ddd, J= 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.34 (m, 15H), 6.37 (s, 2H), 2.90 (m, 6H), 2.70 (dd, J= 14.8 Hz, 7.6 Hz, 6H), 2.24 (ddd, J= 7.6 Hz, 7.6 Hz, 7.6 Hz, 2H)。 General procedure for compound PLC-5 : A 10 mL vial was fitted with a stir bar. Add compound PLC-5.3 (25.0 mg, 0.045 mmol), PLC-5.4 (25.2 mg, 0.056 mmol), EDC•HCl (43.0 mg, 0.22 mmol) and DMAP•TsOH (26.9 mg, 0.089 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthylidene as a green solid Amine - BODIPY PLC-5 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-5 , 16.0 mg, 36% yield. MS ( APCI ) : Calcd. for C59H37BCl2F2N3O5 ([MH] - ) = 986 Found: 986 . 1 H NMR (400 MHz, CDCl 3 ) 8.80 (d, J = 8.4 Hz, 2H), 8.66 (dd, J = 18.0 Hz, 8.0 Hz, 2H), 8.11 (dd, J = 8.0 Hz, 1.6 Hz, 1H ), 7.99 (d, J = 8.0 Hz, 1H), 7.56 (ddd, J = 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.34 (m, 15H), 6.37 (s, 2H), 2.90 (m, 6H), 2.70 (dd, J = 14.8 Hz, 7.6 Hz, 6H), 2.24 (ddd, J = 7.6 Hz, 7.6 Hz, 7.6 Hz, 2H).

合成 PLC-6 PLC-6.3 之一般程序:將100 mL 2頸圓底燒瓶安裝空氣冷凝器及攪拌棒。向該燒瓶中添加化合物1,4,5,6-四氫苯并[6,7]環庚[1,2-b]吡咯 PLC-6.1(220.0 mg,1.2 mmol)及4-羥基-2,6-二甲氧基苯甲醛 PLC-6.2(109.3 mg,0.6 mmol),接著添加無水二氯乙烷(15 ml)。將反應混合物用Ar噴射30分鐘,然後添加TFA (3滴)。將反應溶液加熱上至40℃及在40℃下攪拌過夜。於將反應於冰水浴中冷卻降至0℃後,添加對氯醌(200.0 mg,0.8 mmol)。將反應在0℃下保持30分鐘。然後在0℃下添加BF 3•OEt 2(0.8 mL,6.5 mmol)及Et 3N (0.5 mL,3.6 mmol)。將反應混合物加熱上至50℃持續2小時。將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之己烷(0至80%至90%)作為溶離劑純化,以得到呈暗紫色固體之純BODIPY PLC-6.3,28.0 mg,8%產率。MS (APCI):針對C 35H 30BF 2N 2O 3([M-H]-)計算值= 576實測值:576。 1H NMR (400 MHz, CDCl3) 8.10 (d, J = 7.6 Hz, 2H), 7.29 (dddd, J = 17.2 Hz, 7.2 Hz, 7.2 Hz, 4H), 7.21 (dd, J = 7.2 Hz, 2H), 6.48 (s, 2H), 6.19 (s, 2H), 3.72 (s, 6H), 2.62 (dd, J = 6.8 Hz, 6.8 Hz, 4H), 2.29 (bs, 4H), 2.02 (ddd, J = 14.0 Hz, 7.2 Hz, 7.2 Hz, 4H)。 Synthesis of PLC-6 : General procedure of PLC-6.3 : Install an air condenser and a stirring bar in a 100 mL 2-neck round bottom flask. Add compound 1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-b]pyrrole PLC-6.1 (220.0 mg, 1.2 mmol) and 4-hydroxy-2, 6-Dimethoxybenzaldehyde PLC-6.2 (109.3 mg, 0.6 mmol) followed by addition of anhydrous dichloroethane (15 ml). The reaction mixture was sparged with Ar for 30 min, then TFA (3 drops) was added. The reaction solution was heated up to 40°C and stirred overnight at 40°C. After cooling the reaction down to 0 °C in an ice-water bath, p-chloranil (200.0 mg, 0.8 mmol) was added. The reaction was maintained at 0°C for 30 minutes. Then BF 3 •OEt 2 (0.8 mL, 6.5 mmol) and Et 3 N (0.5 mL, 3.6 mmol) were added at 0°C. The reaction mixture was heated up to 50 °C for 2 hours. The reaction mixture was loaded on silica gel and purified by flash chromatography using DCM in hexane (0 to 80% to 90%) as eluent to give pure BODIPY PLC-6.3 as a dark purple solid, 28.0 mg, 8% yield Rate. MS (APCI) : Calcd. for C35H30BF2N2O3 ([MH]-) = 576 Found : 576 . 1 H NMR (400 MHz, CDCl3) 8.10 (d, J = 7.6 Hz, 2H), 7.29 (dddd, J = 17.2 Hz, 7.2 Hz, 7.2 Hz, 4H), 7.21 (dd, J = 7.2 Hz, 2H) , 6.48 (s, 2H), 6.19 (s, 2H), 3.72 (s, 6H), 2.62 (dd, J = 6.8 Hz, 6.8 Hz, 4H), 2.29 (bs, 4H), 2.02 (ddd, J = 14.0 Hz, 7.2 Hz, 7.2 Hz, 4H).

PLC-6 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-6.3(28.0 mg,0.049 mmol)、 PLC-6.4(27.3 mg,0.061 mmol)、EDC•HCl (46.6 mg,0.24 mmol)及DMAP•TsOH (29.2 mg,0.097 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗紅紫色固體之純RL-萘醯亞胺-BODIPY PLC-6。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-6,4.0 mg,8%產率。MS (APCI):針對C 63H 47BF 2N 3O 7([M-H] -)計算值= 1007實測值:1007。 1H NMR (400 MHz, CDCl 3) 8.66 (dd, J= 18.4 Hz, 8.0 Hz, 2H), 8.11 (dd, J= 8.0 Hz, 1.6 Hz, 3H), 7.99 (d, J= 8.0 Hz, 1H), 7.56 (ddd, J= 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.41 (m, 4H), 7.32 (m, 7H), 7.21 (dd, J= 7.2 Hz, 1.6 Hz, 2H), 6.50 (s, 2H), 6.49 (s, 2H), 3.77 (s, 6H), 2.89 (t, J= 7.2 Hz, 2H), 2.72 (t, J= 7.2 Hz, 2H), 2.62 (m, 4H), 2.30 (bs, 2H), 2.21 (ddd, J= 7.6 Hz, 7.6 Hz, 7.6 Hz, 4H), 2.02 (ddd, J= 6.8 Hz, 6.8 Hz, 6.8 Hz, 4H)。 General procedure for PLC-6 : Install a 10 mL vial with a stir bar. Add compound PLC-6.3 (28.0 mg, 0.049 mmol), PLC-6.4 (27.3 mg, 0.061 mmol), EDC•HCl (46.6 mg, 0.24 mmol) and DMAP•TsOH (29.2 mg, 0.097 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthoyl as a dark reddish-purple solid Imine-BODIPY PLC-6 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-6 , 4.0 mg, 8% yield. MS ( APCI) : Calcd . for C63H47BF2N3O7 ([MH] - ) = 1007 Found : 1007. 1 H NMR (400 MHz, CDCl 3 ) 8.66 (dd, J = 18.4 Hz, 8.0 Hz, 2H), 8.11 (dd, J = 8.0 Hz, 1.6 Hz, 3H), 7.99 (d, J = 8.0 Hz, 1H ), 7.56 (ddd, J = 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.41 (m, 4H), 7.32 (m, 7H), 7.21 (dd, J = 7.2 Hz, 1.6 Hz, 2H), 6.50 (s, 2H), 6.49 (s, 2H), 3.77 (s, 6H), 2.89 (t, J = 7.2 Hz, 2H), 2.72 (t, J = 7.2 Hz, 2H), 2.62 (m, 4H) , 2.30 (bs, 2H), 2.21 (ddd, J = 7.6 Hz, 7.6 Hz, 7.6 Hz, 4H), 2.02 (ddd, J = 6.8 Hz, 6.8 Hz, 6.8 Hz, 4H).

合成 PLC-7 PLC-7.3 之一般程序:將100 mL 2頸圓底燒瓶安裝空氣冷凝器及攪拌棒。向該燒瓶中添加化合物4,5-二氫-1H-苯并[g]吲哚 PLC-7.1(203.1 mg,1.2 mmol)及4-羥基-2,6-二甲氧基苯甲醛 PLC-7.2(109.3 mg,0.6 mmol),接著添加無水二氯乙烷(15 ml)。將反應混合物用Ar噴射30分鐘,然後添加TFA (3滴)。將反應溶液加熱上至40℃及在40℃下攪拌過夜。於將反應於冰水浴中冷卻降至0℃後,添加對氯醌(200.0 mg,0.8 mmol)。將反應在0℃下保持30分鐘。然後在0℃下添加BF 3•OEt 2(0.8 mL,6.5 mmol)及Et 3N (0.5 mL,3.6 mmol)。將反應混合物加熱上至50℃持續2小時。將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之己烷(0至80%至90%)作為溶離劑純化,以得到呈棕金色固體之純BODIPY PLC-7.3,78.4 mg,24%產率。MS (APCI):針對C 33H 28BF 2N 2O 3([M+H] +)計算值= 549實測值:549。 1H NMR (400 MHz, CDCl 3) 8.80 (d, J= 8.0 Hz, 2H), 7.43 (t, J= 8.0 Hz, 2H), 7.29 (m, 2H), 7.23 (d, J= 7.2 Hz, 2H), 6.41 (s, 2H), 6.17 (s, 2H), 5.05 (bs, 1H), 3.69 (s, 6H), 2.90 (t, J= 6.8 Hz, 4H), 2.65 (t, J= 6.8 Hz, 4H)。 Synthesis of PLC-7 : General procedure of PLC-7.3 : Install an air condenser and a stirring bar in a 100 mL 2-neck round bottom flask. To this flask was added compound 4,5-dihydro-1H-benzo[g]indole PLC-7.1 (203.1 mg, 1.2 mmol) and 4-hydroxy-2,6-dimethoxybenzaldehyde PLC-7.2 (109.3 mg, 0.6 mmol), followed by anhydrous dichloroethane (15 ml). The reaction mixture was sparged with Ar for 30 min, then TFA (3 drops) was added. The reaction solution was heated up to 40°C and stirred overnight at 40°C. After cooling the reaction down to 0 °C in an ice-water bath, p-chloranil (200.0 mg, 0.8 mmol) was added. The reaction was maintained at 0°C for 30 minutes. Then BF 3 •OEt 2 (0.8 mL, 6.5 mmol) and Et 3 N (0.5 mL, 3.6 mmol) were added at 0°C. The reaction mixture was heated up to 50 °C for 2 hours. The reaction mixture was loaded on silica gel and purified by flash chromatography using DCM in hexane (0 to 80% to 90%) as eluent to give pure BODIPY PLC-7.3 as a brown-golden solid, 78.4 mg, 24% Yield. MS (APCI): Calcd . for C33H28BF2N2O3 ([M+H] + ) = 549 Found : 549. 1 H NMR (400 MHz, CDCl 3 ) 8.80 (d, J = 8.0 Hz, 2H), 7.43 (t, J = 8.0 Hz, 2H), 7.29 (m, 2H), 7.23 (d, J = 7.2 Hz, 2H), 6.41 (s, 2H), 6.17 (s, 2H), 5.05 (bs, 1H), 3.69 (s, 6H), 2.90 (t, J = 6.8 Hz, 4H), 2.65 (t, J = 6.8 Hz, 4H).

PLC-7 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-7.3(25.0 mg,0.045 mmol)、 PLC-7.4(25.6 mg,0.057 mmol)、EDC•HCl (43.7 mg,0.23 mmol)及DMAP•TsOH (24.7 mg,0.091 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗綠色固體之純RL-萘醯亞胺-BODIPY PLC-7。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-7,23.0 mg,51%產率。MS (APCI):針對C 61H 43BF 2N 3O 7([M-H] -)計算值= 979實測值:979。 1H NMR (400 MHz, CDCl 3) 8.81 (d, J= 8.0 Hz, 2H), 8.67 (dd, J= 18.4 Hz, 7.6 Hz, 2H), 8.11 (dd, J= 8.0 Hz, 1.6 Hz, 1H), 8.00 (d, J= 8.0 Hz, 1H), 7.56 (ddd, J= 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.34 (m, 11H), 7.23 (m, 2H), 6.46 (s, 2H), 6.43 (s, 2H), 3.73 (s, 6H), 2.89 (dd, J= 14.0 Hz, 6.4 Hz, 6H), 2.68 (m, 6H), 2.24 (ddd, J= 7.6 Hz, 7.6 Hz, 7.6 Hz, 2H)。 General procedure for PLC-7 : Install a 10 mL vial with a stir bar. Add compound PLC-7.3 (25.0 mg, 0.045 mmol), PLC-7.4 (25.6 mg, 0.057 mmol), EDC·HCl (43.7 mg, 0.23 mmol) and DMAP·TsOH (24.7 mg, 0.091 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthylamide as a dark green solid imine-BODIPY PLC-7 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-7 , 23.0 mg, 51% yield. MS (APCI): Calcd. for C6iH43BF2N3O7 ( [ MH ] - ) = 979 Found: 979. 1 H NMR (400 MHz, CDCl 3 ) 8.81 (d, J = 8.0 Hz, 2H), 8.67 (dd, J = 18.4 Hz, 7.6 Hz, 2H), 8.11 (dd, J = 8.0 Hz, 1.6 Hz, 1H ), 8.00 (d, J = 8.0 Hz, 1H), 7.56 (ddd, J = 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.34 (m, 11H), 7.23 (m, 2H), 6.46 (s, 2H), 6.43 (s, 2H), 3.73 (s, 6H), 2.89 (dd, J = 14.0 Hz, 6.4 Hz, 6H), 2.68 (m, 6H), 2.24 (ddd, J = 7.6 Hz, 7.6 Hz , 7.6 Hz, 2H).

合成 PLC-8 PLC-8.3 之一般程序:將100 mL 2頸圓底燒瓶安裝空氣冷凝器及攪拌棒。向該燒瓶中添加化合物1,4,5,6-四氫苯并[6,7]環庚[1,2-b]吡咯 PLC-8.1(220.0 mg,1.2 mmol)及4-羥基-2,6-二甲基苯甲醛 PLC-8.2(90.0 mg,0.6 mmol),接著添加無水二氯乙烷(15 ml)。將反應混合物用Ar噴射30分鐘,然後添加TFA (3滴)。將反應溶液加熱上至40℃過夜。於將反應於冰水浴中冷卻降至0℃後,添加對氯醌(200.0 mg,0.8 mmol)。將反應在0℃下保持20分鐘。然後在0℃下添加BF 3•OEt 2(0.8 mL,6.5 mmol)及Et 3N (0.5 mL,3.6 mmol)。將反應混合物加熱上至50℃持續2小時。將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之己烷(0至80%至90%)作為溶離劑純化,以得到呈暗紫色固體之純BODIPY PLC-8.3,162.5 mg,48%產率。MS (APCI):針對C 35H 30BF 2N 2O ([M-H] -)計算值= 543實測值:543。 1H NMR (400 MHz, CDCl 3) 8.08 (d, J= 7.2 Hz, 2H), 8.02 (bs, 1H), 7.28 (m, 6H), 6.66 (bs, 2H), 6.41 (bs, 2H), 2.96 (bs, 4H), 2.89 (bs, 4H), 2.62 (m, 4H), 2.22 (s, 6H)。 Synthesis of PLC-8 : General procedure of PLC-8.3 : Install a 100 mL 2-neck round bottom flask with an air condenser and a stirring bar. Add compound 1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-b]pyrrole PLC-8.1 (220.0 mg, 1.2 mmol) and 4-hydroxy-2, 6-Dimethylbenzaldehyde PLC-8.2 (90.0 mg, 0.6 mmol) followed by addition of anhydrous dichloroethane (15 ml). The reaction mixture was sparged with Ar for 30 min, then TFA (3 drops) was added. The reaction solution was heated up to 40 °C overnight. After cooling the reaction down to 0 °C in an ice-water bath, p-chloranil (200.0 mg, 0.8 mmol) was added. The reaction was maintained at 0°C for 20 minutes. Then BF 3 •OEt 2 (0.8 mL, 6.5 mmol) and Et 3 N (0.5 mL, 3.6 mmol) were added at 0°C. The reaction mixture was heated up to 50 °C for 2 hours. The reaction mixture was loaded on silica gel and purified by flash chromatography using DCM in hexane (0 to 80% to 90%) as eluent to give pure BODIPY PLC-8.3 as a dark purple solid, 162.5 mg, 48% yield Rate. MS ( APCI): Calcd. for C35H30BF2N2O ([MH] - ) = 543 Found : 543. 1 H NMR (400 MHz, CDCl 3 ) 8.08 (d, J = 7.2 Hz, 2H), 8.02 (bs, 1H), 7.28 (m, 6H), 6.66 (bs, 2H), 6.41 (bs, 2H), 2.96 (bs, 4H), 2.89 (bs, 4H), 2.62 (m, 4H), 2.22 (s, 6H).

PLC-8 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-8.3(25.0 mg,0.046 mmol)、 PLC-8.4(25.8 mg,0.057 mmol)、EDC•HCl (44.1 mg,0.23 mmol)及DMAP•TsOH (27.6 mg,0.092 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗紫紅色固體之純RL-萘醯亞胺-BODIPY PLC-8。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-8,31.0 mg,69%產率。MS (APCI):針對C 63H 47BF 2N 3O 5([M-H] -)計算值= 975實測值:975。 1H NMR (400 MHz, CDCl 3) 8.66 (dd, J= 18.4 Hz, 7.6 Hz, 2H), 8.10 (td, J= 8.0 Hz, 1.6 Hz, 2H), 8.08 (bs, 1H), 7.99 (d, J= 8.0 Hz, 1H), 7.56 (ddd, J= 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.36 (m, 11H), 7.22 (dd, J= 7.2 Hz, 2.0 Hz, 2H), 6.95 (s, 2H), 6.43 (s, 2H) 2.88 (t, J= 7.2 Hz, 2H), 2.70 (t, J= 7.2 Hz, 2H), 2.62 (m, 4H), 2.29 (s, 6H), 2.20 (m, 6H), 2.02 (ddd, J= 6.8 Hz, 6.8 Hz, 6.8 Hz, 4H)。 General procedure for PLC-8 : Install a 10 mL vial with a stir bar. Add compound PLC-8.3 (25.0 mg, 0.046 mmol), PLC-8.4 (25.8 mg, 0.057 mmol), EDC•HCl (44.1 mg, 0.23 mmol) and DMAP•TsOH (27.6 mg, 0.092 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthalene as a dark purple solid Imide-BODIPY PLC-8 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-8 , 31.0 mg, 69% yield. MS (APCI) : Calcd . for C63H47BF2N3O5 ([MH] - ) = 975 Found: 975 . 1 H NMR (400 MHz, CDCl 3 ) 8.66 (dd, J = 18.4 Hz, 7.6 Hz, 2H), 8.10 (td, J = 8.0 Hz, 1.6 Hz, 2H), 8.08 (bs, 1H), 7.99 (d , J = 8.0 Hz, 1H), 7.56 (ddd, J = 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.36 (m, 11H), 7.22 (dd, J = 7.2 Hz, 2.0 Hz, 2H), 6.95 (s, 2H), 6.43 (s, 2H) 2.88 (t, J = 7.2 Hz, 2H), 2.70 (t, J = 7.2 Hz, 2H), 2.62 (m, 4H), 2.29 (s, 6H), 2.20 (m, 6H), 2.02 (ddd, J = 6.8 Hz, 6.8 Hz, 6.8 Hz, 4H).

合成 PLC-9 PLC-9 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-9.1(25.0 mg,0.048 mmol)、 PLC-9.2(27.2 mg,0.061 mmol)、EDC•HCl (46.4 mg,0.24 mmol)及DMAP•TsOH (29.0 mg,0.097 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗綠色固體之純RL-萘醯亞胺-BODIPY PLC-9。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-9,25.0 mg,54%產率。MS (APCI):針對C 61H 43BF 2N 3O 5([M-H] -)計算值= 947實測值:947。 1H NMR (400 MHz, CDCl 3) 8.67 (dd, J= 18.4 Hz, 7.6 Hz, 2H), 8.10 (m, 3H), 7.99 (d, J= 8.0 Hz, 1H), 7.56 (ddd, J= 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.34 (m, 11H), 7.23 (m, 2H), 6.95 (m, 2H), 2.88 (t, J= 7.2 Hz, 2H), 2.70 (t, J= 7.2 Hz, 2H), 2.62 (m, 4H), 2.29 (s, 6H), 2.20 (ddd, J= 7.6 Hz, 7.6 Hz, 7.6 Hz, 6H), 2.24 (ddd, J= 7.6 Hz, 7.6 Hz, 7.6 Hz, 2H)。 Synthesis of PLC-9 : General procedure for PLC-9 : Install a 10 mL vial with a stir bar. Add compound PLC-9.1 (25.0 mg, 0.048 mmol), PLC-9.2 (27.2 mg, 0.061 mmol), EDC•HCl (46.4 mg, 0.24 mmol) and DMAP•TsOH (29.0 mg, 0.097 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthylamide as a dark green solid Imine-BODIPY PLC-9 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-9 , 25.0 mg, 54% yield. MS (APCI) : Calcd . for C6iH43BF2N3O5 ([MH] - ) = 947 Found: 947 . 1 H NMR (400 MHz, CDCl 3 ) 8.67 (dd, J = 18.4 Hz, 7.6 Hz, 2H), 8.10 (m, 3H), 7.99 (d, J = 8.0 Hz, 1H), 7.56 (ddd, J = 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.34 (m, 11H), 7.23 (m, 2H), 6.95 (m, 2H), 2.88 (t, J = 7.2 Hz, 2H), 2.70 (t, J = 7.2 Hz, 2H), 2.62 (m, 4H), 2.29 (s, 6H), 2.20 (ddd, J = 7.6 Hz, 7.6 Hz, 7.6 Hz, 6H), 2.24 (ddd, J = 7.6 Hz, 7.6 Hz , 7.6 Hz, 2H).

合成 PLC-10 PLC-10 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-10.1(30.0 mg,0.055 mmol)、 PLC-10.2(32.1 mg,0.069 mmol)、EDC•HCl (52.7 mg,0.275 mmol)及DMAP•TsOH (33.0 mg,0.110 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗紫色固體之純RL-萘醯亞胺-BODIPY PLC-10。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-10,51.0 mg,94%產率。MS (APCI):針對C 63H 48BF 2N 3O 4S ([M-H] -)計算值= 991實測值:991。 1H NMR (400 MHz, CDCl 3) 8.68 (d, J= 8.0 Hz, 1H), 8.48 (d, J= 8.0 Hz, 1H), 8.26 (m, 2H), 8.09 (m, 2H), 7.56 (d, J= 8.0 Hz, 1H), 7.44 (m, 5H), 7.32 (m, 6H), 7.22 (m, 2H), 6.95 (s, 2H), 6.43 (s, 2H), 2.88 (t, J= 7.6 Hz, 2H), 2.70 (t, J= 7.6 Hz, 2H), 2.62 (m, 4H), 2.29 (s, 6H), 2.20 (m, 6H), 2.24 (ddd, J= 6.8 Hz, 6.8 Hz, 6.8 Hz, 4H)。 Synthesis of PLC-10 : General procedure for PLC-10 : Install a 10 mL vial with a stir bar. Add compound PLC-10.1 (30.0 mg, 0.055 mmol), PLC-10.2 (32.1 mg, 0.069 mmol), EDC•HCl (52.7 mg, 0.275 mmol) and DMAP•TsOH (33.0 mg, 0.110 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthylidene as a dark purple solid Amine - BODIPY PLC-10 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-10 , 51.0 mg, 94% yield. MS ( APCI ) : Calcd. for C63H48BF2N3O4S ([MH] - ) = 991 Found : 991. 1 H NMR (400 MHz, CDCl 3 ) 8.68 (d, J = 8.0 Hz, 1H), 8.48 (d, J = 8.0 Hz, 1H), 8.26 (m, 2H), 8.09 (m, 2H), 7.56 ( d, J = 8.0 Hz, 1H), 7.44 (m, 5H), 7.32 (m, 6H), 7.22 (m, 2H), 6.95 (s, 2H), 6.43 (s, 2H), 2.88 (t, J = 7.6 Hz, 2H), 2.70 (t, J = 7.6 Hz, 2H), 2.62 (m, 4H), 2.29 (s, 6H), 2.20 (m, 6H), 2.24 (ddd, J = 6.8 Hz, 6.8 Hz, 6.8 Hz, 4H).

合成PLC-11: PLC-11 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-11.1(30.0 mg,0.058 mmol)、 PLC-11.2(33.8 mg,0.073 mmol)、EDC•HCl (55.6 mg,0.290 mmol)及DMAP•TsOH (34.8 mg,0.116 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗綠色固體之純RL-萘醯亞胺-BODIPY PLC-11。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-11,40.0 mg,72%產率。MS (APCI):針對C 61H 44BF 2N 3O 4S ([M-H] -)計算值= 963實測值:963。 1H NMR (400 MHz, CDCl 3) 8.81 (d, J= 8.0 Hz, 2H), 8.68 (d, J= 8.0 Hz, 1H), 8.48 (d, J= 8.0 Hz, 1H), 8.26 (m, 2H), 7.56 (d, J= 8.0 Hz, 1H), 7.44 (m, 7H), 7.29 (m, 6H), 6.93 (s, 2H), 6.35 (s, 2H), 2.90 (m, 6H), 2.68 (m, 6H), 2.24 (s, 6H), 2.19 (m, 2H)。 Synthesis of PLC-11: General procedure for PLC-11 : Install a 10 mL vial with a stir bar. Add compound PLC-11.1 (30.0 mg, 0.058 mmol), PLC-11.2 (33.8 mg, 0.073 mmol), EDC•HCl (55.6 mg, 0.290 mmol) and DMAP•TsOH (34.8 mg, 0.116 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthylamide as a dark green solid Imine-BODIPY PLC-11 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimine-BODIPY PLC-11 , 40.0 mg, 72% yield. MS ( APCI) : Calcd . for C6iH44BF2N3O4S ([MH] - ) = 963 Found : 963. 1 H NMR (400 MHz, CDCl 3 ) 8.81 (d, J = 8.0 Hz, 2H), 8.68 (d, J = 8.0 Hz, 1H), 8.48 (d, J = 8.0 Hz, 1H), 8.26 (m, 2H), 7.56 (d, J = 8.0 Hz, 1H), 7.44 (m, 7H), 7.29 (m, 6H), 6.93 (s, 2H), 6.35 (s, 2H), 2.90 (m, 6H), 2.68 (m, 6H), 2.24 (s, 6H), 2.19 (m, 2H).

合成 PLC-12 PLC-12 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-12.1(30.0 mg,0.051 mmol)、 PLC-12.2(29.8 mg,0.064 mmol)、EDC•HCl (48.9 mg,0.255 mmol)及DMAP•TsOH (30.6 mg,0.102 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗綠色固體之純RL-萘醯亞胺-BODIPY PLC-12。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-12,31.0 mg,61%產率。MS (APCI):針對C 59H 38BCl 2F 2N 3O 4S ([M+H] +)計算值= 1005實測值:1005。 1H NMR (400 MHz, CDCl 3) 8.81 (m, 2H), 8.68 (d, J= 8.0 Hz, 1H), 8.48 (d, J= 8.0 Hz, 1H), 8.26 (m, 2H), 7.56 (d, J= 8.0 Hz, 1H), 7.43 (m, 7H), 7.31 (m, 6H), 7.25 (m, 2H), 6.37 (s, 2H), 2.93 (m, 4H), 2.87 (d, J= 7.6 Hz, 2H), 2.69 (m, 6H), 2.24 (s, 6H), 2.19 (ddd, J= 7.6 Hz, 7.6 Hz, 7.6 Hz, 2H)。 Synthesis of PLC-12 : General procedure for PLC-12 : Install a 10 mL vial with a stir bar. Add compound PLC-12.1 (30.0 mg, 0.051 mmol), PLC-12.2 (29.8 mg, 0.064 mmol), EDC•HCl (48.9 mg, 0.255 mmol) and DMAP•TsOH (30.6 mg, 0.102 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc (0 to 5%) with DCM as eluent to give pure RL-naphthoyl as a dark green solid Imine-BODIPY PLC-12 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimine-BODIPY PLC-12 , 31.0 mg, 61% yield. MS ( APCI ) : Calcd . for C59H38BCl2F2N3O4S ([M+H] + ) = 1005 Found: 1005. 1 H NMR (400 MHz, CDCl 3 ) 8.81 (m, 2H), 8.68 (d, J = 8.0 Hz, 1H), 8.48 (d, J = 8.0 Hz, 1H), 8.26 (m, 2H), 7.56 ( d, J = 8.0 Hz, 1H), 7.43 (m, 7H), 7.31 (m, 6H), 7.25 (m, 2H), 6.37 (s, 2H), 2.93 (m, 4H), 2.87 (d, J = 7.6 Hz, 2H), 2.69 (m, 6H), 2.24 (s, 6H), 2.19 (ddd, J = 7.6 Hz, 7.6 Hz, 7.6 Hz, 2H).

合成 PLC-13 PLC-13 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-13.1(30.0 mg,0.058 mmol)、 PLC-13.2(33.8 mg,0.073 mmol)、EDC•HCl (55.6 mg,0.290 mmol)及DMAP•TsOH (34.8 mg,0.116 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗綠色固體之純RL-萘醯亞胺-BODIPY PLC-13。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-13,29.0 mg,52%產率。MS (APCI):針對C 61H 44BF 2N 3O 4S ([M-H] -)計算值= 963實測值:963。 1H NMR (400 MHz, CDCl 3) 8.81 (m, 2H), 8.68 (d, J= 8.0 Hz, 1H), 8.48 (d, J= 8.0 Hz, 1H), 8.26 (m, 2H), 7.56 (d, J= 8.0 Hz, 1H), 7.43 (m, 9H), 7.29 (m, 6H), 7.24 (m, 2H), 2.88 (m, 6H), 2.72 (t, J= 7.2 Hz, 2H), 2.54 (m, 4H), 2.21 (ddd, J= 7.2 Hz, 7.2 Hz, 7.2 Hz, 2H)。 Synthesis of PLC-13 : General procedure for PLC-13 : Install a 10 mL vial with a stir bar. Add compound PLC-13.1 (30.0 mg, 0.058 mmol), PLC-13.2 (33.8 mg, 0.073 mmol), EDC·HCl (55.6 mg, 0.290 mmol) and DMAP·TsOH (34.8 mg, 0.116 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc (0 to 5%) with DCM as eluent to give pure RL-naphthoyl as a dark green solid Imine-BODIPY PLC-13 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimine-BODIPY PLC-13 , 29.0 mg, 52% yield. MS ( APCI ): Calcd . for C6iH44BF2N3O4S ([MH] - ) = 963 Found: 963. 1 H NMR (400 MHz, CDCl 3 ) 8.81 (m, 2H), 8.68 (d, J = 8.0 Hz, 1H), 8.48 (d, J = 8.0 Hz, 1H), 8.26 (m, 2H), 7.56 ( d, J = 8.0 Hz, 1H), 7.43 (m, 9H), 7.29 (m, 6H), 7.24 (m, 2H), 2.88 (m, 6H), 2.72 (t, J = 7.2 Hz, 2H), 2.54 (m, 4H), 2.21 (ddd, J = 7.2 Hz, 7.2 Hz, 7.2 Hz, 2H).

合成 PLC-14 PLC-14 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-14.1(30.0 mg,0.055 mmol)、 PLC-14.2(31.8 mg,0.068 mmol)、EDC•HCl (52.7 mg,0.275 mmol)及DMAP•TsOH (33.0 mg,0.110 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗綠色固體之純RL-萘醯亞胺-BODIPY PLC-14。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-14,44.0 mg,80%產率。MS (APCI):針對C 61H 44BF 2N 3O 6S ([M-H] -)計算值= 995實測值995。 1H NMR (400 MHz, CDCl 3) 8.81 (m, 2H), 8.68 (d, J= 8.0 Hz, 1H), 8.48 (d, J= 8.0 Hz, 1H), 8.26 (m, 2H), 7.56 (d, J= 8.0 Hz, 1H), 7.44 (m, 7H), 7.29 (m, 4H), 7.23 (m, 2H), 6.46 (s, 2H), 6.42 (s, 2H), 3.73 (s, 6H), 2.89 (m, 6H), 2.68 (m, 6H), 2.21 (ddd, J= 7.6 Hz, 7.6 Hz, 7.6 Hz, 2H)。 Synthesis of PLC-14 : General procedure for PLC-14 : Install a 10 mL vial with a stir bar. Add compound PLC-14.1 (30.0 mg, 0.055 mmol), PLC-14.2 (31.8 mg, 0.068 mmol), EDC•HCl (52.7 mg, 0.275 mmol) and DMAP•TsOH (33.0 mg, 0.110 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc (0 to 5%) with DCM as eluent to give pure RL-naphthoyl as a dark green solid Imine-BODIPY PLC-14 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimine-BODIPY PLC-14 , 44.0 mg, 80% yield. MS (APCI): Calcd. for C 61 H 44 BF 2 N 3 O 6 S ([MH] ) = 995 found 995. 1 H NMR (400 MHz, CDCl 3 ) 8.81 (m, 2H), 8.68 (d, J = 8.0 Hz, 1H), 8.48 (d, J = 8.0 Hz, 1H), 8.26 (m, 2H), 7.56 ( d, J = 8.0 Hz, 1H), 7.44 (m, 7H), 7.29 (m, 4H), 7.23 (m, 2H), 6.46 (s, 2H), 6.42 (s, 2H), 3.73 (s, 6H ), 2.89 (m, 6H), 2.68 (m, 6H), 2.21 (ddd, J = 7.6 Hz, 7.6 Hz, 7.6 Hz, 2H).

合成 PLC-15 PLC-15 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-15.1(22.0 mg,0.037 mmol)、 PLC-15.2(20.7 mg,0.046 mmol)、EDC•HCl (35.5 mg,0.185 mmol)及DMAP•TsOH (22.2 mg,0.074 mmol),接著添加無水DCM (1.5 ml)及THF (1.5 ml)。將反應混合物加熱上至60℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗綠色固體之純RL-萘醯亞胺-BODIPY PLC-15。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-15,6.0 mg,16%產率。MS (APCI):針對C 67H 52BF 2N 3O 5([M-H] -)計算值= 1027實測值:1027。 1H NMR (400 MHz, CDCl 3) 8.68 (d, J= 8.0 Hz, 1H), 8.64 (d, J= 8.0 Hz, 1H), 8.30 (m, 2H), 8.11 (dd, J= 8.0 Hz, J= 1.6 Hz, 1H), 7.99 (d, J= 8.0 Hz, 1H), 7.56 (td, J= 8.0 Hz, J= 1.6 Hz, 1H), 7.41 (m, 10H), 7.31 (m, 3H), 7.00 (s, 2H), 6.19 (s, 2H), 2.89 (t, J= 7.6 Hz, 2H), 2.71 (t, J= 7.6 Hz, 2H), 2.51 (s, 6H), 2.21 (m, 2H), 1.98 (m, 16H)。 Synthesis of PLC-15 : General procedure for PLC-15 : Install a 10 mL vial with a stir bar. Add compound PLC-15.1 (22.0 mg, 0.037 mmol), PLC-15.2 (20.7 mg, 0.046 mmol), EDC HCl (35.5 mg, 0.185 mmol) and DMAP TsOH (22.2 mg, 0.074 mmol) in this vial, Then dry DCM (1.5 ml) and THF (1.5 ml) were added. The reaction mixture was heated up to 60 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc (0 to 5%) with DCM as eluent to give pure RL-naphthoyl as a dark green solid Imine-BODIPY PLC-15 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-15 , 6.0 mg, 16% yield. MS (APCI): Calcd. for C67H52BF2N3O5 ( [ MH ] - ) = 1027 Found : 1027. 1 H NMR (400 MHz, CDCl 3 ) 8.68 (d, J = 8.0 Hz, 1H), 8.64 (d, J = 8.0 Hz, 1H), 8.30 (m, 2H), 8.11 (dd, J = 8.0 Hz, J = 1.6 Hz, 1H), 7.99 (d, J = 8.0 Hz, 1H), 7.56 (td, J = 8.0 Hz, J = 1.6 Hz, 1H), 7.41 (m, 10H), 7.31 (m, 3H) , 7.00 (s, 2H), 6.19 (s, 2H), 2.89 (t, J = 7.6 Hz, 2H), 2.71 (t, J = 7.6 Hz, 2H), 2.51 (s, 6H), 2.21 (m, 2H), 1.98 (m, 16H).

合成 PLC-16 PLC-16.3 之一般程序:將100 mL 2頸圓底燒瓶安裝空氣冷凝器及攪拌棒。向該燒瓶中添加化合物1,4,5,6-四氫苯并[6,7]環庚[1,2-b]吡咯 PLC-16.1(542.0 mg,2.96 mmol)及4-羥基-2,6-二氟苯甲醛 PLC-16.2(222.6 mg,1.4 mmol),接著添加無水二氯甲烷(20 ml)。將反應混合物用Ar噴射30分鐘,然後添加p-TsOH•H 2O (17.0 mg,0.14 mmol)。將反應溶液在室溫下攪拌2小時。於醛起始物質完全消耗後,添加DDQ (381.4 mg,1.68 mmol)。將反應在室溫下保持1小時。然後添加Et 3N (1.2 mL,8.40 mmol)及將反應在室溫下保持30分鐘,接著在室溫下添加BF 3•OEt 2(2.1 mL,12.6 mmol)。將反應混合物在室溫下再保持1小時。將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之己烷(0至80%至90%)作為溶離劑純化,以得到呈藍金色固體之純BODIPY PLC-16.3,279.0 mg,36%產率。MS (APCI):針對C 33H 25BF 4N 2O ([M-H] -)計算值= 552實測值:552。 Synthesis of PLC-16 : General procedure of PLC-16.3 : Install an air condenser and a stirring bar in a 100 mL 2-neck round bottom flask. Add compound 1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-b]pyrrole PLC-16.1 (542.0 mg, 2.96 mmol) and 4-hydroxy-2, 6-Difluorobenzaldehyde PLC-16.2 (222.6 mg, 1.4 mmol) followed by addition of anhydrous dichloromethane (20 ml). The reaction mixture was sparged with Ar for 30 min, then p-TsOH•H 2 O (17.0 mg, 0.14 mmol) was added. The reaction solution was stirred at room temperature for 2 hours. After complete consumption of the aldehyde starting material, DDQ (381.4 mg, 1.68 mmol) was added. The reaction was maintained at room temperature for 1 hour. Then Et3N (1.2 mL, 8.40 mmol) was added and the reaction was kept at room temperature for 30 minutes, followed by the addition of BF3OEt2 (2.1 mL, 12.6 mmol) at room temperature. The reaction mixture was kept at room temperature for another 1 hour. The reaction mixture was loaded on silica gel and purified by flash chromatography using DCM in hexane (0 to 80% to 90%) as eluent to give pure BODIPY PLC-16.3 as a blue-golden solid, 279.0 mg, 36% Yield. MS ( APCI): Calcd . for C33H25BF4N2O ([MH] - ) = 552 Found: 552.

PLC-16 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-16.3(30.0 mg,0.054 mmol)、 PLC-16.4(30.5 mg,0.068 mmol)、EDC•HCl (51.8 mg,0.270 mmol)及DMAP•TsOH (32.4 mg,0.108 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈綠紫色固體之純RL-萘醯亞胺-BODIPY PLC-16。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-16,25.0 mg,47%產率。MS (APCI):針對C 61H 42BF 4N 3O 5([M-H] -)計算值= 983實測值:983。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.65 (d, J= 8.0 Hz, 1H), 8.61 (d, J= 8.0 Hz, 1H), 8.13 (dd, J= 8.0 Hz, J= 1.6 Hz, 1H), 8.02 (m, 3H), 7.60 (td, J= 8.0 Hz, J= 1.6 Hz, 1H), 7.39 (m, 13H), 7.04 (m, 2H), 6.63 (s, 2H), 2.91 (t, J= 7.2 Hz, 2H), 2.77 (t, J= 7.2 Hz, 2H), 2.64 (m, 4H), 2.70 (dd, J= 6.8 Hz, J= 6.8 Hz, 6H), 2.20 (m, 9H)。 General procedure for PLC-16 : Install a 10 mL vial with a stir bar. Add compound PLC-16.3 (30.0 mg, 0.054 mmol), PLC-16.4 (30.5 mg, 0.068 mmol), EDC•HCl (51.8 mg, 0.270 mmol) and DMAP•TsOH (32.4 mg, 0.108 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthoyl as a green-purple solid Imine-BODIPY PLC-16 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimine-BODIPY PLC-16 , 25.0 mg, 47% yield. MS ( APCI) : Calcd . for C6iH42BF4N3O5 ([MH] - ) = 983 Found: 983. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.65 (d, J = 8.0 Hz, 1H), 8.61 (d, J = 8.0 Hz, 1H), 8.13 (dd, J = 8.0 Hz, J = 1.6 Hz, 1H), 8.02 (m, 3H), 7.60 (td, J = 8.0 Hz, J = 1.6 Hz, 1H), 7.39 (m, 13H), 7.04 (m, 2H), 6.63 (s, 2H), 2.91 ( t, J = 7.2 Hz, 2H), 2.77 (t, J = 7.2 Hz, 2H), 2.64 (m, 4H), 2.70 (dd, J = 6.8 Hz, J = 6.8 Hz, 6H), 2.20 (m, 9H).

合成 PLC-17 PLC-17.3 之一般程序:將100 mL 2頸圓底燒瓶安裝空氣冷凝器及攪拌棒。向該燒瓶中添加化合物4,5-二氫-1H-苯并[g]吲哚 PLC-17.1(507.7 mg,3.0 mmol)及4-羥基-2,6-二氟苯甲醛 PLC-17.2(225.9 mg,1.43 mmol),接著添加無水二氯甲烷(20 ml)。將反應混合物用Ar噴射30分鐘,然後添加p-TsOH•H 2O (17.4 mg,0.143 mmol)。將反應溶液在室溫下攪拌2小時。於醛起始物質完全消耗後,添加DDQ (392.4 mg,1.74 mmol)。將反應在室溫下保持1小時。然後添加Et 3N (1.2 mL,8.64 mmol)及將反應在室溫下保持30分鐘,接著在室溫下添加BF 3•OEt 2(1.6 mL,12.96 mmol)。將反應混合物在室溫下再保持1小時。將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之己烷(0至80%至90%)作為溶離劑純化,以得到呈棕金色固體之純BODIPY PLC-17.3,211.0 mg,28%產率。MS (APCI):針對C 31H 21BF 4N 2O ([M-H] -)計算值= 524實測值:524。 1H NMR (400 MHz, CDCl 3) 8.80 (d, J= 8.0 Hz, 2H), 7.44 (m, 2H), 7.32 (m, 2H), 7.23 (m, 2H), 6.57 (m, 2H), 6.49 (s, 2H), 2.92 (m, 4H), 2.69 (m, 4H)。 Synthesis of PLC-17 : General procedure of PLC-17.3 : Install an air condenser and a stirring bar in a 100 mL 2-neck round bottom flask. To this flask was added compound 4,5-dihydro-1H-benzo[g]indole PLC-17.1 (507.7 mg, 3.0 mmol) and 4-hydroxy-2,6-difluorobenzaldehyde PLC-17.2 (225.9 mg, 1.43 mmol), followed by the addition of anhydrous dichloromethane (20 ml). The reaction mixture was sparged with Ar for 30 min, then p-TsOH•H 2 O (17.4 mg, 0.143 mmol) was added. The reaction solution was stirred at room temperature for 2 hours. After complete consumption of the aldehyde starting material, DDQ (392.4 mg, 1.74 mmol) was added. The reaction was maintained at room temperature for 1 hour. Then Et3N (1.2 mL, 8.64 mmol) was added and the reaction was kept at room temperature for 30 minutes, followed by the addition of BF3OEt2 (1.6 mL, 12.96 mmol) at room temperature. The reaction mixture was kept at room temperature for another 1 hour. The reaction mixture was loaded on silica gel and purified by flash chromatography using DCM in hexane (0 to 80% to 90%) as eluent to give pure BODIPY PLC-17.3 as a brown-golden solid, 211.0 mg, 28% Yield. MS ( APCI): Calcd . for C31H21BF4N2O ([MH] ) = 524 Found: 524. 1 H NMR (400 MHz, CDCl 3 ) 8.80 (d, J = 8.0 Hz, 2H), 7.44 (m, 2H), 7.32 (m, 2H), 7.23 (m, 2H), 6.57 (m, 2H), 6.49 (s, 2H), 2.92 (m, 4H), 2.69 (m, 4H).

PLC-17 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-17.3(30.0 mg,0.057 mmol)、 PLC-17.4(32.1 mg,0.072 mmol)、EDC•HCl (54.6 mg,0.285 mmol)及DMAP•TsOH (34.2 mg,0.114 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗綠色固體之純RL-萘醯亞胺-BODIPY PLC-17。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-17,38.0 mg,70%產率。MS (APCI):針對C 59H 38BF 4N 3O 5([M-H] -)計算值= 955實測值:955。 1H NMR (400 MHz, CDCl 3) 8.80 (m, 2H), 8.68 (d, J= 8.0 Hz, 1H), 8.64 (d, J= 8.0 Hz, 1H), 8.11 (dd, J= 8.0 Hz, J= 1.6 Hz, 1H), 7.99 (d, J= 8.0 Hz, 1H), 7.56 (td, J= 8.0 Hz, J= 1.6 Hz, 1H), 7.38 (m, 12H), 7.24 (m, 1H), 6.94 (m, 2H), 6.50 (s, 2H), 2.90 (m, 6H), 2.70 (dd, J= 6.8 Hz, J= 6.8 Hz, 6H), 2.19 (m, 2H)。 General procedure for PLC-17 : Install a 10 mL vial with a stir bar. Add compound PLC-17.3 (30.0 mg, 0.057 mmol), PLC-17.4 (32.1 mg, 0.072 mmol), EDC•HCl (54.6 mg, 0.285 mmol) and DMAP•TsOH (34.2 mg, 0.114 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthylamide as a dark green solid Imine-BODIPY PLC-17 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-17 , 38.0 mg, 70% yield. MS ( APCI) : Calcd . for C59H38BF4N3O5 ([MH] - ) = 955 Found: 955. 1 H NMR (400 MHz, CDCl 3 ) 8.80 (m, 2H), 8.68 (d, J = 8.0 Hz, 1H), 8.64 (d, J = 8.0 Hz, 1H), 8.11 (dd, J = 8.0 Hz, J = 1.6 Hz, 1H), 7.99 (d, J = 8.0 Hz, 1H), 7.56 (td, J = 8.0 Hz, J = 1.6 Hz, 1H), 7.38 (m, 12H), 7.24 (m, 1H) , 6.94 (m, 2H), 6.50 (s, 2H), 2.90 (m, 6H), 2.70 (dd, J = 6.8 Hz, J = 6.8 Hz, 6H), 2.19 (m, 2H).

合成 PLC-18 PLC-18 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-18.1(30.0 mg,0.054 mmol)、 PLC-18.2(31.6 mg,0.068 mmol)、EDC•HCl (51.8 mg,0.270 mmol)及DMAP•TsOH (32.4 mg,0.108 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗紫色固體之純RL-萘醯亞胺-BODIPY PLC-18。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-18,43.0 mg,78%產率。MS (APCI):針對C 63H 48BF 2N 3O 6S ([M-H] -)計算值= 1023實測值:1023。 1H NMR (400 MHz, CDCl 3) 8.68 (d, J= 8.0 Hz, 1H), 8.47 (d, J= 8.0 Hz, 1H), 8.26 (m, 2H), 8.11 (m, 2H), 7.56 (d, J= 8.0 Hz, 1H), 7.44 (m, 5H), 7.31 (m, 6H), 7.21 (m, 2H), 6.50 (s, 2H), 6.49 (s, 2H), 3.77 (s, 6H), 2.89 (t, J= 7.2 Hz, 2H), 2.71 (t, J= 7.2 Hz, 2H), 2.62 (m, 4H), 2.28 (m, 6H), 2.02 (ddd, J= 7.2 Hz, J= 7.2 Hz, J= 7.2 Hz, 4H)。 Synthesis of PLC-18 : General procedure for PLC-18 : Install a 10 mL vial with a stir bar. Add compound PLC-18.1 (30.0 mg, 0.054 mmol), PLC-18.2 (31.6 mg, 0.068 mmol), EDC·HCl (51.8 mg, 0.270 mmol) and DMAP·TsOH (32.4 mg, 0.108 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthylidene as a dark purple solid Amine - BODIPY PLC-18 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimine-BODIPY PLC-18 , 43.0 mg, 78% yield. MS (APCI) : Calcd . for C63H48BF2N3O6S ([MH] - ) = 1023 Found : 1023. 1 H NMR (400 MHz, CDCl 3 ) 8.68 (d, J = 8.0 Hz, 1H), 8.47 (d, J = 8.0 Hz, 1H), 8.26 (m, 2H), 8.11 (m, 2H), 7.56 ( d, J = 8.0 Hz, 1H), 7.44 (m, 5H), 7.31 (m, 6H), 7.21 (m, 2H), 6.50 (s, 2H), 6.49 (s, 2H), 3.77 (s, 6H ), 2.89 (t, J = 7.2 Hz, 2H), 2.71 (t, J = 7.2 Hz, 2H), 2.62 (m, 4H), 2.28 (m, 6H), 2.02 (ddd, J = 7.2 Hz, J = 7.2 Hz, J = 7.2 Hz, 4H).

合成 PLC-19 PLC-19 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-19.1(30.0 mg,0.057 mmol)、 PLC-19.2(33.3 mg,0.072 mmol)、EDC•HCl (54.6 mg,0.285 mmol)及DMAP•TsOH (34.2 mg,0.114 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗藍綠色固體之純RL-萘醯亞胺-BODIPY PLC-19。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-19,43.0 mg,78%產率。MS (APCI):針對C 59H 38BF 4N 3O 4S ([M-H] -)計算值= 971實測值:971。 1H NMR (400 MHz, CDCl 3) 8.80 (m, 2H), 8.67 (d, J= 8.0 Hz, 1H), 8.47 (d, J= 8.0 Hz, 1H), 8.25 (m, 2H), 7.56 (d, J= 8.0 Hz, 1H), 7.44 (m, 7H), 7.31 (m, 5H), 7.24 (m, 1H), 6.94 (m, 2H), 6.50 (s, 2H), 2.91 (m, 6H), 2.70 (m, 6H), 2.20 (ddd, J= 7.6 Hz, J= 7.6 Hz, J= 7.6 Hz, 4H)。 Synthesis of PLC-19 : General procedure for PLC-19 : Install a 10 mL vial with a stir bar. Add compound PLC-19.1 (30.0 mg, 0.057 mmol), PLC-19.2 (33.3 mg, 0.072 mmol), EDC HCl (54.6 mg, 0.285 mmol) and DMAP TsOH (34.2 mg, 0.114 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthalene as a dark blue-green solid Amide-BODIPY PLC-19 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-19 , 43.0 mg, 78% yield. MS (APCI): Calcd . for C59H38BF4N3O4S ([MH] - ) = 971 Found : 971. 1 H NMR (400 MHz, CDCl 3 ) 8.80 (m, 2H), 8.67 (d, J = 8.0 Hz, 1H), 8.47 (d, J = 8.0 Hz, 1H), 8.25 (m, 2H), 7.56 ( d, J = 8.0 Hz, 1H), 7.44 (m, 7H), 7.31 (m, 5H), 7.24 (m, 1H), 6.94 (m, 2H), 6.50 (s, 2H), 2.91 (m, 6H ), 2.70 (m, 6H), 2.20 (ddd, J = 7.6 Hz, J = 7.6 Hz, J = 7.6 Hz, 4H).

合成 PLC-20 PLC-20 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-20.1(30.0 mg,0.054 mmol)、 PLC-20.2(31.6 mg,0.068 mmol)、EDC•HCl (51.8 mg,0.270 mmol)及DMAP•TsOH (32.4 mg,0.108 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗藍綠色固體之純RL-萘醯亞胺-BODIPY PLC-20。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-20,30.0 mg,56%產率。MS (APCI):針對C 61H 42BF 4N 3O 4S ([M-H] -)計算值= 999實測值:999。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.65 (d, J= 8.0 Hz, 1H), 8.44 (d, J= 8.0 Hz, 1H), 8.28 (m, 2H), 8.03 (m, 2H), 7.61 (d, J= 8.0 Hz, 1H), 7.47 (m, 5H), 7.33 (m, 8H), 7.04 (m, 2H), 6.63 (s, 2H), 2.91 (t, J= 7.2 Hz, 2H), 2.76 (t, J= 7.2 Hz, 2H), 2.64 (m, 4H), 2.35 (bs, 3H), 2.13 (m, 6H)。 Synthesis of PLC-20 : General procedure for PLC-20 : Install a 10 mL vial with a stir bar. Add compound PLC-20.1 (30.0 mg, 0.054 mmol), PLC-20.2 (31.6 mg, 0.068 mmol), EDC•HCl (51.8 mg, 0.270 mmol) and DMAP•TsOH (32.4 mg, 0.108 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthalene as a dark blue-green solid Imide-BODIPY PLC-20 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-20 , 30.0 mg, 56% yield. MS ( APCI) : Calcd . for C6iH42BF4N3O4S ([MH] - ) = 999 Found: 999. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.65 (d, J = 8.0 Hz, 1H), 8.44 (d, J = 8.0 Hz, 1H), 8.28 (m, 2H), 8.03 (m, 2H), 7.61 (d, J = 8.0 Hz, 1H), 7.47 (m, 5H), 7.33 (m, 8H), 7.04 (m, 2H), 6.63 (s, 2H), 2.91 (t, J = 7.2 Hz, 2H ), 2.76 (t, J = 7.2 Hz, 2H), 2.64 (m, 4H), 2.35 (bs, 3H), 2.13 (m, 6H).

合成 PLC-21 PLC-21 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-21.1(30.0 mg,0.055 mmol)、 PLC-21.2(31.0 mg,0.069 mmol)、EDC•HCl (52.7 mg,0.275 mmol)及DMAP•TsOH (33.0 mg,0.110 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗藍綠色固體之純RL-萘醯亞胺-BODIPY PLC-21。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-21,39.0 mg,72%產率。MS (APCI):針對C 63H 48BF 2N 3O 5([M-H]-)計算值= 975實測值:975。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.76 (m, 2H), 8.66 (d, J = 8.0 Hz, 1H), 8.61 (d, J = 8.0 Hz, 1H), 8.13 (dd, J = 8.0 Hz, J = 1.6 Hz, 1H), 8.02 (d, J = 8.0 Hz, 1H), 7.60 (td, J = 8.0 Hz, J = 1.6 Hz, 1H), 7.38 (m, 13H), 7.01 (s, 2H), 2.91 (m, 6H), 2.72 (t, J = 7.2 Hz, 2H), 2.57 (m, 4H), 2.25 (s, 6H), 2.23 (m, 2H), 1.42 (s, 6H)。 Synthesis of PLC-21 : General procedure for PLC-21 : Install a 10 mL vial with a stir bar. Add compound PLC-21.1 (30.0 mg, 0.055 mmol), PLC-21.2 (31.0 mg, 0.069 mmol), EDC•HCl (52.7 mg, 0.275 mmol) and DMAP•TsOH (33.0 mg, 0.110 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthalene as a dark blue-green solid Amide-BODIPY PLC-21 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-21 , 39.0 mg, 72% yield. MS ( APCI ) : Calcd. for C63H48BF2N3O5 ([MH]-) = 975 Found: 975. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.76 (m, 2H), 8.66 (d, J = 8.0 Hz, 1H), 8.61 (d, J = 8.0 Hz, 1H), 8.13 (dd, J = 8.0 Hz, J = 1.6 Hz, 1H), 8.02 (d, J = 8.0 Hz, 1H), 7.60 (td, J = 8.0 Hz, J = 1.6 Hz, 1H), 7.38 (m, 13H), 7.01 (s, 2H), 2.91 (m, 6H), 2.72 (t, J = 7.2 Hz, 2H), 2.57 (m, 4H), 2.25 (s, 6H), 2.23 (m, 2H), 1.42 (s, 6H).

合成 PLC-22 PLC-22 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-22.1(30.0 mg,0.055 mmol)、 PLC-22.2(29.0 mg,0.069 mmol)、EDC•HCl (52.7 mg,0.275 mmol)及DMAP•TsOH (33.0 mg,0.110 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗藍綠色固體之純RL-萘醯亞胺-BODIPY PLC-22。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-22,33.0 mg,63%產率。MS (APCI):針對C 61H 44BF 2N 3O 5([M-H] -)計算值= 947實測值:947。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.67 (d, J= 8.0 Hz, 1H), 8.62 (d, J= 8.0 Hz, 1H), 8.14 (dd, J= 8.0 Hz, J= 1.6 Hz, 1H), 8.05 (m, 2H), 8.02 (d, J= 8.0 Hz, 1H), 7.66 (m, 2H), 7.60 (td, J= 8.0 Hz, J= 1.6 Hz, 1H), 7.37 (m, 11H), 7.01 (s, 2H), 6.46 (s, 2H), 4.04 (s, 2H), 2.63 (m, 4H), 2.30 (m, 9H), 2.04 (m, 4H)。 Synthesis of PLC-22 : General procedure for PLC-22 : Install a 10 mL vial with a stir bar. Add compound PLC-22.1 (30.0 mg, 0.055 mmol), PLC-22.2 (29.0 mg, 0.069 mmol), EDC•HCl (52.7 mg, 0.275 mmol) and DMAP•TsOH (33.0 mg, 0.110 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthalene as a dark blue-green solid Amide-BODIPY PLC-22 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimine-BODIPY PLC-22 , 33.0 mg, 63% yield. MS ( APCI) : Calcd. for C6iH44BF2N3O5 ([MH] - ) = 947 Found: 947 . 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.67 (d, J = 8.0 Hz, 1H), 8.62 (d, J = 8.0 Hz, 1H), 8.14 (dd, J = 8.0 Hz, J = 1.6 Hz, 1H), 8.05 (m, 2H), 8.02 (d, J = 8.0 Hz, 1H), 7.66 (m, 2H), 7.60 (td, J = 8.0 Hz, J = 1.6 Hz, 1H), 7.37 (m, 11H), 7.01 (s, 2H), 6.46 (s, 2H), 4.04 (s, 2H), 2.63 (m, 4H), 2.30 (m, 9H), 2.04 (m, 4H).

合成 PLC-23 PLC-23 之一般程序:將10 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-23.1(30.0 mg,0.051 mmol)、 PLC-23.2(27.0 mg,0.064 mmol)、EDC•HCl (48.9 mg,0.255 mmol)及DMAP•TsOH (30.6 mg,0.102 mmol),接著添加無水DCM (1.5 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至5%)作為溶離劑純化,以得到呈暗藍綠色固體之純RL-萘醯亞胺-BODIPY PLC-23。將該固體用MeOH (10 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-23,17.0 mg,34%產率。MS (APCI):針對C 59H 38BCl 2F 2N 3O 5([M-H] -)計算值= 988實測值:988。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.67 (d, J= 8.0 Hz, 1H), 8.62 (d, J= 8.0 Hz, 1H), 8.14 (dd, J= 8.0 Hz, J= 1.6 Hz, 1H), 8.05 (m, 2H), 8.03 (d, J= 8.0 Hz, 1H), 7.65 (m, 2H), 7.60 (td, J= 8.0 Hz, J= 1.6 Hz, 1H), 7.43 (s, 2H), 7.38 (m, 11H), 6.48 (s, 2H), 4.06 (s, 2H), 2.64 (m, 4H), 2.33 (bs, 3H), 2.05 (m, 4H)。 Synthesis of PLC-23 : General procedure for PLC-23 : Install a 10 mL vial with a stir bar. Add compound PLC-23.1 (30.0 mg, 0.051 mmol), PLC-23.2 (27.0 mg, 0.064 mmol), EDC•HCl (48.9 mg, 0.255 mmol) and DMAP•TsOH (30.6 mg, 0.102 mmol) in this vial, Then dry DCM (1.5 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure RL-naphthalene as a dark blue-green solid Imide-BODIPY PLC-23 . The solid was further triturated with MeOH (10 ml) to give RL-naphthylimide-BODIPY PLC-23 , 17.0 mg, 34% yield. MS ( APCI ) : Calcd. for C59H38BCl2F2N3O5 ([MH] - ) = 988 Found: 988 . 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.67 (d, J = 8.0 Hz, 1H), 8.62 (d, J = 8.0 Hz, 1H), 8.14 (dd, J = 8.0 Hz, J = 1.6 Hz, 1H), 8.05 (m, 2H), 8.03 (d, J = 8.0 Hz, 1H), 7.65 (m, 2H), 7.60 (td, J = 8.0 Hz, J = 1.6 Hz, 1H), 7.43 (s, 2H), 7.38 (m, 11H), 6.48 (s, 2H), 4.06 (s, 2H), 2.64 (m, 4H), 2.33 (bs, 3H), 2.05 (m, 4H).

合成 PLC-24 PLC-24 之一般程序:將含於DCM (5 mL)中之化合物 PLC-24.1(16 mg,0.027 mmol)、化合物 PLC-24.2(19 mg,0.04 mmol)、EDC•HCl (52 mg,0.27 mmol)及DMAP/p-TsOH (8 mg,0.027 mmol)之混合物在室溫下攪拌過夜。然後將所得混合物裝載在矽膠上,藉由急驟層析法使用己烷/DCM (50% à 100% DCM),然後DCM/乙酸乙酯(0% à 5%乙酸乙酯)之溶離劑純化。收集主紅色溶離份及在減壓下濃縮。將所得固體用甲醇研磨,過濾及於空氣中乾燥,以得到暗紅色固體(18 mg,64.6%產率)。LCMS (APCI-):針對C 61H 42BCl 2F 2N 3O 4S (M-)計算值= 1031.23;實測值:1031。 1H NMR (400 MHz, d 2-TCE) δ 8.56 (d, J= 8.2 Hz, 1H), 8.35 (d, J= 8.0 Hz, 1H), 8.19 (dd, J= 8.8, 4.5 Hz, 2H), 7.97 (s, 2H), 7.51 (d, J= 8.0 Hz, 1H), 7.38 (dt, J= 7.3, 2.4 Hz, 5H), 7.29 (d, J= 9.3 Hz, 6H), 7.24 - 7.15 (m, 4H), 6.40 (s, 2H), 2.82 (t, J= 7.5 Hz, 2H), 2.67 (t, J= 7.4 Hz, 2H), 2.54 (d, J= 6.8 Hz, 4H), 2.24 (s, 4H), 2.11 (td, J= 13.4, 11.8, 5.9 Hz, 2H), 2.04 - 1.89 (m, 4H)。 Synthesis of PLC-24 : General procedure for PLC-24 : Compound PLC-24.1 (16 mg, 0.027 mmol), compound PLC-24.2 (19 mg, 0.04 mmol), EDC•HCl (52 mg, 0.27 mmol) contained in DCM (5 mL) ) and DMAP/p-TsOH (8 mg, 0.027 mmol) was stirred overnight at room temperature. The resulting mixture was then loaded onto silica gel and purified by flash chromatography using an eluent of hexane/DCM (50% à 100% DCM), then DCM/ethyl acetate (0% à 5% ethyl acetate). The predominantly red fractions were collected and concentrated under reduced pressure. The resulting solid was triturated with methanol, filtered and dried in air to give a dark red solid (18 mg, 64.6% yield). LCMS ( APCI-): Calcd. for C61H42BCl2F2N3O4S (M-) = 1031.23 ; found : 1031. 1 H NMR (400 MHz, d 2 -TCE) δ 8.56 (d, J = 8.2 Hz, 1H), 8.35 (d, J = 8.0 Hz, 1H), 8.19 (dd, J = 8.8, 4.5 Hz, 2H) , 7.97 (s, 2H), 7.51 (d, J = 8.0 Hz, 1H), 7.38 (dt, J = 7.3, 2.4 Hz, 5H), 7.29 (d, J = 9.3 Hz, 6H), 7.24 - 7.15 ( m, 4H), 6.40 (s, 2H), 2.82 (t, J = 7.5 Hz, 2H), 2.67 (t, J = 7.4 Hz, 2H), 2.54 (d, J = 6.8 Hz, 4H), 2.24 ( s, 4H), 2.11 (td, J = 13.4, 11.8, 5.9 Hz, 2H), 2.04 - 1.89 (m, 4H).

合成 PLC-25 PLC-25 之一般程序:將含於DCM (4 mL)中之化合物 PLC-2.1(16 mg,0.034 mmol)、化合物 Ex-5(27 mg,0.051 mmol)、EDC•HCl (60 mg,0.31 mmol)及DMAP/p-TsOH (8.8 mg,0.03 mmol)之混合物在室溫下攪拌過夜。然後將所得混合物裝載在矽膠上,藉由急驟層析法使用DCM/乙酸乙酯(0% à 10%乙酸乙酯)之溶離劑純化。收集主紅色溶離份及在減壓下濃縮至0.5 mL,然後添加10 mL甲醇。將所得沉澱物過濾及於空氣中乾燥,以得到暗紅色固體(23 mg,62%產率)。LCMS (APCI-):針對C 69H 44BCl 2F 8N 3O 5(M-)計算值= 1227.26;實測值:1227。 1H NMR (400 MHz, d 2-TCE) δ 8.58 (dd, J= 19.5, 8.1 Hz, 2H), 8.18 (d, J= 2.2 Hz, 1H), 8.06 (d, J= 8.1 Hz, 1H), 8.02 (d, J= 1.5 Hz, 2H), 7.97 (t, J= 4.6 Hz, 2H), 7.87 (s, 1H), 7.72 (dd, J= 8.6, 2.1 Hz, 1H), 7.49 (d, J= 8.6 Hz, 1H), 7.39 (d, J= 8.2 Hz, 2H), 7.34 (d, J= 8.3 Hz, 1H), 7.32 - 7.25 (m, 6H), 7.25 - 7.18 (m, 4H), 6.40 (s, 2H), 2.82 (t, J= 7.5 Hz, 2H), 2.67 (t, J= 7.4 Hz, 2H), 2.61 - 2.50 (m, 4H), 2.24 (s, 4H), 2.13 (q, J= 7.4 Hz, 2H), 2.04 - 1.90 (m, 4H)。 Synthesis of PLC-25 : General procedure for PLC-25 : Compound PLC-2.1 (16 mg, 0.034 mmol), compound Ex-5 (27 mg, 0.051 mmol), EDC·HCl (60 mg, 0.31 mmol) in DCM (4 mL) ) and DMAP/p-TsOH (8.8 mg, 0.03 mmol) was stirred overnight at room temperature. The resulting mixture was then loaded onto silica gel and purified by flash chromatography using the eluent of DCM/ethyl acetate (0%→10% ethyl acetate). The main red fractions were collected and concentrated under reduced pressure to 0.5 mL, then 10 mL of methanol was added. The resulting precipitate was filtered and air dried to give a dark red solid (23 mg, 62% yield). LCMS (APCI-): Calcd. for C69H44BCl2F8N3O5 ( M- ) = 1227.26 ; found: 1227. 1 H NMR (400 MHz, d 2 -TCE) δ 8.58 (dd, J = 19.5, 8.1 Hz, 2H), 8.18 (d, J = 2.2 Hz, 1H), 8.06 (d, J = 8.1 Hz, 1H) , 8.02 (d, J = 1.5 Hz, 2H), 7.97 (t, J = 4.6 Hz, 2H), 7.87 (s, 1H), 7.72 (dd, J = 8.6, 2.1 Hz, 1H), 7.49 (d, J = 8.6 Hz, 1H), 7.39 (d, J = 8.2 Hz, 2H), 7.34 (d, J = 8.3 Hz, 1H), 7.32 - 7.25 (m, 6H), 7.25 - 7.18 (m, 4H), 6.40 (s, 2H), 2.82 (t, J = 7.5 Hz, 2H), 2.67 (t, J = 7.4 Hz, 2H), 2.61 - 2.50 (m, 4H), 2.24 (s, 4H), 2.13 (q , J = 7.4 Hz, 2H), 2.04 - 1.90 (m, 4H).

合成 PLC-26 化合物 PLC-26.1(6-(4-(第三丁基)-2-硝基苯氧基)-1H,3H-苯并[de]異𠳭唏-1,3-二酮):向1L 2N圓底燒瓶中放入攪拌棒及放入鋁加熱塊中。將該燒瓶安裝翅片冷凝器、氣體適配器及流動控制器。將該燒瓶用氬氣沖洗。向該燒瓶中添加6-溴-1H,3H-苯并[de]異𠳭唏-1,3-二酮(40.0 mmol,11.084 g)及4-(第三丁基)-2-硝基苯酚(60.0 mmol,11.712 g)、NaOH (20.0 mmol,800 mg)、銅粉(20.0 mmol,1.271 g)及無水NMP (150 mL)。將燒瓶關閉及在氬氣下攪拌。將加熱塊設置至170℃及將反應混合物在此溫度下加熱過夜。LCMS指示反應完全。將反應混合物冷卻至室溫。向燒瓶中添加1N HCl (44 mL)及水(175 mL)。於攪拌約15分鐘後,過濾掉所得沉澱物,用水洗滌。將經乾燥之沉澱物溶解於溫乙酸乙酯中及溫過濾以移除少量不可溶物質。於真空中移除乙酸乙酯。將所得固體用熱甲醇研磨,然後允許冷卻至室溫。過濾掉所得沉澱物,用甲醇洗滌。將固體於真空烘箱中在100℃下乾燥。得到8.18 g (52%產率)。MS (APCI):針對C 22H 17NO 6計算值(M+H) = 392;實測值:392。 1H NMR (400 MHz,四氯乙烷-d 2) δ 8.82 (dd, J = 8.5, 1.2 Hz, 1H), 8.71 (dd, J = 7.3, 1.2 Hz, 1H), 8.49 (d, J = 8.3 Hz, 1H), 8.16 (d, J = 2.4 Hz, 1H), 7.91 (dd, J = 8.4, 7.3 Hz, 1H), 7.80 (dd, J = 8.6, 2.4 Hz, 1H), 7.34 (d, J = 8.6 Hz, 1H), 6.91 (d, J = 8.3 Hz, 1H), 1.43 (s, 9H)。 Synthesis of PLC-26 : Compound PLC-26.1 (6-(4-(tert-butyl)-2-nitrophenoxy)-1H,3H-benzo[de]isomethanol-1,3-dione): Add to 1L 2N A round bottom flask was placed with a stir bar and placed in an aluminum heating block. The flask was fitted with a finned condenser, gas adapter and flow controller. The flask was flushed with argon. To the flask was added 6-bromo-1H,3H-benzo[de]isomethan-1,3-dione (40.0 mmol, 11.084 g) and 4-(tert-butyl)-2-nitrophenol (60.0 mmol, 11.712 g), NaOH (20.0 mmol, 800 mg), copper powder (20.0 mmol, 1.271 g) and anhydrous NMP (150 mL). The flask was closed and stirred under argon. The heat block was set to 170°C and the reaction mixture was heated at this temperature overnight. LCMS indicated complete reaction. The reaction mixture was cooled to room temperature. 1N HCl (44 mL) and water (175 mL) were added to the flask. After stirring for about 15 minutes, the resulting precipitate was filtered off and washed with water. The dried precipitate was dissolved in warm ethyl acetate and filtered warm to remove a small amount of insoluble material. Ethyl acetate was removed in vacuo. The resulting solid was triturated with hot methanol, then allowed to cool to room temperature. The resulting precipitate was filtered off and washed with methanol. The solid was dried in a vacuum oven at 100°C. Obtained 8.18 g (52% yield). MS (APCI): calcd for C22H17NO6 (M+H) = 392 ; found: 392. 1 H NMR (400 MHz, tetrachloroethane-d 2 ) δ 8.82 (dd, J = 8.5, 1.2 Hz, 1H), 8.71 (dd, J = 7.3, 1.2 Hz, 1H), 8.49 (d, J = 8.3 Hz, 1H), 8.16 (d, J = 2.4 Hz, 1H), 7.91 (dd, J = 8.4, 7.3 Hz, 1H), 7.80 (dd, J = 8.6, 2.4 Hz, 1H), 7.34 (d, J = 8.6 Hz, 1H), 6.91 (d, J = 8.3 Hz, 1H), 1.43 (s, 9H).

化合物 PLC-26.2(6-(2-胺基-4-(第三丁基)苯氧基)-1H,3H-苯并[de]異𠳭唏-1,3-二酮):向250 mL 2N圓底燒瓶中放入攪拌棒及安裝翅片冷凝器、氣體適配器及流動控制器。將該燒瓶放入鋁加熱塊中。將該燒瓶用氬氣沖洗。向該燒瓶中添加化合物 PLC-26.1(10.0 mmol,3.914g)及SnCl 2.2H 2O (40.0 mmol,9.024 g),接著2-甲基THF (70 mL)及濃鹽酸(4.0 M) (100 mmol,25 mL)。將該燒瓶關閉及在氬氣下加熱至90℃持續30分鐘,此時TLC顯示完全轉化成產物。將反應混合物冷卻至室溫,然後將pH用2N NaOH調整至pH約8。過濾掉所得沉澱物。將固體用2-甲基THF (8 X 100 mL)萃取。分離層,將有機層經MgSO 4乾燥,過濾及蒸發至乾。將所得固體在120℃下乾燥。得到定量產率之產物。MS (APCI):針對C 22H 19NO 4(M+H)計算值= 362;實測值:362。 1H NMR (400 MHz,四氯乙烷-d 2) δ 8.88 (dd, J = 8.4, 1.2 Hz, 1H), 8.69 (dd, J = 7.3, 1.2 Hz, 1H), 8.48 (d, J = 8.4 Hz, 1H), 7.89 (dd, J = 8.4, 7.3 Hz, 1H), 7.03 - 6.93 (m, 3H), 6.88 (dd, J = 8.4, 2.3 Hz, 1H), 1.35 (s, 9H)。 Compound PLC-26.2 (6-(2-Amino-4-(tert-butyl)phenoxy)-1H,3H-benzo[de]isomethanol-1,3-dione): Add to 250 mL Put a stirring rod in a 2N round bottom flask and install a finned condenser, gas adapter and flow controller. Place the flask in an aluminum heating block. The flask was flushed with argon. To the flask was added compound PLC-26.1 (10.0 mmol, 3.914 g) and SnCl 2 .2H 2 O (40.0 mmol, 9.024 g), followed by 2-methyl THF (70 mL) and concentrated hydrochloric acid (4.0 M) (100 mmol, 25 mL). The flask was closed and heated to 90° C. under argon for 30 minutes, at which time TLC showed complete conversion to product. The reaction mixture was cooled to room temperature, then the pH was adjusted to pH ~8 with 2N NaOH. The resulting precipitate was filtered off. The solid was extracted with 2-methyl THF (8 X 100 mL). The layers were separated, the organic layer was dried over MgSO4 , filtered and evaporated to dryness. The resulting solid was dried at 120°C. The product was obtained in quantitative yield. MS (APCI) : calcd for C22H19NO4 (M+H) = 362; found: 362 . 1 H NMR (400 MHz, tetrachloroethane-d 2 ) δ 8.88 (dd, J = 8.4, 1.2 Hz, 1H), 8.69 (dd, J = 7.3, 1.2 Hz, 1H), 8.48 (d, J = 8.4 Hz, 1H), 7.89 (dd, J = 8.4, 7.3 Hz, 1H), 7.03 - 6.93 (m, 3H), 6.88 (dd, J = 8.4, 2.3 Hz, 1H), 1.35 (s, 9H).

化合物 PLC-26.3(9-(第三丁基)-1H,3H-異𠳭唏[6,5,4-mna]𠮿-1,3-二酮):向40 mL小瓶中放入NaNO 2(30.0 mmol,2.070 g)、水(10 mL)及攪拌棒。將該小瓶放入冰水浴中及攪拌以溶解。向100 mL圓底燒瓶中放入攪拌棒及化合物 PLC-26.2(4.00 mmol,1.446 g)、鹽酸(37%) (20.0 mmol,12.1M,1.65 mL)及冰乙酸(30 mL)。將該燒瓶降低至冰水浴中及攪拌約1分鐘,然後開始歷時3分鐘之時間段以小份添加亞硝酸鈉溶液。將溶液於冰水浴中攪拌1小時。將1 L 2N圓底燒瓶藉由偏離中心頸以一定角度夾緊,使得插入該頸之滴液漏斗將滴入攪拌漩渦之上方。將其他頸安裝翅片冷凝器。向此燒瓶中添加大的攪拌棒、CuSO 4.5H 2O (27.4 mmol,6.842 g)及水(80 mL)。在接近重氮鹽之一小時等待期結束時,將銅(II)溶液放入鋁加熱塊中及將溫度設置至130℃。當銅(II)溶液達到130℃時,將重氮溶液轉移至滴液漏斗。將反應在最大RPM下攪拌及歷時約20分鐘之時間逐滴添加重氮溶液。將所得溶液在130℃下攪拌2分鐘,然後自加熱塊移除及在室溫下攪拌過夜。過濾掉沉澱物,用水洗滌。將粗沉澱物乾燥,然後溶解及於真空中在矽膠上蒸發。藉由管柱層析法在矽膠上純化(220 g,平衡50%己烷/DCM,溶離50% (2 CV)至100% DCM (20 CV),等濃度DCM (15 CV)至0% EtOAc/DCM (0 CV)至1% EtOAc/DCM (10 CV))。產物拖尾。收集具有產物之所有溶離份及於真空中蒸發至乾。得到528 mg (38%產率)。MS (APCI):針對C 22H 16O 4(M+H)計算值= 345;實測值:345。 1H NMR (400 MHz,四氯乙烷-d 2) δ 8.61 (d, J = 7.9 Hz, 1H), 8.56 (d, J = 8.4 Hz, 1H), 8.05 (d, J = 2.2 Hz, 1H), 8.01 (d, J = 8.0 Hz, 1H), 7.66 (dd, J = 8.8, 2.2 Hz, 1H), 7.38 (d, J = 8.7 Hz, 1H), 7.34 (d, J = 8.4 Hz, 1H), 1.44 (s, 9H)。 Compound PLC-26.3 (9-(tertiary butyl)-1H,3H-iso[6,5,4-mna]𠮿 -1,3-diketone): Into a 40 mL vial was placed NaNO 2 (30.0 mmol, 2.070 g), water (10 mL) and a stir bar. Place the vial in an ice water bath and stir to dissolve. Put a stirring bar and compound PLC-26.2 (4.00 mmol, 1.446 g), hydrochloric acid (37%) (20.0 mmol, 12.1M, 1.65 mL) and glacial acetic acid (30 mL) into a 100 mL round bottom flask. The flask was lowered into an ice water bath and stirred for about 1 minute, then the sodium nitrite solution was added in small portions over a period of 3 minutes. The solution was stirred for 1 hour in an ice-water bath. A 1 L 2N round bottom flask was clamped with the neck off center at an angle such that the dropping funnel inserted into the neck would drop above the stirring vortex. Fit the other neck to the finned condenser. To this flask was added a large stir bar, CuSO 4 .5H 2 O (27.4 mmol, 6.842 g) and water (80 mL). Near the end of the one hour waiting period for the diazonium salt, the copper(II) solution was placed in an aluminum heating block and the temperature was set to 130°C. When the copper(II) solution reached 130 °C, the diazo solution was transferred to the dropping funnel. The reaction was stirred at maximum RPM and the diazonium solution was added dropwise over a period of approximately 20 minutes. The resulting solution was stirred at 130°C for 2 minutes, then removed from the heat block and stirred overnight at room temperature. The precipitate was filtered off and washed with water. The crude precipitate was dried, then dissolved and evaporated on silica gel in vacuo. Purified by column chromatography on silica gel (220 g, equilibrated 50% hexane/DCM, eluting 50% (2 CV) to 100% DCM (20 CV), isocratic DCM (15 CV) to 0% EtOAc /DCM (0 CV) to 1% EtOAc/DCM (10 CV)). Product smears. All fractions bearing product were collected and evaporated to dryness in vacuo. Obtained 528 mg (38% yield). MS (APCI): Calcd. for C22H16O4 (M+H) = 345; found : 345 . 1 H NMR (400 MHz, tetrachloroethane-d 2 ) δ 8.61 (d, J = 7.9 Hz, 1H), 8.56 (d, J = 8.4 Hz, 1H), 8.05 (d, J = 2.2 Hz, 1H ), 8.01 (d, J = 8.0 Hz, 1H), 7.66 (dd, J = 8.8, 2.2 Hz, 1H), 7.38 (d, J = 8.7 Hz, 1H), 7.34 (d, J = 8.4 Hz, 1H ), 1.44 (s, 9H).

化合物 PLC-26.4(4-(4-(9-(第三丁基)-1,3-二側氧基-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)苯基)丁酸):向100 mL 2N RBF中放入攪拌棒及安裝翅片冷凝器、氣體適配體及流動控制閥。將該燒瓶用氬氣沖洗及放入化合物 PLC-26.3(1.525 mmol,525 mg)、4-(4-胺基苯基)丁酸(3.05 mmol,546 mg)及DMAP (0.1113 mmol,14 mg)。向該燒瓶中添加無水DMF (10 mL)。將該燒瓶密封及在氬氣下攪拌。將加熱塊設置至175℃及將反應加熱及攪拌6.5小時,然後在室溫下攪拌過夜。向反應混合物中添加丙酮(25 mL)及水(25 mL)。將沉澱物攪拌5分鐘,然後過濾掉,用1:1水:丙酮洗滌。將沉澱物在氬氣流下在120℃下乾燥。得到738 mg (96%產率)。MS (APCI):針對C 32H 27NO 5(M+H)計算值= 506;實測值:506。 1H NMR (400 MHz, DMSO-d 6) δ 12.12 (s, 1H), 8.48 - 8.29 (m, 3H), 8.23 (d, J = 2.3 Hz, 1H), 7.68 (dd, J = 8.8, 2.3 Hz, 1H), 7.43 - 7.30 (m, 4H), 7.25 (d, J = 7.9 Hz, 2H), 2.75 - 2.64 (m, 2H), 2.30 (t, J = 7.4 Hz, 2H), 1.88 (p, J = 7.5 Hz, 2H), 1.41 (s, 9H)。 Compound PLC-26.4 (4-(4-(9-(tert-butyl)-1,3-two-side oxy-1H-𠮿 and[2,1,9-def]isoquinolin-2(3H)-yl)phenyl)butanoic acid): Into 100 mL of 2N RBF with stir bar and finned condenser, gas aptamer and flow control valve. The flask was flushed with argon and charged with compound PLC-26.3 (1.525 mmol, 525 mg), 4-(4-aminophenyl)butanoic acid (3.05 mmol, 546 mg) and DMAP (0.1113 mmol, 14 mg) . Anhydrous DMF (10 mL) was added to the flask. The flask was sealed and stirred under argon. The heat block was set to 175°C and the reaction was heated and stirred for 6.5 hours, then at room temperature overnight. Acetone (25 mL) and water (25 mL) were added to the reaction mixture. The precipitate was stirred for 5 minutes, then filtered off and washed with 1:1 water:acetone. The precipitate was dried at 120°C under argon flow. Obtained 738 mg (96% yield). MS (APCI): Calcd. for C32H27NO5 (M+H) = 506; found : 506 . 1 H NMR (400 MHz, DMSO-d 6 ) δ 12.12 (s, 1H), 8.48 - 8.29 (m, 3H), 8.23 (d, J = 2.3 Hz, 1H), 7.68 (dd, J = 8.8, 2.3 Hz, 1H), 7.43 - 7.30 (m, 4H), 7.25 (d, J = 7.9 Hz, 2H), 2.75 - 2.64 (m, 2H), 2.30 (t, J = 7.4 Hz, 2H), 1.88 (p , J = 7.5 Hz, 2H), 1.41 (s, 9H).

化合物 PLC-264-(4-(9-(第三丁基)-1,3-二側氧基-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)苯基)丁酸(3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯酯):向40 mL小瓶中放入攪拌棒、3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯酚(0.050 mmol,29.3 mg)、化合物 PLC-26.4(0.075 mmol,37.9 mg)、DMAP.pTsOH鹽(0.100 mmol,29.4 mg)及EDC.HCl (0.075 mmol,14.4 mg),接著無水DCM (10 mL)。將小瓶加蓋及在室溫下攪拌4.5小時。將反應混合物用己烷稀釋(至約35 mL)及裝載至固體負荷濾筒(約20 g SiO 2)上。將反應混合物藉由管柱層析法在矽膠上純化(120 g,平衡100%甲苯,溶離100% (5 CV)至5% EtOAc/甲苯(30 CV))。將含有產物之溶離份蒸發至乾及藉由急驟層析法在矽膠上再純化(固體負荷,120 g管柱,平衡40% DCM/己烷,溶離40% (2 CV)至100% DCM (10 CV)至等濃度DCM直至化合物完全溶離))。將含有產物之溶離份於真空中蒸發至乾。得到19.8 mg (37%產率)。MS (APCI):針對C 65H 50BCl 2F 2N 3O 5(M-)計算值= 1071;實測值1071。 1H NMR (400 MHz,亞甲基氯-d 2) δ 8.65 (d, J = 7.9 Hz, 1H), 8.58 (d, J = 8.3 Hz, 1H), 8.12 (d, J = 2.3 Hz, 1H), 8.05 (d, J = 8.0 Hz, 1H), 8.00 (d, J = 6.8 Hz, 2H), 7.63 (dd, J = 8.7, 2.3 Hz, 1H), 7.47 - 7.43 (m, 2H), 7.40 (s, 2H), 7.38 - 7.24 (m, 10H), 6.51 (s, 2H), 2.90 (t, J = 7.6 Hz, 2H), 2.75 (t, J = 7.4 Hz, 2H), 2.64 (t, J = 6.8 Hz, 4H), 2.43 - 2.26 (m, 4H), 2.21 (p, J = 7.5 Hz, 2H), 2.05 (p, J = 7.0 Hz, 4H), 1.44 (s, 9H)。 Compound PLC-26 4-(4-(9-(tert-butyl)-1,3-dioxo-1H-𠮿 And[2,1,9-def]isoquinolin-2(3H)-yl)phenyl)butanoic acid (3,5-dichloro-4-(19,19-difluoro-6,7,11, 12,13,19-Hexahydro-5H-18l4,19l4-Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3 ',4']cyclohepta[1',2':4,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenyl ester): to Put a stirring bar, 3,5-dichloro-4-(19,19-difluoro-6,7,11,12,13,19-hexahydro-5H-18l4,19l4-benzo[ 3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']cyclohepta[1',2':4,5] Pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenol (0.050 mmol, 29.3 mg), compound PLC-26.4 (0.075 mmol, 37.9 mg), DMAP. pTsOH salt (0.100 mmol, 29.4 mg) and EDC.HCl (0.075 mmol, 14.4 mg), followed by anhydrous DCM (10 mL). The vial was capped and stirred at room temperature for 4.5 hours. The reaction mixture was diluted with hexanes (to about 35 mL) and loaded onto a solids loading cartridge (about 20 g Si02 ). The reaction mixture was purified by column chromatography on silica gel (120 g, equilibrate 100% toluene, elute 100% (5 CV) to 5% EtOAc/toluene (30 CV)). Fractions containing product were evaporated to dryness and repurified by flash chromatography on silica gel (solids load, 120 g column, equilibrated 40% DCM/hexane, eluting 40% (2 CV) to 100% DCM ( 10 CV) to isoconcentration DCM until the compound is completely eluted)). Fractions containing product were evaporated to dryness in vacuo. Obtained 19.8 mg (37% yield). MS (APCI ) : Calcd . for C65H50BCl2F2N3O5 (M-) = 1071; found 1071 . 1 H NMR (400 MHz, methylene chloride-d 2 ) δ 8.65 (d, J = 7.9 Hz, 1H), 8.58 (d, J = 8.3 Hz, 1H), 8.12 (d, J = 2.3 Hz, 1H ), 8.05 (d, J = 8.0 Hz, 1H), 8.00 (d, J = 6.8 Hz, 2H), 7.63 (dd, J = 8.7, 2.3 Hz, 1H), 7.47 - 7.43 (m, 2H), 7.40 (s, 2H), 7.38 - 7.24 (m, 10H), 6.51 (s, 2H), 2.90 (t, J = 7.6 Hz, 2H), 2.75 (t, J = 7.4 Hz, 2H), 2.64 (t, J = 6.8 Hz, 4H), 2.43 - 2.26 (m, 4H), 2.21 (p, J = 7.5 Hz, 2H), 2.05 (p, J = 7.0 Hz, 4H), 1.44 (s, 9H).

合成 PLC-27 化合物 PLC-27.2(2-(4-(9-(第三丁基)-1,3-二側氧基-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)苯基)乙酸):化合物 PLC-27.2係以與化合物 PLC-26.4相似方式自化合物 PLC-27.1(1.191 mmol,410 mg)、2-(4-胺基苯基)乙酸(2.98 mmol,450 mg)及DMAP (0.0869 mmol,11 mg)合成。得到定量產率之產物。MS (APCI):針對C 30H 23NO 5(M+H)計算值= 478;實測值:478。 1H NMR (400 MHz, DMSO-d 6) δ 8.48 (d, J = 7.9 Hz, 1H), 8.44 (d, J = 8.3 Hz, 1H), 8.38 (d, J = 8.1 Hz, 1H), 8.27 (d, J = 2.4 Hz, 1H), 7.69 (dd, J = 8.8, 2.3 Hz, 1H), 7.45 - 7.38 (m, 4H), 7.31 - 7.27 (m, 2H), 3.68 (s, 2H), 1.41 (s, 9H)。 Synthesis of PLC-27 : Compound PLC-27.2 (2-(4-(9-(tert-butyl)-1,3-dioxo-1H-𠮿 [2,1,9-def]isoquinolin-2(3H)-yl)phenyl)acetic acid): compound PLC-27.2 was obtained from compound PLC-27.1 (1.191 mmol, 410 mg), 2-(4-aminophenyl)acetic acid (2.98 mmol, 450 mg) and DMAP (0.0869 mmol, 11 mg). The product was obtained in quantitative yield. MS ( APCI ): calcd for C30H23NO5 (M+H) = 478; found: 478 . 1 H NMR (400 MHz, DMSO-d 6 ) δ 8.48 (d, J = 7.9 Hz, 1H), 8.44 (d, J = 8.3 Hz, 1H), 8.38 (d, J = 8.1 Hz, 1H), 8.27 (d, J = 2.4 Hz, 1H), 7.69 (dd, J = 8.8, 2.3 Hz, 1H), 7.45 - 7.38 (m, 4H), 7.31 - 7.27 (m, 2H), 3.68 (s, 2H), 1.41 (s, 9H).

化合物 PLC-272-(4-(9-(第三丁基)-1,3-二側氧基-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)苯基)乙酸(3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯酯):化合物 PLC-27係自3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯酚(0.100 mmol,58.6 mg)、化合物 PLC-27.2(0.150 mmol,71.6 mg)、DMAP/pTsOH鹽(0.200 mmol,58.8 mg)及EDC/HCl (0.150 mmol,28.8 mg),接著無水DCM (10 mL)合成。將小瓶加蓋及在室溫下攪拌過夜。第二天,添加更多化合物EDC.HCl (0.200 mmol,38.8 mg)及在室溫下攪拌90分鐘。添加更多EDC.HCl (0.200 mmol,38.3 mg)及繼續在室溫下攪拌2小時。添加化合物 PLC-27.2(0.075 mmol,35.8 mg)及繼續在室溫下攪拌2小時。將粗製反應混合物藉由急驟層析法在矽膠上純化(固體負荷,120 g管柱,平衡40% DCM/己烷,溶離40% (2 CV)至100% DCM (10 CV)至等濃度DCM直至化合物完全溶離))。將含有產物之溶離份於真空中蒸發至乾。得到11.0 mg (11%產率)。MS (APCI):針對C 63H 46BCl 2F 2N 3O 5(M-)計算值= 1043;實測值:1043。 1H NMR (400 MHz, 亞甲基氯-d 2) δ 8.67 (d, J = 7.9 Hz, 1H), 8.60 (d, J = 8.4 Hz, 1H), 8.13 (d, J = 2.3 Hz, 1H), 8.07 (d, J = 8.0 Hz, 1H), 8.00 (d, J = 6.9 Hz, 2H), 7.64 (dd, J = 8.8, 2.3 Hz, 1H), 7.62 - 7.58 (m, 2H), 7.44 (s, 2H), 7.40 - 7.27 (m, 10H), 6.51 (s, 2H), 4.07 (s, 2H), 2.70 - 2.58 (m, 4H), 2.33 (s, 4H), 2.05 (p, J = 7.1 Hz, 4H), 1.44 (s, 9H)。 Compound PLC-27 2-(4-(9-(tert-butyl)-1,3-dioxo-1H-𠮿 And[2,1,9-def]isoquinolin-2(3H)-yl)phenyl)acetic acid (3,5-dichloro-4-(19,19-difluoro-6,7,11,12 ,13,19-Hexahydro-5H-18l4,19l4-Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenyl ester): compound PLC -27 is derived from 3,5-dichloro-4-(19,19-difluoro-6,7,11,12,13,19-hexahydro-5H-18l4,19l4-benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[2, 1-f][1,3,2]diazaborin-9-yl)phenol (0.100 mmol, 58.6 mg), compound PLC-27.2 (0.150 mmol, 71.6 mg), DMAP/pTsOH salt (0.200 mmol , 58.8 mg) and EDC/HCl (0.150 mmol, 28.8 mg), followed by anhydrous DCM (10 mL) for synthesis. The vial was capped and stirred overnight at room temperature. The next day, more compound EDC.HCl (0.200 mmol, 38.8 mg) was added and stirred at room temperature for 90 minutes. More EDC.HCl (0.200 mmol, 38.3 mg) was added and stirring was continued at room temperature for 2 hours. Compound PLC-27.2 (0.075 mmol, 35.8 mg) was added and stirring was continued at room temperature for 2 hours. The crude reaction mixture was purified by flash chromatography on silica gel (solids load, 120 g column, equilibrated 40% DCM/hexane, eluting 40% (2 CV) to 100% DCM (10 CV) to isocratic DCM until the compound is completely dissolved)). Fractions containing product were evaporated to dryness in vacuo. Obtained 11.0 mg (11% yield). MS (APCI) : Calcd. for C63H46BCl2F2N3O5 (M-) = 1043; found : 1043 . 1 H NMR (400 MHz, methylene chloride-d 2 ) δ 8.67 (d, J = 7.9 Hz, 1H), 8.60 (d, J = 8.4 Hz, 1H), 8.13 (d, J = 2.3 Hz, 1H ), 8.07 (d, J = 8.0 Hz, 1H), 8.00 (d, J = 6.9 Hz, 2H), 7.64 (dd, J = 8.8, 2.3 Hz, 1H), 7.62 - 7.58 (m, 2H), 7.44 (s, 2H), 7.40 - 7.27 (m, 10H), 6.51 (s, 2H), 4.07 (s, 2H), 2.70 - 2.58 (m, 4H), 2.33 (s, 4H), 2.05 (p, J = 7.1 Hz, 4H), 1.44 (s, 9H).

合成化合物 PLC-28 化合物 PLC-28.2 2-(4-(9- -1,3- 二側氧基 -1H- 𠮿 [2,1,9-def] 異喹啉 -2(3H)- ) 苯基 ) 乙酸:將含於DMF (8 mL)中之 PLC-28.1(400.0 mg,1.1 mmol)、 4- 胺基苯基乙酸(329.4 mg,2.2 mmol)及DMAP (9.3 mg,0.080 mmol)之混合物在室溫下脫氣。然後將混合物加熱上至165℃及在此溫度下保持3小時。TLC及LCMS顯示約95%轉化而無可觀察到之副反應。將混合物冷卻降至50℃。然後將其倒入丙酮溶液(40 mL)中,將其藉由冰水浴預先冷卻。將混合物在0℃下保持2小時及然後保持在室溫下攪拌過夜。透過真空過濾收集固體及藉由丙酮(4 mL)洗滌。及將其藉由真空烘箱在100℃下乾燥3小時,以得到呈黃棕色固體之純化合物 PLC-28.2395.0 mg,73%產率。MS (APCI):針對C 26H 14BrNO 5([M+H] +)計算值= 500實測值:500。 1H NMR (400 MHz, CDCl2CDCl2) δ 8.65 (d, J = 8.0 Hz, 1H), 8.62 (d, J = 8.0 Hz, 1H), 8.21 (dd, J = 6.4 Hz, 2.4 Hz, 1H), 7.99 (bs, 1H), 7.95 (t, J = 7.6 Hz, 1H), 7.67 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 7.53 (d, J = 8.0 Hz, 2H), 7.37 (d, J = 8.4 Hz, 1H), 7.32 (m, 3H), 2.94 (s, 2H)。 Synthesis of compound PLC-28 Compound PLC-28.2 2-(4-(9- bromo -1,3- dioxo -1H- 𠮿 [2,1,9-def] isoquinolin -2(3H)-yl ) phenyl ) acetic acid: PLC-28.1 (400.0 mg, 1.1 mmol), 4- amine in DMF (8 mL) A mixture of phenylphenylacetic acid (329.4 mg, 2.2 mmol) and DMAP (9.3 mg, 0.080 mmol) was degassed at room temperature. The mixture was then heated up to 165°C and maintained at this temperature for 3 hours. TLC and LCMS showed about 95% conversion with no observable side reactions. The mixture was cooled down to 50 °C. It was then poured into acetone solution (40 mL), which was precooled by an ice-water bath. The mixture was kept at 0°C for 2 hours and then kept stirring at room temperature overnight. The solid was collected by vacuum filtration and washed by acetone (4 mL). And it was dried by vacuum oven at 100° C. for 3 hours to obtain pure compound PLC-28.2 395.0 mg as a yellow-brown solid, 73% yield. MS (APCI): Calcd. for C26H14BrNO5 ([M+H] + ) = 500 Found : 500 . 1 H NMR (400 MHz, CDCl2CDCl2) δ 8.65 (d, J = 8.0 Hz, 1H), 8.62 (d, J = 8.0 Hz, 1H), 8.21 (dd, J = 6.4 Hz, 2.4 Hz, 1H), 7.99 (bs, 1H), 7.95 (t, J = 7.6 Hz, 1H), 7.67 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 7.53 (d, J = 8.0 Hz, 2H), 7.37 (d, J = 8.4 Hz, 1H), 7.32 (m, 3H), 2.94 (s, 2H).

化合物 PLC-28.3 – 2-(4-(9-(4- 異丙基苯基 )-1,3- 二側氧基 -1H- 𠮿 [2,1,9-def] 異喹啉 -2(3H)- ) 苯基 ) 乙酸:將含於THF-DMF-H 2O (10 mL/ 2 mL/ 1 mL)中之 PLC-28.2(175.0 mg,0.35 mmol)、 4- 異丙基苯基硼酸(114.8 mg,0.70 mmol)、Pd(dppf)Cl 2(18.0 mg,0.025 mmol)及K 2CO 3(130.4 mg,0.95 mmol)之混合物在室溫下脫氣。然後將混合物加熱上至80℃及在此溫度下保持過夜。TLC及LCMS顯示反應完全。將混合物冷卻降至室溫。然後將其添加0.1N HCl (75 mL)及EtOAc (75 mL)。一旦藉由分液漏斗分離,就於將水溶液用NaCl飽和後將其用THF (75 mL*3)進一步萃取。將合併之有機相經無水Na 2SO 4乾燥,然後將其過濾及在旋轉蒸發器下濃縮,及藉由矽膠急驟層析法使用0至40% EtOAc /具有0.1% TFA之DCM作為溶離劑純化,以得到呈黃色固體之 PLC-28.3,70.0 mg,37%產率。MS (APCI):針對C 35H 25NO 5([M-H] -) =計算值539實測值:539。 1H NMR (400 MHz, CDCl 2CDCl 2) δ 8.66 (d, J= 7.6 Hz, 1H), 8.61 (d, J= 8.4 Hz, 1H), 8.26 (s, 1H), 8.06 (d, J= 8.0 Hz, 1H), 7.79 (dd, J= 8.4 Hz, 2.0 Hz, 1H), 7.45 (m, 11H), 3.81 (s, 2H), 3.01 (quintet, J= 7.2 Hz, 1H), 1.33 (d, J= 7.2 Hz, 6H)。 Compound PLC-28.3 – 2-(4-(9-(4- isopropylphenyl )-1,3- dioxo -1H- 𠮿 And [2,1,9-def] isoquinolin -2(3H) -yl ) phenyl )acetic acid : PLC- 28.2 (175.0 mg, 0.35 mmol), 4- isopropylphenylboronic acid (114.8 mg, 0.70 mmol), Pd(dppf)Cl 2 (18.0 mg, 0.025 mmol) and K 2 CO 3 (130.4 mg, 0.95 mmol) The mixture was degassed at room temperature. The mixture was then heated up to 80°C and kept at this temperature overnight. TLC and LCMS showed the reaction was complete. The mixture was cooled to room temperature. Then it was added 0.1N HCl (75 mL) and EtOAc (75 mL). Once separated by a separatory funnel, the aqueous solution was further extracted with THF (75 mL*3) after it was saturated with NaCl. The combined organic phases were dried over anhydrous Na2SO4 , then filtered and concentrated under a rotary evaporator, and purified by silica gel flash chromatography using 0 to 40% EtOAc/DCM with 0.1% TFA as eluent , to obtain PLC-28.3 as a yellow solid, 70.0 mg, 37% yield. MS (APCI): Calculated for C35H25NO5 ([MH] - ) = 539 Found: 539 . 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) δ 8.66 (d, J = 7.6 Hz, 1H), 8.61 (d, J = 8.4 Hz, 1H), 8.26 (s, 1H), 8.06 (d, J = 8.0 Hz, 1H), 7.79 (dd, J = 8.4 Hz, 2.0 Hz, 1H), 7.45 (m, 11H), 3.81 (s, 2H), 3.01 (quintet, J = 7.2 Hz, 1H), 1.33 (d , J = 7.2 Hz, 6H).

化合物 PLC-28 合成:將25 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-28.4(44.0 mg,0.075 mmol)、 PLC-28.3(81.0 mg,0.15 mmol)、EDC•HCl (71.9 mg,0.38 mmol)及DMAP•TsOH (45.0 mg,0.15 mmol),接著添加無水DCM (4.4 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至4%)作為溶離劑純化,以得到呈暗藍色固體之純RL-萘醯亞胺-BODIPY PLC-28。將固體用MeOH (15 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-28,46.0 mg,55%產率。MS (APCI):針對C 68H 48BCl 2F 2N 3O 5([M-H] -)計算值= 1106實測值:1106。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.67 (d, J= 8.0 Hz, 1H), 8.63 (d, J= 8.0 Hz, 1H), 8.29 (d, J= 2.4 Hz, 1H), 8.11 (d, J= 8.0 Hz, 1H), 8.05 (m, 2H), 7.81 (dd, J= 8.0 Hz, J= 2.4 Hz, 1H), 7.65 (m, 4H), 7.51 (d, J= 8.0 Hz, 1H), 7.39 (m, 11H), 7.30 (m, 2H), 6.49 (s, 2H), 4.07 (s, 2H), 3.01 (pentet, J= 6.8 Hz, 1H), 2.64 (m, 4H), 2.33 (bs, 3H), 2.06 (m, 4H), 1.33 (d, J= 6.8 Hz, 6H)。 Compound PLC-28 Synthesis: A 25 mL vial was fitted with a stir bar. Add compound PLC-28.4 (44.0 mg, 0.075 mmol), PLC-28.3 (81.0 mg, 0.15 mmol), EDC·HCl (71.9 mg, 0.38 mmol) and DMAP·TsOH (45.0 mg, 0.15 mmol) to this vial, Then dry DCM (4.4 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc (0 to 4%) in DCM as eluent to give pure RL-naphthalene as a dark blue solid Amide-BODIPY PLC-28 . The solid was further triturated with MeOH (15 ml) to give RL-naphthylimide-BODIPY PLC-28 , 46.0 mg, 55% yield. MS ( APCI ) : Calcd . for C68H48BCl2F2N3O5 ([MH] - ) = 1106 Found: 1106. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.67 (d, J = 8.0 Hz, 1H), 8.63 (d, J = 8.0 Hz, 1H), 8.29 (d, J = 2.4 Hz, 1H), 8.11 ( d, J = 8.0 Hz, 1H), 8.05 (m, 2H), 7.81 (dd, J = 8.0 Hz, J = 2.4 Hz, 1H), 7.65 (m, 4H), 7.51 (d, J = 8.0 Hz, 1H), 7.39 (m, 11H), 7.30 (m, 2H), 6.49 (s, 2H), 4.07 (s, 2H), 3.01 (pentet, J = 6.8 Hz, 1H), 2.64 (m, 4H), 2.33 (bs, 3H), 2.06 (m, 4H), 1.33 (d, J = 6.8 Hz, 6H).

合成化合物 PLC-29 化合物 29.1 – 2-(4-(1,3- 二側氧基 -9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -2(3H)- ) 苯基 ) 乙酸:將100 mL小瓶安裝攪拌棒。向該小瓶中,將含於THF/DMF/H 2O (22 ml/ 4.4 ml/ 2.2 ml)中之化合物 PLC-28.2(400.0 mg,0.80 mmol)、 4-( 三氟甲基 ) 苯基硼酸(262.2 mg,1.6 mmol)、Pd(dppf)Cl 2(41.0 mg,0.056 mmol)及K 2CO 3(298.0 mg,2.2 mmol)在室溫下脫氣。將反應混合物加熱上至80℃及將反應在此溫度下保持過夜。TLC係用於監測反應。於完成後,將反應藉由添加0.1N HCl (150 mL)及EtOAc (150 mL)處理。將水相藉由THF (150 mL*3)進一步萃取。將合併之有機相經無水Na 2SO 4乾燥,在旋轉蒸發器下濃縮及藉由急驟層析法使用含DCM之EtOAc (0至40%,具有0.1% TFA)作為溶離劑純化,以得到呈黃色/黃棕色固體之純RL-萘醯亞胺衍生物 PLC-29.1。363.0 mg,80%產率。MS (APCI):針對C 33H 18F 3NO 5([M+H] +)計算值= 566實測值:566。 1H NMR (400 MHz, DMSO-d 6) 8.76 (m, 1H), 8.56 (m, 2H), 8.52 (dd, J= 8.0 Hz, J= 3.2 Hz, 1H), 8.15 (m, 2H), 8.06 (m, 1H), 7.94 (d, J= 8.0 Hz, 2H), 7.66 (dd, J= 8.0 Hz, J= 4.0 Hz, 1H), 7.53 (m, 1H), 7.45 (d, J= 8.0 Hz, 2H), 7.33 (d, J= 8.0 Hz, 2H), 3.72 (s, 2H)。 Synthesis of compound PLC-29 Compound 29.1 – 2-(4-(1,3- Dioxo -9-(4-( trifluoromethyl ) phenyl )-1H- 𠮿 And [2,1,9-def] isoquinolin -2(3H)-yl ) phenyl ) acetic acid: A 100 mL vial was fitted with a stir bar. To the vial, compound PLC-28.2 (400.0 mg, 0.80 mmol), 4-( trifluoromethyl ) phenylboronic acid in THF/DMF/H 2 O (22 ml/ 4.4 ml/ 2.2 ml) was added (262.2 mg, 1.6 mmol), Pd(dppf)Cl 2 (41.0 mg, 0.056 mmol) and K 2 CO 3 (298.0 mg, 2.2 mmol) were degassed at room temperature. The reaction mixture was heated up to 80 °C and the reaction was kept at this temperature overnight. TLC was used to monitor the reaction. Upon completion, the reaction was worked up by addition of 0.1N HCl (150 mL) and EtOAc (150 mL). The aqueous phase was further extracted by THF (150 mL*3). The combined organic phases were dried over anhydrous Na 2 SO 4 , concentrated under rotary evaporator and purified by flash chromatography using EtOAc (0 to 40% with 0.1% TFA) in DCM as eluent to give Pure RL-Naphthoimide derivative PLC-29.1 as a yellow/yellow-brown solid. 363.0 mg, 80% yield. MS (APCI): Calcd . for C33H18F3NO5 ([M+H] + ) = 566 Found : 566 . 1 H NMR (400 MHz, DMSO-d 6 ) 8.76 (m, 1H), 8.56 (m, 2H), 8.52 (dd, J = 8.0 Hz, J = 3.2 Hz, 1H), 8.15 (m, 2H), 8.06 (m, 1H), 7.94 (d, J = 8.0 Hz, 2H), 7.66 (dd, J = 8.0 Hz, J = 4.0 Hz, 1H), 7.53 (m, 1H), 7.45 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 3.72 (s, 2H).

化合物 PLC-29 將25 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-28.4(40.0 mg,0.068 mmol)、 PLC-29.1(77.5 mg,0.137 mmol)、EDC•HCl (65.2 mg,0.340 mmol)及DMAP•TsOH (41.1 mg,0.137 mmol),接著添加無水DCM (4 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至4%)作為溶離劑純化,以得到呈暗藍色固體之純RL-萘醯亞胺-BODIPY PLC-29。將固體用MeOH (15 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-29,46.0 mg,60%產率。MS (APCI):針對C 66H 41BCl 2F 5N 3O 5([M-H] -)計算值= 1132實測值:1132。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.69 (d, J= 8.0 Hz, 1H), 8.65 (d, J= 8.0 Hz, 1H), 8.30 (d, J= 2.0 Hz, 1H), 8.11 (d, J= 8.0 Hz, 1H), 8.06 (m, 2H), 7.82 (m, 5H), 7.65 (m, 2H), 7.55 (d, J= 8.0 Hz, 1H), 7.39 (m, 9H), 7.30 (m, 2H), 6.48 (s, 2H), 4.07 (s, 2H), 2.63 (m, 4H), 2.33 (bs, 3H), 2.06 (m, 4H)。 Compound PLC-29 : A 25 mL vial was fitted with a stir bar. Add compound PLC-28.4 (40.0 mg, 0.068 mmol), PLC-29.1 (77.5 mg, 0.137 mmol), EDC•HCl (65.2 mg, 0.340 mmol) and DMAP•TsOH (41.1 mg, 0.137 mmol) to this vial, Then dry DCM (4 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 4%) as eluent to give pure RL-naphthalene as a dark blue solid Imide-BODIPY PLC-29 . The solid was further triturated with MeOH (15 ml) to give RL-naphthylimide-BODIPY PLC-29 , 46.0 mg, 60% yield. MS ( APCI ) : Calcd . for C66H41BCl2F5N3O5 ( [MH] - ) = 1132 Found : 1132. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.69 (d, J = 8.0 Hz, 1H), 8.65 (d, J = 8.0 Hz, 1H), 8.30 (d, J = 2.0 Hz, 1H), 8.11 ( d, J = 8.0 Hz, 1H), 8.06 (m, 2H), 7.82 (m, 5H), 7.65 (m, 2H), 7.55 (d, J = 8.0 Hz, 1H), 7.39 (m, 9H), 7.30 (m, 2H), 6.48 (s, 2H), 4.07 (s, 2H), 2.63 (m, 4H), 2.33 (bs, 3H), 2.06 (m, 4H).

合成化合物 PLC-30 化合物 PLC-30.1 —2-(4-(9-(3,5- ( 三氟甲基 ) 苯基 )-1,3- 二側氧基 -1H- 𠮿 [2,1,9-def] 異喹啉 -2(3H)- ) 苯基 ) 乙酸:將100 mL小瓶安裝攪拌棒。向該小瓶中,將含於THF/DMF/H 2O (22 ml/ 4.4 ml/ 2.2 ml)中之化合物 PLC-28.2(400.0 mg,0.80 mmol)、 3,5- ( 三氟甲基 ) 苯基硼酸(262.2 mg,1.6 mmol)、Pd(dppf)Cl 2(41.0 mg,0.056 mmol)及K 2CO 3(412.6 mg,2.2 mmol)在室溫下脫氣。將反應混合物加熱上至80℃及將反應在此溫度下保持過夜。TLC係用於監測反應。於完成後,將反應藉由添加0.1N HCl (150 mL)及EtOAc (150 mL)處理。將水相藉由THF (150 mL*3)進一步萃取。將合併之有機相經無水Na 2SO 4乾燥,在旋轉蒸發器下濃縮及藉由急驟層析法使用含DCM之EtOAc (0至40%,具有0.1% TFA)作為溶離劑純化,以得到呈黃色/黃棕色固體之純RL-萘醯亞胺衍生物 PLC-30.1。311.0 mg,61%產率。MS (APCI):針對C 34H 17F 6NO 5([M+H] +)計算值= 634實測值:634。 1H NMR (400 MHz, DMSO-d 6) 8.73 (m, 1H), 8.46 (m, 5H), 8.10 (m, 2H), 7.57 (m, 1H), 7.42 (d, J= 8.0 Hz, 2H), 7.40 (m, 1H), 7.30 (d, J= 8.0 Hz, 2H), 3.72 (s, 2H)。 Synthetic compound PLC-30 Compound PLC-30.1 —2-(4-(9-(3,5- bis ( trifluoromethyl ) phenyl )-1,3- dioxo -1H- 𠮿 And [2,1,9-def] isoquinolin -2(3H)-yl ) phenyl ) acetic acid: A 100 mL vial was fitted with a stir bar. To this vial, compound PLC-28.2 (400.0 mg, 0.80 mmol), 3,5- bis ( trifluoromethyl ) in THF/DMF/H 2 O (22 ml/ 4.4 ml/ 2.2 ml) was added Phenylboronic acid (262.2 mg, 1.6 mmol), Pd(dppf) Cl2 (41.0 mg, 0.056 mmol) and K2CO3 ( 412.6 mg, 2.2 mmol) were degassed at room temperature. The reaction mixture was heated up to 80 °C and the reaction was kept at this temperature overnight. TLC was used to monitor the reaction. Upon completion, the reaction was worked up by addition of 0.1N HCl (150 mL) and EtOAc (150 mL). The aqueous phase was further extracted by THF (150 mL*3). The combined organic phases were dried over anhydrous Na 2 SO 4 , concentrated under rotary evaporator and purified by flash chromatography using EtOAc (0 to 40% with 0.1% TFA) in DCM as eluent to give Pure RL-Naphthoimide derivative PLC-30.1 as yellow/yellow-brown solid. 311.0 mg, 61% yield. MS (APCI ) : Calcd . for C34H17F6NO5 ([M+H] + ) = 634 Found : 634. 1 H NMR (400 MHz, DMSO-d 6 ) 8.73 (m, 1H), 8.46 (m, 5H), 8.10 (m, 2H), 7.57 (m, 1H), 7.42 (d, J = 8.0 Hz, 2H ), 7.40 (m, 1H), 7.30 (d, J = 8.0 Hz, 2H), 3.72 (s, 2H).

化合物 PLC-30 將25 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-28.4(40.0 mg,0.068 mmol)、 PLC-30.1(86.8 mg,0.137 mmol)、EDC•HCl (65.2 mg,0.340 mmol)及DMAP•TsOH (41.1 mg,0.137 mmol),接著添加無水DCM (4 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至4%)作為溶離劑純化,以得到呈暗藍色固體之純RL-萘醯亞胺-BODIPY PLC-30。將固體用MeOH (15 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-30,76.0 mg,93%產率。MS (APCI):針對C 67H 40BCl 2F 8N 3O 5([M-H] -)計算值= 1200實測值:1200。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.70 (d, J= 8.0 Hz, 1H), 8.66 (d, J= 8.0 Hz, 1H), 8.28 (d, J= 2.0 Hz, 1H), 8.15 (d, J= 8.0 Hz, 1H), 8.06 (m, 4H), 7.96 (m, 1H), 7.82 (dd, J= 8.0 Hz, J= 2.0 Hz, 1H), 7.65 (m, 2H), 7.58 (d, J= 8.0 Hz, 1H), 7.39 (m, 9H), 7.30 (m, 2H), 6.48 (s, 2H), 4.07 (s, 2H), 2.63 (m, 4H), 2.33 (bs, 3H), 2.05 (m, 4H)。 Compound PLC-30 : A 25 mL vial was fitted with a stir bar. Add compound PLC-28.4 (40.0 mg, 0.068 mmol), PLC-30.1 (86.8 mg, 0.137 mmol), EDC•HCl (65.2 mg, 0.340 mmol) and DMAP•TsOH (41.1 mg, 0.137 mmol) in this vial, Then dry DCM (4 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 4%) as eluent to give pure RL-naphthalene as a dark blue solid Imide-BODIPY PLC-30 . The solid was further triturated with MeOH (15 ml) to give RL-naphthylimide-BODIPY PLC-30 , 76.0 mg, 93% yield. MS ( APCI) : Calcd . for C67H40BCl2F8N3O5 ([MH] - ) = 1200 Found : 1200. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.70 (d, J = 8.0 Hz, 1H), 8.66 (d, J = 8.0 Hz, 1H), 8.28 (d, J = 2.0 Hz, 1H), 8.15 ( d, J = 8.0 Hz, 1H), 8.06 (m, 4H), 7.96 (m, 1H), 7.82 (dd, J = 8.0 Hz, J = 2.0 Hz, 1H), 7.65 (m, 2H), 7.58 ( d, J = 8.0 Hz, 1H), 7.39 (m, 9H), 7.30 (m, 2H), 6.48 (s, 2H), 4.07 (s, 2H), 2.63 (m, 4H), 2.33 (bs, 3H ), 2.05 (m, 4H).

合成化合物 PLC-31 化合物 PLC-31.1 – 2-(4-(9-(4-( 第三丁基 ) 苯基 )-1,3- 二側氧基 -1H- 𠮿 [2,1,9-def] 異喹啉 -2(3H)- ) 苯基 ) 乙酸:將含於THF-DMF-H 2O (10 mL/ 2 mL/ 1 mL)中之 PLC-28.2(175.0 mg,0.35 mmol)、 4- 第三丁基苯基硼酸(124.6 mg,0.70 mmol)、Pd(dppf)Cl 2(18.0 mg,0.025 mmol)及K 2CO 3(130.4 mg,0.95 mmol)之混合物在室溫下脫氣。然後將混合物加熱上至80℃及在此溫度下保持過夜。TLC及LCMS顯示反應完全。將混合物冷卻降至室溫。然後將其添加0.1N HCl (75 mL)及EtOAc (75 mL)。一旦藉由分液漏斗分離,就於將水溶液用NaCl飽和後將其用THF (75 mL*3)進一步萃取。將合併之有機相經無水Na 2SO 4乾燥,然後將其過濾及在旋轉蒸發器下濃縮,及藉由矽膠急驟層析法使用0至40% EtOAc /具有0.1% TFA之DCM作為溶離劑純化,以得到呈黃色固體之 PLC-31.1,76.0 mg,39%產率。MS (APCI):針對C 36H 27NO 5([M-H] -)計算值= 553實測值:553。 1H NMR (400 MHz, CDCl 2CDCl 2) δ 8.69 (d, J= 8.0 Hz, 1H), 8.64 (d, J= 8.4 Hz, 1H), 8.24 (d, J= 8.4 Hz, 1H), 8.03 (d, J= 8.0 Hz, 1H), 7.76 (dd, J= 8.4 Hz, 2.0 Hz, 1H), 7.53 (m, 7H), 7.33 (m, 4H), 3.77 (s, 2H), 1.40 (s, 9H)。 Synthesis of compound PLC-31 Compound PLC-31.1 – 2-(4-(9-(4-( tert-butyl ) phenyl )-1,3- dioxo -1H- 𠮿 And [2,1,9-def] isoquinolin -2(3H) -yl ) phenyl )acetic acid : PLC- 28.2 (175.0 mg, 0.35 mmol), 4- tert-butylphenylboronic acid (124.6 mg, 0.70 mmol), Pd(dppf)Cl 2 (18.0 mg, 0.025 mmol) and K 2 CO 3 (130.4 mg, 0.95 mmol ) mixture was degassed at room temperature. The mixture was then heated up to 80°C and kept at this temperature overnight. TLC and LCMS showed the reaction was complete. The mixture was cooled to room temperature. Then it was added 0.1N HCl (75 mL) and EtOAc (75 mL). Once separated by a separatory funnel, the aqueous solution was further extracted with THF (75 mL*3) after it was saturated with NaCl. The combined organic phases were dried over anhydrous Na2SO4 , then filtered and concentrated under a rotary evaporator, and purified by silica gel flash chromatography using 0 to 40% EtOAc/DCM with 0.1% TFA as eluent , to obtain PLC-31.1 as a yellow solid, 76.0 mg, 39% yield. MS (APCI): Calcd. for C36H27NO5 ([MH] - ) = 553 Found : 553. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) δ 8.69 (d, J = 8.0 Hz, 1H), 8.64 (d, J = 8.4 Hz, 1H), 8.24 (d, J = 8.4 Hz, 1H), 8.03 (d, J = 8.0 Hz, 1H), 7.76 (dd, J = 8.4 Hz, 2.0 Hz, 1H), 7.53 (m, 7H), 7.33 (m, 4H), 3.77 (s, 2H), 1.40 (s , 9H).

化合物 PLC-31 將25 mL小瓶安裝攪拌棒。向該小瓶中添加化合物 PLC-28.4(40.0 mg,0.068 mmol)、 PLC-31.1(75.8 mg,0.137 mmol)、EDC•HCl (65.2 mg,0.340 mmol)及DMAP•TsOH (41.1 mg,0.137 mmol),接著添加無水DCM (4 ml)。將反應混合物加熱上至40℃過夜。於將反應冷卻降至室溫後,將反應混合物裝載矽膠及藉由急驟層析法使用含DCM之EtOAc (0至4%)作為溶離劑純化,以得到呈暗藍色固體之純RL-萘醯亞胺-BODIPY PLC-31。將固體用MeOH (15 ml)進一步研磨,以得到RL-萘醯亞胺-BODIPY PLC-31,40.0 mg,52%產率。MS (APCI):針對C 69H 50BCl 2F 2N 3O 5([M-H] -)計算值= 1120實測值:1120。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.69 (d, J= 8.0 Hz, 1H), 8.63 (d, J= 8.0 Hz, 1H), 8.30 (d, J= 2.0 Hz, 1H), 8.11 (d, J= 8.0 Hz, 1H), 8.06 (m, 2H), 7.82 (dd, J= 8.0 Hz, J= 2.0 Hz, 1H), 7.65 (m, 4H), 7.54 (m, 3H), 7.39 (m, 9H), 7.30 (m, 2H), 6.49 (s, 2H), 4.07 (s, 2H), 2.63 (m, 4H), 2.33 (bs, 3H), 2.06 (m, 4H), 1,40 (s, 9H)。 Compound PLC-31 : A 25 mL vial was fitted with a stir bar. Add compound PLC-28.4 (40.0 mg, 0.068 mmol), PLC-31.1 (75.8 mg, 0.137 mmol), EDC·HCl (65.2 mg, 0.340 mmol) and DMAP·TsOH (41.1 mg, 0.137 mmol) in this vial, Then dry DCM (4 ml) was added. The reaction mixture was heated up to 40 °C overnight. After cooling the reaction down to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 4%) as eluent to give pure RL-naphthalene as a dark blue solid Amide-BODIPY PLC-31 . The solid was further triturated with MeOH (15 ml) to give RL-naphthylimide-BODIPY PLC-31 , 40.0 mg, 52% yield. MS (APCI) : Calcd . for C69H50BCl2F2N3O5 ([MH] - ) = 1120 Found: 1120 . 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.69 (d, J = 8.0 Hz, 1H), 8.63 (d, J = 8.0 Hz, 1H), 8.30 (d, J = 2.0 Hz, 1H), 8.11 ( d, J = 8.0 Hz, 1H), 8.06 (m, 2H), 7.82 (dd, J = 8.0 Hz, J = 2.0 Hz, 1H), 7.65 (m, 4H), 7.54 (m, 3H), 7.39 ( m, 9H), 7.30 (m, 2H), 6.49 (s, 2H), 4.07 (s, 2H), 2.63 (m, 4H), 2.33 (bs, 3H), 2.06 (m, 4H), 1,40 (s, 9H).

合成化合物 PLC-32 化合物 PLC-32.1 化合物 PLC-32.1 之一般程序:將 Ex-4.3(6.3 g,17.159 mmol,1 eq)懸浮於35 mL無水DMSO中,在RT下,將甘胺酸(2.31 g,30.77 mmol,1.8 eq)添加至反應混合物中。將所得混合物在130℃下攪拌1小時(混合物未溶解),然後將其加熱至160℃持續1小時,LMCMS顯示反應完成。於冷卻至室溫後,將固體產物過濾,用水(250 mL)洗滌,然後於真空烘箱中乾燥,以得到6.5 g青黃色固體,產率90%。 1H NMR (400 MHz, DMSO-d 6) δ 8.65 (s, 1H), 8.50 (s, 1H), 8.46 (d, J = 8.2 Hz, 2H), 8.09 (d, J = 8.0 Hz, 2H), 7.99 (d, J = 8.7 Hz, 1H), 7.87 (d, J = 8.0 Hz, 2H), 7.58 (d, J = 8.6 Hz, 1H), 7.45 (d, J = 8.4 Hz, 1H), 4.71 (s, 2H)。 Synthesis of compound PLC-32 Compound PLC-32.1 General procedure for compound PLC-32.1 : Ex-4.3 (6.3 g, 17.159 mmol, 1 eq) was suspended in 35 mL of anhydrous DMSO, glycine (2.31 g, 30.77 mmol, 1.8 eq) was added to the reaction mixture. The resulting mixture was stirred at 130°C for 1 hour (the mixture did not dissolve), then it was heated to 160°C for 1 hour, LMCMS showed the reaction was complete. After cooling to room temperature, the solid product was filtered, washed with water (250 mL), and then dried in a vacuum oven to obtain 6.5 g of a cyan-yellow solid, yield 90%. 1 H NMR (400 MHz, DMSO-d 6 ) δ 8.65 (s, 1H), 8.50 (s, 1H), 8.46 (d, J = 8.2 Hz, 2H), 8.09 (d, J = 8.0 Hz, 2H) , 7.99 (d, J = 8.7 Hz, 1H), 7.87 (d, J = 8.0 Hz, 2H), 7.58 (d, J = 8.6 Hz, 1H), 7.45 (d, J = 8.4 Hz, 1H), 4.71 (s, 2H).

化合物 PLC-32.2 化合物 PLC-32.2 之一般程序:PLC-32.1(4.24 g,10.0 mmol,1 eq)懸浮於2-MeTHF (150 ml)、H 2O (5.0 ml)中,添加4-(第三丁基)苯硼酸(3.56 g,20 mmol,2 eq)、K 2CO 3(2.76 g,20 mmol,2 eq)、Pd(dppf) Cl 2DCM (163.3 mg,0.2 mmol,0.02 eq)。將反應混合物藉由Vac- Fill氬氣循環3次脫氣,在95℃下在氬氣氛圍下攪拌及加熱12小時。於冷卻至室溫後,添加乙酸乙酯(150 ml),用1N HCl酸化至pH 4至5。將有機層用水洗滌,分離,濃縮。將殘留物於DMF (15 ml)中攪拌,過濾,以獲得固體,將其用MeOH (50 mL)洗滌,然後於真空烘箱中乾燥,以得到4.1 g青黃色固體產物,85%產率。MS (APCI):針對C 20H 10BrNO 5(M-H)計算值= 423;實測值:423。 1H NMR (400 MHz, DMSO-d 6) δ 8.33 (d, J = 6.1 Hz, 3H), 8.24 (d, J = 7.9 Hz, 1H), 7.95 (s, 1H), 7.78 (d, J = 8.3 Hz, 1H), 7.70 (d, J = 7.9 Hz, 2H), 7.50 (d, J = 7.9 Hz, 2H), 7.39 (d, J = 8.3 Hz, 1H), 7.29 (d, J = 8.2 Hz, 1H), 4.52 (s, 2H), 2.89 (s, 3H), 2.73 (s, 3H), 2.54 - 2.47 (m, 21H), 1.34 (s, 10H)。 Compound PLC-32.2 General procedure for compound PLC-32.2 : PLC-32.1 (4.24 g, 10.0 mmol, 1 eq) was suspended in 2-MeTHF (150 ml), H 2 O (5.0 ml), and 4-(para. Tributyl)phenylboronic acid (3.56 g, 20 mmol, 2 eq), K2CO3 (2.76 g, 20 mmol, 2 eq), Pd ( dppf) Cl2DCM (163.3 mg, 0.2 mmol, 0.02 eq). The reaction mixture was degassed by Vac-Fill argon cycles 3 times, stirred and heated at 95°C under argon atmosphere for 12 hours. After cooling to room temperature, ethyl acetate (150 ml) was added and acidified to pH 4-5 with 1N HCl. The organic layer was washed with water, separated and concentrated. The residue was stirred in DMF (15 ml), filtered to obtain a solid, which was washed with MeOH (50 mL) and dried in a vacuum oven to give 4.1 g of the product as a cyan-yellow solid, 85% yield. MS (APCI): Calcd. for C20H10BrNO5 ( MH ) = 423; found: 423 . 1 H NMR (400 MHz, DMSO-d 6 ) δ 8.33 (d, J = 6.1 Hz, 3H), 8.24 (d, J = 7.9 Hz, 1H), 7.95 (s, 1H), 7.78 (d, J = 8.3 Hz, 1H), 7.70 (d, J = 7.9 Hz, 2H), 7.50 (d, J = 7.9 Hz, 2H), 7.39 (d, J = 8.3 Hz, 1H), 7.29 (d, J = 8.2 Hz , 1H), 4.52 (s, 2H), 2.89 (s, 3H), 2.73 (s, 3H), 2.54 - 2.47 (m, 21H), 1.34 (s, 10H).

化合物 PLC-32 化合物 PLC-32 之一般程序:將 PLC-32.2(71.62 mg,0.15 mmol,1.5 eq)懸浮於無水DCM (10.0 ml)中。向混合物中添加 PLC-2.1(58.5 mg,0.1 mmol,1 eq)、DMAP-pTSA (58.8 mg,0.2 mmol,2eq)、EDC.HCl (57.5 mg,0.3 mmol,3 eq),然後在室溫下在氬氣氛圍下攪拌5小時,用DCM (150 ml)稀釋,過濾,將固體用50 ml DCM洗滌,收集濾液,裝載至80 g SiO 2管柱上,利用Hex-DCM (1/1),僅DCM,然後含0.5% EA之DCM溶離。將良好溶離份濃縮,然後用MeOH洗滌,得到80 mg,產率96%。MS (APCI):針對C 63H 46BCl 2F 2N 3O 5(M-)計算值= 1044;實測值:1044。 1H NMR (400 MHz, d 2-TCE) δ 8.63 (d, J = 7.9 Hz, 1H), 8.58 (d, J = 8.3 Hz, 1H), 8.20 (d, J = 2.1 Hz, 1H), 8.01 (d, J = 8.1 Hz, 1H), 7.98 - 7.91 (m, 2H), 7.73 (dd, J = 8.7, 2.1 Hz, 1H), 7.59 - 7.51 (m, 2H), 7.49 - 7.44 (m, 2H), 7.42 (d, J = 8.6 Hz, 1H), 7.38 (s, 2H), 7.32 (d, J = 8.3 Hz, 1H), 7.27 (dt, J = 7.3, 3.7 Hz, 4H), 7.20 (dt, J = 5.1, 3.7 Hz, 2H), 6.35 (s, 2H), 5.18 (s, 2H), 2.54 (t, J = 6.7 Hz, 4H), 2.22 (s, 4H), 1.99 - 1.90 (m, 4H), 1.31 (s, 10H)。 Compound PLC-32 General procedure for compound PLC-32 : PLC-32.2 (71.62 mg, 0.15 mmol, 1.5 eq) was suspended in anhydrous DCM (10.0 ml). To the mixture was added PLC-2.1 (58.5 mg, 0.1 mmol, 1 eq), DMAP-pTSA (58.8 mg, 0.2 mmol, 2 eq), EDC.HCl (57.5 mg, 0.3 mmol, 3 eq), and then Stir under argon atmosphere for 5 hours, dilute with DCM (150 ml), filter, wash solid with 50 ml DCM, collect filtrate, load onto 80 g SiO 2 column, utilize Hex-DCM (1/1), DCM alone, then DCM with 0.5% EA was eluted. The good fractions were concentrated and then washed with MeOH to give 80 mg, 96% yield. MS ( APCI ) : Calcd. for C63H46BCl2F2N3O5 (M-) = 1044; found : 1044. 1 H NMR (400 MHz, d 2 -TCE) δ 8.63 (d, J = 7.9 Hz, 1H), 8.58 (d, J = 8.3 Hz, 1H), 8.20 (d, J = 2.1 Hz, 1H), 8.01 (d, J = 8.1 Hz, 1H), 7.98 - 7.91 (m, 2H), 7.73 (dd, J = 8.7, 2.1 Hz, 1H), 7.59 - 7.51 (m, 2H), 7.49 - 7.44 (m, 2H ), 7.42 (d, J = 8.6 Hz, 1H), 7.38 (s, 2H), 7.32 (d, J = 8.3 Hz, 1H), 7.27 (dt, J = 7.3, 3.7 Hz, 4H), 7.20 (dt , J = 5.1, 3.7 Hz, 2H), 6.35 (s, 2H), 5.18 (s, 2H), 2.54 (t, J = 6.7 Hz, 4H), 2.22 (s, 4H), 1.99 - 1.90 (m, 4H), 1.31 (s, 10H).

化合物 PLC-33 之合成程序 化合物 PLC-33.1 化合物 PLC-33.1 之一般程序:PLC-32.1(7.0 g,16.50 mmol,1eq)懸浮於2-MeTHF (150 mL)中,添加4-(三氟甲基)苯硼酸(5.648 g,29.7 mmol,1.8 eq)、K 2CO 3(4.65 g,33 mmol,2 eq)、H 2O (15 ml)、Pd(dppf)Cl 2DCM ( 269.5 mg,0.33 mmol,0.02 eq)。Vac- Fill氬氣循環3次,將所得混合物在95℃下在氬氣氛圍下攪拌及加熱12小時,將混合物冷卻至室溫,添加1N HCl (20 ml),攪拌15分鐘,然後在RT下保持1小時。將固體過濾,在室溫下用DMF攪拌15分鐘,然後過濾,將青黃色固體用MeOH洗滌,然後於真空烘箱中乾燥,以得到6.70 g青黃色固體,將其用於下個步驟無需進一步純化。83%產率。MS (APCI):針對C 27H 14F 3NO 5(M-)計算值= 489;實測值:489。 1H NMR (400 MHz, DMSO-d 6) δ 8.52 (s, 1H), 8.37 (q, J = 8.1, 7.7 Hz, 3H), 8.04 (d, J = 7.9 Hz, 2H), 7.93 (d, J = 8.7 Hz, 1H), 7.84 (d, J = 8.0 Hz, 2H), 7.49 (d, J = 8.6 Hz, 1H), 7.34 (d, J = 8.3 Hz, 1H), 4.67 (s, 2H)。 Synthetic procedure of compound PLC-33 Compound PLC-33.1 General procedure for compound PLC-33.1 : PLC-32.1 (7.0 g, 16.50 mmol, 1 eq) was suspended in 2-MeTHF (150 mL), 4-(trifluoromethyl)phenylboronic acid (5.648 g , 29.7 mmol, 1.8 eq), K 2 CO 3 (4.65 g, 33 mmol, 2 eq), H 2 O (15 ml), Pd(dppf)Cl 2 DCM (269.5 mg, 0.33 mmol, 0.02 eq). Vac-Fill argon was circulated 3 times, the resulting mixture was stirred and heated at 95 °C under argon atmosphere for 12 hours, the mixture was cooled to room temperature, 1N HCl (20 ml) was added, stirred for 15 minutes, and then heated at RT. Leave on for 1 hour. The solid was filtered, stirred with DMF at room temperature for 15 minutes, then filtered, and the cyan-yellow solid was washed with MeOH and dried in a vacuum oven to give 6.70 g of a cyan-yellow solid, which was used in the next step without further purification . 83% yield. MS ( APCI): Calcd. for C27H14F3NO5 (M-) = 489 ; found: 489. 1 H NMR (400 MHz, DMSO-d 6 ) δ 8.52 (s, 1H), 8.37 (q, J = 8.1, 7.7 Hz, 3H), 8.04 (d, J = 7.9 Hz, 2H), 7.93 (d, J = 8.7 Hz, 1H), 7.84 (d, J = 8.0 Hz, 2H), 7.49 (d, J = 8.6 Hz, 1H), 7.34 (d, J = 8.3 Hz, 1H), 4.67 (s, 2H) .

化合物 PLC-33 化合物 PLC-33 之一般程序:PLC-33.1(73.4 mg,0.15 mmol,1.5 eq)懸浮於無水DCM (10.0 ml)中,添加 PLC-2.1(58.5 mg,0.1 mmol,1 eq)、DMAP-pTSA (58.8 mg,0.2 mmol,2 eq)、EDC.HCl (57.5 mg,0.3 mmol,3 eq),在室溫下在氬氣氛圍下攪拌5小時,用DCM (150 ml)稀釋,過濾,將固體用50 ml DCM洗滌,收集濾液,裝載至80 g SiO 2管柱上,利用Hex-DCM (1/1),僅DCM,然後含0.5% EA之DCM溶離,收集純溶離份,濃縮,利用熱MeOH洗滌,以得到82 mg暗紫色固體,產率77%。MS (APCI):針對化學式:C 60H 37BCl 2F 5N 3O 5(M-)計算值= 1055;實測值:1055。 1H NMR (400 MHz, d 2-TCE) δ 8.66 (d, J = 7.9 Hz, 1H), 8.61 (d, J = 8.4 Hz, 1H), 8.21 (d, J = 2.2 Hz, 1H), 8.04 (d, J = 8.1 Hz, 1H), 7.96 (s, 2H), 7.73 (dd, J = 9.7, 1.8 Hz, H), 7.47 (d, J = 8.6 Hz, 1H), 7.38 (s, 1H), 7.35 (d, J = 8.4 Hz, 1H), 7.27 (dt, J = 7.3, 3.7 Hz, 3H), 7.23 - 7.16 (m, 2H), 6.35 (s, 2H), 5.19 (s, 2H), 2.53 (d, J = 7.4 Hz, 4H), 2.22 (s, 4H), 2.03 - 1.86 (m, 4H)。 Compound PLC-33 General procedure for compound PLC- 33: PLC-33.1 (73.4 mg, 0.15 mmol, 1.5 eq) was suspended in anhydrous DCM (10.0 ml), PLC-2.1 (58.5 mg, 0.1 mmol, 1 eq) was added , DMAP-pTSA (58.8 mg, 0.2 mmol, 2 eq), EDC.HCl (57.5 mg, 0.3 mmol, 3 eq), stirred at room temperature under argon atmosphere for 5 hours, diluted with DCM (150 ml), Filtrate, wash the solid with 50 ml DCM, collect the filtrate, load onto an 80 g SiO column, elute using Hex-DCM (1/1), DCM only, then DCM containing 0.5% EA, collect the pure fraction, Concentrated, washed with hot MeOH to afford 82 mg of a dark purple solid, 77% yield. MS ( APCI ) : Calcd for Formula: C60H37BCl2F5N3O5 (M- ) = 1055; found : 1055. 1 H NMR (400 MHz, d 2 -TCE) δ 8.66 (d, J = 7.9 Hz, 1H), 8.61 (d, J = 8.4 Hz, 1H), 8.21 (d, J = 2.2 Hz, 1H), 8.04 (d, J = 8.1 Hz, 1H), 7.96 (s, 2H), 7.73 (dd, J = 9.7, 1.8 Hz, H), 7.47 (d, J = 8.6 Hz, 1H), 7.38 (s, 1H) , 7.35 (d, J = 8.4 Hz, 1H), 7.27 (dt, J = 7.3, 3.7 Hz, 3H), 7.23 - 7.16 (m, 2H), 6.35 (s, 2H), 5.19 (s, 2H), 2.53 (d, J = 7.4 Hz, 4H), 2.22 (s, 4H), 2.03 - 1.86 (m, 4H).

PLC-34 之合成程序 化合物 PLC-34.1 之一般程序:Ex-4.3(1.223 g,3.33 mmol,1 eq)懸浮於35 mL無水DMSO中,在室溫下,將5-胺基-1-戊醇(0.687 g,6.66 mmol,2 eq)添加至反應混合物中。將所得混合物在160℃下攪拌45分鐘,LMCMS顯示反應完成。於冷卻至室溫後,過濾固體產物,用水(250 mL)然後MeOH (100 mL)洗滌,於真空烘箱中乾燥,得到1.2 g青黃色固體,產率85%。MS (APCI):針對C 23H 18BrNO 4(M-)計算值= 453;實測值:453。 1H NMR (400 MHz, d 2-TCE) δ 8.52 (d, J = 7.8 Hz, 1H), 8.48 (d, J = 8.3 Hz, 1H), 8.09 (d, J = 2.3 Hz, 1H), 7.82 (d, J = 8.0 Hz, 1H), 7.54 (dd, J = 8.8, 2.3 Hz, 1H), 7.23 (d, J = 8.3 Hz, 1H), 7.19 (d, J = 8.8 Hz, 1H), 4.14 - 4.02 (m, 2H), 3.64 - 3.49 (m, 2H), 1.68 (p, J = 7.7 Hz, 2H), 1.60 - 1.54 (m, 2H), 1.41 (q, J = 8.0 Hz, 2H), 1.28 (s, 1H)。 Synthesis program of PLC-34 General procedure for compound PLC-34.1 : Ex-4.3 (1.223 g, 3.33 mmol, 1 eq) was suspended in 35 mL of anhydrous DMSO, and 5-amino-1-pentanol (0.687 g, 6.66 mmol, 2 eq) was added to the reaction mixture. The resulting mixture was stirred at 160 °C for 45 minutes, LMCMS showed the reaction was complete. After cooling to room temperature, the solid product was filtered, washed with water (250 mL) then MeOH (100 mL), and dried in a vacuum oven to give 1.2 g of a cyan solid, 85% yield. MS ( APCI ): Calcd. for C23H18BrNO4 (M-) = 453; found: 453. 1 H NMR (400 MHz, d 2 -TCE) δ 8.52 (d, J = 7.8 Hz, 1H), 8.48 (d, J = 8.3 Hz, 1H), 8.09 (d, J = 2.3 Hz, 1H), 7.82 (d, J = 8.0 Hz, 1H), 7.54 (dd, J = 8.8, 2.3 Hz, 1H), 7.23 (d, J = 8.3 Hz, 1H), 7.19 (d, J = 8.8 Hz, 1H), 4.14 - 4.02 (m, 2H), 3.64 - 3.49 (m, 2H), 1.68 (p, J = 7.7 Hz, 2H), 1.60 - 1.54 (m, 2H), 1.41 (q, J = 8.0 Hz, 2H), 1.28 (s, 1H).

化合物 PLC-34.2 之一般程序:將 PLC-34.1(1.13 g,2.5 mmol,1 eq)懸浮於DMF (10 ml)、H 2O (5 ml)中,添加4-三氟甲基苯硼酸(0.949 g,5.0 mmol,2 eq)、K 2CO 3(0.691 g,5.0 mmol,2 eq)、Pd(dppf) Cl 2DCM (40.8 mg,0.05 mmol,0.02 eq)。將混合物藉由Vac- Fill氬氣循環3次脫氣,在90℃下攪拌及加熱5小時。將反應混合物冷卻至室溫,添加水。將所得混合物在室溫下保持12小時。將青黃色固體過濾,用水然後MeOH甲醇洗滌,以得到1.24 g青黃色固體,產率95%。MS (APCI):針對C 30H 22F 3NO 4(M-)計算值= 517;實測值:517。 1H NMR (400 MHz, d 2-TCE) δ 8.56 (d, J = 7.9 Hz, 1H), 8.51 (d, J = 8.3 Hz, 1H), 8.17 (d, J = 2.1 Hz, 1H), 7.97 (d, J = 8.0 Hz, 1H), 7.69 (dd, J = 10.3, 1.9 Hz, 4H), 7.42 (d, J = 8.6 Hz, 1H), 7.28 (d, J = 8.3 Hz, 1H), 4.09 (t, J = 7.5 Hz, 2H), 3.57 (q, J = 6.2 Hz, 2H), 1.69 (p, J = 7.8 Hz, 2H), 1.61 - 1.54 (m, 2H), 1.42 (q, J = 8.0 Hz, 2H), 1.28 (t, J = 5.5 Hz, 1H)。 General procedure for compound PLC-34.2 : PLC-34.1 (1.13 g, 2.5 mmol, 1 eq) was suspended in DMF (10 ml), H 2 O (5 ml), 4-trifluoromethylphenylboronic acid (0.949 g, 5.0 mmol, 2 eq), K2CO3 (0.691 g, 5.0 mmol , 2 eq), Pd(dppf)Cl2DCM ( 40.8 mg, 0.05 mmol, 0.02 eq). The mixture was degassed by Vac-Fill argon cycles 3 times, stirred and heated at 90°C for 5 hours. The reaction mixture was cooled to room temperature and water was added. The resulting mixture was kept at room temperature for 12 hours. The cyan-yellow solid was filtered, washed with water and then MeOH methanol to give 1.24 g of cyan-yellow solid, 95% yield. MS ( APCI): Calcd. for C30H22F3NO4 (M-) = 517 ; found: 517. 1 H NMR (400 MHz, d 2 -TCE) δ 8.56 (d, J = 7.9 Hz, 1H), 8.51 (d, J = 8.3 Hz, 1H), 8.17 (d, J = 2.1 Hz, 1H), 7.97 (d, J = 8.0 Hz, 1H), 7.69 (dd, J = 10.3, 1.9 Hz, 4H), 7.42 (d, J = 8.6 Hz, 1H), 7.28 (d, J = 8.3 Hz, 1H), 4.09 (t, J = 7.5 Hz, 2H), 3.57 (q, J = 6.2 Hz, 2H), 1.69 (p, J = 7.8 Hz, 2H), 1.61 - 1.54 (m, 2H), 1.42 (q, J = 8.0 Hz, 2H), 1.28 (t, J = 5.5 Hz, 1H).

化合物 PLC-34.3 之一般程序:PLC-34.2(0.66 g,1.288 mmol)及48% HBr水溶液(20.0 ml)之混合物藉由加熱塊在120℃下回流(HBr 48% bp:126℃) 5小時,同時攪拌。於冷卻至室溫後,將混合物倒入冰水中,將固體過濾,用水洗滌,於真空烘箱中乾燥,以得到82%含有未反應之SM之所需化合物。得到0.7 g青黃色固體,產率93%。將產物用於下個步驟,無需進一步純化。MS (APCI):針對C 30H 21BrF 3NO 3(M-)計算值= 581;實測值:581。 1H NMR (400 MHz, d 2-TCE) δ 8.57 (d, J = 7.9Hz, 1H), 8.51 (d, J = 8.3 Hz, 1H), 8.18 (d, J = 2.2 Hz, 1H), 7.98 (d, J = 7.9 Hz, 1H), 7.69 (dd, J = 9.6, 2.0 Hz, 4H), 7.43 (d, J = 8.6 Hz, 1H), 7.28 (d, J = 8.3 Hz,1H), 4.09 (t, J = 7.5 Hz, 3H), 3.38 (t, J = 6.7 Hz, 2H), 1.97 - 1.81 (m, 2H), 1.69 (t, J = 7.8 Hz, 2H)。 General procedure for compound PLC-34.3 : A mixture of PLC-34.2 (0.66 g, 1.288 mmol) and 48% aqueous HBr (20.0 ml) was refluxed at 120° C. (HBr 48% bp: 126° C.) for 5 hours via a heating block , while stirring. After cooling to room temperature, the mixture was poured into ice water, the solid was filtered, washed with water, and dried in a vacuum oven to give 82% of the desired compound containing unreacted SM. 0.7 g of a cyan-yellow solid was obtained with a yield of 93%. The product was used in the next step without further purification. MS ( APCI): Calcd. for C30H21BrF3NO3 (M-) = 581 ; found : 581. 1 H NMR (400 MHz, d 2 -TCE) δ 8.57 (d, J = 7.9Hz, 1H), 8.51 (d, J = 8.3 Hz, 1H), 8.18 (d, J = 2.2 Hz, 1H), 7.98 (d, J = 7.9 Hz, 1H), 7.69 (dd, J = 9.6, 2.0 Hz, 4H), 7.43 (d, J = 8.6 Hz, 1H), 7.28 (d, J = 8.3 Hz, 1H), 4.09 (t, J = 7.5 Hz, 3H), 3.38 (t, J = 6.7 Hz, 2H), 1.97 - 1.81 (m, 2H), 1.69 (t, J = 7.8 Hz, 2H).

化合物 PLC-34 化合物 PLC-34 之一般程序:將 PLC-34.3(87.06 mg,0.15 mmol,1.5 eq)懸浮於無水DMF (10.0 ml)中,添加 PLC-2.1(63.65 mg,0.10 mmol,1 eq)、K 2CO 3(41.46 mg,0.3 mmol,2 eq)、NaI (8.3 mg,催化量)。將所得混合物在65℃下在氬氣氛圍下攪拌15小時,冷卻至室溫,將固體過濾,用50 ml水洗滌,將粗產物裝載至40 g矽膠管柱上,利用Hex: DCM (9:1)至DCM溶離,得到75 mg紅棕色固體,產率69%。MS (APCI):針對C 63H 45BCl 2F 5N 3O 4(M-)計算值= 1083;實測值:1083。 1H NMR (400 MHz, d 2-TCE) δ 8.59 (d, J = 7.9 Hz, 1H), 8.54 (d, J = 8.3 Hz, 1H), 8.18 (d, J = 2.1 Hz, 1H),8.00 (d, J = 8.1 Hz, 1H), 7.96 (s, 1H), 7.70 (dd, J = 7.4, 2.2 Hz, 3H), 7.43 (d, J = 8.6 Hz, 1H), 7.30 (d, J = 8.3 Hz, 1H), 7.29 - 7.25 (m, 2H), 7.22 - 7.19 (m, 1H), 6.98 (s, 2H), 6.39 (s, 2H), 4.15 (t, J = 7.5 Hz, 2H), 3.99 (t, J = 6.2 Hz, 2H), 2.55 (t, J = 6.6 Hz, 2H), 2.23 (s, 2H), 1.98 - 1.92 (m, 2H), 1.86 (s, 1H), 1.77 (s, 1H), 1.58 (s, 2H)。 Compound PLC-34 General procedure for compound PLC-34 : PLC-34.3 (87.06 mg, 0.15 mmol, 1.5 eq) was suspended in anhydrous DMF (10.0 ml), PLC-2.1 (63.65 mg, 0.10 mmol, 1 eq) was added , K 2 CO 3 (41.46 mg, 0.3 mmol, 2 eq), NaI (8.3 mg, catalytic amount). The resulting mixture was stirred at 65° C. under an argon atmosphere for 15 hours, cooled to room temperature, the solid was filtered, washed with 50 ml of water, and the crude product was loaded onto a 40 g silica gel column, and the mixture was collected using Hex:DCM (9: 1) to DCM dissolution, obtain 75 mg reddish-brown solid, productive rate 69%. MS (APCI) : Calcd . for C63H45BCl2F5N3O4 (M-) = 1083; found : 1083. 1 H NMR (400 MHz, d 2 -TCE) δ 8.59 (d, J = 7.9 Hz, 1H), 8.54 (d, J = 8.3 Hz, 1H), 8.18 (d, J = 2.1 Hz, 1H), 8.00 (d, J = 8.1 Hz, 1H), 7.96 (s, 1H), 7.70 (dd, J = 7.4, 2.2 Hz, 3H), 7.43 (d, J = 8.6 Hz, 1H), 7.30 (d, J = 8.3 Hz, 1H), 7.29 - 7.25 (m, 2H), 7.22 - 7.19 (m, 1H), 6.98 (s, 2H), 6.39 (s, 2H), 4.15 (t, J = 7.5 Hz, 2H), 3.99 (t, J = 6.2 Hz, 2H), 2.55 (t, J = 6.6 Hz, 2H), 2.23 (s, 2H), 1.98 - 1.92 (m, 2H), 1.86 (s, 1H), 1.77 (s , 1H), 1.58 (s, 2H).

PLC-35 之合成程序 化合物 PLC-35.1 – 9- -2-(2-(2- 羥基乙氧基 ) 乙基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -1,3(2H)- 二酮之一般程序:將100 mL燒瓶安裝攪拌棒。向該燒瓶中,將含於DMF (30 ml)中之 Ex-4.3(1.5 g,4.1 mmol)、2-(2-胺基乙氧基)乙-1-醇(859.0 mg,8.2 mmol)及DMAP (35.1 mg,0.3 mmol)在室溫下脫氣。將反應混合物加熱上至165℃及將反應在此溫度下保持2小時。TLC及LCMS顯示反應完全。將反應冷卻降至室溫。添加H 2O (70 ml)以沉澱產物。藉由過濾收集沉澱物。將固體藉由H 2O (150 ml)洗滌及於真空烘箱中在100℃下進一步乾燥3小時,以得到呈黃色固體之 PLC-35.1用於下個步驟無需進一步純化。1.45 g,78%產率。MS (APCI):針對C 22H 16BrNO 5([M-H] -)計算值= 454實測值:454。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.62 (d, J= 8.0 Hz, 1H), 8.59 (d, J= 8.0 Hz, 1H), 8.19 (d, J= 2.4 Hz, 1H), 7.92 (d, J= 8.0 Hz, 1H), 7.65 (dd, J= 8.0 Hz, J= 2.4 Hz, 2H), 7.33 (d, J= 8.0 Hz, 1H), 7.29 (d, J= 8.0 Hz, 1H), 4.42 (t, J= 5.6 Hz, 2H), 3.85 (t, J= 5.6 Hz, 2H), 3.67 (m, 4H)。 Synthesis program of PLC-35 Compound PLC-35.1 – 9- Bromo -2-(2-(2- hydroxyethoxy ) ethyl )-1H- 𠮿 General procedure for [2,1,9-def]isoquinoline-1,3(2H)-dione : A 100 mL flask was fitted with a stir bar. Into the flask, Ex-4.3 (1.5 g, 4.1 mmol), 2-(2-aminoethoxy)ethan-1-ol (859.0 mg, 8.2 mmol) and DMAP (35.1 mg, 0.3 mmol) was degassed at room temperature. The reaction mixture was heated up to 165°C and the reaction was maintained at this temperature for 2 hours. TLC and LCMS showed the reaction was complete. The reaction was cooled to room temperature. H2O (70 ml) was added to precipitate the product. The precipitate was collected by filtration. The solid was washed by H2O (150 ml) and further dried in a vacuum oven at 100 °C for 3 hours to give PLC-35.1 as a yellow solid which was used in the next step without further purification. 1.45 g, 78% yield. MS ( APCI ): Calcd. for C22H16BrNO5 ([MH] ) = 454 Found: 454. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.62 (d, J = 8.0 Hz, 1H), 8.59 (d, J = 8.0 Hz, 1H), 8.19 (d, J = 2.4 Hz, 1H), 7.92 ( d, J = 8.0 Hz, 1H), 7.65 (dd, J = 8.0 Hz, J = 2.4 Hz, 2H), 7.33 (d, J = 8.0 Hz, 1H), 7.29 (d, J = 8.0 Hz, 1H) , 4.42 (t, J = 5.6 Hz, 2H), 3.85 (t, J = 5.6 Hz, 2H), 3.67 (m, 4H).

化合物 PLC-35.2 2-(2-(2- 羥基乙氧基 ) 乙基 )-9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -1,3(2H)- 二酮之一般程序:將250 mL燒瓶安裝攪拌棒。向該燒瓶中,將含於THF/DMF/H 2O (48 ml/ 9.6 ml/ 4.8 ml)中之 PLC-35.1(800.0 mg,1.8 mmol)、4-(三氟甲基)苯基硼酸(670.0 mg,3.5 mmol)、Pd(dppf)Cl 2(90.6 mg,0.1 mmol)及K 2CO 3(659.5 mg,4.8 mmol)在室溫下脫氣。將反應混合物加熱上至80℃及將反應在此溫度下保持過夜。TLC係用於監測反應。於完成後,將反應藉由添加H 2O (150 ml)處理,以沉澱產物。藉由過濾收集沉澱物。將固體藉由H 2O (200 ml)及MeOH (20 ml)洗滌,及於真空烘箱中在100℃下進一步乾燥3小時,以得到呈黃綠色固體之 PLC-35.2用於下個步驟無需進一步純化。定量產率。MS (APCI):針對C 29H 20F 3NO 5([M+H] +)計算值= 520實測值:520。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.67 (d, J= 8.0 Hz, 1H), 8.61 (d, J= 8.0 Hz, 1H), 8.26 (d, J= 2.0 Hz, 1H), 8.07 (d, J= 8.0 Hz, 1H), 7.79 (m, 5H), 7.52 (d, J= 8.4 Hz, 1H), 7.38 (d, J= 8.4 Hz, 1H), 5.11 (bs, 1H), 4.44 (t, J= 1.6 Hz, 2H), 3.86 (t, J= 1.6 Hz, 2H), 3.68 (m, 4H)。 Compound PLC-35.2 2-(2-(2- hydroxyethoxy ) ethyl )-9-(4-( trifluoromethyl ) phenyl )-1H- 𠮿 General procedure for [2,1,9-def]isoquinoline-1,3(2H)-dione : A 250 mL flask was fitted with a stir bar. To the flask , PLC-35.1 (800.0 mg, 1.8 mmol), 4-(trifluoromethyl)phenylboronic acid ( 670.0 mg, 3.5 mmol), Pd(dppf)Cl 2 (90.6 mg, 0.1 mmol) and K 2 CO 3 (659.5 mg, 4.8 mmol) were degassed at room temperature. The reaction mixture was heated up to 80 °C and the reaction was kept at this temperature overnight. TLC was used to monitor the reaction. Upon completion, the reaction was worked up by addition of H2O (150 ml) to precipitate the product. The precipitate was collected by filtration. The solid was washed by H 2 O (200 ml) and MeOH (20 ml), and further dried in a vacuum oven at 100° C. for 3 hours to give PLC-35.2 as a yellow-green solid which was used in the next step without further purification. Quantitative yield. MS (APCI): Calcd . for C29H20F3NO5 ([M+H] + ) = 520 Found : 520. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.67 (d, J = 8.0 Hz, 1H), 8.61 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 2.0 Hz, 1H), 8.07 ( d, J = 8.0 Hz, 1H), 7.79 (m, 5H), 7.52 (d, J = 8.4 Hz, 1H), 7.38 (d, J = 8.4 Hz, 1H), 5.11 (bs, 1H), 4.44 ( t, J = 1.6 Hz, 2H), 3.86 (t, J = 1.6 Hz, 2H), 3.68 (m, 4H).

化合物 PLC-35.3A PLC-35.3B 甲磺酸 2-(2-(1,3- 二側氧基 -9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -2(3H)- ) 乙氧基 ) 乙酯及 2-(2-(2- 氯乙氧基 ) 乙基 )-9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -1,3(2H)- 二酮之一般程序100 mL燒瓶安裝攪拌棒。向該燒瓶中添加 PLC-35.2(900.0 mg,1.7 mmol)及DMF/THF (18 ml/ 6 ml)。將溶液在室溫下脫氣。添加甲磺醯氯(595.4 mg,5.2 mmol)及TEA (526.2 mg,5.2 mmol)。然後將溶液加熱上至90℃及將其在此溫度下保持20分鐘。TLC係用於監測反應。於完成後,將反應藉由添加H 2O (150 ml)處理,以沉澱產物。藉由過濾收集沉澱物。將固體藉由H 2O (100 ml)及MeOH (15 ml)洗滌,及於真空烘箱中在100℃下進一步乾燥3小時,以得到呈黃色固體之 PLC-35.3APLC-35.3B(約1:1莫耳比率)之混合物用於下個步驟無需進一步純化。定量產率。針對PLC-35.4A,MS (APCI):針對C 30H 22F 3NO 7S ([M+H] +)計算值= 598實測值:598。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.65 (d, J= 8.0 Hz, 1H), 8.60 (d, J= 8.0 Hz, 1H), 8.26 (d, J= 2.0 Hz, 1H), 8.07 (d, J= 8.0 Hz, 1H), 7.78 (m, 5H), 7.52 (d, J= 8.4 Hz, 1H), 7.38 (d, J= 8.4 Hz, 1H), 4.44 (t, J= 2.0 Hz, 2H), 4.35 (m, 2H), 3.86 (t, J= 2.0 Hz, 2H), 3.81 (m, 2H), 3.01 (s, 3H)。針對PLC-35.4B,MS (APCI):針對C 29H 19ClF 3NO 4([M-H] -)計算值= 537實測值:537。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.66 (d, J= 8.0 Hz, 1H), 8.61 (d, J= 8.0 Hz, 1H), 8.26 (d, J= 2.0 Hz, 1H), 8.07 (d, J= 8.0 Hz, 1H), 7.79 (m, 5H), 7.52 (d, J= 8.4 Hz, 1H), 7.37 (d, J= 8.4 Hz, 1H), 4.43 (t, J= 2.0 Hz, 2H), 3.86 (t, J= 2.0 Hz, 2H), 3.81 (t, J= 1.6 Hz, 2H), 3.63 (t, J= 1.6 Hz, 2H)。 Compounds PLC-35.3A and PLC-35.3B Methanesulfonic acid 2-(2-(1,3- dioxo -9-(4-( trifluoromethyl ) phenyl )-1H- 𠮿 And [2,1,9-def] isoquinolin -2(3H)-yl ) ethoxy ) ethyl ester and 2-(2-(2- chloroethoxy ) ethyl )-9-(4- ( Trifluoromethyl ) phenyl )-1H- 𠮿 General procedure for [2,1,9-def]isoquinoline-1,3(2H)-dione : A 100 mL flask was fitted with a stir bar. To the flask was added PLC-35.2 (900.0 mg, 1.7 mmol) and DMF/THF (18 ml/6 ml). The solution was degassed at room temperature. Methanesulfonyl chloride (595.4 mg, 5.2 mmol) and TEA (526.2 mg, 5.2 mmol) were added. The solution was then heated up to 90°C and kept at this temperature for 20 minutes. TLC was used to monitor the reaction. Upon completion, the reaction was worked up by addition of H2O (150 ml) to precipitate the product. The precipitate was collected by filtration. The solid was washed by H 2 O (100 ml) and MeOH (15 ml), and further dried in a vacuum oven at 100° C. for 3 hours to give PLC-35.3A and PLC-35.3B as yellow solids (ca. 1:1 molar ratio) was used in the next step without further purification. Quantitative yield. For PLC-35.4A, MS (APCI): Calculated for C 30 H 22 F 3 NO 7 S ([M+H] + ) = 598 Found: 598. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.65 (d, J = 8.0 Hz, 1H), 8.60 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 2.0 Hz, 1H), 8.07 ( d, J = 8.0 Hz, 1H), 7.78 (m, 5H), 7.52 (d, J = 8.4 Hz, 1H), 7.38 (d, J = 8.4 Hz, 1H), 4.44 (t, J = 2.0 Hz, 2H), 4.35 (m, 2H), 3.86 (t, J = 2.0 Hz, 2H), 3.81 (m, 2H), 3.01 (s, 3H). For PLC -35.4B, MS (APCI): Calcd. for C29H19CIF3NO4 ( [ MH] - ) = 537 Found: 537 . 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.66 (d, J = 8.0 Hz, 1H), 8.61 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 2.0 Hz, 1H), 8.07 ( d, J = 8.0 Hz, 1H), 7.79 (m, 5H), 7.52 (d, J = 8.4 Hz, 1H), 7.37 (d, J = 8.4 Hz, 1H), 4.43 (t, J = 2.0 Hz, 2H), 3.86 (t, J = 2.0 Hz, 2H), 3.81 (t, J = 1.6 Hz, 2H), 3.63 (t, J = 1.6 Hz, 2H).

化合物 PLC-35.4 – 2,6- 二氯 -4-(2-(2-(1,3- 二側氧基 -9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -2(3H)- ) 乙氧基 ) 乙氧基 ) 苯甲醛之一般程序:向100 ml燒瓶中添加NaH (69.1 mg,2.9 mmol)及DMF (20 ml),接著添加4-羥基-2,6-二氯苯甲醛(413.3 mg,2.2 mmol)。將混合物保持在室溫下攪拌10分鐘。添加 PLC-35.3A(0.7 mmol)及 PLC-35.3B(0.7 mmol)之混合物(總計862.0 mg,1.4 mmol)。將反應加熱上至160℃及保持在此溫度下攪拌過夜。TLC (含50% EtOAc之己烷)顯示反應完全。將反應混合物藉由矽膠急驟層析法使用含EtOAc之DCM (0至40%)作為溶離劑純化,以得到呈黃色固體之純化合物 PLC-35.4,580.0 mg,60%產率。MS (APCI):針對C 36H 22Cl 2F 3NO 6([M-H] -)計算值= 691實測值:691。 1H NMR (400 MHz, CDCl 2CDCl 2) δ 10.06 (s, 1H), 8.60 (d, J= 8.0 Hz, 1H), 8.57 (d, J= 8.0 Hz, 1H), 8.24 (d, J= 2.0 Hz, 1H), 8.02 (d, J= 8.0 Hz, 1H), 7.81 (m, 5H), 7.52 (d, J= 8.0 Hz, 1H), 7.34 (d, J= 8.0 Hz, 1H), 6.56 (s, 2H), 4.44 (t, J= 2.0 Hz, 2H), 3.98 (m, 2H), 3.93 (t, J= 2.0 Hz, 2H), 3.86 (m, 2H)。 Compound PLC-35.4 – 2,6- dichloro -4-(2-(2-(1,3- dioxo -9-(4-( trifluoromethyl ) phenyl )-1H- 𠮿 General procedure for [2,1,9-def] isoquinolin -2(3H)-yl ) ethoxy ) ethoxy ) benzaldehyde : To a 100 ml flask was added NaH (69.1 mg, 2.9 mmol) and DMF (20 ml) followed by 4-hydroxy-2,6-dichlorobenzaldehyde (413.3 mg, 2.2 mmol). The mixture was kept stirring at room temperature for 10 minutes. A mixture of PLC-35.3A (0.7 mmol) and PLC-35.3B (0.7 mmol) (total 862.0 mg, 1.4 mmol) was added. The reaction was heated up to 160 °C and kept stirring at this temperature overnight. TLC (50% EtOAc in hexanes) showed the reaction was complete. The reaction mixture was purified by flash chromatography on silica gel using EtOAc in DCM (0 to 40%) as eluent to give pure compound PLC-35.4 as a yellow solid, 580.0 mg, 60% yield. MS ( APCI ): Calcd . for C36H22Cl2F3NO6 ([MH] - ) = 691 Found: 691. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) δ 10.06 (s, 1H), 8.60 (d, J = 8.0 Hz, 1H), 8.57 (d, J = 8.0 Hz, 1H), 8.24 (d, J = 2.0 Hz, 1H), 8.02 (d, J = 8.0 Hz, 1H), 7.81 (m, 5H), 7.52 (d, J = 8.0 Hz, 1H), 7.34 (d, J = 8.0 Hz, 1H), 6.56 (s, 2H), 4.44 (t, J = 2.0 Hz, 2H), 3.98 (m, 2H), 3.93 (t, J = 2.0 Hz, 2H), 3.86 (m, 2H).

化合物 PLC-35 – 2-(2-(2-(3,5- 二氯 -4-(19,19- 二氟 -6,7,11,12,13,19- 六氫 -5H-18l4,19l4- 苯并 [3',4'] 環庚 [1',2':4,5] 吡咯并 [1,2-c] 苯并 [3',4'] 環庚 [1',2':4,5] 吡咯并 [2,1-f][1,3,2] 二氮雜硼雜苯 -9- ) 苯氧基 ) 乙氧基 ) 乙基 )-9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -1,3(2H)- 二酮之一般程序:將100 mL 2頸圓底燒瓶安裝空氣冷凝器及攪拌棒。向該燒瓶中添加 PLC-35.4(140.0 mg,0.2 mmol)及 Ex-7.3(77.7 mg,0.4 mmol),接著添加無水二氯甲烷(4 ml)。將反應混合物用Ar噴射30分鐘,然後添加p-TsOH•H 2O (1.2 mg,0.01 mmol)。將反應溶液在此溫度下保持2小時。然後添加DDQ (25.0 mg,0.1 mmol)。將反應在室溫下保持30分鐘。然後在室溫下添加BF 3•OEt 2(0.3 mL,2.4 mmol)及Et 3N (0.2 mL,1.6 mmol)。將反應混合物在室溫下保持過夜。將反應混合物裝載矽膠及藉由急驟層析法使用含EtOAc之DCM (0至5%)作為溶離劑純化,以得到呈暗紫色固體之純 PLC-35,121.0 mg,55%產率。MS (APCI):針對C 62H 43BCl 2F 5N 3O 5([M-H] -)計算值= 1086實測值:1086。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.69 (d, J= 8.0 Hz, 1H), 8.63 (d, J= 8.0 Hz, 1H), 8.26 (d, J= 2.4 Hz, 1H), 8.08 (d, J= 8.0 Hz, 1H), 8.04 (m, 2H), 7.78 (m, 5H), 7.51 (d, J= 8.0 Hz, 1H), 7.34 (m, 7H), 6.99 (s, 2H), 6.44 (s, 2H), 4.49 (t, J= 2.0 Hz, 2H), 4.18 (m, 2H), 3.96 (m, 4H),  2.63 (m, 4H), 2.31 (bs, 4H), 2.04 (m, 4H)。 Compound PLC-35 – 2-(2-(2-(3,5- dichloro -4-(19,19- difluoro -6,7,11,12,13,19- hexahydro -5H-18l4, 19l4- Benzo [3',4'] cyclohepta [1',2':4,5] pyrrolo [1,2-c] benzo [3',4'] cyclohepta [1',2' :4,5] pyrrolo [2,1-f][1,3,2] diazaborin-9-yl)phenoxy ) ethoxy ) ethyl ) -9- ( 4- ( Trifluoromethyl ) phenyl )-1H- 𠮿 General procedure for [2,1,9-def]isoquinoline-1,3(2H)-dione : A 100 mL 2-neck round bottom flask was equipped with an air condenser and a stirring bar. To the flask was added PLC-35.4 (140.0 mg, 0.2 mmol) and Ex-7.3 (77.7 mg, 0.4 mmol), followed by anhydrous dichloromethane (4 ml). The reaction mixture was sparged with Ar for 30 min, then p-TsOH•H 2 O (1.2 mg, 0.01 mmol) was added. The reaction solution was kept at this temperature for 2 hours. Then DDQ (25.0 mg, 0.1 mmol) was added. The reaction was kept at room temperature for 30 minutes. Then BF 3 •OEt 2 (0.3 mL, 2.4 mmol) and Et 3 N (0.2 mL, 1.6 mmol) were added at room temperature. The reaction mixture was kept at room temperature overnight. The reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc in DCM (0 to 5%) as eluent to give pure PLC-35 as a dark purple solid, 121.0 mg, 55% yield. MS ( APCI ): Calcd. for C62H43BCl2F5N3O5 ( [ MH] - ) = 1086 Found : 1086. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.69 (d, J = 8.0 Hz, 1H), 8.63 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 2.4 Hz, 1H), 8.08 ( d, J = 8.0 Hz, 1H), 8.04 (m, 2H), 7.78 (m, 5H), 7.51 (d, J = 8.0 Hz, 1H), 7.34 (m, 7H), 6.99 (s, 2H), 6.44 (s, 2H), 4.49 (t, J = 2.0 Hz, 2H), 4.18 (m, 2H), 3.96 (m, 4H), 2.63 (m, 4H), 2.31 (bs, 4H), 2.04 (m , 4H).

化合物 PLC-36 之合成程序 化合物 PLC-36.5– (2-(4-(9- -1,3- 二側氧基 -1H- 𠮿 [2,1,9-def] 異喹啉 -2(3H)- ) 苯基 ) 乙酸 ) 之一般程序:將100 mL 2N圓底燒瓶放入鋁加熱塊中及放入攪拌棒。將該燒瓶安裝翅片冷凝器/氣體適配器及流動控制閥。將系統用氬氣沖洗。向該燒瓶中添加 Ex-4.3(0.702 mmol,250 mg)、2-(4-胺基苯基)乙酸(1.754 mmol,265 mg)及DMAP (0.0512 mmol,6.3 mg),接著無水DMF (10 mL)。將反應混合物在氬氣下攪拌及將加熱塊設置至170℃。將反應混合物在170℃下攪拌9小時,然後在室溫下攪拌。將粗製反應混合物用75 mL水稀釋。將此混合物攪拌5分鐘,然後過濾掉粗產物,藉由抽吸乾燥5分鐘。將濕沉澱物於真空烘箱中在約110℃下乾燥過夜。得到微黃色粉末,366 mg (107%產率)。NMR顯示約10至15%二甲基醯胺副產物。MS (APCI):針對C 26H 14BrNO 5(M+H)計算值= 500;實測值:500。 1H NMR (400 MHz, DMSO- d 6) δ 8.60 (d, J= 2.3 Hz, 1H), 8.49 - 8.45 (m, 2H), 8.39 (d, J= 8.1 Hz, 1H), 7.80 - 7.75 (m, 1H), 7.48 - 7.43 (m, 2H), 7.43 - 7.38 (m, 2H), 7.31 - 7.27 (m, 2H), 3.67 (s, 2H)。 Synthetic procedure of compound PLC-36 Compound PLC-36.5– (2-(4-(9- bromo -1,3- dioxo -1H- 𠮿 General procedure for [ 2,1,9-def] isoquinolin -2(3H)-yl )phenyl ) acetic acid ) : A 100 mL 2N round bottom flask was placed in an aluminum heating block and a stir bar was placed. The flask was fitted with a finned condenser/gas adapter and flow control valve. The system was flushed with argon. To the flask was added Ex-4.3 (0.702 mmol, 250 mg), 2-(4-aminophenyl)acetic acid (1.754 mmol, 265 mg) and DMAP (0.0512 mmol, 6.3 mg), followed by anhydrous DMF (10 mL ). The reaction mixture was stirred under argon and the heating block was set to 170 °C. The reaction mixture was stirred at 170°C for 9 hours and then at room temperature. The crude reaction mixture was diluted with 75 mL of water. The mixture was stirred for 5 minutes, then the crude product was filtered off and dried by suction for 5 minutes. The wet precipitate was dried overnight in a vacuum oven at about 110°C. A yellowish powder was obtained, 366 mg (107% yield). NMR showed about 10 to 15% dimethylamide by-product. MS ( APCI ) : Calcd. for C26H14BrNO5 (M+H) = 500; found: 500. 1 H NMR (400 MHz, DMSO- d 6 ) δ 8.60 (d, J = 2.3 Hz, 1H), 8.49 - 8.45 (m, 2H), 8.39 (d, J = 8.1 Hz, 1H), 7.80 - 7.75 ( m, 1H), 7.48 - 7.43 (m, 2H), 7.43 - 7.38 (m, 2H), 7.31 - 7.27 (m, 2H), 3.67 (s, 2H).

化合物 PLC-36.2 – (2-(4-(2-(2-(2- 甲氧乙氧基 ) 乙氧基 ) 乙氧基 ) 苯基 )-4,4,5,5- 四甲基 -1,3,2- 二氧雜硼戊環 ) 之一般程序:將250 mL 2N圓底燒瓶放入鋁加熱塊中及放入攪拌棒。將該燒瓶安裝翅片冷凝器/氣體適配器及流動控制閥。將系統用氬氣沖洗。向該燒瓶中添加4-(4,4,5,5-四甲基-1,3,2-二氧雜硼戊環-2-基)苯酚(11.0 mmol,2.421 g)、1-溴-2-(2-(2-甲氧乙氧基)乙氧基)乙烷(10.0 mmol,2.48 mL)、無水DMF (25 mL)及K 2CO 3(11.0 mmol,1.520 g)。將反應混合物在氬氣氛圍下在室溫下攪拌5分鐘,然後將加熱塊設置在50℃及將反應混合物在50℃下攪拌6小時,然後在室溫下歷時週末。將反應混合物用水(約200 mL)稀釋,然後用乙醚(3 X 100 mL)萃取。將合併之醚層用飽和NaHCO 3水溶液(50 mL)、鹽水(50 mL)洗滌,經MgSO 4乾燥,過濾及於真空中蒸發至乾。得到淺黃色油(4.166 g,114%產率)。NMR指示其為所需產物及起始溴-甘醇之混合物,估計約57%產物。用於下個步驟無需進一步純化。MS (APCI):針對C 19H 31BO 6(M+H)計算值= 367;實測值:367。 1H NMR (400 MHz,甲醇- d 4) δ 7.69 - 7.63 (m, 2H), 6.95 - 6.90 (m, 2H), 4.18 - 4.11 (m, 2H), 3.86 - 3.82 (m, 2H), 3.72 - 3.67 (m, 2H), 3.66 - 3.60 (m, 2H), 3.54 - 3.48 (m, 4H), 3.34 (s, 3H)。 Compound PLC-36.2 – (2-(4-(2-(2-(2- methoxyethoxy ) ethoxy ) ethoxy ) phenyl )-4,4,5,5 - tetramethyl- General procedure for 1,3,2- dioxaborolane ) : Place a 250 mL 2N round bottom flask in an aluminum heating block and place a stir bar. The flask was fitted with a finned condenser/gas adapter and flow control valve. The system was flushed with argon. To the flask was added 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (11.0 mmol, 2.421 g), 1-bromo- 2-(2-(2-Methoxyethoxy)ethoxy)ethane (10.0 mmol, 2.48 mL), anhydrous DMF (25 mL) and K2CO3 ( 11.0 mmol, 1.520 g). The reaction mixture was stirred at room temperature under an atmosphere of argon for 5 minutes, then the heat block was set at 50°C and the reaction mixture was stirred at 50°C for 6 hours, then at room temperature over the weekend. The reaction mixture was diluted with water (about 200 mL), then extracted with diethyl ether (3 X 100 mL). The combined ether layers were washed with saturated aqueous NaHCO 3 (50 mL), brine (50 mL), dried over MgSO 4 , filtered and evaporated to dryness in vacuo. A pale yellow oil was obtained (4.166 g, 114% yield). NMR indicated it was a mixture of desired product and starting bromo-glycol, estimated about 57% product. Used in the next step without further purification. MS (APCI): calcd for C19H31BO6 (M+H) = 367; found : 367 . 1 H NMR (400 MHz, methanol- d 4 ) δ 7.69 - 7.63 (m, 2H), 6.95 - 6.90 (m, 2H), 4.18 - 4.11 (m, 2H), 3.86 - 3.82 (m, 2H), 3.72 - 3.67 (m, 2H), 3.66 - 3.60 (m, 2H), 3.54 - 3.48 (m, 4H), 3.34 (s, 3H).

化合物 PLC-36.3 – (2-(4-(9-(4-(2-(2-(2- 甲氧乙氧基 ) 乙氧基 ) 乙氧基 ) 苯基 )-1,3- 二側氧基 -1H- 𠮿 [2,1,9-def] 異喹啉 -2(3H)- ) 苯基 ) 乙酸 ) 之一般程序:將250 mL 2N圓底燒瓶放入鋁加熱塊中及放入攪拌棒。將該燒瓶安裝翅片冷凝器/氣體適配器及流動控制閥。將系統用氬氣沖洗。向該燒瓶中添加 PLC-36.1(2.00 mmol,1001 mg)、 PLC-36.2(4.00 mmol,1465 mg)、K 2CO 3(5.50 mmol,760 mg)及Pd(dppf)Cl 2(0.140 mmol,102 mg),接著添加THF (60 mL)、DMF (12 mL)及水(6 mL)。將反應混合物在氬氣下攪拌及用氮氣噴射10分鐘。停止氮氣噴射及繼續在氬氣下攪拌。將加熱塊設置在80℃持續2小時。將反應混合物用6N HCl (5 mL)中止及用水(50 mL)及THF (50 mL)稀釋。添加氯化鈉直至水層飽和,然後分離層,及將水層用THF (3 X 50 mL)萃取。將合併之有機層用鹽水(50 mL)洗滌,經MgSO 4乾燥,過濾,及於真空中蒸發至乾(包含DMF)。將粗產物蒸發至約50 g急驟矽膠上及放入裝載器中。藉由在矽膠上急驟層析法純化(220 g,固體負荷,平衡100% DCM,溶離100% DCM (2 CV) à 40% (EtOAc/0.1% TFA)/DCM (20CV) à 70% (EtOAc/0.1% TFA)/DCM (20 CV))。將含有產物之溶離份於真空中蒸發至乾。得到黃色固體,722 mg (55%產率)。MS (APCI):針對C 39H 33NO 9(M+H)計算值= 660;實測值:660。 1H NMR (400 MHz, DMSO- d 6) δ 8.57 (d, J= 2.2 Hz, 1H), 8.52 (s, 2H), 8.48 (d, J= 8.3 Hz, 1H), 7.90 (dd, J= 8.7, 2.2 Hz, 1H), 7.84 - 7.78 (m, 2H), 7.55 (d, J= 8.7 Hz, 1H), 7.48 (d, J= 8.3 Hz, 1H), 7.41 (d, J= 8.1 Hz, 2H), 7.33 - 7.26 (m, 2H), 7.12 - 7.07 (m, 2H), 4.22 - 4.14 (m, 2H), 3.82 - 3.76 (m, 2H), 3.68 (s, 2H), 3.65 - 3.59 (m, 2H), 3.58 - 3.51 (m, 4H), 3.48 - 3.41 (m, 2H), 3.25 (s, 3H)。 Compound PLC-36.3 – (2-(4-(9-(4-(2-(2-(2- methoxyethoxy ) ethoxy ) ethoxy ) phenyl )-1,3- two sides Oxy -1H- 𠮿 General procedure for [ 2,1,9-def] isoquinolin -2(3H) -yl ) phenyl ) acetic acid ) : A 250 mL 2N round bottom flask was placed in an aluminum heating block and a stir bar was placed. The flask was fitted with a finned condenser/gas adapter and flow control valve. The system was flushed with argon. To the flask was added PLC-36.1 (2.00 mmol, 1001 mg), PLC-36.2 (4.00 mmol, 1465 mg), K 2 CO 3 (5.50 mmol, 760 mg) and Pd(dppf)Cl 2 (0.140 mmol, 102 mg), followed by the addition of THF (60 mL), DMF (12 mL) and water (6 mL). The reaction mixture was stirred under argon and sparged with nitrogen for 10 minutes. The nitrogen sparge was stopped and stirring was continued under argon. Set the heat block at 80 °C for 2 hours. The reaction mixture was quenched with 6N HCl (5 mL) and diluted with water (50 mL) and THF (50 mL). Sodium chloride was added until the aqueous layer was saturated, then the layers were separated, and the aqueous layer was extracted with THF (3×50 mL). The combined organic layers were washed with brine (50 mL), dried over MgSO 4 , filtered, and evaporated to dryness (containing DMF) in vacuo. The crude product was evaporated onto about 50 g of flash silica gel and placed in a loader. Purified by flash chromatography on silica gel (220 g, solid load, equilibrated 100% DCM, eluting 100% DCM (2 CV) à 40% (EtOAc/0.1% TFA)/DCM (20CV) à 70% (EtOAc /0.1% TFA)/DCM (20 CV)). Fractions containing product were evaporated to dryness in vacuo. Obtained a yellow solid, 722 mg (55% yield). MS (APCI): Calcd. for C39H33NO9 (M+H) = 660; found : 660 . 1 H NMR (400 MHz, DMSO- d 6 ) δ 8.57 (d, J = 2.2 Hz, 1H), 8.52 (s, 2H), 8.48 (d, J = 8.3 Hz, 1H), 7.90 (dd, J = 8.7, 2.2 Hz, 1H), 7.84 - 7.78 (m, 2H), 7.55 (d, J = 8.7 Hz, 1H), 7.48 (d, J = 8.3 Hz, 1H), 7.41 (d, J = 8.1 Hz, 2H), 7.33 - 7.26 (m, 2H), 7.12 - 7.07 (m, 2H), 4.22 - 4.14 (m, 2H), 3.82 - 3.76 (m, 2H), 3.68 (s, 2H), 3.65 - 3.59 ( m, 2H), 3.58 - 3.51 (m, 4H), 3.48 - 3.41 (m, 2H), 3.25 (s, 3H).

化合物 PLC-36 – 2-(4-(9-(4-(2-(2-(2- 甲氧乙氧基 ) 乙氧基 ) 乙氧基 ) 苯基 )-1,3- 二側氧基 -1H- 𠮿 [2,1,9-def] 異喹啉 -2(3H)- ) 苯基 ) 乙酸 (3,5- 二氯 -4-(19,19- 二氟 -6,7,11,12,13,19- 六氫 -5H-18l4,19l4- 苯并 [3',4'] 環庚 [1',2':4,5] 吡咯并 [1,2-c] 苯并 [3',4'] 環庚 [1',2':4,5] 吡咯并 [2,1-f][1,3,2] 二氮雜硼雜苯 -9- ) 苯酯 ) 之一般程序:向40 mL小瓶中放入攪拌棒,接著 PLC-2.1– 3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯酚(0.050 mmol,29.3 mg)、 PLC-36.3(0.075 mmol,49.5 mg)、DMAP. pTsOH鹽(0.100 mmol,29.4 mg)及EDC.HCl (0.300 mmol,29 mg),接著無水DCM。將小瓶加蓋,及將反應混合物在室溫下攪拌過夜。將粗反應藉由幾滴TFA中止及裝載至裝載器中之約65 g急驟矽膠上。藉由急驟層析法在矽膠上純化(120 g,固體負荷,平衡100% DCM,溶離100% DCM (3 CV) à 5.8% EtOAc/DCM (11.6 CV) à 13.3% EtOAc/DCM (6.0 CV) à 50% EtOAc/DCM (10 CV))。將含有產物之溶離份於真空中蒸發至乾。將粗產物用熱甲醇研磨。過濾掉產物,藉由抽吸乾燥,然後於真空烘箱中在約110℃下乾燥。得到暗紅色固體,47.1 mg (77%產率)。MS (APCI):針對C 72H 56BCl 2F 2N 3O 9(M-)計算值= 1225;實測值:1225。 1H NMR (400 MHz,四氯乙烷- d 2 ) δ 8.68 (d, J= 7.8 Hz, 1H), 8.63 (d, J= 8.3 Hz, 1H), 8.25 (d, J= 2.1 Hz, 1H), 8.11 (d, J= 8.1 Hz, 1H), 8.09 - 8.00 (m, 2H), 7.78 (dd, J= 8.6, 2.1 Hz, 1H), 7.69 - 7.61 (m, 4H), 7.50 (d, J= 8.6 Hz, 1H), 7.46 - 7.34 (m, 9H), 7.33 - 7.26 (m, 2H), 7.14 - 7.05 (m, 2H), 6.48 (s, 2H), 4.22 (t, J= 4.7 Hz, 2H), 4.07 (s, 2H), 3.94 - 3.88 (m, 2H), 3.78 - 3.72 (m, 2H), 3.72 - 3.62 (m, 4H), 3.59 - 3.53 (m, 2H), 3.38 (s, 3H), 2.64 (t, J= 6.8 Hz, 4H), 2.44 - 2.22 (m, 4H), 2.12 - 1.97 (m, 4H)。 Compound PLC-36 – 2-(4-(9-(4-(2-(2-(2- methoxyethoxy ) ethoxy ) ethoxy ) phenyl )-1,3- dioxo base -1H- 𠮿 And [2,1,9-def] isoquinolin -2(3H)-yl ) phenyl ) acetic acid (3,5- dichloro -4-(19,19 -difluoro -6,7,11,12 ,13,19- Hexahydro -5H-18l4,19l4- Benzo [3',4'] cyclohepta [1',2':4,5] pyrrolo [1,2-c] benzo [3',4'] cyclohepta [1',2':4,5] pyrrolo [2,1-f][1,3,2] diazaborin -9- yl ) phenyl ester ) general procedure : Add a stir bar to a 40 mL vial, followed by PLC-2.1 – 3,5-dichloro-4-(19,19-difluoro-6,7,11,12,13,19-hexahydro-5H- 18l4,19l4-Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']cyclohepta[1', 2':4,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenol (0.050 mmol, 29.3 mg), PLC-36.3 (0.075 mmol, 49.5 mg), DMAP.p TsOH salt (0.100 mmol, 29.4 mg) and EDC.HCl (0.300 mmol, 29 mg), followed by anhydrous DCM. The vial was capped, and the reaction mixture was stirred overnight at room temperature. The crude reaction was quenched with a few drops of TFA and loaded onto approximately 65 g of flash silica gel in a loader. Purified by flash chromatography on silica gel (120 g, solids load, equilibrated 100% DCM, eluted 100% DCM (3 CV) à 5.8% EtOAc/DCM (11.6 CV) à 13.3% EtOAc/DCM (6.0 CV) à 50% EtOAc/DCM (10 CV). Fractions containing product were evaporated to dryness in vacuo. The crude product was triturated with hot methanol. The product was filtered off, dried by suction and then dried in a vacuum oven at about 110°C. Obtained as a dark red solid, 47.1 mg (77% yield). MS ( APCI) : Calcd. for C72H56BCl2F2N3O9 (M-) = 1225 ; found : 1225. 1 H NMR (400 MHz, tetrachloroethane - d 2 ) δ 8.68 (d, J = 7.8 Hz, 1H), 8.63 (d, J = 8.3 Hz, 1H), 8.25 (d, J = 2.1 Hz, 1H ), 8.11 (d, J = 8.1 Hz, 1H), 8.09 - 8.00 (m, 2H), 7.78 (dd, J = 8.6, 2.1 Hz, 1H), 7.69 - 7.61 (m, 4H), 7.50 (d, J = 8.6 Hz, 1H), 7.46 - 7.34 (m, 9H), 7.33 - 7.26 (m, 2H), 7.14 - 7.05 (m, 2H), 6.48 (s, 2H), 4.22 (t, J = 4.7 Hz , 2H), 4.07 (s, 2H), 3.94 - 3.88 (m, 2H), 3.78 - 3.72 (m, 2H), 3.72 - 3.62 (m, 4H), 3.59 - 3.53 (m, 2H), 3.38 (s , 3H), 2.64 (t, J = 6.8 Hz, 4H), 2.44 - 2.22 (m, 4H), 2.12 - 1.97 (m, 4H).

化合物 PLC-37 之合成程序 化合物 PLC-37.1 – (9- -2-(2- 羥乙基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -1,3(2H)- 二酮 ) 之一般程序:將50 mL 2N圓底燒瓶放入鋁加熱塊中及放入攪拌棒。將該燒瓶安裝翅片冷凝器/氣體適配器、塞子及流動控制閥。將系統用氬氣沖洗。向該燒瓶中添加 Ex-4.3(3.00 mmol,1101 mg)、乙醇胺(12.0 mmol,0.725 mL)及DMAP (0.900 mmol,110 mg),接著添加無水DMF (8 mL)。將反應混合物在氬氣下攪拌及將加熱塊設置至165℃。將反應混合物在此溫度下攪拌3小時,然後將反應混合物冷卻至室溫。將溶劑於真空中蒸發至乾。將殘留物用水(50 mL)及6N HCL水溶液(10 mL)研磨。將混合物音波處理幾分鐘,然後在室溫下攪拌30分鐘,然後過濾掉固體產物,用水洗滌。將粗濾餅於真空烘箱中在約110℃下乾燥過夜。得到暗棕色固體,1.038 g (84%產率)。MS (APCI):針對C 20H 12BrNO 4(M+H)計算值= 410;實測值:410。 Synthetic procedure of compound PLC-37 Compound PLC-37.1 – (9- bromo -2-(2- hydroxyethyl )-1H- 𠮿 General procedure for [ 2,1,9-def] isoquinoline -1,3(2H) -dione ) : Place a 50 mL 2N round bottom flask in an aluminum heating block and place a stir bar. The flask was fitted with a finned condenser/gas adapter, stopper and flow control valve. The system was flushed with argon. To the flask was added Ex-4.3 (3.00 mmol, 1101 mg), ethanolamine (12.0 mmol, 0.725 mL) and DMAP (0.900 mmol, 110 mg), followed by anhydrous DMF (8 mL). The reaction mixture was stirred under argon and the heating block was set to 165°C. The reaction mixture was stirred at this temperature for 3 hours, then the reaction mixture was cooled to room temperature. The solvent was evaporated to dryness in vacuo. The residue was triturated with water (50 mL) and 6N aqueous HCL (10 mL). The mixture was sonicated for several minutes, then stirred at room temperature for 30 minutes, then the solid product was filtered off and washed with water. The crude filter cake was dried overnight in a vacuum oven at about 110°C. Obtained as a dark brown solid, 1.038 g (84% yield). MS ( APCI ): Calcd. for C20H12BrNO4 (M+H) = 410; found: 410 .

化合物 PLC-37.2 – (2-(2- 羥乙基 )-9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -1,3(2H)- 二酮 ) 之一般程序PLC-39.2係以與 PLC-36.7類似方式自含於THF/DMF/H 2O (60 mL/12 mL/6 mL)中之 PLC-37.1(2.531 mmol,1.038 g)、(4-(三氟甲基)苯基)硼酸(5.062 mmol,961 mg)、K 2CO 3(6.960 mmol,962 mg)及Pd(dppf)Cl 2(0.177 mmol,130 mg)在80℃下30分鐘合成。將粗產物藉由添加水(100 mL)沉澱,然後過濾掉所得固體,用水洗滌。將粗產物用甲醇研磨,然後於真空烘箱中在約110℃下乾燥過夜。得到1.017 g (84%產率)。MS (APCI):針對C 27H 16F 3NO 4(M+H)計算值= 476;實測值:476。 1H NMR (400 MHz, TCE) δ 8.66 (d, J = 7.8 Hz, 1H), 8.61 (d, J = 8.3 Hz, 1H), 8.25 (d, J = 2.2 Hz, 1H), 8.06 (d, J = 8.0 Hz, 1H), 7.83 - 7.75 (m, 5H), 7.52 (d, J = 8.6 Hz, 1H), 7.37 (d, J = 8.4 Hz, 1H), 4.45 (t, J = 5.2 Hz, 2H), 3.98 (q, J = 5.3 Hz, 2H), 2.49 (t, J = 5.5 Hz, 1H)。 Compound PLC-37.2 – (2-(2- Hydroxyethyl )-9-(4-( trifluoromethyl ) phenyl )-1H- 𠮿 General procedure for [ 2,1,9-def] isoquinoline -1,3(2H) -dione ) : PLC- 39.2 is self-contained in THF/DMF/H 2 O ( 60 mL/12 mL/6 mL) of PLC-37.1 (2.531 mmol, 1.038 g), (4-(trifluoromethyl)phenyl)boronic acid (5.062 mmol, 961 mg), K 2 CO 3 (6.960 mmol , 962 mg) and Pd(dppf)Cl 2 (0.177 mmol, 130 mg) were synthesized at 80°C for 30 minutes. The crude product was precipitated by adding water (100 mL), then the resulting solid was filtered off and washed with water. The crude product was triturated with methanol, then dried in a vacuum oven at about 110 °C overnight. Obtained 1.017 g (84% yield). MS (APCI): Calcd. for C27H16F3NO4 (M+H) = 476 ; found : 476. 1 H NMR (400 MHz, TCE) δ 8.66 (d, J = 7.8 Hz, 1H), 8.61 (d, J = 8.3 Hz, 1H), 8.25 (d, J = 2.2 Hz, 1H), 8.06 (d, J = 8.0 Hz, 1H), 7.83 - 7.75 (m, 5H), 7.52 (d, J = 8.6 Hz, 1H), 7.37 (d, J = 8.4 Hz, 1H), 4.45 (t, J = 5.2 Hz, 2H), 3.98 (q, J = 5.3 Hz, 2H), 2.49 (t, J = 5.5 Hz, 1H).

化合物 PLC-37.3 – (2-(2- 氯乙基 )-9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -1,3(2H)- 二酮 ) 之一般程序:將250 mL 2N圓底燒瓶放入鋁加熱塊中及放入攪拌棒。將該燒瓶安裝翅片冷凝器/氣體適配器、塞子及流動控制閥。將系統用氬氣沖洗。向該燒瓶中添加 PLC-37.2(2.124 mmol,1.01 g)、 pTsCl (6.372 mmol,1.215 g)、無水DMF (20 mL)及Et 3N (6.372 mmol,0.888 mL)。將反應混合物在氬氣下攪拌及加熱至80℃持續2小時。當甲苯磺酸鹽藉由氯離子原位置換時,意外反應發生。將反應混合物冷卻至室溫及用水(100 mL)稀釋。過濾掉粗產物,用水洗滌。將粗產物用MeOH研磨。將產物於真空烘箱中在約110℃下乾燥過夜。得到974 mg橙色固體(93%產率)。MS (APCI):針對C 27H 15ClF 3NO 3(M+H)計算值= 494;實測值:494。 1H NMR (400 MHz, TCE) δ 8.67 (d, J = 7.9 Hz, 1H), 8.62 (d, J = 8.3 Hz, 1H), 8.27 (d, J = 2.2 Hz, 1H), 8.08 (d, J = 7.9 Hz, 1H), 7.86 - 7.73 (m, 5H), 7.53 (d, J = 8.6 Hz, 1H), 7.39 (d, J = 8.4 Hz, 1H), 4.56 (t, J = 6.9 Hz, 2H), 3.87 (t, J = 6.8 Hz, 2H)。 Compound PLC-37.3 – (2-(2- Chloroethyl )-9-(4-( trifluoromethyl ) phenyl )-1H- 𠮿 General procedure for [ 2,1,9-def] isoquinoline -1,3(2H) -dione ) : Place a 250 mL 2N round bottom flask in an aluminum heating block and place a stir bar. The flask was fitted with a finned condenser/gas adapter, stopper and flow control valve. The system was flushed with argon. To the flask was added PLC-37.2 (2.124 mmol, 1.01 g), pTsCl (6.372 mmol, 1.215 g), anhydrous DMF (20 mL) and Et3N (6.372 mmol, 0.888 mL). The reaction mixture was stirred and heated to 80 °C under argon for 2 hours. When the tosylate was displaced in situ by the chloride ion, an unexpected reaction occurred. The reaction mixture was cooled to room temperature and diluted with water (100 mL). The crude product was filtered off and washed with water. The crude product was triturated with MeOH. The product was dried overnight in a vacuum oven at about 110°C. Obtained 974 mg of an orange solid (93% yield). MS (APCI): calcd for C27H15ClF3NO3 (M+H) = 494 ; found : 494 . 1 H NMR (400 MHz, TCE) δ 8.67 (d, J = 7.9 Hz, 1H), 8.62 (d, J = 8.3 Hz, 1H), 8.27 (d, J = 2.2 Hz, 1H), 8.08 (d, J = 7.9 Hz, 1H), 7.86 - 7.73 (m, 5H), 7.53 (d, J = 8.6 Hz, 1H), 7.39 (d, J = 8.4 Hz, 1H), 4.56 (t, J = 6.9 Hz, 2H), 3.87 (t, J = 6.8 Hz, 2H).

化合物 PLC-37.4 – (2,6- 二氯 -4-(2-(1,3- 二側氧基 -9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -1,3(2H)- ) 乙氧基 ) 苯甲醛 ) 之一般程序:將100 mL 2N圓底燒瓶放入鋁加熱塊中及放入攪拌棒。將該燒瓶安裝翅片冷凝器/氣體適配器、塞子及流動控制閥。將系統用氬氣沖洗。向該燒瓶中添加NaH (60%含於礦物油中) (1.214 mmol,29.1 mg,60%,49 mg),接著添加無水DMF (20 mL)。向該燒瓶中添加2,6-二氯-4-羥基苯甲醛(1.821 mmol,348 mg)。將反應混合物在氬氣下攪拌及將加熱塊設置在50℃。將反應在50℃下攪拌5分鐘,然後添加 PLC-37.3(0.607 mmol,300 mg)。將燒瓶塞住及在氬氣下攪拌。將加熱塊溫度提高至160℃。將反應混合物在160℃下攪拌90分鐘,然後在室溫下攪拌過夜。將粗產物藉由添加水(100 mL)及過濾掉產物,用水洗滌析出。將粗產物溶解於DCM中及於真空中蒸發至乾。將粗產物於真空中蒸發至急驟矽膠(約20 g)上。藉由急驟層析法在矽膠上純化(120 g,固體負荷,平衡100% DCM/己烷,溶離100% DCM/己烷(7 CV) à 0% EtOAc/DCM (0 CV) à 0% EtOAc/DCM (5 CV) à 40% EtOAc/DCM (40 CV)。將含有產物之溶離份於真空中蒸發至乾。得到152 mg (39%產率)黃色固體。MS (APCI):針對C 34H 18Cl 2F 3NO 5(M-)計算值= 647;實測值:647。 1H NMR (400 MHz, TCE) δ 10.36 (s, 1H), 8.68 (d, J = 7.9 Hz, 1H), 8.63 (d, J = 8.3 Hz, 1H), 8.26 (d, J = 2.1 Hz, 1H), 8.07 (d, J = 8.0 Hz, 1H), 7.85 - 7.72 (m, 5H), 7.52 (d, J = 8.6 Hz, 1H), 7.39 (d, J = 8.4 Hz, 1H), 6.99 (s, 2H), 6.93 (s, 1H), 4.65 (t, J = 6.1 Hz, 2H), 4.40 (t, J = 6.1 Hz, 2H)。 Compound PLC-37.4 – (2,6- dichloro -4-(2-(1,3- dioxo -9-(4-( trifluoromethyl ) phenyl )-1H- 𠮿 General procedure for [ 2,1,9-def] isoquinolin -1,3(2H) -yl ) ethoxy ) benzaldehyde ) : Place a 100 mL 2N round bottom flask in an aluminum heating block and place stir bar. The flask was fitted with a finned condenser/gas adapter, stopper and flow control valve. The system was flushed with argon. To the flask was added NaH (60% in mineral oil) (1.214 mmol, 29.1 mg, 60%, 49 mg) followed by dry DMF (20 mL). To the flask was added 2,6-dichloro-4-hydroxybenzaldehyde (1.821 mmol, 348 mg). The reaction mixture was stirred under argon and the heating block was set at 50 °C. The reaction was stirred at 50 °C for 5 minutes, then PLC-37.3 (0.607 mmol, 300 mg) was added. The flask was stoppered and stirred under argon. Increase the heating block temperature to 160°C. The reaction mixture was stirred at 160°C for 90 minutes, then at room temperature overnight. The crude product was precipitated by adding water (100 mL) and filtering off the product, washing with water. The crude product was dissolved in DCM and evaporated to dryness in vacuo. The crude product was evaporated in vacuo onto a flash of silica gel (ca. 20 g). Purified by flash chromatography on silica gel (120 g, solids load, equilibrated 100% DCM/hexane, eluting 100% DCM/hexane (7 CV) à 0% EtOAc/DCM (0 CV) à 0% EtOAc /DCM (5 CV) à 40% EtOAc/DCM (40 CV). Fractions containing product were evaporated to dryness in vacuo. 152 mg (39% yield) of a yellow solid was obtained. MS (APCI): for C 34 Calcd for H 18 Cl 2 F 3 NO 5 (M-) = 647; , 8.63 (d, J = 8.3 Hz, 1H), 8.26 (d, J = 2.1 Hz, 1H), 8.07 (d, J = 8.0 Hz, 1H), 7.85 - 7.72 (m, 5H), 7.52 (d, J = 8.6 Hz, 1H), 7.39 (d, J = 8.4 Hz, 1H), 6.99 (s, 2H), 6.93 (s, 1H), 4.65 (t, J = 6.1 Hz, 2H), 4.40 (t, J = 6.1 Hz, 2H).

化合物 PLC-37 化合物 PLC-37 – (2-(2-(3,5- 二氯 -4-(19,19- 二氟 -6,7,11,12,13,19- 六氫 -5H-18l4,19l4- 苯并 [3',4'] 環庚 [1',2':4,5] 吡咯并 [1,2-c] 苯并 [3',4'] 環庚 [1',2':4,5] 吡咯并 [2,1-f][1,3,2] 二氮雜硼雜苯 -9- ) 苯氧基 ) 乙基 )-9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -1,3(2H)- 二酮 ) 之一般程序:將100 mL 2N圓底燒瓶放入鋁加熱塊中及放入攪拌棒。將該燒瓶安裝翅片冷凝器/氣體適配器、塞子及流動控制閥。將系統用氬氣沖洗。向該燒瓶中添加 PLC-37.4(0.075 mmol,49 mg)及 Ex-7.3– 1,4,5,6-四氫苯并[6,7]環庚[1,2-b]吡咯(0.1575 mmol,29 mg),接著添加無水DCM (20 mL)。在氬氣氛圍下,將反應混合物用氮氣噴射10分鐘。一對 pTsOH.H 2O之小顆粒在抹刀末端聚集及將此等浸入反應混合物中。繼續攪拌及用氮氣噴射另外5分鐘。停止氮氣噴射及將反應混合物在室溫下攪拌1小時,此時TLC顯示完全轉化成所需二吡咯甲烷。向燒瓶中添加DDQ (0.1275 mmol,29 mg)及將反應混合物在室溫下攪拌15分鐘。TLC指示完全氧化成二吡咯甲烷。向燒瓶中添加Et 3N (0.600 mmol,0.084 mL)及BF 3.OEt 2(0.900 mmol,0.111 mL)。於2分鐘後重複兩種試劑之添加,然後將加熱塊設置至50℃及將反應混合物在此溫度下在氬氣下攪拌2小時。將粗製BODIPY直接裝載至急驟矽膠(25 g)上。藉由急驟層析法在矽膠上純化(80 g,固體負荷,平衡80% DCM/己烷,溶離80% DCM/己烷(2 CV) à 100 DCM/己烷(5 CV) à等濃度100% DCM/己烷(約25 CV) à 100% DCM/己烷/0.5% EtOAc改性劑(約10 CV))。產物作為寬峰溶離。將含有產物之溶離份於真空中蒸發至乾。得到暗紅色固體,89 mg (定量產率)。MS (APCI):針對C 60H 39BCl 2F 5N 3O 4(M-)計算值= 1041;實測值1041。 1H NMR (400 MHz, TCE) δ 8.72 (d, J = 7.9 Hz, 1H), 8.67 (d, J = 8.4 Hz, 1H), 8.27 (d, J = 2.2 Hz, 1H), 8.10 (d, J = 8.1 Hz, 1H), 8.04 (dd, J = 5.8, 3.5 Hz, 2H), 7.84 - 7.75 (m, 5H), 7.53 (d, J = 8.6 Hz, 1H), 7.41 (d, J = 8.3 Hz, 1H), 7.39 - 7.32 (m, 4H), 7.32 - 7.25 (m, 2H), 7.14 (s, 2H), 4.70 (t, J = 6.2 Hz, 2H), 4.42 (t, J = 6.2 Hz, 2H), 2.62 (t, J = 7.0 Hz, 4H), 2.41 - 2.18 (m, 4H), 2.11 - 1.93 (m, 4H)。 Compound PLC-37 Compound PLC-37 – (2-(2-(3,5- dichloro -4-(19,19- difluoro -6,7,11,12,13,19- hexahydro -5H- 18l4,19l4- Benzo [3',4'] cyclohepta [1',2':4,5] pyrrolo [1,2-c] benzo [3',4'] cyclohepta [1', 2':4,5] pyrrolo [2,1-f][1,3,2] diazaborin -9- yl ) phenoxy ) ethyl ) -9-(4-( trifluoro Methyl ) phenyl )-1H- 𠮿 General procedure for [ 2,1,9-def] isoquinoline -1,3(2H) -dione ) : Place a 100 mL 2N round bottom flask in an aluminum heating block and place a stir bar. The flask was fitted with a finned condenser/gas adapter, stopper and flow control valve. The system was flushed with argon. To this flask was added PLC-37.4 (0.075 mmol, 49 mg) and Ex-7.3 – 1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-b]pyrrole (0.1575 mmol , 29 mg), followed by the addition of anhydrous DCM (20 mL). Under an atmosphere of argon, the reaction mixture was sparged with nitrogen for 10 minutes. A pair of small particles of pTsOH.H2O aggregated at the end of the spatula and dipped these into the reaction mixture. Stirring was continued and sparged with nitrogen for another 5 minutes. The nitrogen sparge was stopped and the reaction mixture was stirred at room temperature for 1 hour, at which time TLC showed complete conversion to the desired dipyrromethane. DDQ (0.1275 mmol, 29 mg) was added to the flask and the reaction mixture was stirred at room temperature for 15 minutes. TLC indicated complete oxidation to dipyrromethane. To the flask was added Et 3 N (0.600 mmol, 0.084 mL) and BF 3 .OEt 2 (0.900 mmol, 0.111 mL). The addition of both reagents was repeated after 2 minutes, then the heat block was set to 50°C and the reaction mixture was stirred at this temperature under argon for 2 hours. Crude BODIPY was loaded directly onto flash silica gel (25 g). Purify by flash chromatography on silica gel (80 g, solids load, equilibrate 80% DCM/hexane, elute 80% DCM/hexane (2 CV) à 100 DCM/hexane (5 CV) à isocratic 100 % DCM/hexane (about 25 CV) à 100% DCM/hexane/0.5% EtOAc modifier (about 10 CV)). The product elutes as a broad peak. Fractions containing product were evaporated to dryness in vacuo. Obtained as a dark red solid, 89 mg (quantitative yield). MS (APCI) : Calcd. for C60H39BCl2F5N3O4 ( M- ) = 1041; found 1041. 1 H NMR (400 MHz, TCE) δ 8.72 (d, J = 7.9 Hz, 1H), 8.67 (d, J = 8.4 Hz, 1H), 8.27 (d, J = 2.2 Hz, 1H), 8.10 (d, J = 8.1 Hz, 1H), 8.04 (dd, J = 5.8, 3.5 Hz, 2H), 7.84 - 7.75 (m, 5H), 7.53 (d, J = 8.6 Hz, 1H), 7.41 (d, J = 8.3 Hz, 1H), 7.39 - 7.32 (m, 4H), 7.32 - 7.25 (m, 2H), 7.14 (s, 2H), 4.70 (t, J = 6.2 Hz, 2H), 4.42 (t, J = 6.2 Hz , 2H), 2.62 (t, J = 7.0 Hz, 4H), 2.41 - 2.18 (m, 4H), 2.11 - 1.93 (m, 4H).

PLC-38 之合成程序 合成 PLC-38.1 (9- -2-(3- 羥丙基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -1,3(2H)- 二酮 ) Ex-4.3(1.223 g,3.33 mmol,1 eq)懸浮於35 mL無水DMSO中,在RT下,將3-胺基-1-丙醇(1.5 g,20.0 mmol,6 eq)添加至反應混合物中。將所得混合物在160℃下攪拌45分鐘,LCMS顯示反應完全。於冷卻至室溫後,將固體產物過濾,將固體用水(250 mL)然後MeOH (100 mL)洗滌,於真空烘箱中乾燥,以得到1.2 g青黃色固體,產率92%。MS (APCI):針對C 23H 18BrNO 4(M-)計算值= 425;實測值:425。 1H NMR (400 MHz) δ 8.56 (d, J= 7.9 Hz, 1H), 8.52 (d, J= 8.4 Hz, 1H), 8.13 (d, J= 2.3 Hz, 1H), 7.86 (d, J= 7.9 Hz, 1H), 7.57 (dd, J= 8.8, 2.3 Hz, 1H), 7.26 (d, J= 8.4 Hz, 1H), 7.22 (d, J= 8.8 Hz, 1H), 4.24 (t, J= 6.1 Hz, 2H), 3.48 (q, J= 6.1 Hz, 2H), 3.06 (t, J= 6.9 Hz, 1H), 1.95 - 1.83 (m, 2H)。 Synthesis program of PLC-38 Synthesis of PLC-38.1 (9- bromo -2-(3- hydroxypropyl )-1H- 𠮿 and [2,1,9-def] isoquinoline -1,3(2H) -dione ) : Suspend Ex-4.3 (1.223 g, 3.33 mmol, 1 eq) in 35 mL of anhydrous DMSO at RT , 3-Amino-1-propanol (1.5 g, 20.0 mmol, 6 eq) was added to the reaction mixture. The resulting mixture was stirred at 160 °C for 45 minutes, LCMS showed the reaction was complete. After cooling to room temperature, the solid product was filtered, the solid was washed with water (250 mL) then MeOH (100 mL), and dried in a vacuum oven to give 1.2 g of a cyan-yellow solid in 92% yield. MS ( APCI ): Calcd. for C23H18BrNO4 (M-) = 425; found: 425. 1 H NMR (400 MHz) δ 8.56 (d, J = 7.9 Hz, 1H), 8.52 (d, J = 8.4 Hz, 1H), 8.13 (d, J = 2.3 Hz, 1H), 7.86 (d, J = 7.9 Hz, 1H), 7.57 (dd, J = 8.8, 2.3 Hz, 1H), 7.26 (d, J = 8.4 Hz, 1H), 7.22 (d, J = 8.8 Hz, 1H), 4.24 (t, J = 6.1 Hz, 2H), 3.48 (q, J = 6.1 Hz, 2H), 3.06 (t, J = 6.9 Hz, 1H), 1.95 - 1.83 (m, 2H).

合成 PLC-38.2 (2-(3- 羥丙基 )-9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -1,3(2H)- 二酮 ) PLC-38.1(1.06 g,2.5 mmol,1 eq)懸浮於DMF (10 ml)、H 2O (5 ml)中,添加4-三氟甲基苯硼酸(0.949 g,5.0 mmol,2 eq)、K 2CO 3(0.691 g,5.0 mmol,2 eq)、Pd(dppf)Cl 2·DCM (40.8 mg,0.05 mmol,0.02 eq)。將混合物藉由Vac- Fill氬氣循環3次脫氣,在90℃下攪拌及加熱5小時。將反應混合物冷卻至室溫,添加水。將所得混合物在室溫下保持12小時。過濾青黃色固體,用水然後MeOH洗滌,以得到1.04 g青黃色固體,產率85%。MS (APCI):針對C 30H 22F 3NO 4(M-)計算值= 517;實測值:517。 1H NMR (400 MHz) δ 8.56 (d, J= 7.9 Hz, 1H), 8.51 (d, J= 8.3 Hz, 1H), 8.17 (d, J= 2.1 Hz, 1H), 7.97 (d, J= 8.0 Hz, 1H), 7.69 (dd, J= 10.3, 1.9 Hz, 4H), 7.42 (d, J= 8.6 Hz, 1H), 7.28 (d, J= 8.3 Hz, 1H), 4.09 (t, J= 7.5 Hz, 2H), 3.57 (q, J= 6.2 Hz, 2H), 1.69 (p, J= 7.8 Hz, 2H), 1.61 - 1.54 (m, 2H), 1.42 (q, J= 8.0 Hz, 2H), 1.28 (t, J= 5.5 Hz, 1H)。 Synthesis of PLC-38.2 (2-(3- hydroxypropyl )-9-(4-( trifluoromethyl ) phenyl )-1H- 𠮿 and [2,1,9-def] isoquinoline -1,3(2H) -dione ) : PLC-38.1 (1.06 g, 2.5 mmol, 1 eq) was suspended in DMF (10 ml), H 2 O (5 ml), add 4-trifluoromethylphenylboronic acid (0.949 g, 5.0 mmol, 2 eq), K 2 CO 3 (0.691 g, 5.0 mmol, 2 eq), Pd(dppf)Cl 2 ·DCM ( 40.8 mg, 0.05 mmol, 0.02 eq). The mixture was degassed by Vac-Fill argon cycles 3 times, stirred and heated at 90°C for 5 hours. The reaction mixture was cooled to room temperature and water was added. The resulting mixture was kept at room temperature for 12 hours. The cyan solid was filtered, washed with water and then MeOH to give 1.04 g of cyan solid, 85% yield. MS ( APCI): Calcd. for C30H22F3NO4 (M-) = 517 ; found: 517. 1 H NMR (400 MHz) δ 8.56 (d, J = 7.9 Hz, 1H), 8.51 (d, J = 8.3 Hz, 1H), 8.17 (d, J = 2.1 Hz, 1H), 7.97 (d, J = 8.0 Hz, 1H), 7.69 (dd, J = 10.3, 1.9 Hz, 4H), 7.42 (d, J = 8.6 Hz, 1H), 7.28 (d, J = 8.3 Hz, 1H), 4.09 (t, J = 7.5 Hz, 2H), 3.57 (q, J = 6.2 Hz, 2H), 1.69 (p, J = 7.8 Hz, 2H), 1.61 - 1.54 (m, 2H), 1.42 (q, J = 8.0 Hz, 2H) , 1.28 (t, J = 5.5 Hz, 1H).

合成 PLC-38.3 (2-(3- 溴丙基 )-9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -1,3(2H)- 二酮 ) PLC-38.2(1.6 g,3.2 mmol)及48% HBr水溶液(30.0 ml)之混合物藉由加熱塊在130℃下加熱至回流3天,同時攪拌。接下來2天添加相同體積之48% aq HBr超過2次,總量為90 ml。於冷卻至室溫後,將混合物倒入冰水中,將固體過濾,用水洗滌,於真空烘箱中乾燥,以得到82%含有未反應之SM之所需化合物。得到1.7 g青黃色固體,產率96%。將產物用於下個步驟,無需進一步純化。MS (APCI):針對C 30H 21BrF 3NO 3(M-)計算值= 551;實測值:551。 1H NMR (400 MHz) δ 8.55 (d, J= 7.9 Hz, 1H), 8.50 (d, J= 8.4 Hz, 1H), 8.15 (d, J= 2.2 Hz, 1H), 7.96 (d, J= 8.0 Hz, 1H), 7.70 (s, 5H), 7.41 (d, J= 8.6 Hz, 1H), 7.27 (d, J= 8.3 Hz, 1H), 4.22 (t, J= 7.1 Hz, 2H), 3.45 (t, J= 6.8 Hz, 2H), 2.25 (q, J= 6.9 Hz, 2H)。 Synthesis of PLC-38.3 (2-(3- bromopropyl )-9-(4-( trifluoromethyl ) phenyl )-1H- 𠮿 And [2,1,9-def] isoquinoline -1,3(2H) -dione ) : A mixture of PLC-38.2 (1.6 g, 3.2 mmol) and 48% HBr aqueous solution (30.0 ml) was heated by The mass was heated to reflux at 130°C for 3 days with stirring. The same volume of 48% aq HBr was added more than 2 times over the next 2 days, for a total of 90 ml. After cooling to room temperature, the mixture was poured into ice water, the solid was filtered, washed with water, and dried in a vacuum oven to give 82% of the desired compound containing unreacted SM. 1.7 g of a cyan-yellow solid was obtained with a yield of 96%. The product was used in the next step without further purification. MS ( APCI): Calcd. for C30H21BrF3NO3 (M-) = 551 ; found : 551. 1 H NMR (400 MHz) δ 8.55 (d, J = 7.9 Hz, 1H), 8.50 (d, J = 8.4 Hz, 1H), 8.15 (d, J = 2.2 Hz, 1H), 7.96 (d, J = 8.0 Hz, 1H), 7.70 (s, 5H), 7.41 (d, J = 8.6 Hz, 1H), 7.27 (d, J = 8.3 Hz, 1H), 4.22 (t, J = 7.1 Hz, 2H), 3.45 (t, J = 6.8 Hz, 2H), 2.25 (q, J = 6.9 Hz, 2H).

合成 PLC-38 (2-(3-(3,5- 二氯 -4-(19,19- 二氟 -6,7,11,12,13,19- 六氫 -5H-18l4,19l4- 苯并 [3',4'] 環庚 [1',2':4,5] 吡咯并 [1,2c] 苯并 [3',4'] 環庚 [1',2':4,5] 吡咯并 [2,1-f][1,3,2] 二雜環硼雜苯 -9- ) 苯氧基 ) 丙基 )-9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -1,3(2H)- 二酮 ) PLC-38.3(41.425 mg,0.075 mmol,1.15 eq)懸浮於無水DMF (2.0 ml)中,添加 PLC-2.1(38.04 mg,0.065 mmol,1 eq)、K 2CO 3(0.73 mg,0.15 mmol,2.3 eq)、NaI (4.15 mg)。將所得混合物在85℃下在氬氣氛圍下攪拌16小時,冷卻至室溫,將固體過濾,用50 ml水洗滌,將粗產物裝載至40 g矽膠管柱上,利用Hex: DCM (9:1)至DCM溶離,得到49 mg暗紫色固體,產率71%。MS (APCI):針對C 63H 45BCl 2F 5N 3O 4(M-)計算值= 1055;實測值:1055。 1H NMR (400 MHz, ) δ 8.60 (d, J= 7.8 Hz, 1H), 8.55 (d, J= 8.3 Hz, 1H), 8.18 (d, J= 2.2 Hz, 1H), 8.00 (d, J= 8.1 Hz, 1H), 7.95 (d, J= 5.9 Hz, 2H), 7.74 - 7.65 (m, 4H), 7.44 (d, J= 8.6 Hz, 1H), 7.34 - 7.24 (m, 4H), 7.24 - 7.14 (m, 2H), 6.91 (s, 2H), 6.38 (s, 2H), 4.36 (t, J= 6.9 Hz, 2H), 4.13 (t, J= 6.1 Hz, 2H), 2.54 (t, J= 6.7 Hz, 4H), 2.28 - 2.19 (m, 4H), 2.06 - 1.85 (m, 4H), 0.78 (d, J= 14.2 Hz, 2H)。 Synthesis of PLC-38 (2-(3-(3,5- dichloro -4-(19,19- difluoro -6,7,11,12,13,19- hexahydro -5H-18l4,19l4- benzene And [3',4'] cyclohepta [1',2':4,5] pyrrolo [1,2c] benzo [3',4'] cyclohepta [1',2':4,5] Pyrrolo [2,1-f][1,3,2] biheteroborin-9-yl)phenoxy ) propyl ) -9- ( 4- ( trifluoromethyl ) phenyl )- 1H- 𠮿 and [2,1,9-def] isoquinoline -1,3(2H) -dione ) : PLC-38.3 (41.425 mg, 0.075 mmol, 1.15 eq) was suspended in anhydrous DMF (2.0 ml), added PLC-2.1 (38.04 mg, 0.065 mmol, 1 eq), K2CO3 (0.73 mg, 0.15 mmol, 2.3 eq), NaI (4.15 mg). The resulting mixture was stirred at 85° C. under an argon atmosphere for 16 hours, cooled to room temperature, the solid was filtered, washed with 50 ml of water, and the crude product was loaded onto a 40 g silica gel column, and the mixture was collected using Hex:DCM (9: 1) to DCM dissolution, to obtain 49 mg dark purple solid, yield 71%. MS ( APCI) : Calcd . for C63H45BCl2F5N3O4 (M-) = 1055 ; found: 1055. 1 H NMR (400 MHz, ) δ 8.60 (d, J = 7.8 Hz, 1H), 8.55 (d, J = 8.3 Hz, 1H), 8.18 (d, J = 2.2 Hz, 1H), 8.00 (d, J = 8.1 Hz, 1H), 7.95 (d, J = 5.9 Hz, 2H), 7.74 - 7.65 (m, 4H), 7.44 (d, J = 8.6 Hz, 1H), 7.34 - 7.24 (m, 4H), 7.24 - 7.14 (m, 2H), 6.91 (s, 2H), 6.38 (s, 2H), 4.36 (t, J = 6.9 Hz, 2H), 4.13 (t, J = 6.1 Hz, 2H), 2.54 (t, J = 6.7 Hz, 4H), 2.28 - 2.19 (m, 4H), 2.06 - 1.85 (m, 4H), 0.78 (d, J = 14.2 Hz, 2H).

PLC-39 之合成程序 化合物 39.1:將含於THF/DMF/水(30 mL/6 mL/3 mL)之共溶劑中之化合物 Ex-4.4(649 mg,1.23 mmol)、4-(三氟甲基)苯基硼酸(467 mg,2.46 mmol)、Pd(dppf)Cl 2(45 mg,0.06 mmol)、碳酸鉀(345 mg,2.5 mmol)之混合物脫氣,然後在80℃下加熱過夜。將混合物用300 mL乙酸乙酯及50 mL 0.6 N鹽酸水溶液處理。將水相用乙酸乙酯(150 mL x 3)萃取。收集有機相及用鹽水(100mL x 2)洗滌,經硫酸鈉乾燥,然後乾裝載在矽膠上及藉由急驟層析法使用DCM/EA (0%至80% EA與0.1% TFA)之溶離劑純化。收集主要所需溶離份,在減壓下移除溶劑,得到黃色固體(414 mg,57%產率)。 1H NMR (400 MHz, d 2-TCE) δ 8.55 (dd, J = 18.1, 8.1 Hz, 2H), 8.16 (d, J = 2.2 Hz, 1H), 8.00 (d, J = 8.1 Hz, 1H), 7.68 (dd, J = 8.6, 2.1 Hz, 1H), 7.66 - 7.59 (m, 2H), 7.43 (d, J = 8.6 Hz, 1H), 7.32 (tt, J = 8.2, 4.2 Hz, 5H), 7.20 - 7.13 (m, 2H), 2.72 (t, J = 7.6 Hz, 2H), 2.39 (t, J = 7.3 Hz, 2H), 1.99 (q, J = 7.4 Hz, 2H)。 Synthesis program of PLC-39 Compound 39.1 : Compound Ex-4.4 (649 mg, 1.23 mmol), 4-(trifluoromethyl)phenylboronic acid ( A mixture of 467 mg, 2.46 mmol), Pd(dppf) Cl2 (45 mg, 0.06 mmol), potassium carbonate (345 mg, 2.5 mmol) was degassed and then heated at 80°C overnight. The mixture was treated with 300 mL ethyl acetate and 50 mL 0.6 N aqueous hydrochloric acid. The aqueous phase was extracted with ethyl acetate (150 mL x 3). The organic phase was collected and washed with brine (100 mL x 2), dried over sodium sulfate, then dry-loaded on silica gel and eluent by flash chromatography using DCM/EA (0% to 80% EA and 0.1% TFA) purification. The main desired fractions were collected and the solvent was removed under reduced pressure to give a yellow solid (414 mg, 57% yield). 1 H NMR (400 MHz, d 2 -TCE) δ 8.55 (dd, J = 18.1, 8.1 Hz, 2H), 8.16 (d, J = 2.2 Hz, 1H), 8.00 (d, J = 8.1 Hz, 1H) , 7.68 (dd, J = 8.6, 2.1 Hz, 1H), 7.66 - 7.59 (m, 2H), 7.43 (d, J = 8.6 Hz, 1H), 7.32 (tt, J = 8.2, 4.2 Hz, 5H), 7.20 - 7.13 (m, 2H), 2.72 (t, J = 7.6 Hz, 2H), 2.39 (t, J = 7.3 Hz, 2H), 1.99 (q, J = 7.4 Hz, 2H).

化合物 PLC-39:將含於DCM (5 mL)中之 PLC-1.3(32 mg,0.0547 mmol)、 PLC-39.1(48.7 mg,0.082 mmol)、EDC•HCl (60 mg,0.31 mmol)及DMAP/p-TsOH (15 mg,0.05 mmol)之混合物在室溫下攪拌過夜。然後將所得混合物裝載在矽膠上,藉由急驟層析法使用DCM/乙酸乙酯(0%至10%乙酸乙酯)之溶離劑純化。收集主紅色溶離份及在減壓下濃縮至0.5 mL,然後添加10 mL甲醇。將所得沉澱物過濾及於空氣中乾燥,以得到暗紅色固體(44 mg,產率69%)。 1H NMR (400 MHz, d 2-TCE) δ 8.56 (dd, J = 17.8, 8.1 Hz, 2H), 8.16 (d, J = 2.2 Hz, 1H), 7.99 (dd, J = 19.8, 6.8 Hz, 3H), 7.68 (dd, J = 8.6, 2.1 Hz, 1H), 7.66 - 7.59 (m, 2H), 7.44 (d, J = 8.6 Hz, 1H), 7.41 - 7.35 (m, 2H), 7.35 - 7.25 (m, 9H), 7.22 (dd, J = 8.7, 4.2 Hz, 4H), 6.40 (s, 2H), 2.82 (t, J = 7.5 Hz, 2H), 2.67 (t, J = 7.4 Hz, 2H), 2.55 (t, J = 6.7 Hz, 4H), 2.24 (bs, 4H), 2.14 (q, J = 7.5 Hz, 2H), 1.96 (t, J = 7.1 Hz, 4H)。 Compound PLC-39 : PLC-1.3 (32 mg, 0.0547 mmol), PLC-39.1 (48.7 mg, 0.082 mmol), EDC·HCl (60 mg, 0.31 mmol) and DMAP/ A mixture of p-TsOH (15 mg, 0.05 mmol) was stirred overnight at room temperature. The resulting mixture was then loaded onto silica gel and purified by flash chromatography using an eluent of DCM/ethyl acetate (0% to 10% ethyl acetate). The main red fractions were collected and concentrated under reduced pressure to 0.5 mL, then 10 mL of methanol was added. The resulting precipitate was filtered and air dried to give a dark red solid (44 mg, 69% yield). 1 H NMR (400 MHz, d 2 -TCE) δ 8.56 (dd, J = 17.8, 8.1 Hz, 2H), 8.16 (d, J = 2.2 Hz, 1H), 7.99 (dd, J = 19.8, 6.8 Hz, 3H), 7.68 (dd, J = 8.6, 2.1 Hz, 1H), 7.66 - 7.59 (m, 2H), 7.44 (d, J = 8.6 Hz, 1H), 7.41 - 7.35 (m, 2H), 7.35 - 7.25 (m, 9H), 7.22 (dd, J = 8.7, 4.2 Hz, 4H), 6.40 (s, 2H), 2.82 (t, J = 7.5 Hz, 2H), 2.67 (t, J = 7.4 Hz, 2H) , 2.55 (t, J = 6.7 Hz, 4H), 2.24 (bs, 4H), 2.14 (q, J = 7.5 Hz, 2H), 1.96 (t, J = 7.1 Hz, 4H).

PLC-40 之合成程序 化合物 40.1:將含於1,4-二噁烷/DMF/水(15 mL/3 mL/1.5 mL)中之9-溴-2-(3-羥丙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮( PLC-38.1,330 mg,0.778 mmol)、(2,4,6-三異丙基苯基)硼酸(290 mg,1.17 mmol)、Pd(PPh 3) 4(80 mg,0.069 mmol)、K 2CO 3(320 mg,2.32 mmol)之混合物脫氣及在90℃下加熱24小時。將所得混合物用水及乙酸乙酯處理。收集有機相及裝載在矽膠上,藉由急驟層析法使用DCM/EA (0%至40% EA)之溶離劑純化。收集所需溶離份,於減壓下移除溶劑後,得到黃色固體(210 mg,49%產率)。LCMS (APCI-):針對C 36H 37NO 4計算值547.27;實測值:547。 1H NMR (400 MHz, d 2-TCE) δ 8.60 - 8.48 (m, 2H), 7.93 - 7.76 (m, 2H), 7.45 - 7.24 (m, 3H), 6.99 (s, 2H), 4.25 (t, J = 6.1 Hz, 2H), 4.01 (q, J = 7.2 Hz, 2H), 3.47 (t, J = 5.5 Hz, 2H), 2.88 (p, J = 6.8 Hz, 1H), 2.65 - 2.43 (m, 2H), 1.89 (d, J = 6.2 Hz, 2H), 1.24 (d, J = 6.9 Hz, 6H), 1.03 (t, J = 7.1 Hz, 12H)。 Synthesis program of PLC-40 Compound 40.1 : 9-bromo-2-(3-hydroxypropyl)-1H-𠮿 in 1,4-dioxane/DMF/water (15 mL/3 mL/1.5 mL) A[2,1,9-def]isoquinoline-1,3(2H)-dione ( PLC-38.1 , 330 mg, 0.778 mmol), (2,4,6-triisopropylphenyl)boronic acid (290 mg, 1.17 mmol), Pd(PPh 3 ) 4 (80 mg, 0.069 mmol), K 2 CO 3 (320 mg, 2.32 mmol) was degassed and heated at 90° C. for 24 hours. The resulting mixture was treated with water and ethyl acetate. The organic phase was collected and loaded on silica gel, purified by flash chromatography using the eluent of DCM/EA (0% to 40% EA). The desired fractions were collected and a yellow solid (210 mg, 49% yield) was obtained after removal of the solvent under reduced pressure. LCMS (APCI-): Calcd. for C36H37NO4 , 547.27 ; found: 547. 1 H NMR (400 MHz, d 2 -TCE) δ 8.60 - 8.48 (m, 2H), 7.93 - 7.76 (m, 2H), 7.45 - 7.24 (m, 3H), 6.99 (s, 2H), 4.25 (t , J = 6.1 Hz, 2H), 4.01 (q, J = 7.2 Hz, 2H), 3.47 (t, J = 5.5 Hz, 2H), 2.88 (p, J = 6.8 Hz, 1H), 2.65 - 2.43 (m , 2H), 1.89 (d, J = 6.2 Hz, 2H), 1.24 (d, J = 6.9 Hz, 6H), 1.03 (t, J = 7.1 Hz, 12H).

化合物 40.2:在室溫下,向含於20 mL DCM中之化合物 PLC-40.1(210 mg,0.384 mmol)之溶液中添加四溴化碳(CBr 4,252 mg,0.76 mmol)、三苯基膦(203 mg,0.77 mmol)。將整體攪拌30分鐘。TLC顯示反應完成。將混合物裝載在矽膠上及藉由急驟層析法使用己烷/DCM (0%至100% DCM)之溶離劑純化。收集所需溶離份,在減壓下濃縮,以得到黃色固體(100 mg,43%產率)。LCMS (APCI+):針對C 36H 37BrNO 3(M+H)計算值:610.19;實測值:610。 1H NMR (400 MHz, d 2-TCE) δ 8.52 (dd, J = 8.1, 2.5 Hz, 2H), 8.00 - 7.72 (m, 2H), 7.45 - 7.19 (m, 3H), 6.98 (s, 2H), 4.23 (t, J = 7.0 Hz, 2H), 3.44 (t, J = 6.8 Hz, 2H), 3.01 - 2.80 (m, 1H), 2.69 - 2.45 (m, 2H), 2.26 (q, J = 6.9 Hz, 2H), 1.24 (d, J = 6.9 Hz, 6H), 1.03 (t, J = 6.9 Hz, 12H)。 Compound 40.2 : To a solution of compound PLC-40.1 (210 mg, 0.384 mmol) in 20 mL of DCM was added carbon tetrabromide ( CBr4 , 252 mg, 0.76 mmol), triphenylphosphine at room temperature (203 mg, 0.77 mmol). The whole was stirred for 30 minutes. TLC showed the reaction was complete. The mixture was loaded on silica gel and purified by flash chromatography using the eluent of hexane/DCM (0% to 100% DCM). The desired fractions were collected and concentrated under reduced pressure to give a yellow solid (100 mg, 43% yield). LCMS (APCI+): Calcd. for C36H37BrNO3 (M+H): 610.19 ; found: 610 . 1 H NMR (400 MHz, d 2 -TCE) δ 8.52 (dd, J = 8.1, 2.5 Hz, 2H), 8.00 - 7.72 (m, 2H), 7.45 - 7.19 (m, 3H), 6.98 (s, 2H ), 4.23 (t, J = 7.0 Hz, 2H), 3.44 (t, J = 6.8 Hz, 2H), 3.01 - 2.80 (m, 1H), 2.69 - 2.45 (m, 2H), 2.26 (q, J = 6.9 Hz, 2H), 1.24 (d, J = 6.9 Hz, 6H), 1.03 (t, J = 6.9 Hz, 12H).

化合物 40:將含於無水DMF中之化合物 PLC-40.2(50 mg,0.082 mmol)、 PLC-1.3(58.5 mg,0.10 mmol)、K 2CO 3(20.7 mg,0.15 mmol)之混合物音波處理3分鐘,然後在75℃下在氬氣氛圍下加熱5小時。將所得混合物用100 mL DCM稀釋,用0.1N HCl水溶液(50 mL x 2)洗滌,經MgSO 4乾燥,濃縮至50 mL,然後裝載在矽膠上,及藉由急驟層析法使用DCM/EA (0%至5% EA)之溶離劑純化。收集主要所需溶離份,濃縮及用甲醇研磨,接著過濾,以得到暗紅色固體(70 mg,76.6%產率)。LCMS (APCI-):針對C 69H 60BCl 2F 2N 3O 4計算值:1113.40;實測值:1113。 1H NMR (400 MHz, d 2-TCE) δ 8.63 - 8.43 (m, 2H), 8.08 - 7.72 (m, 4H), 7.46 - 7.13 (m, 9H), 6.94 (d, J = 31.3 Hz, 4H), 6.38 (s, 2H), 4.35 (t, J = 6.8 Hz, 2H), 4.12 (t, J = 5.9 Hz, 2H), 2.98 - 2.77 (m, 1H), 2.54 (q, J = 6.8 Hz, 6H), 2.23 (d, J = 6.0 Hz, 6H), 2.04 - 1.89 (m, 4H), 1.23 (d, J = 6.9 Hz, 6H), 1.02 (dd, J = 6.9, 3.5 Hz, 12H)。 Compound 40 : A mixture of compounds PLC-40.2 (50 mg, 0.082 mmol), PLC-1.3 (58.5 mg, 0.10 mmol), K 2 CO 3 (20.7 mg, 0.15 mmol) in anhydrous DMF was sonicated for 3 minutes , and then heated at 75 °C under an argon atmosphere for 5 h. The resulting mixture was diluted with 100 mL of DCM, washed with 0.1 N aqueous HCl (50 mL x 2), dried over MgSO 4 , concentrated to 50 mL, then loaded onto silica gel, and purified by flash chromatography using DCM/EA ( 0% to 5% EA) for eluent purification. The main desired fractions were collected, concentrated and triturated with methanol followed by filtration to give a dark red solid (70 mg, 76.6% yield). LCMS ( APCI-): Calcd . for C69H60BCl2F2N3O4 : 1113.40 ; found: 1113. 1 H NMR (400 MHz, d 2 -TCE) δ 8.63 - 8.43 (m, 2H), 8.08 - 7.72 (m, 4H), 7.46 - 7.13 (m, 9H), 6.94 (d, J = 31.3 Hz, 4H ), 6.38 (s, 2H), 4.35 (t, J = 6.8 Hz, 2H), 4.12 (t, J = 5.9 Hz, 2H), 2.98 - 2.77 (m, 1H), 2.54 (q, J = 6.8 Hz , 6H), 2.23 (d, J = 6.0 Hz, 6H), 2.04 - 1.89 (m, 4H), 1.23 (d, J = 6.9 Hz, 6H), 1.02 (dd, J = 6.9, 3.5 Hz, 12H) .

合成化合物 PLC-41 化合物 PLC-41.1合成之一般程序— 9-溴-2-(4-羥丁基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將100 mL燒瓶安裝攪拌棒。向該燒瓶中,將含於DMF (20 ml)中之化合物 Ex-4.3(1.0 g,2.7 mmol)、4-胺基丁-1-醇(485.3 mg,5.4 mmol)及DMAP (23.1 mg, 0.19 mmol)在室溫下脫氣。將反應混合物加熱上至165℃及將反應在此溫度下保持2.5小時。TLC及LCMS顯示反應完全。將反應冷卻降至室溫。添加H 2O (80 ml)。藉由真空過濾收集固體產物及用H 2O (100 ml)洗滌及於真空烘箱中在100℃下進一步乾燥3小時,以得到呈棕色固體之 PLC-41.1用於下個步驟無需進一步純化。908.0 mg,77%產率。MS (APCI):針對化學式C 22H 16BrNO 4([M-H]-)計算值= 438實測值:438。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.62 (d, J = 8.0 Hz, 1H), 8.58 (d, J = 8.0 Hz, 1H), 8.19 (d, J = 2.4 Hz, 1H), 7.93 (d, J = 8.0 Hz, 1H), 7.64 (dd, J = 8.0 Hz, J = 2.4 Hz, 2H), 7.32 (d, J = 8.0 Hz, 1H), 7.28 (d, J = 8.0 Hz, 1H), 4.20 (t, J = 7.2 Hz, 2H), 3.83 (t, J = 6.0 Hz, 2H), 1.82 (m, 2H), 1.69 (m, 2H)。 Synthesis of compound PLC-41 General procedure for the synthesis of compound PLC-41.1 — 9-bromo-2-(4-hydroxybutyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: Install a 100 mL flask with a stir bar. Into the flask, compound Ex-4.3 (1.0 g, 2.7 mmol), 4-aminobutan-1-ol (485.3 mg, 5.4 mmol) and DMAP (23.1 mg, 0.19 mmol) was degassed at room temperature. The reaction mixture was heated up to 165°C and the reaction was maintained at this temperature for 2.5 hours. TLC and LCMS showed the reaction was complete. The reaction was cooled to room temperature. H2O (80 ml) was added. The solid product was collected by vacuum filtration and washed with H2O (100 ml) and further dried in a vacuum oven at 100 °C for 3 hours to give PLC-41.1 as a brown solid which was used in the next step without further purification. 908.0 mg, 77% yield. MS (APCI): Calcd for Formula C22H16BrNO4 ([MH]-) = 438 Found: 438 . 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.62 (d, J = 8.0 Hz, 1H), 8.58 (d, J = 8.0 Hz, 1H), 8.19 (d, J = 2.4 Hz, 1H), 7.93 ( d, J = 8.0 Hz, 1H), 7.64 (dd, J = 8.0 Hz, J = 2.4 Hz, 2H), 7.32 (d, J = 8.0 Hz, 1H), 7.28 (d, J = 8.0 Hz, 1H) , 4.20 (t, J = 7.2 Hz, 2H), 3.83 (t, J = 6.0 Hz, 2H), 1.82 (m, 2H), 1.69 (m, 2H).

化合物 PLC-41.2合成之一般程序— 2-(4-羥丁基)-9-(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將250 mL燒瓶安裝攪拌棒。向該燒瓶中,將含於THF/DMF/H 2O (60 ml/ 12 ml/ 6 ml)中之化合物 PLC-41.1(900.0 mg,2.1 mmol)、4-(三氟甲基)苯基硼酸(780.0 mg,4.1 mmol)、Pd(dppf)Cl 2(107.5 mg,0.15 mmol)及K 2CO 3(782.5 mg,5.7 mmol)在室溫下脫氣。將反應混合物加熱上至80℃及將反應在此溫度下保持過夜。TLC係用於監測反應。於完成後,將反應藉由添加H 2O (150 ml)處理以沉澱產物。藉由過濾收集沉澱物。將固體藉由H 2O (200 ml)及MeOH (20 ml)洗滌,及於真空烘箱中在100℃下進一步乾燥3小時,以得到呈黃色固體之 PLC-41.2用於下個步驟無需進一步純化。990.0 mg,94%產率。MS (APCI):針對化學式C 29H 20F 3NO 4([M+H]+)計算值= 504實測值:504。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.67 (d, J = 8.0 Hz, 1H), 8.61 (d, J = 8.0 Hz, 1H), 8.27 (d, J = 2.4 Hz, 1H), 8.08 (d, J = 8.0 Hz, 1H), 7.80 (m, 5H), 7.52 (d, J = 8.4 Hz, 1H), 7.38 (d, J = 8.4 Hz, 1H), 4.22 (t, J = 7.2 Hz, 2H), 3.73 (t, J = 6.0 Hz, 2H), 1.84 (m, 4H)。 General procedure for the synthesis of compound PLC-41.2 — 2-(4-hydroxybutyl)-9-(4-(trifluoromethyl)phenyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: A 250 mL flask was fitted with a stir bar. To the flask, compound PLC-41.1 (900.0 mg, 2.1 mmol), 4-(trifluoromethyl)phenylboronic acid in THF/DMF/H 2 O (60 ml/ 12 ml/ 6 ml) (780.0 mg, 4.1 mmol), Pd(dppf)Cl 2 (107.5 mg, 0.15 mmol) and K 2 CO 3 (782.5 mg, 5.7 mmol) were degassed at room temperature. The reaction mixture was heated up to 80 °C and the reaction was kept at this temperature overnight. TLC was used to monitor the reaction. Upon completion, the reaction was worked up by addition of H2O (150 ml) to precipitate the product. The precipitate was collected by filtration. The solid was washed by H 2 O (200 ml) and MeOH (20 ml), and further dried in a vacuum oven at 100° C. for 3 hours to give PLC-41.2 as a yellow solid which was used in the next step without further purification . 990.0 mg, 94% yield. MS ( APCI ): Calcd for Formula C29H20F3NO4 ([M+H]+) = 504 Found : 504. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.67 (d, J = 8.0 Hz, 1H), 8.61 (d, J = 8.0 Hz, 1H), 8.27 (d, J = 2.4 Hz, 1H), 8.08 ( d, J = 8.0 Hz, 1H), 7.80 (m, 5H), 7.52 (d, J = 8.4 Hz, 1H), 7.38 (d, J = 8.4 Hz, 1H), 4.22 (t, J = 7.2 Hz, 2H), 3.73 (t, J = 6.0 Hz, 2H), 1.84 (m, 4H).

化合物 PLC-41.3合成之一般程序—4-甲基苯磺酸4-(1,3-二側氧基-9-(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)丁酯:將100 mL燒瓶安裝攪拌棒。向該燒瓶中添加化合物 PLC-41.2(200.0 mg,0.40 mmol)及DCE (20 ml)。將溶液在室溫下脫氣。添加對甲苯磺酸酐(519.0 mg,1.6 mmol)及TEA (221.0 μL,1.6 mmol)。然後將溶液加熱上至90℃及將其在此溫度下保持4小時。TLC及LCMS係用於監測反應。添加更多DCE (20 mL)、對甲苯磺酸酐(519.0 mg,1.6 mmol)。將反應冷卻降至室溫。添加H 2O (100 ml)、TEA (221.0 μL,1.6 mmol)。將反應在90℃下保持過夜。於添加H 2O (150 ml)以停止反應後,將混合物用DCM (150 ml *3)萃取。將合併之有機相經無水Na 2SO 4乾燥及在真空蒸發器下濃縮,以得到呈黃色固體之 PLC-41.3,將其用於下個步驟無需進一步純化。MS (APCI):針對化學式:C 36H 26F 3NO 6S ([M-H]-)計算值= 657實測值:657。 1H NMR (400 MHz, CDCl 3) 8.55 (d, J = 8.0 Hz, 1H), 8.51 (d, J = 8.0 Hz, 1H), 8.16 (d, J = 2.0 Hz, 1H), 7.92 (d, J = 8.0 Hz, 1H), 7.76 (m, 7H), 7.41 (d, J = 8.4 Hz, 1H), 7.32 (d, J = 8.0 Hz, 2H), 7.24 (d, J = 8.0 Hz, 1H), 4.10 (m, 4H), 2.42 (s, 3H), 1.76 (m, 4H)。 General procedure for the synthesis of compound PLC-41.3—4- (1,3-dioxo-9-(4-(trifluoromethyl)phenyl)-1H-𠮿 of 4-methylbenzenesulfonic acid And[2,1,9-def]isoquinolin-2(3H)-yl)butyl ester: A 100 mL flask was fitted with a stir bar. Compound PLC-41.2 (200.0 mg, 0.40 mmol) and DCE (20 ml) were added to the flask. The solution was degassed at room temperature. p-Toluenesulfonic anhydride (519.0 mg, 1.6 mmol) and TEA (221.0 μL, 1.6 mmol) were added. The solution was then heated up to 90°C and kept at this temperature for 4 hours. TLC and LCMS were used to monitor the reaction. Add more DCE (20 mL), p-toluenesulfonic anhydride (519.0 mg, 1.6 mmol). The reaction was cooled to room temperature. Add H2O (100 ml), TEA (221.0 μL, 1.6 mmol). The reaction was kept at 90°C overnight. After adding H 2 O (150 ml) to stop the reaction, the mixture was extracted with DCM (150 ml *3). The combined organic phases were dried over anhydrous Na2SO4 and concentrated under vacuum evaporator to give PLC-41.3 as a yellow solid which was used in the next step without further purification. MS (APCI) : Calculated for Formula: C36H26F3NO6S ([MH]-) = 657 Found: 657. 1 H NMR (400 MHz, CDCl 3 ) 8.55 (d, J = 8.0 Hz, 1H), 8.51 (d, J = 8.0 Hz, 1H), 8.16 (d, J = 2.0 Hz, 1H), 7.92 (d, J = 8.0 Hz, 1H), 7.76 (m, 7H), 7.41 (d, J = 8.4 Hz, 1H), 7.32 (d, J = 8.0 Hz, 2H), 7.24 (d, J = 8.0 Hz, 1H) , 4.10 (m, 4H), 2.42 (s, 3H), 1.76 (m, 4H).

化合物 PLC-41.4合成之一般程序— 2,6-二氯-4-(4-(1,3-二側氧基-9-(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)丁氧基)苯甲醛:向25 ml小瓶中放入含 PLC-41.3(131.5 mg,0.20 mmol)及4-羥基-2,6-二氯苯甲醛(42.0 mg,0.22 mmol)之DMF (5 mL)。將溶液在室溫下脫氣,添加K 2CO 3(41.4 mg,0.30 mmol)。將反應在室溫下進一步脫氣。然後將其升溫上至65℃及在此溫度下保持攪拌過夜。TLC (含50% EtOAc之己烷)顯示反應完全。將反應混合物藉由矽膠急驟層析法使用EtOAc /己烷(5%至40%)作為溶離劑純化,以得到呈產量固體之純化合物 PLC-41.4,27.0 mg,歷經2個步驟20%產率。MS (APCI):針對化學式:C 36H 22Cl 2F 3NO 5([M-H]-)計算值= 676實測值:676。 1H NMR (400 MHz, CDCl 3) δ 10.37 (s, 1H), 8.67 (d, J = 8.0 Hz, 1H), 8.63 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 2.4 Hz, 1H), 8.05 (d, J = 8.0 Hz, 1H), 7.78 (bs, 4H), 7.75 (m, 1H), 7.49 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 8.0 Hz, 1H), 6.88 (s, 2H), 4.26 (m, 2H), 4.09 (m, 2H), 1.96 (m, 4H)。 General procedure for the synthesis of compound PLC-41.4 — 2,6-dichloro-4-(4-(1,3-dioxo-9-(4-(trifluoromethyl)phenyl)-1H-𠮿 And[2,1,9-def]isoquinolin-2(3H)-yl)butoxy)benzaldehyde: put into a 25 ml vial containing PLC-41.3 (131.5 mg, 0.20 mmol) and 4-hydroxyl -2,6-Dichlorobenzaldehyde (42.0 mg, 0.22 mmol) in DMF (5 mL). The solution was degassed at room temperature and K2CO3 (41.4 mg, 0.30 mmol) was added. The reaction was further degassed at room temperature. It was then warmed up to 65°C and kept stirring at this temperature overnight. TLC (50% EtOAc in hexanes) showed the reaction was complete. The reaction mixture was purified by flash chromatography on silica gel using EtOAc/hexane (5% to 40%) as eluent to give pure compound PLC-41.4 as a yield solid, 27.0 mg, 20% yield over 2 steps . MS ( APCI ) : Calculated for Formula: C36H22Cl2F3NO5 ([MH]-) = 676 Found: 676. 1 H NMR (400 MHz, CDCl 3 ) δ 10.37 (s, 1H), 8.67 (d, J = 8.0 Hz, 1H), 8.63 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 2.4 Hz , 1H), 8.05 (d, J = 8.0 Hz, 1H), 7.78 (bs, 4H), 7.75 (m, 1H), 7.49 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 8.0 Hz , 1H), 6.88 (s, 2H), 4.26 (m, 2H), 4.09 (m, 2H), 1.96 (m, 4H).

化合物 PLC-41合成之一般程序— 2-(4-(3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯氧基)丁基)-9-(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將50 mL 2頸圓底燒瓶安裝空氣冷凝器及攪拌棒。向該燒瓶中添加 PLC-41.4(27.0 mg,0.04 mmol)及 Ex-7.3(15.3 mg,0.084 mmol),接著添加無水二氯甲烷(5 ml)。將反應混合物在室溫下脫氣,然後添加p-TsOH•H 2O (0.2 mg,0.002 mmol)。將反應溶液在此溫度下保持2小時。然後添加DDQ (5.0 mg,0.02 mmol)。將反應在此溫度下保持1小時。然後在室溫下添加BF3•OEt 2(59 μL,0.48 mmol)及Et 3N (44 μL,0.32 mmol)。將反應混合物在室溫下保持過夜。將反應混合物裝載矽膠及藉由急驟層析法使用EtOAc / DCM (0至3%)作為溶離劑純化,以得到呈暗紫色固體之純 PLC-41,12.0 mg,28%產率。MS (APCI):針對化學式:C 62H 43BCl 2F 5N 3O 4([M-H]-)計算值= 1070實測值:1070。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.69 (d, J = 8.0 Hz, 1H), 8.64 (d, J = 8.0 Hz, 1H), 8.28 (d, J = 2.4 Hz, 1H), 8.09 (d, J = 8.0 Hz, 1H), 8.05 (m, 2H), 7.79 (m, 5H), 7.53 (d, J = 8.0 Hz, 1H), 7.38 (m, 5H), 7.30 (m, 2H), 7.08 (s, 2H), 6.48 (s, 2H), 4.30 (bs, 2H), 4.14 (bs, 2H), 2.64 (m, 4H), 2.32 (bs, 4H), 2.00 (m, 8H)。 General procedure for the synthesis of compound PLC-41—2- (4-(3,5-dichloro-4-(19,19-difluoro-6,7,11,12,13,19-hexahydro-5H-18l4 ,19l4-Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']cyclohepta[1',2 ':4,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenoxy)butyl)-9-(4-(trifluoromethane Base) phenyl) -1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: Install an air condenser and a stirring bar in a 50 mL 2-necked round bottom flask. To the flask was added PLC-41.4 (27.0 mg, 0.04 mmol) and Ex-7.3 (15.3 mg, 0.084 mmol), followed by anhydrous dichloromethane (5 ml). The reaction mixture was degassed at room temperature, then p-TsOH•H 2 O (0.2 mg, 0.002 mmol) was added. The reaction solution was kept at this temperature for 2 hours. Then DDQ (5.0 mg, 0.02 mmol) was added. The reaction was maintained at this temperature for 1 hour. Then BF3•OEt 2 (59 μL, 0.48 mmol) and Et 3 N (44 μL, 0.32 mmol) were added at room temperature. The reaction mixture was kept at room temperature overnight. The reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc/DCM (0 to 3%) as eluent to give pure PLC-41 as a dark purple solid, 12.0 mg, 28% yield. MS ( APCI ) : Calculated for Formula : C62H43BCl2F5N3O4 ([MH]-) = 1070 Found: 1070. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.69 (d, J = 8.0 Hz, 1H), 8.64 (d, J = 8.0 Hz, 1H), 8.28 (d, J = 2.4 Hz, 1H), 8.09 ( d, J = 8.0 Hz, 1H), 8.05 (m, 2H), 7.79 (m, 5H), 7.53 (d, J = 8.0 Hz, 1H), 7.38 (m, 5H), 7.30 (m, 2H), 7.08 (s, 2H), 6.48 (s, 2H), 4.30 (bs, 2H), 4.14 (bs, 2H), 2.64 (m, 4H), 2.32 (bs, 4H), 2.00 (m, 8H).

合成化合物 PLC-42 化合物 PLC-42.1合成之一般程序— 9-溴-2-(2-(2-(2-羥基乙氧基)乙氧基)乙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將100 mL燒瓶安裝攪拌棒。向該燒瓶中,將含於DMF (25 ml)中之化合物 Ex-4.3(1.3 g,3.4 mmol)、2-(2-(2-胺基乙氧基)乙氧基)乙-1-醇(1.0 g,6.8 mmol)及DMAP (29.0 mg, 0.24 mmol)在室溫下脫氣。將反應混合物加熱上至165℃及將反應在此溫度下保持2小時。TLC及LCMS顯示反應完全。將反應冷卻降至50℃。將溶液倒入具有冰水浴之預冷卻之丙酮(100 ml)溶液中。將混合物在此溫度下保持2小時及然後在室溫下保持過夜。藉由過濾收集沉澱物。將固體藉由H 2O (150 ml)洗滌及於真空烘箱中在100℃下進一步乾燥3小時,以得到呈棕色固體之 PLC-42.1用於下個步驟無需進一步純化。805.0 mg,48%產率。MS (APCI):針對化學式:C 24H 20BrNO 6([M-H]-)計算值= 498實測值:498。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.61 (d, J = 8.0 Hz, 1H), 8.58 (d, J = 8.0 Hz, 1H), 8.18 (d, J = 2.4 Hz, 1H), 7.91 (d, J = 8.0 Hz, 1H), 7.64 (dd, J = 8.0 Hz, J = 2.4 Hz, 2H), 7.32 (d, J = 8.0 Hz, 1H), 7.28 (d, J = 8.0 Hz, 1H), 4.42 (t, J = 6.0 Hz, 2H), 3.83 (t, J = 6.0 Hz, 2H), 3.63 (m, 8H)。 Synthesis of compound PLC-42 General procedure for the synthesis of compound PLC-42.1 — 9-bromo-2-(2-(2-(2-hydroxyethoxy)ethoxy)ethyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: Install a 100 mL flask with a stir bar. Into the flask, compound Ex-4.3 (1.3 g, 3.4 mmol), 2-(2-(2-aminoethoxy)ethoxy)ethan-1-ol in DMF (25 ml) (1.0 g, 6.8 mmol) and DMAP (29.0 mg, 0.24 mmol) were degassed at room temperature. The reaction mixture was heated up to 165°C and the reaction was maintained at this temperature for 2 hours. TLC and LCMS showed the reaction was complete. The reaction was cooled down to 50 °C. The solution was poured into a pre-cooled acetone (100 ml) solution with an ice-water bath. The mixture was kept at this temperature for 2 hours and then at room temperature overnight. The precipitate was collected by filtration. The solid was washed by H 2 O (150 ml) and further dried in a vacuum oven at 100° C. for 3 hours to give PLC-42.1 as a brown solid which was used in the next step without further purification. 805.0 mg, 48% yield. MS (APCI): Calculated for Formula: C24H20BrNO6 ([MH]-) = 498 Found: 498 . 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.61 (d, J = 8.0 Hz, 1H), 8.58 (d, J = 8.0 Hz, 1H), 8.18 (d, J = 2.4 Hz, 1H), 7.91 ( d, J = 8.0 Hz, 1H), 7.64 (dd, J = 8.0 Hz, J = 2.4 Hz, 2H), 7.32 (d, J = 8.0 Hz, 1H), 7.28 (d, J = 8.0 Hz, 1H) , 4.42 (t, J = 6.0 Hz, 2H), 3.83 (t, J = 6.0 Hz, 2H), 3.63 (m, 8H).

化合物 PLC-42.2合成之一般程序— 2-(2-(2-(2-羥基乙氧基)乙氧基)乙基)-9-(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將250 mL燒瓶安裝攪拌棒。向該燒瓶中,將含於THF/DMF/H 2O (44 ml/ 8.8 ml/ 4.4 ml)中之化合物1621-36 (800.0 mg,1.6 mmol)、4-(三氟甲基)苯基硼酸(609.8 mg,3.2 mmol)、Pd(dppf)Cl 2(82.4 mg,0.1 mmol)及K 2CO 3(600.0 mg,4.4 mmol)在室溫下脫氣。將反應混合物加熱上至80℃及將反應在此溫度下保持過夜。TLC係用於監測反應。於完成後,將反應藉由添加H 2O (150 ml)處理以沉澱產物。藉由過濾收集沉澱物。將固體藉由H 2O (200 ml)及MeOH (20 ml)洗滌,及於真空烘箱中在100℃下進一步乾燥3小時,以得到呈黃色固體之 PLC-42.2用於下個步驟無需進一步純化。定量產率。MS (APCI):針對化學式:C 31H 24F 3NO 6([M+H]+)計算值= 564實測值:564。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.67 (d, J = 8.0 Hz, 1H), 8.61 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 2.0 Hz, 1H), 8.07 (d, J = 8.0 Hz, 1H), 7.96 (bs, 1H), 7.80 (m, 5H), 7.52 (d, J = 8.4 Hz, 1H), 7.37 (d, J = 8.4 Hz, 1H), 4.43 (t, J = 6.0 Hz, 2H), 3.84 (t, J = 6.0 Hz, 2H), 3.70 (m, 2H), 3.64 (m, 4H), 3.54 (m, 2H)。 General procedure for the synthesis of compound PLC-42.2—2- (2-(2-(2-hydroxyethoxy)ethoxy)ethyl)-9-(4-(trifluoromethyl)phenyl)-1H- 𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: A 250 mL flask was fitted with a stir bar. To the flask, compound 1621-36 (800.0 mg, 1.6 mmol), 4-(trifluoromethyl)phenylboronic acid in THF/DMF/H 2 O (44 ml/ 8.8 ml/ 4.4 ml) was added (609.8 mg, 3.2 mmol), Pd(dppf)Cl 2 (82.4 mg, 0.1 mmol) and K 2 CO 3 (600.0 mg, 4.4 mmol) were degassed at room temperature. The reaction mixture was heated up to 80 °C and the reaction was kept at this temperature overnight. TLC was used to monitor the reaction. Upon completion, the reaction was worked up by addition of H2O (150 ml) to precipitate the product. The precipitate was collected by filtration. The solid was washed by H 2 O (200 ml) and MeOH (20 ml), and further dried in a vacuum oven at 100° C. for 3 hours to give PLC-42.2 as a yellow solid which was used in the next step without further purification . Quantitative yield. MS (APCI ): Calculated for Formula: C31H24F3NO6 ( [M+H]+) = 564 Found : 564. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.67 (d, J = 8.0 Hz, 1H), 8.61 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 2.0 Hz, 1H), 8.07 ( d, J = 8.0 Hz, 1H), 7.96 (bs, 1H), 7.80 (m, 5H), 7.52 (d, J = 8.4 Hz, 1H), 7.37 (d, J = 8.4 Hz, 1H), 4.43 ( t, J = 6.0 Hz, 2H), 3.84 (t, J = 6.0 Hz, 2H), 3.70 (m, 2H), 3.64 (m, 4H), 3.54 (m, 2H).

化合物 PLC-42.3合成之一般程序—4-甲基苯磺酸2-(2-(2-(1,3-二側氧基-9-(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)乙氧基)乙氧基)乙酯:將100 mL燒瓶安裝攪拌棒。向該燒瓶中添加化合物1621-41 (300.0 mg,0.53 mmol)及NMP (8 ml)。將溶液在室溫下脫氣。添加對甲苯磺酸酐(522.2 mg,1.6 mmol)及TEA (162.0 mg,1.6 mmol)。然後將溶液加熱上至90℃及將其在此溫度下保持過夜。TLC及LCMS係用於監測反應。甚至利用延長之時間,反應停留在90轉化。於添加更多對甲苯磺酸酐(130.0 mg)後,轉化可提高至97%。將反應冷卻降至室溫。添加H 2O (100 ml)。將混合物用DCM (150 ml *3)萃取。將合併之有機相經無水Na 2SO 4乾燥及在真空蒸發器下濃縮,以得到呈黃色溶液(具有NMP作為殘留物)之 PLC-42.3,將其用於下個步驟無需進一步純化。MS (APCI):針對化學式:C 38H 30F 3NO 8S ([M-H]-)計算值= 717實測值:717。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.64 (d, J = 8.0 Hz, 1H), 8.58 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 2.4 Hz, 1H), 8.06 (d, J = 8.0 Hz, 1H), 7.76 (m, 7H), 7.51 (d, J = 8.4 Hz, 1H), 7.34 (m, 3H), 4.38 (t, J = 6.0 Hz, 2H), 4.05 (m, 2H), 3.76 (t, J = 6.0 Hz, 2H), 3.61 (m, 4H), 3.54 (m, 2H), 2.42 (s, 3H)。 General procedure for the synthesis of compound PLC-42.3—2- (2-(2-(1,3-dioxo-9-(4-(trifluoromethyl)phenyl)-1H) of 4-methylbenzenesulfonic acid -𠮿 And[2,1,9-def]isoquinolin-2(3H)-yl)ethoxy)ethoxy)ethyl ester: A 100 mL flask was fitted with a stir bar. To the flask was added compound 1621-41 (300.0 mg, 0.53 mmol) and NMP (8 ml). The solution was degassed at room temperature. p-Toluenesulfonic anhydride (522.2 mg, 1.6 mmol) and TEA (162.0 mg, 1.6 mmol) were added. The solution was then heated up to 90°C and kept at this temperature overnight. TLC and LCMS were used to monitor the reaction. Even with extended time, the reaction stayed at 90 conversion. After adding more p-toluenesulfonic anhydride (130.0 mg), the conversion could be increased to 97%. The reaction was cooled to room temperature. H2O (100 ml) was added. The mixture was extracted with DCM (150 ml *3). The combined organic phases were dried over anhydrous Na2SO4 and concentrated under vacuum evaporator to give PLC-42.3 as a yellow solution (with NMP as residue), which was used in the next step without further purification. MS (APCI) : Calculated for Formula : C38H30F3NO8S ([MH]-) = 717 Found: 717. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.64 (d, J = 8.0 Hz, 1H), 8.58 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 2.4 Hz, 1H), 8.06 ( d, J = 8.0 Hz, 1H), 7.76 (m, 7H), 7.51 (d, J = 8.4 Hz, 1H), 7.34 (m, 3H), 4.38 (t, J = 6.0 Hz, 2H), 4.05 ( m, 2H), 3.76 (t, J = 6.0 Hz, 2H), 3.61 (m, 4H), 3.54 (m, 2H), 2.42 (s, 3H).

化合物 PLC-42.4合成之一般程序— 2,6-二氯-4-(2-(2-(2-(1,3-二側氧基-9-(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)乙氧基)乙氧基)乙氧基)苯甲醛:向25 ml小瓶中放入含 PLC-42.3(186.6 mg,0.26 mmol)及4-羥基-2,6-二氯苯甲醛(54.6 mg,0.29 mmol)之DMF (5 mL)。將溶液在室溫下脫氣,添加K 2CO 3(53.8 mg,0.39 mmol)。將反應在室溫下進一步脫氣。然後將其升溫上至65℃及在此溫度下保持攪拌過夜。TLC (含50% EtOAc之己烷)顯示反應完全。將反應混合物藉由矽膠急驟層析法使用EtOAc /己烷(0%至40%至60%)作為溶離劑純化,以得到呈產量固體之純化合物 PLC-42.4,37.0 mg,歷經2個步驟19%產率。MS (APCI):針對化學式:C 38H 26Cl 2F 3NO 7([M-H]-)計算值= 736實測值:736。 1H NMR (400 MHz, CDCl 2CDCl 2) δ 10.20 (s, 1H), 8.62 (d, J = 8.0 Hz, 1H), 8.57 (d, J = 8.0 Hz, 1H), 8.20 (d, J = 2.0 Hz, 1H), 8.01 (d, J = 8.0 Hz, 1H), 7.80 (s, 4H), 7.76 (dd, J = 8.0 Hz, 2.0 Hz, 1H), 7.47 (d, J = 8.0 Hz, 1H), 7.33 (d, J = 8.0 Hz, 1H), 6.69 (s, 2H), 4.45 (t, J = 6.0 Hz, 2H), 3.86 (m, 4H), 3.72 (m, 6H)。 General procedure for the synthesis of compound PLC-42.4—2,6- dichloro-4-(2-(2-(2-(1,3-dioxo-9-(4-(trifluoromethyl)phenyl) )-1H-𠮿 and[2,1,9-def]isoquinolin-2(3H)-yl)ethoxy)ethoxy)ethoxy)benzaldehyde: Into a 25 ml vial, add PLC-42.3 (186.6 mg , 0.26 mmol) and 4-hydroxy-2,6-dichlorobenzaldehyde (54.6 mg, 0.29 mmol) in DMF (5 mL). The solution was degassed at room temperature and K2CO3 (53.8 mg, 0.39 mmol) was added. The reaction was further degassed at room temperature. It was then warmed up to 65°C and kept stirring at this temperature overnight. TLC (50% EtOAc in hexanes) showed the reaction was complete. The reaction mixture was purified by flash chromatography on silica gel using EtOAc/hexane (0% to 40% to 60%) as eluent to give pure compound PLC-42.4 as a yield solid, 37.0 mg, over 2 steps 19 %Yield. MS (APCI ) : Calculated for Formula: C38H26Cl2F3NO7 ([MH]-) = 736 Found: 736. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) δ 10.20 (s, 1H), 8.62 (d, J = 8.0 Hz, 1H), 8.57 (d, J = 8.0 Hz, 1H), 8.20 (d, J = 2.0 Hz, 1H), 8.01 (d, J = 8.0 Hz, 1H), 7.80 (s, 4H), 7.76 (dd, J = 8.0 Hz, 2.0 Hz, 1H), 7.47 (d, J = 8.0 Hz, 1H ), 7.33 (d, J = 8.0 Hz, 1H), 6.69 (s, 2H), 4.45 (t, J = 6.0 Hz, 2H), 3.86 (m, 4H), 3.72 (m, 6H).

化合物 PLC-42合成之一般程序— 2-(2-(2-(2-(3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯氧基)乙氧基)乙氧基)乙基)-9-(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將100 mL 2頸圓底燒瓶安裝空氣冷凝器及攪拌棒。向該燒瓶中添加 PLC-42.4(37.0 mg,0.05 mmol)及1605-44 (19.3 mg,0.11 mmol),接著添加無水二氯甲烷(5 ml)。將反應混合物在室溫下脫氣,然後添加p-TsOH•H 2O (0.3 mg,0.003 mmol)。將反應溶液在此溫度下保持2小時。然後添加DDQ (6.2 mg,0.03 mmol)。將反應在此溫度下保持1小時。然後在室溫下添加BF3•OEt 2(74 μL,0.6 mmol)及Et 3N (56 μL,0.4 mmol)。將反應混合物在室溫下保持過夜。將反應混合物裝載矽膠及藉由急驟層析法使用EtOAc / DCM (0至6%)作為溶離劑純化,以得到呈暗紫色固體之純 PLC-42,7.0 mg,13%產率。MS (APCI):針對化學式:C 64H 47BCl 2F 5N 3O 6([M-H]-)計算值= 1130實測值:1130。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.68 (d, J = 8.0 Hz, 1H), 8.63 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 2.4 Hz, 1H), 8.08 (d, J = 8.0 Hz, 1H), 8.04 (m, 2H), 7.78 (bs, 4H), 7.78 (dd, J = 8.0 Hz, 2.0 Hz, 1H), 7.50 (d, J = 8.0 Hz, 1H), 7.37 (m, 5H), 7.29 (m, 2H), 7.07 (s, 2H), 6.46 (s, 2H), 4.46 (t, J = 8.4 Hz, 2H), 4.13 (t, J = 4.4 Hz, 2H), 3.86 (m, 4H), 3.74 (m, 4H), 2.63 (m, 4H), 2.31 (bs, 4H), 2.04 (m, 4H)。 General procedure for the synthesis of compound PLC-42 - 2-(2-(2-(2-(3,5-dichloro-4-(19,19-difluoro-6,7,11,12,13,19- Hexahydro-5H-18l4,19l4-Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']ring Hepta[1',2':4,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenoxy)ethoxy)ethoxy )ethyl)-9-(4-(trifluoromethyl)phenyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: Install an air condenser and a stirring bar in a 100 mL 2-neck round bottom flask. To the flask was added PLC-42.4 (37.0 mg, 0.05 mmol) and 1605-44 (19.3 mg, 0.11 mmol), followed by anhydrous dichloromethane (5 ml). The reaction mixture was degassed at room temperature, then p-TsOH•H 2 O (0.3 mg, 0.003 mmol) was added. The reaction solution was kept at this temperature for 2 hours. Then DDQ (6.2 mg, 0.03 mmol) was added. The reaction was maintained at this temperature for 1 hour. Then BF3•OEt 2 (74 μL, 0.6 mmol) and Et 3 N (56 μL, 0.4 mmol) were added at room temperature. The reaction mixture was kept at room temperature overnight. The reaction mixture was loaded on silica gel and purified by flash chromatography using EtOAc/DCM (0 to 6%) as eluent to give pure PLC-42 as a dark purple solid, 7.0 mg, 13% yield. MS (APCI): Calculated for Formula: C64H47BCl2F5N3O6 ( [MH]-) = 1130 Found : 1130 . 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.68 (d, J = 8.0 Hz, 1H), 8.63 (d, J = 8.0 Hz, 1H), 8.26 (d, J = 2.4 Hz, 1H), 8.08 ( d, J = 8.0 Hz, 1H), 8.04 (m, 2H), 7.78 (bs, 4H), 7.78 (dd, J = 8.0 Hz, 2.0 Hz, 1H), 7.50 (d, J = 8.0 Hz, 1H) , 7.37 (m, 5H), 7.29 (m, 2H), 7.07 (s, 2H), 6.46 (s, 2H), 4.46 (t, J = 8.4 Hz, 2H), 4.13 (t, J = 4.4 Hz, 2H), 3.86 (m, 4H), 3.74 (m, 4H), 2.63 (m, 4H), 2.31 (bs, 4H), 2.04 (m, 4H).

合成化合物 PLC-43 合成化合物 PLC-43化合物 PLC-43.1合成之一般程序— 2-(3-羥丙基)-9-(全氟苯基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將100 mL燒瓶安裝攪拌棒。向該燒瓶中,將含於DMF (30 ml)中之化合物 PLC-38.1(400.0 mg,0.9 mmol)、(全氟苯基)硼酸(240.0 mg,1.1 mmol)、Pd 2(dba) 3(43.0 mg,0.05 mmol)、CsF (285.6 mg,1.9 mmol)、Ag 2O (259.4 mg,1.1 mmol)及(t-Bu) 3P (1.9 ml,1.9 mmol)在室溫下脫氣。將反應混合物加熱上至80℃及將反應在此溫度下保持過夜。TLC係用於監測反應。於完成後,將反應藉由矽膠急驟層析法使用EtOAc /己烷(5至10至50至70%)作為溶離劑純化,以得到呈黃色固體之純化合物 PLC-43.1,136.0 mg,28%產率。MS (APCI):針對化學式C 27H 14F 5NO 4([M-H]-)計算值= 511實測值:511。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.57 (d, J = 8.0 Hz, 1H), 8.55 (d, J = 8.0 Hz, 1H), 8.07 (s, 1H), 7.92 (d, J = 8.0 Hz, 1H), 7.53 (d, J = 8.0 Hz, 1H), 7.46 (d, J = 8.0 Hz, 1H), 7.32 (d, J = 8.0 Hz, 1H), 4.25 (t, J = 6.0 Hz, 2H), 3.48 (m, 2H), 3.07 (t, J = 6.8 Hz, 1H), 1.90 (m, 2H)。 Synthesis of compound PLC-43 Synthesis of compound PLC-43 General procedure for the synthesis of compound PLC-43.1 — 2-(3-hydroxypropyl)-9-(perfluorophenyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: Install a 100 mL flask with a stir bar. To the flask, compound PLC-38.1 (400.0 mg, 0.9 mmol), (perfluorophenyl)boronic acid (240.0 mg, 1.1 mmol), Pd 2 (dba) 3 (43.0 mg, 0.05 mmol), CsF (285.6 mg, 1.9 mmol), Ag 2 O (259.4 mg, 1.1 mmol) and (t-Bu) 3 P (1.9 ml, 1.9 mmol) were degassed at room temperature. The reaction mixture was heated up to 80 °C and the reaction was kept at this temperature overnight. TLC was used to monitor the reaction. Upon completion, the reaction was purified by silica gel flash chromatography using EtOAc/hexane (5 to 10 to 50 to 70%) as eluent to give pure compound PLC-43.1 as a yellow solid, 136.0 mg, 28% Yield. MS ( APCI ): Calcd for Formula C27H14F5NO4 ([MH] - ) = 511 Found: 511. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.57 (d, J = 8.0 Hz, 1H), 8.55 (d, J = 8.0 Hz, 1H), 8.07 (s, 1H), 7.92 (d, J = 8.0 Hz, 1H), 7.53 (d, J = 8.0 Hz, 1H), 7.46 (d, J = 8.0 Hz, 1H), 7.32 (d, J = 8.0 Hz, 1H), 4.25 (t, J = 6.0 Hz, 2H), 3.48 (m, 2H), 3.07 (t, J = 6.8 Hz, 1H), 1.90 (m, 2H).

化合物 PLC-43.2合成之一般程序— 2-(3-溴丙基)-9-(全氟苯基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將100 mL燒瓶安裝攪拌棒。向該燒瓶中添加化合物1644-10 (136.0 mg,0.3 mmol)、CBr 4(176.3 mg,0.5 mmol)、PPh 3(140.2 mg,0.5 mmol)及DCE (12 ml)。將溶液在室溫下脫氣。將反應在此溫度下保持30分鐘。TLC及LCMS係用於監測反應。於完成後,將反應藉由矽膠急驟層析法使用EtOAc /己烷(5至10至50至70%)作為溶離劑純化,以得到呈黃色固體之純化合物 PLC-43.2,116.0 mg,76%產率。MS (APCI):針對C 27H 13BrF 5NO 3([M+H]+)計算值= 573實測值:573。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.64 (d, J = 8.0 Hz, 1H), 8.61 (d, J = 8.0 Hz, 1H), 8.15 (d, J = 1.6 Hz, 1H), 7.99 (d, J = 8.0 Hz, 1H), 7.61 (m, 1H), 7.54 (d, J = 8.0 Hz, 1H), 7.39 (d, J = 8.0 Hz, 1H), 4.32 (t, J = 6.8 Hz, 2H), 3.54 (t, J = 6.8 Hz, 2H), 2.34 (五重峰,J = 6.8 Hz, 2H)。 General procedure for the synthesis of compound PLC-43.2 — 2-(3-bromopropyl)-9-(perfluorophenyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: Install a 100 mL flask with a stir bar. To the flask was added compound 1644-10 (136.0 mg, 0.3 mmol), CBr4 (176.3 mg, 0.5 mmol), PPh3 (140.2 mg, 0.5 mmol) and DCE (12 ml). The solution was degassed at room temperature. The reaction was maintained at this temperature for 30 minutes. TLC and LCMS were used to monitor the reaction. Upon completion, the reaction was purified by silica gel flash chromatography using EtOAc/hexane (5 to 10 to 50 to 70%) as eluent to give pure compound PLC-43.2 as a yellow solid, 116.0 mg, 76% Yield. MS (APCI): Calcd . for C27H13BrF5NO3 ([M+H]+) = 573 Found: 573 . 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.64 (d, J = 8.0 Hz, 1H), 8.61 (d, J = 8.0 Hz, 1H), 8.15 (d, J = 1.6 Hz, 1H), 7.99 ( d, J = 8.0 Hz, 1H), 7.61 (m, 1H), 7.54 (d, J = 8.0 Hz, 1H), 7.39 (d, J = 8.0 Hz, 1H), 4.32 (t, J = 6.8 Hz, 2H), 3.54 (t, J = 6.8 Hz, 2H), 2.34 (quintet, J = 6.8 Hz, 2H).

化合物 PLC-43合成之一般程序—2-(3-(3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯氧基)丙基)-9-(全氟苯基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:向25 ml小瓶中添加 PLC-1.3(73.4 mg,0.1 mmol)、 PLC-43.2(60.0 mg,0.1 mmol)、K 2CO 3(28.7 mg,0.2 mmol)及DMF (2 ml)。將混合物在室溫下音波處理2分鐘。然後將其升溫上至75℃及在此溫度下保持攪拌4小時。TLC (含50% EtOAc之己烷)顯示反應完全。將反應混合物藉由矽膠急驟層析法使用EtOAc /己烷(0至3%)作為溶離劑純化,以得到呈暗紫色固體之純化合物 PLC-43,91.0 mg,81%產率。MS (APCI):針對化學式:C 60H 37BCl 2F 7N 3O 4([M-H]-)計算值= 1077實測值:1077。 1H NMR (400 MHz, CDCl 2CDCl 2) 8.67 (d, J = 8.0 Hz, 1H), 8.63 (d, J = 8.0 Hz, 1H), 8.18 (bs, 1H), 8.05 (m, 2H), 8.01 (d, J = 8.0 Hz, 1H), 7.61 (m, 1H), 7.54 (d, J = 8.0 Hz, 1H), 7.38 (m, 5H), 7.30 (m, 2H), 7.02 (s, 2H), 6.47 (s, 2H), 4.44 (t, J = 6.0 Hz, 2H), 4.22 (t, J = 6.0 Hz, 2H), 2.64 (m, 4H), 2.32 (m, 6H), 2.05 (m, 4H)。 General procedure for the synthesis of compound PLC-43—2- (3-(3,5-dichloro-4-(19,19-difluoro-6,7,11,12,13,19-hexahydro-5H-18l4 ,19l4-Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']cyclohepta[1',2 ':4,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenoxy)propyl)-9-(perfluorophenyl)- 1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: To a 25 ml vial, add PLC-1.3 (73.4 mg, 0.1 mmol), PLC-43.2 (60.0 mg, 0.1 mmol ), K 2 CO 3 (28.7 mg, 0.2 mmol) and DMF (2 ml). The mixture was sonicated for 2 min at room temperature. It was then warmed up to 75°C and kept stirring at this temperature for 4 hours. TLC (50% EtOAc in hexanes) showed the reaction was complete. The reaction mixture was purified by flash chromatography on silica gel using EtOAc/hexanes (0 to 3%) as eluent to afford pure compound PLC-43 as a dark purple solid, 91.0 mg, 81% yield. MS (APCI) : Calcd for Formula: C60H37BCl2F7N3O4 ( [MH] - ) = 1077 Found : 1077. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) 8.67 (d, J = 8.0 Hz, 1H), 8.63 (d, J = 8.0 Hz, 1H), 8.18 (bs, 1H), 8.05 (m, 2H), 8.01 (d, J = 8.0 Hz, 1H), 7.61 (m, 1H), 7.54 (d, J = 8.0 Hz, 1H), 7.38 (m, 5H), 7.30 (m, 2H), 7.02 (s, 2H ), 6.47 (s, 2H), 4.44 (t, J = 6.0 Hz, 2H), 4.22 (t, J = 6.0 Hz, 2H), 2.64 (m, 4H), 2.32 (m, 6H), 2.05 (m , 4H).

合成化合物 PLC-44 化合物 PLC-44.1:9-(3,5-雙(三氟甲基)苯基)-2-(3-羥丙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將化合物 PLC-38.1(0.4241 g,1.0 mmol,1 eq)懸浮於DMF (5 ml)、H 2O (0.5 ml)中,添加(雙-3,5-三氟甲基)苯硼酸(0.51586 g,2.0 mmol,2 eq)、K 2CO 3(0.27642 g,2.0 mmol,2 eq)、Pd(dppf)Cl 2DCM (16.33 mg,0.02 mmol,0.02 eq)。將所得混合物Vac- Fill氬氣循環3次,在80℃下攪拌及加熱45分鐘,混合物變得黏性,添加15 ml DMF,繼續在80℃下攪拌另外15分鐘。將反應混合物冷卻至室溫,藉由蒸發器濃縮,添加水至殘留物混合物中,在RT下保持1小時。過濾沉澱物,得到570 mg青黃色固體,將其用MeOH洗滌,以得到270 mg純產物。產率48%。MS (APCI):針對化學式:C 29H 17F 6NO 4(M-)計算值= 557;實測值:557。 1H NMR (400 MHz, ) δ 8.60 (d, J = 7.9 Hz, 1H), 8.55 (d, J = 8.4 Hz, 1H), 8.17 (d, J = 2.2 Hz, 1H), 8.03 (d, J = 8.1 Hz, 1H), 8.00 (s, 2H), 7.87 (s, 1H), 7.70 (dd, J = 8.7, 2.1 Hz, 1H), 7.47 (d, J = 8.6 Hz, 1H), 7.31 (d, J = 8.3 Hz, 1H), 4.25 (t, J = 6.2 Hz, 2H), 3.49 (d, J = 6.1 Hz, 3H), 3.08 (t, J = 6.8 Hz, 1H), 1.90 (t, J = 6.0 Hz, 2H)。 Synthesis of compound PLC-44 Compound PLC-44.1 : 9-(3,5-bis(trifluoromethyl)phenyl)-2-(3-hydroxypropyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: Compound PLC-38.1 (0.4241 g, 1.0 mmol, 1 eq) was suspended in DMF (5 ml), H 2 O (0.5 ml), add (bis-3,5-trifluoromethyl)phenylboronic acid (0.51586 g, 2.0 mmol, 2 eq), K 2 CO 3 (0.27642 g, 2.0 mmol, 2 eq), Pd(dppf ) Cl2DCM (16.33 mg, 0.02 mmol, 0.02 eq). The resulting mixture was Vac-Fill argon circulated 3 times, stirred and heated at 80°C for 45 minutes, the mixture became viscous, 15 ml DMF was added and stirring was continued at 80°C for another 15 minutes. The reaction mixture was cooled to room temperature, concentrated by evaporator, water was added to the residue mixture and kept at RT for 1 h. The precipitate was filtered to give 570 mg of a cyan-yellow solid, which was washed with MeOH to give 270 mg of pure product. Yield 48%. MS (APCI) : Calcd for Formula: C29H17F6NO4 (M-) = 557 ; found: 557. 1 H NMR (400 MHz, ) δ 8.60 (d, J = 7.9 Hz, 1H), 8.55 (d, J = 8.4 Hz, 1H), 8.17 (d, J = 2.2 Hz, 1H), 8.03 (d, J = 8.1 Hz, 1H), 8.00 (s, 2H), 7.87 (s, 1H), 7.70 (dd, J = 8.7, 2.1 Hz, 1H), 7.47 (d, J = 8.6 Hz, 1H), 7.31 (d , J = 8.3 Hz, 1H), 4.25 (t, J = 6.2 Hz, 2H), 3.49 (d, J = 6.1 Hz, 3H), 3.08 (t, J = 6.8 Hz, 1H), 1.90 (t, J = 6.0 Hz, 2H).

化合物 PLC-44.2:9-(3,5-雙(三氟甲基)苯基)-2-(3-溴丙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將含於48% HBr水溶液(30.0 ml)中之 PLC-44.1(558 mg,1.0 mmol)之混合物藉由加熱塊在130℃下加熱至回流16小時。LCMS顯示>90%轉化。於冷卻至RT後,將固體過濾,用水洗滌,於真空烘箱中乾燥,以得到含有一些未反應之SM之所需化合物。得到600 mg青黃色固體,產率86%。將產物用於下個步驟無需進一步純化。MS (APCI):針對化學式:C 29H 16BrF 6NO 34(M-)計算值= 620;實測值620。 1H NMR (400 MHz) δ 8.58 (d, J = 7.8 Hz, 1H), 8.53 (d, J = 8.4 Hz, 1H), 8.16 (d, J = 2.3 Hz, 1H), 8.04 - 7.97 (m, 2H), 7.86 (s, 1H), 7.70 (dd, J = 8.6, 2.2 Hz, 1H), 7.46 (d, J = 8.6 Hz, 1H), 7.30 (d, J = 8.3 Hz, 1H), 4.23 (t, J = 7.1 Hz, 2H), 3.45 (t, J = 6.8 Hz, 2H), 2.34 - 2.16 (m, 2H)。 Compound PLC-44.2 : 9-(3,5-bis(trifluoromethyl)phenyl)-2-(3-bromopropyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: A mixture of PLC-44.1 (558 mg, 1.0 mmol) in 48% aqueous HBr (30.0 ml) was borrowed Heat to reflux at 130°C for 16 hours by heating block. LCMS showed >90% conversion. After cooling to RT, the solid was filtered, washed with water, and dried in a vacuum oven to give the desired compound with some unreacted SM. Obtained 600 mg of cyan-yellow solid with a yield of 86%. The product was used in the next step without further purification. MS (APCI) : Calcd. for Formula: C29H16BrF6NO34 ( M-) = 620 ; found 620. 1 H NMR (400 MHz) δ 8.58 (d, J = 7.8 Hz, 1H), 8.53 (d, J = 8.4 Hz, 1H), 8.16 (d, J = 2.3 Hz, 1H), 8.04 - 7.97 (m, 2H), 7.86 (s, 1H), 7.70 (dd, J = 8.6, 2.2 Hz, 1H), 7.46 (d, J = 8.6 Hz, 1H), 7.30 (d, J = 8.3 Hz, 1H), 4.23 ( t, J = 7.1 Hz, 2H), 3.45 (t, J = 6.8 Hz, 2H), 2.34 - 2.16 (m, 2H).

化合物 PLC-44:9-(3,5-雙(三氟甲基)苯基)-2-(3-(3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯氧基)丙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將化合物 PLC-44.2(46.52 mg,0.075 mmol,1.15 eq)懸浮於無水DMF (2.0 ml)中,添加 PLC-1.3(38.04 mg,0.065 mmol,1 eq)、K 2CO 3(20.73 mg,0.15 mmol,2.3 eq)、NaI (4.15 mg,催化量)。將所得物在85℃下在氬氣氛圍下攪拌3小時。將混合物過濾,將固體用50 ml水洗滌,然後裝載至40 g管柱上,用Hex: DCM (9:1至僅DCM)溶離,將來自管柱之產物用EtOH洗滌,得到53 mg暗紫色固體。產率62%。MS (APCI):針對化學式:C 62H 40BCl 2F 8N 3O 4(M-)計算值= 1124;實測值:1124。 1H NMR (400 MHz) δ 8.61 (d, J = 7.8 Hz, 1H), 8.55 (d, J = 8.3 Hz, 1H), 8.16 (d, J = 2.2 Hz, 1H), 8.04 (d, J = 8.1 Hz, 1H), 8.00 (s, 2H), 7.95 (t, J = 4.7 Hz, 2H), 7.86 (s, 1H), 7.70 (dd, J = 8.6, 2.2 Hz, 1H), 7.47 (d, J = 8.6 Hz, 1H), 7.32 (d, J = 8.3 Hz, 1H), 7.27 (dt, J = 7.4, 3.7 Hz, 3H), 7.23 - 7.15 (m, 2H), 6.92 (s, 2H), 6.38 (s, 2H), 4.36 (t, J = 7.0 Hz, 2H), 4.13 (t, J = 6.0 Hz, 2H), 2.54 (t, J = 6.8 Hz, 4H), 2.24 (s, 4H), 1.96 (t, J = 7.2 Hz, 4H)。 Compound PLC-44 : 9-(3,5-bis(trifluoromethyl)phenyl)-2-(3-(3,5-dichloro-4-(19,19-difluoro-6,7, 11,12,13,19-Hexahydro-5H-18l4,19l4-Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo [3',4']cyclohepta[1',2':4,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenoxy )propyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: Compound PLC-44.2 (46.52 mg, 0.075 mmol, 1.15 eq) was suspended in anhydrous DMF (2.0 ml), added PLC-1.3 (38.04 mg, 0.065 mmol, 1 eq), K2CO3 (20.73 mg, 0.15 mmol, 2.3 eq), NaI (4.15 mg, catalytic amount). The resultant was stirred at 85 °C for 3 hours under argon atmosphere. The mixture was filtered, the solid was washed with 50 ml of water, then loaded onto a 40 g column, eluted with Hex:DCM (9:1 to DCM only), the product from the column was washed with EtOH to give 53 mg of a dark purple solid . Yield 62%. MS ( APCI ) : Calcd for Formula: C62H40BCl2F8N3O4 (M-) = 1124 ; found : 1124. 1 H NMR (400 MHz) δ 8.61 (d, J = 7.8 Hz, 1H), 8.55 (d, J = 8.3 Hz, 1H), 8.16 (d, J = 2.2 Hz, 1H), 8.04 (d, J = 2.2 Hz, 1H), 8.04 (d, J = 8.1 Hz, 1H), 8.00 (s, 2H), 7.95 (t, J = 4.7 Hz, 2H), 7.86 (s, 1H), 7.70 (dd, J = 8.6, 2.2 Hz, 1H), 7.47 (d, J = 8.6 Hz, 1H), 7.32 (d, J = 8.3 Hz, 1H), 7.27 (dt, J = 7.4, 3.7 Hz, 3H), 7.23 - 7.15 (m, 2H), 6.92 (s, 2H), 6.38 (s, 2H), 4.36 (t, J = 7.0 Hz, 2H), 4.13 (t, J = 6.0 Hz, 2H), 2.54 (t, J = 6.8 Hz, 4H), 2.24 (s, 4H), 1.96 (t, J = 7.2 Hz, 4H).

合成化合物 PLC-45化合物 PLC-45.1:4'-(第三丁基)-3-硝基-[1,1'-聯苯]-4-醇:在室溫下,將4-溴-2-硝基-苯酚(5.45 g,25.0 mmol)及4-(第三丁基)苯硼酸(5.563 g,31.25 mmol)溶解於二噁烷(100 mL)中及攪拌5分鐘。於形成透明溶液後,快速添加Pd (PPh 3) 2Cl 2(0.175 g,0.25 mmol)及4N K 2CO 3水溶液(25.0 ml,50 mmol,2 eq);將混合物藉由Vac-Fil氮氣循環3次脫氣,之後在80℃下加熱4小時。於將反應冷卻至RT後,將pH用4N HCl水溶液調整至5至6,用乙酸乙酯(250 mL)萃取,透過短矽藻土墊。將墊用EA (150 ml x2)洗滌。合併有機層及用鹽水(25 mL)洗滌,經無水MgSO 4乾燥,及在減壓下濃縮。將殘留物溶解至Hex: EA (95:5) (150 ml)中,藉由透過短矽藻土墊過濾來過濾掉深色固體,將濾液濃縮,以得到黃色固體,將其用己烷研磨,以得到3.8 黃色固體,產率56%。MS (APCI):針對化學式:C 16H 17NO 3(M-)計算值= 271;實測值:271。 1H NMR (400 MHz,氯仿-d) δ 10.57 (s, 1H), 8.32 (d, J = 2.3 Hz, 1H), 7.83 (dd, J = 8.7, 2.4 Hz, 1H), 7.50 (d, J = 1.5 Hz, 4H), 7.23 (d, J = 8.7 Hz, 1H), 1.37 (s, 9H)。 Synthesis of compound PLC-45 : Compound PLC-45.1 : 4'-(tert-butyl)-3-nitro-[1,1'-biphenyl]-4-ol: at room temperature, 4-bromo-2-nitro-phenol (5.45 g, 25.0 mmol) and 4-(tert-butyl)phenylboronic acid (5.563 g, 31.25 mmol) were dissolved in dioxane (100 mL) and stirred for 5 minutes. After a clear solution formed, Pd( PPh3 ) 2Cl2 (0.175 g, 0.25 mmol) and 4N aqueous K2CO3 (25.0 ml, 50 mmol, 2 eq) were added rapidly; the mixture was circulated through Vac-Fil nitrogen Degassed 3 times, then heated at 80° C. for 4 hours. After cooling the reaction to RT, the pH was adjusted to 5-6 with 4N aqueous HCl, extracted with ethyl acetate (250 mL), and passed through a short pad of Celite. The pad was washed with EA (150 ml x2). The organic layers were combined and washed with brine (25 mL), dried over anhydrous MgSO 4 , and concentrated under reduced pressure. The residue was dissolved in Hex:EA (95:5) (150 ml), the dark solid was filtered off by filtration through a short pad of Celite, and the filtrate was concentrated to give a yellow solid, which was triturated with hexane , to obtain 3.8 yellow solids, yield 56%. MS (APCI) : Calcd. for Formula: C16H17NO3 (M-) = 271 ; found: 271. 1 H NMR (400 MHz, chloroform-d) δ 10.57 (s, 1H), 8.32 (d, J = 2.3 Hz, 1H), 7.83 (dd, J = 8.7, 2.4 Hz, 1H), 7.50 (d, J = 1.5 Hz, 4H), 7.23 (d, J = 8.7 Hz, 1H), 1.37 (s, 9H).

化合物 PLC-45.2:將4-溴萘二甲酸酐(10 g,36 mmol,1.15 eq)、4'-(第三丁基)-3-硝基-[1,1'-聯苯]-4-醇( PLC-45.1) (8.5 g,31.32 mmol,1 eq)、NaOH (0.864 g,21.6 mmol,0.6 eq)於無水NMP (65 mL)中混合,添加銅粉(1.371 g,21.6mmol,0.6 eq),將所得混合物藉由Vac-Fil氮氣循環3次脫氣,之後在145℃下在N 2氛圍下加熱及攪拌5小時,然後在RT下過夜。將反應混合物用HCl水溶液處理;於RT下靜置12小時後,將棕色固體沉澱物,過濾,用熱MeOH (250 ml x3)洗滌,以得到(10.8 g,23.1 mmol)淺棕色固體,產率73%,純度86%。MS (APCI):針對化學式:C 28H 21NO 6(M-)計算值= 467;實測值:467。 Compound PLC-45.2 : 4-bromonaphthalic anhydride (10 g, 36 mmol, 1.15 eq), 4'-(tert-butyl)-3-nitro-[1,1'-biphenyl]-4 -Alcohol ( PLC-45.1 ) (8.5 g, 31.32 mmol, 1 eq), NaOH (0.864 g, 21.6 mmol, 0.6 eq) were mixed in anhydrous NMP (65 mL), copper powder (1.371 g, 21.6 mmol, 0.6 eq), the resulting mixture was degassed by Vac-Fil nitrogen cycles 3 times, then heated and stirred at 145 °C under N2 atmosphere for 5 h, then overnight at RT. The reaction mixture was treated with aqueous HCl; after standing at RT for 12 hours, a brown solid precipitated, filtered, and washed with hot MeOH (250 ml x 3) to give (10.8 g, 23.1 mmol) a light brown solid, yield 73%, purity 86%. MS (APCI) : Calcd. for Formula: C28H21NO6 (M-) = 467 ; found: 467.

化合物 PLC-45.3:6-((3-胺基-4'-(第三丁基)-[1,1'-聯苯]-4-基)氧基)-1H,3H-苯并[de]異𠳭唏-1,3-二酮:向含於2-MeTHF (70.0 mL)及HCl (4 M,26.1 mL,10 eq)中之 PLC-45.2(4.885g,10.45 mmol,1.0 eq)之混合物中以一份式添加SnCl 2.2H 2O (9.4 g,41.75 mmol,4.0 eq)。將混合物在90℃下攪拌1/2小時。TLC (己烷/乙酸乙酯= 7:3)及LCMS顯示反應完成。過濾掉白色固體,用EA/2-MeTHF (1:1) (100 mLx 2)洗滌。將合併之有機濾液用水洗滌,分離,在減壓下濃縮,以得到黏性固體殘留物。將粗產物用50℃之熱水100 mL洗滌1/2小時,過濾,然後在減壓下乾燥,以得到呈黃棕色固體之 PLC-45.3(4.5 g,10.28 mmol)。98%產率。MS (APCI):針對化學式:C 28H 23NO 4(M-)計算值= 437;實測值:437 Compound PLC-45.3 : 6-((3-amino-4'-(tert-butyl)-[1,1'-biphenyl]-4-yl)oxy)-1H,3H-benzo[de ] Isodione-1,3-dione: To PLC-45.2 (4.885g, 10.45 mmol, 1.0 eq) in 2-MeTHF (70.0 mL) and HCl (4 M, 26.1 mL, 10 eq) To the mixture was added SnCl 2 .2H 2 O (9.4 g, 41.75 mmol, 4.0 eq) in one portion. The mixture was stirred at 90 °C for 1/2 hour. TLC (hexane/ethyl acetate = 7:3) and LCMS showed the reaction was complete. The white solid was filtered off and washed with EA/2-MeTHF (1:1) (100 mL x 2). The combined organic filtrates were washed with water, separated and concentrated under reduced pressure to give a sticky solid residue. The crude product was washed with 100 mL of hot water at 50 °C for 1/2 hour, filtered, and then dried under reduced pressure to give PLC-45.3 (4.5 g, 10.28 mmol) as a yellow-brown solid. 98% yield. MS (APCI): Calcd for Formula: C28H23NO4 (M-) = 437; Found: 437

化合物 PLC-45.4:9-(4-(第三丁基)苯基)-1H,3H-異𠳭唏[6,5,4-mna]𠮿-1,3-二酮:在0℃下,向含化合物 PLC-45.3(1.844 g,4.215 mmol,1.0 eq)之AcOH (28.5 mL)及H 2O (9.0 mL)中逐滴添加濃HCl (2.445 mL)及含NaNO 2(2.9 g,42.15 mmol,10 eq)之H 2O (9 mL)及在0℃下攪拌1小時。經由滴液漏斗在130℃下歷時1/2小時時間將以上溶液添加至含CuSO 45H 2O (4.35 g,17.42 mmol,4.1 eq)之H 2O (175 ml)、AcOH (11 ml)中。於完成添加後,將所得物繼續在相同溫度130℃下攪拌另外15分鐘。將混合物過濾及用H 2O (3 x 100 mL)洗滌,得到0.445 g粗產物,將其用EtOH研磨,以得到0.42 g純化合物,產率30%。MS (APCI):針對化學式:C 28H 20O 4(M-)計算值= 420;實測值:420 Compound PLC-45.4 : 9-(4-(tert-butyl)phenyl)-1H,3H-iso[6,5,4-mna]𠮿 -1,3-Diketone: To compound PLC-45.3 (1.844 g, 4.215 mmol, 1.0 eq) in AcOH (28.5 mL) and H2O (9.0 mL) was added conc. HCl dropwise at 0 °C ( 2.445 mL) and H 2 O (9 mL) containing NaNO 2 (2.9 g, 42.15 mmol, 10 eq) and stirred at 0° C. for 1 hour. The above solution was added to CuSO 4 5H 2 O (4.35 g, 17.42 mmol, 4.1 eq) in H 2 O (175 ml), AcOH (11 ml) via dropping funnel at 130° C. over a period of ½ hour . After the addition was complete, the resultant was continued to be stirred at the same temperature 130° C. for another 15 minutes. The mixture was filtered and washed with H 2 O (3 x 100 mL) to give 0.445 g of crude product which was triturated with EtOH to give 0.42 g of pure compound, 30% yield. MS (APCI ) : Calcd for Formula: C28H20O4 (M-) = 420; Found: 420

化合物 PLC-45.5:9-(4-(第三丁基)苯基)-2-(3-羥丙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:在室溫下,向含化合物 PLC-45.4(0.420 g,1.0 mmol,1.0 eq)之無水DMSO (4 mL)中添加3-胺基-1-丙醇(0.300 g,4.0 mmol,4.0 eq),將所得混合物歷時45分鐘時間在130℃下攪拌。於完成反應後,藉由過濾移除DMSO。將固體用水(50 ml x 3)洗滌及於真空烘箱中乾燥,以達成0.45 g黃色固體;產率94%。MS (APCI):針對化學式:C 31H 27NO 4(M-)計算值= 477;實測值:477。 1H NMR (400 MHz,氯仿-d) δ 10.44 (s, 2H), 8.65 (d, J = 7.8 Hz, 1H), 8.60 (d, J = 8.3 Hz, 1H), 8.25 (d, J = 2.0 Hz, 1H), 8.03 (d, J = 8.0 Hz, 1H), 7.76 (dd, J = 8.6, 2.1 Hz, 1H), 7.61 (d, J = 8.3 Hz, 2H), 7.54 (d, J = 8.2 Hz, 2H), 7.45 (d, J = 8.6 Hz, 1H), 7.32 (d, J = 8.3 Hz, 1H), 6.50 (s, 2H), 4.42 (t, J = 6.9 Hz, 2H), 4.17 (t, J = 6.2 Hz, 2H), 2.54 (s, 6H), 2.28 (s, 2H), 1.40 (s, 9H)。 Compound PLC-45.5 : 9-(4-(tert-butyl)phenyl)-2-(3-hydroxypropyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: Add compound PLC-45.4 (0.420 g, 1.0 mmol, 1.0 eq) to anhydrous DMSO (4 mL) was added 3-amino-1-propanol (0.300 g, 4.0 mmol, 4.0 eq) and the resulting mixture was stirred at 130°C over a period of 45 minutes. After completing the reaction, DMSO was removed by filtration. The solid was washed with water (50 ml x 3) and dried in a vacuum oven to achieve 0.45 g of yellow solid; 94% yield. MS (APCI): Calcd for Formula: C31H27NO4 (M-) = 477 ; found: 477. 1 H NMR (400 MHz, chloroform-d) δ 10.44 (s, 2H), 8.65 (d, J = 7.8 Hz, 1H), 8.60 (d, J = 8.3 Hz, 1H), 8.25 (d, J = 2.0 Hz, 1H), 8.03 (d, J = 8.0 Hz, 1H), 7.76 (dd, J = 8.6, 2.1 Hz, 1H), 7.61 (d, J = 8.3 Hz, 2H), 7.54 (d, J = 8.2 Hz, 2H), 7.45 (d, J = 8.6 Hz, 1H), 7.32 (d, J = 8.3 Hz, 1H), 6.50 (s, 2H), 4.42 (t, J = 6.9 Hz, 2H), 4.17 ( t, J = 6.2 Hz, 2H), 2.54 (s, 6H), 2.28 (s, 2H), 1.40 (s, 9H).

化合物 PLC-45.6:2-(3-溴丙基)-9-(4-(第三丁基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將1643-002 (0.453g,0.95 mmol)及48% HBr水溶液(20 ml)之混合物攪拌及藉由加熱塊在130℃下加熱8小時。LCMS顯示SM完全消耗。將混合物冷卻至RT及在RT下靜置16小時。過濾黃色固體,用水洗滌若干次,於真空烘箱中乾燥,以得到0.275 g,產率96%。將產物用於下個步驟無需進一步純化。MS (APCI):針對化學式:C 31H 26BrNO 3(M-)計算值= 540;實測值:540。 1H NMR (400 MHz) δ 8.59 (d, J = 7.8 Hz, 1H), 8.53 (d, J = 8.4 Hz, 1H), 8.19 (s, 1H), 7.99 (d, J= 8.0 Hz, 1H), 7.72 (d, J = 8.7 Hz, 1H), 7.55 (d, J = 8.0 Hz, 2H), 7.45 (d, J = 8.0 Hz, 2H), 7.41 (d, J = 8.5 Hz, 1H), 7.29 (d, J = 8.4 Hz, 1H), 4.25 (s, 2H), 3.48 (d, J = 6.1 Hz, 2H), 3.16 (d, J = 6.8 Hz, 1H), 1.90 (s, 2H), 1.31 (s, 9H)。 Compound PLC-45.6 : 2-(3-bromopropyl)-9-(4-(tert-butyl)phenyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: A mixture of 1643-002 (0.453 g, 0.95 mmol) and 48% aqueous HBr (20 ml) was stirred and heated by The heating block was heated at 130°C for 8 hours. LCMS showed complete consumption of SM. The mixture was cooled to RT and stood at RT for 16 hours. The yellow solid was filtered, washed several times with water, dried in a vacuum oven to give 0.275 g, yield 96%. The product was used in the next step without further purification. MS ( APCI ) : Calcd. for Formula: C31H26BrNO3 (M-) = 540; found: 540. 1 H NMR (400 MHz) δ 8.59 (d, J = 7.8 Hz, 1H), 8.53 (d, J = 8.4 Hz, 1H), 8.19 (s, 1H), 7.99 (d, J = 8.0 Hz, 1H) , 7.72 (d, J = 8.7 Hz, 1H), 7.55 (d, J = 8.0 Hz, 2H), 7.45 (d, J = 8.0 Hz, 2H), 7.41 (d, J = 8.5 Hz, 1H), 7.29 (d, J = 8.4 Hz, 1H), 4.25 (s, 2H), 3.48 (d, J = 6.1 Hz, 2H), 3.16 (d, J = 6.8 Hz, 1H), 1.90 (s, 2H), 1.31 (s, 9H).

化合物 PLC-45:9-(4-(第三丁基)苯基)-2-(3-(3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯氧基)丙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將化合物 PLC-45.6(40.53 mg,0.075 mmol,1.15 eq)懸浮於無水DMF (2.0 ml)中,添加 PLC-1.3(38.04 mg,0.065 mmol,1 eq)、K 2CO 3(20.73 mg,0.15 mmol,2.3 eq)、NaI (4.15 mg,催化量)。將所得混合物在85℃下在氬氣氛圍下攪拌4小時。藉由蒸發器在53℃下移除DMF及水;將殘留物用50 ml熱水洗滌,然後裝載至40 g管柱上,用Hex: DCM (9:1至僅DCM (4CV))然後DCM/EtAco (99:1)溶離,將來自管柱層析法純化之產物用熱水洗滌,以得到27 mg暗紫色固體,產率38.5%。MS (APCI):針對化學式:C 64H 50BCl 2F 2N 3O 4(M-)計算值= 1044;實測值:1044。 1H 1H NMR (400 MHz,氯仿-d) δ 8.70 (d, J = 7.9 Hz, 1H), 8.64 (d, J = 8.4 Hz, 1H), 8.25 (d, J =2.2 Hz, 1H), 8.09 (d, J = 7.3 Hz, 2H), 8.05 (d, J = 8.0 Hz, 1H), 7.76 (dd, J = 8.6, 2.1 Hz, 1H), 7.60 (d,J = 8.4 Hz, 2H), 7.53 (d, J = 8.6 Hz, 2H), 7.45 (d, J = 8.6 Hz, 1H), 7.35 (d, J = 8.4 Hz, 1H), 7.33 - 7.29 (m, 3H), 7.22 (d, J = 7.1 Hz, 2H), 6.95 (s, 2H), 6.42 (s, 2H), 4.47 (t, J = 6.8 Hz, 2H), 4.21 (t, J = 6.0 Hz, 2H), 2.62 (t, J = 6.8 Hz, 4H), 2.40 - 2.24 (m, 4H), 2.09 - 1.97 (m, 4H), 1.39 (s, 9H)。 Compound PLC-45 : 9-(4-(tert-butyl)phenyl)-2-(3-(3,5-dichloro-4-(19,19-difluoro-6,7,11,12 ,13,19-Hexahydro-5H-18l4,19l4-Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenoxy)propyl )-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: Compound PLC-45.6 (40.53 mg, 0.075 mmol, 1.15 eq) was suspended in dry DMF (2.0 ml), added PLC-1.3 (38.04 mg, 0.065 mmol, 1 eq), K2CO3 (20.73 mg, 0.15 mmol, 2.3 eq), NaI (4.15 mg, catalytic amount). The resulting mixture was stirred at 85 °C for 4 h under an atmosphere of argon. DMF and water were removed by evaporator at 53°C; the residue was washed with 50 ml hot water, then loaded onto a 40 g column with Hex:DCM (9:1 to DCM only (4CV)) then DCM /EtAco (99:1), the product from column chromatography purification was washed with hot water to afford 27 mg of a dark purple solid, yield 38.5%. MS (APCI) : Calcd . for Formula: C64H50BCl2F2N3O4 (M- ) = 1044 ; found : 1044. 1H 1H NMR (400 MHz, chloroform-d) δ 8.70 (d, J = 7.9 Hz, 1H), 8.64 (d, J = 8.4 Hz, 1H), 8.25 (d, J = 2.2 Hz, 1H), 8.09 (d, J = 7.3 Hz, 2H), 8.05 (d, J = 8.0 Hz, 1H), 7.76 (dd, J = 8.6, 2.1 Hz, 1H), 7.60 (d, J = 8.4 Hz, 2H), 7.53 (d, J = 8.6 Hz, 2H), 7.45 (d, J = 8.6 Hz, 1H), 7.35 (d, J = 8.4 Hz, 1H), 7.33 - 7.29 (m, 3H), 7.22 (d, J = 7.1 Hz, 2H), 6.95 (s, 2H), 6.42 (s, 2H), 4.47 (t, J = 6.8 Hz, 2H), 4.21 (t, J = 6.0 Hz, 2H), 2.62 (t, J = 6.8 Hz, 4H), 2.40 - 2.24 (m, 4H), 2.09 - 1.97 (m, 4H), 1.39 (s, 9H).

合成化合物 PLC-46化合物 PLC-46.2:9-(3,5-雙(三氟甲基)苯基)-2-(2-羥乙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:步驟1:將 Ex-4.3(0.735 g,2.0 mmol,1.0 eq)及3-胺基-1-乙醇(0.732 g,12.0 mmol,6.0 eq)之混合物放入20 mL小瓶中及用隔膜蓋密封。將所得混合物歷時45分鐘之時間在160℃下攪拌。於冷卻至RT後,將反應在RT下用MeOH (10 mL)攪拌15分鐘,然後過濾。將粗產物 PLC-46.1用於下個步驟無需進一步純化。MS (APCI):針對分子式:C 20H 12BrNO 4(M-)計算值= 410;實測值:410。 1H NMR (400 MHz,氯仿-d) δ 8.62 (d, J = 8.3 Hz, 1H), 8.20 (d, J = 2.3 Hz, 1H), 7.93 (d, J =7.9 Hz, 1H), 7.62 (dd, J = 8.8, 2.3 Hz, 1H), 7.32 (d, J = 8.3 Hz, 1H), 7.28 (s, 1H), 4.55 - 4.40 (m, 2H), 3.99 (s, 2H), 2.49 (s, 1H), 2.22 (t, J = 7.6 Hz, 1H)。步驟2:在RT下,將以上步驟之粗產物與DMF (5 ml)、H 2O (0.5 ml)、(雙-3,5-三氟甲基)苯硼酸(1.031 g,4.0 mmol,2 eq)、K 2CO 3(0.553 g,4.0 mmol,2 eq)、Pd(dppf)Cl 2DCM (32.66 mg,0.04 mmol,0.02 eq)混合,Vac-Fill氬氣循環3次,在80℃下攪拌及加熱45分鐘,混合物變得黏性,添加5 ml DMF,繼續在80℃下攪拌另外15分鐘。將反應混合物冷卻至室溫,藉由蒸發器濃縮,添加水至反應混合物中,在RT下保持1小時,過濾沉澱物,得到1.1 g青黃色固體,將其用MeOH洗滌,以得到0.85 g所需產物, PLC-46.2。產率80%。MS (APCI):針對化學式:C 28H 15F 6NO 4(M-)計算值= 543;實測值:543。 1H NMR (400 MHz,氯仿-d) δ 8.71 (d, J = 7.7 Hz, 1H), 8.65 (d, J = 8.2 Hz, 1H), 8.26 (s, 1H), 8.11 (s, 1H), 8.09 (s, 1H), 8.03 (s, 3H), 7.99 (s, 1H), 7.94 (s, 1H), 7.77 (d, J = 8.7 Hz, 1H), 7.53 (d, J = 8.8 Hz, 2H), 7.37 (d, J = 8.4 Hz, 1H), 4.49 (d, J = 5.5 Hz, 2H), 4.01 (d, J = 5.4 Hz, 2H), 3.73 (s, 1H)。 Synthesis of compound PLC-46 : Compound PLC-46.2 : 9-(3,5-bis(trifluoromethyl)phenyl)-2-(2-hydroxyethyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: Step 1: Combine Ex-4.3 (0.735 g, 2.0 mmol, 1.0 eq) and 3-amino-1-ethanol (0.732 g, 12.0 mmol, 6.0 eq) of the mixture was placed in a 20 mL vial and sealed with a septum cap. The resulting mixture was stirred at 160°C over a period of 45 minutes. After cooling to RT, the reaction was stirred with MeOH (10 mL) at RT for 15 min, then filtered. The crude product PLC-46.1 was used in the next step without further purification. MS (APCI): Calcd. for Formula: C20H12BrNO4 (M-) = 410; found : 410. 1 H NMR (400 MHz, chloroform-d) δ 8.62 (d, J = 8.3 Hz, 1H), 8.20 (d, J = 2.3 Hz, 1H), 7.93 (d, J = 7.9 Hz, 1H), 7.62 ( dd, J = 8.8, 2.3 Hz, 1H), 7.32 (d, J = 8.3 Hz, 1H), 7.28 (s, 1H), 4.55 - 4.40 (m, 2H), 3.99 (s, 2H), 2.49 (s , 1H), 2.22 (t, J = 7.6 Hz, 1H). Step 2: At RT, the crude product from the above step was mixed with DMF (5 ml), H 2 O (0.5 ml), (bis-3,5-trifluoromethyl)phenylboronic acid (1.031 g, 4.0 mmol, 2 eq), K 2 CO 3 (0.553 g, 4.0 mmol, 2 eq), Pd(dppf)Cl 2 DCM (32.66 mg, 0.04 mmol, 0.02 eq) mixed, Vac-Fill argon cycle 3 times, at 80°C After stirring and heating for 45 minutes, the mixture became viscous, 5 ml DMF was added and stirring was continued at 80 °C for another 15 minutes. The reaction mixture was cooled to room temperature, concentrated by evaporator, water was added to the reaction mixture, kept at RT for 1 h, the precipitate was filtered to obtain 1.1 g of a cyan-yellow solid, which was washed with MeOH to obtain 0.85 g of the The desired product, PLC-46.2 . The yield is 80%. MS (APCI): Calcd for Formula: C28H15F6NO4 ( M- ) = 543; found: 543. 1 H NMR (400 MHz, chloroform-d) δ 8.71 (d, J = 7.7 Hz, 1H), 8.65 (d, J = 8.2 Hz, 1H), 8.26 (s, 1H), 8.11 (s, 1H), 8.09 (s, 1H), 8.03 (s, 3H), 7.99 (s, 1H), 7.94 (s, 1H), 7.77 (d, J = 8.7 Hz, 1H), 7.53 (d, J = 8.8 Hz, 2H ), 7.37 (d, J = 8.4 Hz, 1H), 4.49 (d, J = 5.5 Hz, 2H), 4.01 (d, J = 5.4 Hz, 2H), 3.73 (s, 1H).

化合物 PLC-46:9-(3,5-雙(三氟甲基)苯基)-2-(2-(3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯氧基)乙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮:將三苯基膦(39.34 mg,0.15 mmol)、 PLC-1.3(76.08 g,0.13 mmol)及 PLC-46.2(81.51 g,0.15 mmol)溶解於無水甲苯(2 mL)中;在室溫下歷時15分鐘逐滴添加0.15 ml 1M DIAD/甲苯+ 1 mL無水甲苯之溶液。將所得混合物在氬氣氛圍下攪拌16小時。連續添加另外三苯基膦(19.73 mg,0.075 mmol)及0.075 ml 1M DIAD/甲苯+ 0.5 mL無水甲苯及將混合物再攪拌8小時。純化:將RX混合物裝載至80 g SiO 2管柱,利用Hex: DCM (7:3),(1:4),然後僅DCM溶離,收集含有所需化合物之溶離份,濃縮。將暗紫色固體用水,然後MeOH洗滌,於真空烘箱中乾燥,以得到43 mg暗棕紫色固體;產率42%。MS (APCI):針對化學式:C 61H 38BCl 2F 8N 3O 4(M-)計算值= 1110,實測值:1110。 1H NMR (400 MHz,氯仿-d) δ 8.74 (d, J = 7.9 Hz, 1H), 8.68 (d, J = 8.3 Hz, 1H), 8.26 (d, J = 2.2 Hz, 1H), 8.11 (d, J = 8.0 Hz, 1H), 8.09 - 8.03 (m, 4H), 7.95 (s,1H), 7.77 (dd, J = 8.6, 2.2 Hz, 1H), 7.53 (d, J = 8.6 Hz, 1H), 7.38 (d, J = 8.3 Hz,1H), 7.35 - 7.26 (m, 4H), 7.21 (dd, J = 6.8, 2.0 Hz, 2H), 7.11 (s, 2H), 6.39 (s, 2H), 4.72 (t, J = 6.2 Hz, 2H), 4.43 (t, J = 6.2 Hz, 2H), 2.61 (t, J = 6.8 Hz, 4H), 2.29 (s, 4H), 2.02 (q, J = 6.8 Hz, 4H)。 Compound PLC-46 : 9-(3,5-bis(trifluoromethyl)phenyl)-2-(2-(3,5-dichloro-4-(19,19-difluoro-6,7, 11,12,13,19-Hexahydro-5H-18l4,19l4-Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo [3',4']cyclohepta[1',2':4,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenoxy )ethyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione: Triphenylphosphine (39.34 mg, 0.15 mmol), PLC-1.3 (76.08 g, 0.13 mmol) and PLC- 46.2 (81.51 g, 0.15 mmol) was dissolved in anhydrous toluene (2 mL); a solution of 0.15 ml 1M DIAD/toluene + 1 mL anhydrous toluene was added dropwise over 15 min at room temperature. The resulting mixture was stirred under argon atmosphere for 16 hours. Additional triphenylphosphine (19.73 mg, 0.075 mmol) and 0.075 ml 1M DIAD/toluene + 0.5 mL anhydrous toluene were added successively and the mixture was stirred for a further 8 hours. Purification: The RX mixture was loaded onto a 80 g SiO 2 column and eluted using Hex:DCM (7:3), (1:4), then only DCM, and the fractions containing the desired compound were collected and concentrated. The dark purple solid was washed with water, then MeOH, and dried in a vacuum oven to give 43 mg of a dark brown purple solid; 42% yield. MS ( APCI ) : Calculated for Formula: C61H38BCl2F8N3O4 ( M- ) = 1110 , found : 1110. 1 H NMR (400 MHz, chloroform-d) δ 8.74 (d, J = 7.9 Hz, 1H), 8.68 (d, J = 8.3 Hz, 1H), 8.26 (d, J = 2.2 Hz, 1H), 8.11 ( d, J = 8.0 Hz, 1H), 8.09 - 8.03 (m, 4H), 7.95 (s,1H), 7.77 (dd, J = 8.6, 2.2 Hz, 1H), 7.53 (d, J = 8.6 Hz, 1H ), 7.38 (d, J = 8.3 Hz,1H), 7.35 - 7.26 (m, 4H), 7.21 (dd, J = 6.8, 2.0 Hz, 2H), 7.11 (s, 2H), 6.39 (s, 2H) , 4.72 (t, J = 6.2 Hz, 2H), 4.43 (t, J = 6.2 Hz, 2H), 2.61 (t, J = 6.8 Hz, 4H), 2.29 (s, 4H), 2.02 (q, J = 6.8 Hz, 4H).

合成化合物 PLC-47 化合物 PLC-47.1:(9-溴-2-(6-羥己基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮):將化合物 Ex-4.3(6.534 mmol,2.401g)、6-胺基己-1-醇(13.08 mmol,1533 mg)及DMAP (1.962 mmol,240 mg)及DMF合併。過濾掉粗產物及用水洗滌,然後將濕沉澱物用於下個步驟無需進一步純化。MS (APCI):針對化學式:C 24H 20BrNO 4(M+H)計算值= 466;實測值:466。 Synthesis of compound PLC-47 : Compound PLC-47.1 : (9-bromo-2-(6-hydroxyhexyl)-1H-𠮿 and[2,1,9-def]isoquinoline-1,3(2H)-dione): Compound Ex-4.3 (6.534 mmol, 2.401g), 6-aminohexan-1-ol (13.08 mmol , 1533 mg) and DMAP (1.962 mmol, 240 mg) and DMF combined. The crude product was filtered off and washed with water, then the wet precipitate was used in the next step without further purification. MS (APCI): Calcd for Formula: C24H20BrNO4 (M+H) = 466; found : 466 .

化合物 PLC-47.2:(2-(6-羥己基)-9-(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮):在80℃下,以與以上方法相似方法將含於THF (120 mL)/DMF (24 mL)/H 2O (12 mL)之化合物 PLC-47.1(假設100%產率,6.534 mmol,3.047 g)、(4-(三氟甲基)苯基)硼酸(13.068 mmol,2.482 g)、K 2CO 3(17.969 mmol,2483 mg)及Pd(dppf)Cl 2(0.4574 mmol,335 mg)合併。於添加水及過濾後,將所得沉澱物用水,然後甲醇洗滌。將產物藉由抽吸乾燥,然後於真空中乾燥。得到1.191 g (34%產率,基於化合物29.3,2個步驟)。MS (APCI):針對化學式:C 31H 24F 3NO 4(M+H)計算值= 532;實測值:532。 Compound PLC-47.2 : (2-(6-hydroxyhexyl)-9-(4-(trifluoromethyl)phenyl)-1H-𠮿 and[2,1,9-def]isoquinoline-1,3(2H)-dione): at 80°C, in THF (120 mL)/DMF (24 mL) Compound PLC-47.1 (assumed 100% yield, 6.534 mmol, 3.047 g), (4-(trifluoromethyl)phenyl)boronic acid (13.068 mmol, 2.482 g ) in /H 2 O (12 mL), K 2 CO 3 (17.969 mmol, 2483 mg) and Pd(dppf)Cl 2 (0.4574 mmol, 335 mg) were combined. After adding water and filtering, the resulting precipitate was washed with water, then methanol. The product was dried by suction and then in vacuo. Obtained 1.191 g (34% yield based on compound 29.3 over 2 steps). MS (APCI) : Calcd for Formula: C31H24F3NO4 (M+H) = 532 ; found: 532.

化合物 PLC-47.3:(2-(6-溴己基)-9-(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮):向250 mL 2N RBF中放入攪拌棒及安裝氣體適配器/翅片冷凝器及流動控制器。向燒瓶中添加化合物 PLC-47.2(2.239 mmol,1.190 g),接著48% HBr/H 2O (30 mL)。將加熱塊設置至130℃及將反應混合物在此溫度下攪拌3小時。添加另一部分之48% HBr/H 2O (30 mL)及將反應混合物在130℃下攪拌過夜。將反應混合物冷卻至室溫及用水(約100 mL)稀釋,然後過濾掉沉澱物,用水然後甲醇洗滌。將產物裝載至裝載器中之約25 g矽膠上。藉由急驟層析法在矽膠上純化(120 g,固體負荷,平衡0% EtOAc/DCM,0% (2 CV)至10% EtOAc/DCM (20 CV))。收集具有產物之溶離份及於真空中蒸發至乾。得到約80%純之物質。得到黃色固體,1.073 g (80%產率)。MS (APCI):針對化學式:C 31H 23BrF 3NO 3(M+H)計算值= 594;實測值:594。 1H NMR (400 MHz, TCE) δ 8.63 (d, J = 7.9 Hz, 1H), 8.58 (d, J = 8.3 Hz, 1H), 8.23 (d, J = 2.1 Hz, 1H), 8.03 (d, J = 8.0 Hz, 1H), 7.84 - 7.73 (m, 5H), 7.49 (d, J = 8.6 Hz, 1H), 7.34 (d, J = 8.3 Hz, 1H), 4.19 - 4.09 (m, 2H), 3.44 (td, J = 6.8, 1.9 Hz, 2H), 1.90 (p, J = 6.9 Hz, 2H), 1.75 (p, J = 7.8 Hz, 2H), 1.57 - 1.38 (m, 4H)。 Compound PLC-47.3 : (2-(6-bromohexyl)-9-(4-(trifluoromethyl)phenyl)-1H-𠮿 And [2,1,9-def]isoquinoline-1,3(2H)-dione): Put a stir bar into 250 mL 2N RBF and install gas adapter/fin condenser and flow controller. Compound PLC-47.2 (2.239 mmol, 1.190 g) was added to the flask, followed by 48% HBr/H 2 O (30 mL). The heat block was set to 130°C and the reaction mixture was stirred at this temperature for 3 hours. Another portion of 48% HBr/ H2O (30 mL) was added and the reaction mixture was stirred at 130 °C overnight. The reaction mixture was cooled to room temperature and diluted with water (about 100 mL), then the precipitate was filtered off, washed with water and then methanol. The product was loaded onto approximately 25 g of silica gel in the loader. Purified by flash chromatography on silica gel (120 g, solids load, equilibration 0% EtOAc/DCM, 0% (2 CV) to 10% EtOAc/DCM (20 CV)). Fractions bearing product were collected and evaporated to dryness in vacuo. About 80% pure material was obtained. A yellow solid was obtained, 1.073 g (80% yield). MS (APCI) : Calcd for Formula: C31H23BrF3NO3 (M+H) = 594 ; found : 594. 1 H NMR (400 MHz, TCE) δ 8.63 (d, J = 7.9 Hz, 1H), 8.58 (d, J = 8.3 Hz, 1H), 8.23 (d, J = 2.1 Hz, 1H), 8.03 (d, J = 8.0 Hz, 1H), 7.84 - 7.73 (m, 5H), 7.49 (d, J = 8.6 Hz, 1H), 7.34 (d, J = 8.3 Hz, 1H), 4.19 - 4.09 (m, 2H), 3.44 (td, J = 6.8, 1.9 Hz, 2H), 1.90 (p, J = 6.9 Hz, 2H), 1.75 (p, J = 7.8 Hz, 2H), 1.57 - 1.38 (m, 4H).

化合物 PLC-47.4:(2,6-二氯-4-((6-(1,3-二側氧基-9-(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)己基)氧基)苯甲醛):化合物 PLC-47.4係以與化合物34.4相似方式自含於無水DMF (10 mL)中之化合物 PLC-47.3(0.200 mmol,119 mg)、2,6-二氯-4-羥基苯甲醛(0.300 mmol,57 mg)及K 2CO 3(0.260 mmol,36 mg)合成。將粗製化合物溶解於DCM中及裝載至裝載器中之約5 g矽膠上。藉由急驟層析法在矽膠上純化(80 g,固體負荷,平衡70% DCM/己烷,溶離70% (2 CV)至100% DCM/己烷(5 CV)至等濃度100% DCM/己烷(5 CV)至0% EtOAc/DCM (0 CV)至等濃度0% EtOAc/DCM (5 CV)至10% EtOAc/DCM (20 CV))。將含有產物之溶離份於真空中蒸發至乾。得到黃色固體,113 mg,(60%產率)。MS (APCI):針對化學式:C 38H 26Cl 2F 3NO 5(M+H)計算值= 704;實測值:704。 1H NMR (400 MHz, TCE) δ 10.37 (s, 1H), 8.64 (d, J = 7.9 Hz, 1H), 8.59 (d, J = 8.4 Hz, 1H), 8.25 (d, J = 2.2 Hz, 1H), 8.05 (d, J = 8.0 Hz, 1H), 7.78 (dd, J = 11.2, 1.9 Hz, 5H), 7.50 (d, J = 8.6 Hz, 1H), 7.36 (d, J = 8.3 Hz, 1H), 6.92 (s, 2H), 4.23 - 4.11 (m, 2H), 4.02 (t, J = 6.4 Hz, 2H), 1.89 - 1.70 (m, 4H), 1.59 - 1.45 (m, 4H)。 Compound PLC-47.4 : (2,6-dichloro-4-((6-(1,3-dioxo-9-(4-(trifluoromethyl)phenyl)-1H-𠮿 and[2,1,9-def]isoquinolin-2(3H)-yl)hexyl)oxy)benzaldehyde): compound PLC-47.4 was self-contained in anhydrous DMF (10 mL) in a similar manner to compound 34.4 Compound PLC-47.3 (0.200 mmol, 119 mg), 2,6-dichloro-4-hydroxybenzaldehyde (0.300 mmol, 57 mg) and K 2 CO 3 (0.260 mmol, 36 mg) were synthesized. The crude compound was dissolved in DCM and loaded onto ~5 g of silica gel in a loader. Purify by flash chromatography on silica gel (80 g, solids load, equilibrate 70% DCM/hexane, elute 70% (2 CV) to 100% DCM/hexane (5 CV) to isocratic 100% DCM/hexane Hexane (5 CV) to 0% EtOAc/DCM (0 CV) to isocratic 0% EtOAc/DCM (5 CV) to 10% EtOAc/DCM (20 CV)). Fractions containing product were evaporated to dryness in vacuo. Obtained a yellow solid, 113 mg, (60% yield). MS ( APCI) : Calcd for Formula: C38H26Cl2F3NO5 (M+H) = 704; found : 704. 1 H NMR (400 MHz, TCE) δ 10.37 (s, 1H), 8.64 (d, J = 7.9 Hz, 1H), 8.59 (d, J = 8.4 Hz, 1H), 8.25 (d, J = 2.2 Hz, 1H), 8.05 (d, J = 8.0 Hz, 1H), 7.78 (dd, J = 11.2, 1.9 Hz, 5H), 7.50 (d, J = 8.6 Hz, 1H), 7.36 (d, J = 8.3 Hz, 1H), 6.92 (s, 2H), 4.23 - 4.11 (m, 2H), 4.02 (t, J = 6.4 Hz, 2H), 1.89 - 1.70 (m, 4H), 1.59 - 1.45 (m, 4H).

化合物 PLC-47:(2-(6-(3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯氧基)己基)-9-(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮):化合物 PLC-47係以與以上方法相似方式自化合物 PLC-47.4(0.1164 mmol,82 mg)、1,4,5,6-四氫苯并[6,7]環庚[1,2-b]吡咯(0.2444 mmol,45 mg ( Ex-7.3)及pTsOH.H2O (0.0058 mmol,1.1 mg),然後DDQ (0.1989 mmol,45 mg)及2X Et3N (0.9312 mmol,0.130 mL)及BF3.OEt2 (1.397 mmol,0.172 mL)於無水DCM (20 mL)中在室溫下,然後在50℃下合成。將粗製反應混合物用約25%己烷稀釋,然後裝載至裝載器中之約15 g矽膠上。藉由急驟層析法在矽膠上純化(80 g,固體負荷,平衡70% DCM/己烷,溶離70% (2 CV)至100% DCM/己烷(5 CV)至等濃度100% DCM/己烷(5 CV)至100% DCM/己烷(等濃度)之0.5% EtOAc改性劑)。將含有產物之溶離份於真空中蒸發至乾。得到深紅色固體,79 mg (62%產率)。MS (APCI):針對化學式:C 64H 47BCl 2F 5N 3O 4(M+H)計算值= 1098;實測值:1098。 1H NMR (400 MHz, TCE) δ 8.66 (d, J = 7.9 Hz, 1H), 8.61 (d, J = 8.3 Hz, 1H), 8.26 (d, J = 2.1 Hz, 1H), 8.10 - 8.01 (m, 3H), 7.78 (dd, J = 9.4, 1.7 Hz, 5H), 7.55 - 7.46 (m, 5H), 7.43 - 7.32 (m, 5H), 7.33 - 7.25 (m, 2H), 7.07 (s, 2H), 6.48 (s, 2H), 4.20 (t, J = 7.7 Hz, 2H), 4.06 (t, J = 6.3 Hz, 2H), 2.63 (t, J = 6.9 Hz, 4H), 2.42 - 2.19 (m, 4H), 2.08 - 2.00 (m, 2H), 1.88 (q, J = 7.3 Hz, 2H), 1.85 - 1.73 (m, 2H), 1.67 - 1.49 (m, 4H)。 Compound PLC-47 : (2-(6-(3,5-dichloro-4-(19,19-difluoro-6,7,11,12,13,19-hexahydro-5H-18l4,19l4- Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']cyclohepta[1',2':4 ,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenoxy)hexyl)-9-(4-(trifluoromethyl)phenyl )-1H-𠮿 and[2,1,9-def]isoquinoline-1,3(2H)-dione): Compound PLC-47 was obtained from compound PLC-47.4 (0.1164 mmol, 82 mg), 1 , 4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-b]pyrrole (0.2444 mmol, 45 mg ( Ex-7.3 ) and pTsOH.H2O (0.0058 mmol, 1.1 mg), then DDQ (0.1989 mmol, 45 mg) and 2X Et3N (0.9312 mmol, 0.130 mL) and BF3.OEt2 (1.397 mmol, 0.172 mL) were synthesized in anhydrous DCM (20 mL) at room temperature and then at 50 °C. The crude reaction mixture was diluted with about 25% hexane, then loaded onto about 15 g of silica gel in a loader. Purified by flash chromatography on silica gel (80 g, solids load, equilibrated 70% DCM/hexane, eluting 70% (2 CV) to 100% DCM/hexane (5 CV) to isocratic 100% DCM/hexane (5 CV) to 100% DCM/hexane (isocratic) in 0.5% EtOAc modifier). Fractions containing product were evaporated to dryness in vacuo. Dark red solid was obtained, 79 mg (62% yield). MS (APCI): For formula: C 64 H 47 BCl 2 F 5 N 3 O 4 (M+ H) Calculated = 1098; found: 1098. 1 H NMR (400 MHz, TCE) δ 8.66 (d, J = 7.9 Hz, 1H), 8.61 (d, J = 8.3 Hz, 1H), 8.26 (d, J = 2.1 Hz, 1H), 8.10 - 8.01 (m, 3H), 7.78 (dd, J = 9.4, 1.7 Hz, 5H), 7.55 - 7.46 (m, 5H), 7.43 - 7.32 (m, 5H), 7.33 - 7.25 (m, 2H), 7.07 (s, 2H), 6.48 (s, 2H), 4.20 (t, J = 7.7 Hz, 2H), 4.06 (t, J = 6.3 Hz, 2H), 2.63 (t, J = 6.9 Hz, 4H), 2.42 - 2.19 (m, 4H), 2.08 - 2.00 (m, 2H), 1.88 (q, J = 7.3 Hz, 2H), 1.85 - 1.73 (m, 2H), 1.67 - 1.49 (m, 4H).

合成化合物 PLC-48 化合物 PLC-48.2(4-(2-(3-(3,5-二氯-4-甲醯基苯氧基)丙基)-1,3-二側氧基-2,3-二氫-1H-𠮿并[2,1,9-def]異喹啉-9-基)苯甲酸第三丁酯):化合物 PLC-48.2係以與以上程序相似方式自含於無水DMF (10 mL)中之化合物 PLC-48.1(0.1471 mmol)、2,6-二氯-4-羥基苯甲醛(0.441 mmol,84 mg)及K 2CO 3(0.4120 mmol,57 mg)合成。將粗反應用碎冰(約50 g)稀釋。一旦其全部熔化,將粗產物藉由離心單離。將產物溶解於DCM中及於真空中蒸發至乾。得到定量產率黃色固體。MS (APCI):針對化學式:C 39H 29Cl 2NO 7(M+H)計算值= 694;實測值:694。 1H NMR (400 MHz, TCE) δ 10.37 (s, 1H), 8.64 (d, J = 7.9 Hz, 1H), 8.59 (d, J = 8.3 Hz, 1H), 8.28 (d, J = 2.2 Hz, 1H), 8.13 (d, J = 8.1 Hz, 2H), 8.07 (d, J = 8.0 Hz, 1H), 7.81 (dd, J = 8.6, 2.1 Hz, 1H), 7.75 (d, J = 8.2 Hz, 2H), 7.52 (d, J = 8.6 Hz, 1H), 7.38 (d, J = 8.3 Hz, 1H), 6.85 (s, 2H), 4.39 (t, J = 6.7 Hz, 2H), 4.18 (t, J = 5.9 Hz, 2H), 2.28 (p, J = 5.9 Hz, 2H), 1.64 (s, 9H)。 Synthesis of compound PLC-48 Compound PLC-48.2 (4-(2-(3-(3,5-dichloro-4-formylphenoxy)propyl)-1,3-dioxo-2,3-dihydro- 1H-𠮿 [2,1,9-def]isoquinolin-9-yl)tert-butylbenzoate): Compound PLC-48.2 was obtained from compound PLC contained in anhydrous DMF (10 mL) in a similar manner to the above procedure Synthesis of -48.1 (0.1471 mmol), 2,6-dichloro-4-hydroxybenzaldehyde (0.441 mmol, 84 mg) and K 2 CO 3 (0.4120 mmol, 57 mg). The crude reaction was diluted with crushed ice (ca. 50 g). Once it was all melted, the crude product was isolated by centrifugation. The product was dissolved in DCM and evaporated to dryness in vacuo. A yellow solid was obtained in quantitative yield. MS ( APCI ) : Calcd for Formula: C39H29Cl2NO7 (M+H) = 694; found : 694. 1 H NMR (400 MHz, TCE) δ 10.37 (s, 1H), 8.64 (d, J = 7.9 Hz, 1H), 8.59 (d, J = 8.3 Hz, 1H), 8.28 (d, J = 2.2 Hz, 1H), 8.13 (d, J = 8.1 Hz, 2H), 8.07 (d, J = 8.0 Hz, 1H), 7.81 (dd, J = 8.6, 2.1 Hz, 1H), 7.75 (d, J = 8.2 Hz, 2H), 7.52 (d, J = 8.6 Hz, 1H), 7.38 (d, J = 8.3 Hz, 1H), 6.85 (s, 2H), 4.39 (t, J = 6.7 Hz, 2H), 4.18 (t, J = 5.9 Hz, 2H), 2.28 (p, J = 5.9 Hz, 2H), 1.64 (s, 9H).

化合物 PLC-48(4-(2-(3-(3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯氧基)丙基)-1,3-二側氧基-2,3-二氫-1H-𠮿并[2,1,9-def]異喹啉-9-基)苯甲酸第三丁酯):化合物 PLC-48係以與上述程序相似方式自化合物 PLC-48.2(0.1471 mmol,102 mg)、1,4,5,6-四氫苯并[6,7]環庚[1,2-b]吡咯( Ex-7.3,0.3090 mmol,57 mg)及TFA (1% v/v),然後DDQ (0.2501 mmol,57 mg)及2X Et 3N (1.177 mmol,0.164 mL)及BF 3.OEt 2(1.765 mmol,0.218 mL)於無水DCM (20 mL)中在室溫下,然後在50℃下合成。將粗製反應混合物用己烷稀釋及裝載至裝載器中之約20 g矽膠上。藉由急驟層析法在矽膠上純化(220 g,固體負荷,平衡10% EtOAc/己烷,溶離10% (2 CV)至30% EtOAc/己烷(40 CV))。將含有純產物之溶離份於真空中蒸發至乾。得到80 mg (50%產率)。MS (APCI):針對化學式:C 65H 50BCl 2F 2N 3O 6(M+H)計算值= 1088;實測值:1088。 1H NMR (400 MHz, TCE) δ 8.69 (d, J = 7.8 Hz, 1H), 8.63 (d, J = 8.3 Hz, 1H), 8.28 (d, J = 2.2 Hz, 1H), 8.16 - 8.10 (m, 2H), 8.09 (d, J = 8.1 Hz, 1H), 8.05 (t, J = 4.7 Hz, 2H), 7.80 (dd, J = 8.6, 2.1 Hz, 1H), 7.77 - 7.71 (m, 2H), 7.51 (d, J = 8.6 Hz, 1H), 7.42 - 7.33 (m, 5H), 7.33 - 7.25 (m, 2H), 7.01 (s, 2H), 6.47 (s, 2H), 4.44 (t, J = 6.9 Hz, 2H), 4.22 (t, J = 6.0 Hz, 2H), 2.63 (t, J = 6.9 Hz, 4H), 2.40 - 2.24 (m, 6H), 2.11 - 2.00 (m, 4H), 1.62 (s, 9H)。 Compound PLC-48 (4-(2-(3-(3,5-dichloro-4-(19,19-difluoro-6,7,11,12,13,19-hexahydro-5H-18l4, 19l4-Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']cyclohepta[1',2' :4,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenoxy)propyl)-1,3-dioxo-2 ,3-Dihydro-1H-𠮿 and[2,1,9-def]isoquinolin-9-yl)tert-butylbenzoate): compound PLC-48 was obtained from compound PLC-48.2 (0.1471 mmol, 102 mg), 1,4,5,6-Tetrahydrobenzo[6,7]cyclohepta[1,2-b]pyrrole ( Ex-7.3 , 0.3090 mmol, 57 mg) and TFA (1% v/v), then DDQ (0.2501 mmol, 57 mg) and 2X Et 3 N (1.177 mmol, 0.164 mL) and BF 3 .OEt 2 (1.765 mmol, 0.218 mL) in anhydrous DCM (20 mL) at room temperature, then at 50°C synthesis. The crude reaction mixture was diluted with hexane and loaded onto approximately 20 g of silica gel in a loader. Purified by flash chromatography on silica gel (220 g, solids load, equilibrate 10% EtOAc/hexane, elute 10% (2 CV) to 30% EtOAc/hexane (40 CV)). Fractions containing pure product were evaporated to dryness in vacuo. Obtained 80 mg (50% yield). MS (APCI): Calcd. for Formula: C65H50BCl2F2N3O6 ( M + H) = 1088 ; found: 1088. 1 H NMR (400 MHz, TCE) δ 8.69 (d, J = 7.8 Hz, 1H), 8.63 (d, J = 8.3 Hz, 1H), 8.28 (d, J = 2.2 Hz, 1H), 8.16 - 8.10 ( m, 2H), 8.09 (d, J = 8.1 Hz, 1H), 8.05 (t, J = 4.7 Hz, 2H), 7.80 (dd, J = 8.6, 2.1 Hz, 1H), 7.77 - 7.71 (m, 2H ), 7.51 (d, J = 8.6 Hz, 1H), 7.42 - 7.33 (m, 5H), 7.33 - 7.25 (m, 2H), 7.01 (s, 2H), 6.47 (s, 2H), 4.44 (t, J = 6.9 Hz, 2H), 4.22 (t, J = 6.0 Hz, 2H), 2.63 (t, J = 6.9 Hz, 4H), 2.40 - 2.24 (m, 6H), 2.11 - 2.00 (m, 4H), 1.62 (s, 9H).

合成化合物 PLC-49 化合物 PLC-49.1(9-(4-丁基苯基)-2-(3-羥丙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮):化合物 PLC-49.1係以與以上程序相似方式自含於THF (30 mL)/DMF (6 mL)/水(3 mL)中之化合物 PLC-38.1(1.500 mmol,636 mg)、(4-丁基苯基)硼酸(3.00 mmol,534 mg)、K 2CO 3(4.125 mmol,570 mg)及Pd(dppf)Cl 2(0.105 mmol,77 mg)在80℃下合成。過濾掉沉澱化合物,用水洗滌,及於真空中乾燥。得到棕黃色固體,655 mg (92%產率)。MS (APCI):針對化學式:C 31H 27NO 4(M+H)計算值= 478;實測值:478。 1H NMR (400 MHz, TCE) δ 8.66 (d, J = 7.9 Hz, 1H), 8.61 (d, J = 8.4 Hz, 1H), 8.26 (d, J = 2.1 Hz, 1H), 8.06 (d, J = 8.0 Hz, 1H), 7.79 (dd, J = 8.6, 2.1 Hz, 1H), 7.61 (d, J = 7.9 Hz, 2H), 7.48 (d, J = 8.6 Hz, 1H), 7.41 - 7.30 (m, 3H), 4.34 (t, J = 6.1 Hz, 2H), 3.57 (q, J = 6.0 Hz, 2H), 3.24 (t, J = 6.9 Hz, 1H), 2.70 (t, J = 7.7 Hz, 2H), 2.06 - 1.92 (m, 2H), 1.75 - 1.64 (m, 2H), 1.42 (h, J = 7.4 Hz, 2H), 0.98 (t, J = 7.3 Hz, 3H)。 Synthesis of compound PLC-49 : Compound PLC-49.1 (9-(4-butylphenyl)-2-(3-hydroxypropyl)-1H-𠮿 and[2,1,9-def]isoquinoline-1,3(2H)-dione): Compound PLC-49.1 was self-contained in THF (30 mL)/DMF (6 mL) in a similar manner to the above procedure Compound PLC-38.1 (1.500 mmol, 636 mg), (4-butylphenyl)boronic acid (3.00 mmol, 534 mg), K 2 CO 3 (4.125 mmol, 570 mg) and Pd in /water (3 mL) (dppf) Cl2 (0.105 mmol, 77 mg) was synthesized at 80°C. The precipitated compound was filtered off, washed with water, and dried in vacuo. Obtained as a tan solid, 655 mg (92% yield). MS (APCI): Calcd for Formula: C31H27NO4 (M+H) = 478 ; found: 478. 1 H NMR (400 MHz, TCE) δ 8.66 (d, J = 7.9 Hz, 1H), 8.61 (d, J = 8.4 Hz, 1H), 8.26 (d, J = 2.1 Hz, 1H), 8.06 (d, J = 8.0 Hz, 1H), 7.79 (dd, J = 8.6, 2.1 Hz, 1H), 7.61 (d, J = 7.9 Hz, 2H), 7.48 (d, J = 8.6 Hz, 1H), 7.41 - 7.30 ( m, 3H), 4.34 (t, J = 6.1 Hz, 2H), 3.57 (q, J = 6.0 Hz, 2H), 3.24 (t, J = 6.9 Hz, 1H), 2.70 (t, J = 7.7 Hz, 2H), 2.06 - 1.92 (m, 2H), 1.75 - 1.64 (m, 2H), 1.42 (h, J = 7.4 Hz, 2H), 0.98 (t, J = 7.3 Hz, 3H).

化合物 PLC-49.2(4-甲基苯磺酸3-(9-(4-丁基苯基)-1,3-二側氧基-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)丙酯):將100 mL 2N圓底燒瓶放入鋁加熱塊中及放入攪拌棒。將該燒瓶安裝翅片冷凝器/氣體適配器及流動控制閥。將系統用氬氣沖洗。向該燒瓶中添加 PLC-49.1(0.325 mmol,155 mg)、4-甲基苯磺酸酐(1.30 mmol,424 mg)及無水DCE (20 mL)。將反應混合物在氬氣下在室溫下攪拌及添加Et 3N (1.463 mmol,0.20 mL)。將反應混合物在氬氣下攪拌及將加熱塊設置至90℃及在此溫度下攪拌1小時。將反應冷卻至室溫及裝載至裝載器中之約15 g矽膠上。藉由急驟層析法在矽膠上純化(80 g,固體負荷,平衡0% EtOAc/DCM,溶離0% (2 CV)至10% EtOAc/DCM (10 CV))。將含有產物之溶離份於真空中蒸發至乾。得到黃色固體,157 mg (77%產率)。MS (APCI):針對化學式:C 38H 33NO 6S (M+H)計算值= 632;實測值:632。 1H NMR (400 MHz, TCE) δ 8.61 (d, J = 7.9 Hz, 1H), 8.56 (d, J = 8.4 Hz, 1H), 8.24 (d, J = 2.2 Hz, 1H), 8.04 (d, J = 8.1 Hz, 1H), 7.81 - 7.72 (m, 3H), 7.61 (d, J = 8.1 Hz, 2H), 7.47 (d, J = 8.6 Hz, 1H), 7.40 - 7.27 (m, 5H), 4.19 (dt, J = 11.9, 6.6 Hz, 4H), 2.70 (t, J = 7.8 Hz, 2H), 2.42 (s, 3H), 2.19 - 2.07 (m, 2H), 1.76 - 1.64 (m, 2H), 1.42 (h, J = 7.3 Hz, 2H), 0.98 (t, J = 7.4 Hz, 3H)。 Compound PLC-49.2 (4-methylbenzenesulfonic acid 3-(9-(4-butylphenyl)-1,3-dioxo-1H-𠮿 And [2,1,9-def]isoquinolin-2(3H)-yl)propyl ester): Place a 100 mL 2N round bottom flask in an aluminum heating block and place a stir bar. The flask was fitted with a finned condenser/gas adapter and flow control valve. The system was flushed with argon. To the flask was added PLC-49.1 (0.325 mmol, 155 mg), 4-methylbenzenesulfonic anhydride (1.30 mmol, 424 mg) and anhydrous DCE (20 mL). The reaction mixture was stirred at room temperature under argon and Et3N (1.463 mmol, 0.20 mL) was added. The reaction mixture was stirred under argon and the heating block was set to 90°C and stirred at this temperature for 1 hour. The reaction was cooled to room temperature and loaded onto approximately 15 g of silica gel in a loader. Purified by flash chromatography on silica gel (80 g, solids load, equilibration 0% EtOAc/DCM, eluting 0% (2 CV) to 10% EtOAc/DCM (10 CV)). Fractions containing product were evaporated to dryness in vacuo. Obtained as a yellow solid, 157 mg (77% yield). MS ( APCI ): Calcd . for Formula: C38H33NO6S (M+H) = 632; found: 632. 1 H NMR (400 MHz, TCE) δ 8.61 (d, J = 7.9 Hz, 1H), 8.56 (d, J = 8.4 Hz, 1H), 8.24 (d, J = 2.2 Hz, 1H), 8.04 (d, J = 8.1 Hz, 1H), 7.81 - 7.72 (m, 3H), 7.61 (d, J = 8.1 Hz, 2H), 7.47 (d, J = 8.6 Hz, 1H), 7.40 - 7.27 (m, 5H), 4.19 (dt, J = 11.9, 6.6 Hz, 4H), 2.70 (t, J = 7.8 Hz, 2H), 2.42 (s, 3H), 2.19 - 2.07 (m, 2H), 1.76 - 1.64 (m, 2H) , 1.42 (h, J = 7.3 Hz, 2H), 0.98 (t, J = 7.4 Hz, 3H).

化合物 PLC-49.3(4-(3-(9-(4-丁基苯基)-1,3-二側氧基-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)丙氧基)-2,6-二氯苯甲醛):化合物 PLC-49.3係以與上述程序相似方式自含於無水DMF (10 mL)中之 PLC-49.2(0.122 mmol,77 mg)、2,6-二氯-4-羥基苯甲醛(0.366 mmol,70 mg)及K 2CO 3(0.341 mmol,47 mg)合成。將粗產物裝載至裝載器中之約15 g矽膠上。藉由急驟層析法在矽膠上純化(80 g,固體負荷,平衡0% EtOAc/DCM,溶離0% (2 CV)至10% EtOAc/DCM (10 CV))。將含有產物之溶離份於真空中蒸發至乾。得到黃色固體,60 mg (76%產率)。MS (APCI):針對化學式:C 38H 29Cl 2NO 5(M+H)計算值= 650;實測值:650。 1H NMR (400 MHz, TCE) δ 10.37 (s, 1H), 8.63 (d, J = 7.9 Hz, 1H), 8.58 (d, J = 8.3 Hz, 1H), 8.26 (d, J = 2.1 Hz, 1H), 8.06 (d, J = 8.1 Hz, 1H), 7.79 (dd, J = 8.6, 2.1 Hz, 1H), 7.64 - 7.58 (m, 2H), 7.48 (d, J = 8.6 Hz, 1H), 7.36 (d, J = 7.2 Hz, 1H), 7.34 (d, J = 7.1 Hz, 2H), 6.85 (s, 2H), 4.39 (t, J = 6.8 Hz, 2H), 4.18 (t, J = 6.0 Hz, 2H), 2.70 (t, J = 7.8 Hz, 2H), 2.28 (p, J = 6.5 Hz, 2H), 1.73 - 1.62 (m, 2H), 1.42 (h, J = 7.4 Hz, 2H), 0.98 (t, J = 7.3 Hz, 3H)。 Compound PLC-49.3 (4-(3-(9-(4-butylphenyl)-1,3-dioxo-1H-𠮿 and[2,1,9-def]isoquinolin-2(3H)-yl)propoxy)-2,6-dichlorobenzaldehyde): Compound PLC-49.3 was self-contained in a similar manner to the procedure above PLC-49.2 (0.122 mmol, 77 mg), 2,6-dichloro-4-hydroxybenzaldehyde (0.366 mmol, 70 mg) and K 2 CO 3 (0.341 mmol, 47 mg) in anhydrous DMF (10 mL) synthesis. The crude product was loaded onto about 15 g of silica gel in the loader. Purified by flash chromatography on silica gel (80 g, solids load, equilibration 0% EtOAc/DCM, eluting 0% (2 CV) to 10% EtOAc/DCM (10 CV)). Fractions containing product were evaporated to dryness in vacuo. Obtained as a yellow solid, 60 mg (76% yield). MS (APCI) : Calcd . for Formula: C38H29Cl2NO5 (M+H) = 650; found : 650. 1 H NMR (400 MHz, TCE) δ 10.37 (s, 1H), 8.63 (d, J = 7.9 Hz, 1H), 8.58 (d, J = 8.3 Hz, 1H), 8.26 (d, J = 2.1 Hz, 1H), 8.06 (d, J = 8.1 Hz, 1H), 7.79 (dd, J = 8.6, 2.1 Hz, 1H), 7.64 - 7.58 (m, 2H), 7.48 (d, J = 8.6 Hz, 1H), 7.36 (d, J = 7.2 Hz, 1H), 7.34 (d, J = 7.1 Hz, 2H), 6.85 (s, 2H), 4.39 (t, J = 6.8 Hz, 2H), 4.18 (t, J = 6.0 Hz, 2H), 2.70 (t, J = 7.8 Hz, 2H), 2.28 (p, J = 6.5 Hz, 2H), 1.73 - 1.62 (m, 2H), 1.42 (h, J = 7.4 Hz, 2H), 0.98 (t, J = 7.3 Hz, 3H).

化合物 PLC-49(9-(4-丁基苯基)-2-(3-(3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯氧基)丙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮):化合物 PLC-49係以與化合物32相似方式自化合物 PLC-49.3(0.0922 mmol,60 mg)、1,4,5,6-四氫苯并[6,7]環庚[1,2-b]吡咯( Ex-7.3,0.194 mmol,36 mg)及TFA (0.2% v/v)在室溫下,然後DDQ (0.157 mmol,36 mg)及2X Et 3N (0.738 mmol,0.10 mL)及BF 3.OEt 2(1.107 mmol,0.14 mL)於無水DCM (20 mL)中在室溫下,然後在50℃下合成。將粗製反應混合物裝載至裝載器中之約30 g矽膠上。藉由急驟層析法在矽膠上純化(120 g,固體負荷,平衡0% EtOAc/己烷,溶離0% (2 CV)至5% EtOAc/DCM (30 CV))。將含有產物之溶離份於真空中蒸發至乾。得到42 mg深紅色固體,44%產率。MS (APCI):針對化學式:C 64H 50BCl 2F 2N 3O 4(M+H)計算值= 1044;實測值:1044。 1H NMR (400 MHz, TCE) δ 8.67 (d, J = 7.8 Hz, 1H), 8.62 (d, J = 8.3 Hz, 1H), 8.25 (d, J = 2.1 Hz, 1H), 8.12 - 8.01 (m, 3H), 7.78 (dd, J = 8.6, 2.1 Hz, 1H), 7.65 - 7.56 (m, 2H), 7.48 (d, J = 8.6 Hz, 1H), 7.42 - 7.24 (m, 9H), 7.01 (s, 2H), 6.47 (s, 2H), 4.45 (s, 2H), 4.22 (t, J = 6.0 Hz, 6H), 2.70 (t, J = 7.8 Hz, 2H), 2.64 (t, J = 6.8 Hz, 4H), 2.42 - 2.23 (m, 6H), 2.11 - 1.97 (m, 4H), 1.73 – 1.62 (m, 2H), 1.42 (h, J = 7.3 Hz, 2H), 0.98 (t, J = 7.3 Hz, 3H)。 Compound PLC-49 (9-(4-butylphenyl)-2-(3-(3,5-dichloro-4-(19,19-difluoro-6,7,11,12,13,19 -Hexahydro-5H-18l4,19l4-Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4'] Cyclohepta[1',2':4,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenoxy)propyl)-1H- 𠮿 and[2,1,9-def]isoquinoline-1,3(2H)-dione): Compound PLC-49 was obtained from compound PLC-49.3 (0.0922 mmol, 60 mg), 1 ,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-b]pyrrole ( Ex-7.3 , 0.194 mmol, 36 mg) and TFA (0.2% v/v) at room temperature , then DDQ (0.157 mmol, 36 mg) and 2X Et 3 N (0.738 mmol, 0.10 mL) and BF 3 .OEt 2 (1.107 mmol, 0.14 mL) in anhydrous DCM (20 mL) at room temperature, then in Synthesized at 50°C. The crude reaction mixture was loaded onto approximately 30 g of silica gel in the loader. Purified by flash chromatography on silica gel (120 g, solids load, equilibration 0% EtOAc/Hexane, eluting 0% (2 CV) to 5% EtOAc/DCM (30 CV)). Fractions containing product were evaporated to dryness in vacuo. Obtained 42 mg of dark red solid, 44% yield. MS ( APCI ) : Calcd for Formula : C64H50BCl2F2N3O4 (M+H) = 1044; found : 1044. 1 H NMR (400 MHz, TCE) δ 8.67 (d, J = 7.8 Hz, 1H), 8.62 (d, J = 8.3 Hz, 1H), 8.25 (d, J = 2.1 Hz, 1H), 8.12 - 8.01 ( m, 3H), 7.78 (dd, J = 8.6, 2.1 Hz, 1H), 7.65 - 7.56 (m, 2H), 7.48 (d, J = 8.6 Hz, 1H), 7.42 - 7.24 (m, 9H), 7.01 (s, 2H), 6.47 (s, 2H), 4.45 (s, 2H), 4.22 (t, J = 6.0 Hz, 6H), 2.70 (t, J = 7.8 Hz, 2H), 2.64 (t, J = 6.8 Hz, 4H), 2.42 - 2.23 (m, 6H), 2.11 - 1.97 (m, 4H), 1.73 – 1.62 (m, 2H), 1.42 (h, J = 7.3 Hz, 2H), 0.98 (t, J = 7.3 Hz, 3H).

合成化合物 PLC-50 化合物 PLC-50.1(2-(3-羥丙基)-9-(4-(戊氧基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮):化合物 PLC-50.1係以與以上程序相似方式自含於THF (30 mL)/DMF (6 mL)/水(3 mL)之化合物 PLC-38.1(1.500 mmol,636.0 mg)、(4-(戊氧基)苯基)硼酸(3.00 mmol,624 mg)、K 2CO 3(4.125 mmol,570 mg)及Pd(dppf)Cl 2(0.105 mmol,77 mg)在80℃下合成。過濾掉沉澱化合物,用水洗滌,及於真空中乾燥。得到棕黃色固體,730 mg (96%產率)。MS (APCI):針對化學式:C 32H 29NO 5(M+H)計算值= 508;實測值:508。 1H NMR (400 MHz, TCE) δ 8.66 (d, J = 7.9 Hz, 1H), 8.61 (d, J = 8.4 Hz, 1H), 8.21 (d, J = 2.1 Hz, 1H), 8.06 (d, J = 8.0 Hz, 1H), 7.75 (dd, J = 8.6, 2.1 Hz, 1H), 7.65 - 7.57 (m, 2H), 7.47 (d, J = 8.6 Hz, 1H), 7.36 (d, J = 8.4 Hz, 1H), 7.10 - 6.99 (m, 2H), 4.33 (t, J = 6.1 Hz, 2H), 4.03 (t, J = 6.6 Hz, 2H), 3.62 - 3.51 (m, 2H), 3.25 (t, J = 6.9 Hz, 1H), 2.08 - 1.91 (m, 2H), 1.84 (p, J = 6.7 Hz, 2H), 1.55 - 1.34 (m, 4H), 0.97 (t, J = 7.1 Hz, 3H)。 Synthetic compound PLC-50 : Compound PLC-50.1 (2-(3-hydroxypropyl)-9-(4-(pentyloxy)phenyl)-1H-𠮿 and[2,1,9-def]isoquinoline-1,3(2H)-dione): Compound PLC-50.1 was self-contained in THF (30 mL)/DMF (6 mL) in a similar manner to the above procedure Compound PLC-38.1 (1.500 mmol, 636.0 mg), (4-(pentyloxy)phenyl)boronic acid (3.00 mmol, 624 mg), K 2 CO 3 (4.125 mmol, 570 mg)/water (3 mL) and Pd(dppf)Cl 2 (0.105 mmol, 77 mg) were synthesized at 80°C. The precipitated compound was filtered off, washed with water, and dried in vacuo. Obtained as a tan solid, 730 mg (96% yield). MS (APCI): Calcd for Formula: C32H29NO5 ( M+H) = 508; found : 508. 1 H NMR (400 MHz, TCE) δ 8.66 (d, J = 7.9 Hz, 1H), 8.61 (d, J = 8.4 Hz, 1H), 8.21 (d, J = 2.1 Hz, 1H), 8.06 (d, J = 8.0 Hz, 1H), 7.75 (dd, J = 8.6, 2.1 Hz, 1H), 7.65 - 7.57 (m, 2H), 7.47 (d, J = 8.6 Hz, 1H), 7.36 (d, J = 8.4 Hz, 1H), 7.10 - 6.99 (m, 2H), 4.33 (t, J = 6.1 Hz, 2H), 4.03 (t, J = 6.6 Hz, 2H), 3.62 - 3.51 (m, 2H), 3.25 (t , J = 6.9 Hz, 1H), 2.08 - 1.91 (m, 2H), 1.84 (p, J = 6.7 Hz, 2H), 1.55 - 1.34 (m, 4H), 0.97 (t, J = 7.1 Hz, 3H) .

化合物 PLC-50.2(4-甲基苯磺酸3-(1,3-二側氧基-9-(4-(戊氧基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)丙酯):化合物 PLC-50.2係以與化合物46.2相似方式自含於無水DCE (20 mL)中之化合物 PLC-50.1(1.550 mmol,787 mg)、4-甲基苯磺酸酐(6.202 mmol,2024 mg)及Et 3N (6.977 mmol,0.97 mL)在90℃下合成。將粗產物裝載至裝載器中之約65 g矽膠上。藉由急驟層析法在矽膠上純化(120 g,固體負荷,平衡0% EtOAc/DCM,溶離0% (2 CV)至10% EtOAc/DCM (10 CV)至等濃度10%)。將含有產物之溶離份於真空中蒸發至乾,以得到黃色固體,528 mg (51%產率)。MS (APCI):針對化學式:C 39H 35NO 7S (M+H)計算值= 662;實測值:662。 1H NMR (400 MHz, TCE) δ 8.58 (d, J = 7.8 Hz, 1H), 8.53 (d, J = 8.4 Hz, 1H), 8.17 (d, J = 2.2 Hz, 1H), 8.00 (d, J = 8.1 Hz, 1H), 7.79 - 7.75 (m, 2H), 7.73 (dd, J = 8.8, 2.3 Hz, 1H), 7.63 - 7.57 (m, 2H), 7.43 (d, J = 8.6 Hz, 1H), 7.35 - 7.28 (m, 3H), 7.08 - 7.01 (m, 2H), 4.25 - 4.13 (m, 4H), 4.03 (t, J = 6.6 Hz, 2H), 2.42 (s, 3H), 2.12 (p, J = 6.6 Hz, 2H), 1.90 - 1.77 (m, 2H), 1.55 - 1.34 (m, 4H), 0.97 (t, J = 7.1 Hz, 3H)。 Compound PLC-50.2 (4-methylbenzenesulfonic acid 3-(1,3-dioxo-9-(4-(pentyloxy)phenyl)-1H-𠮿 [2,1,9-def]isoquinolin-2(3H)-yl)propyl ester): Compound PLC -50.2 was obtained from compound PLC-50.2 contained in dry DCE (20 mL) in a similar manner to compound 46.2 50.1 (1.550 mmol, 787 mg), 4-methylbenzenesulfonic anhydride (6.202 mmol, 2024 mg) and Et 3 N (6.977 mmol, 0.97 mL) were synthesized at 90°C. The crude product was loaded onto approximately 65 g of silica gel in the loader. Purified by flash chromatography on silica gel (120 g, solids load, equilibration 0% EtOAc/DCM, eluting 0% (2 CV) to 10% EtOAc/DCM (10 CV) to isocratic 10%). Fractions containing product were evaporated to dryness in vacuo to afford a yellow solid, 528 mg (51% yield). MS (APCI ) : Calcd. for Formula: C39H35NO7S ( M+H) = 662; found: 662. 1 H NMR (400 MHz, TCE) δ 8.58 (d, J = 7.8 Hz, 1H), 8.53 (d, J = 8.4 Hz, 1H), 8.17 (d, J = 2.2 Hz, 1H), 8.00 (d, J = 8.1 Hz, 1H), 7.79 - 7.75 (m, 2H), 7.73 (dd, J = 8.8, 2.3 Hz, 1H), 7.63 - 7.57 (m, 2H), 7.43 (d, J = 8.6 Hz, 1H ), 7.35 - 7.28 (m, 3H), 7.08 - 7.01 (m, 2H), 4.25 - 4.13 (m, 4H), 4.03 (t, J = 6.6 Hz, 2H), 2.42 (s, 3H), 2.12 ( p, J = 6.6 Hz, 2H), 1.90 - 1.77 (m, 2H), 1.55 - 1.34 (m, 4H), 0.97 (t, J = 7.1 Hz, 3H).

化合物 PLC-50.3(2,6-二氯-4-(3-(1,3-二側氧基-9-(4-(戊氧基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)丙氧基)苯甲醛):化合物 PLC-50.3係以與上述程序相似方式自含於無水DMF (10 mL)中之化合物 PLC-50.2(0.180 mmol,119 mg)、2,6-二氯-4-羥基苯甲醛(0.539 mmol,103 mg)及K 2CO 3(0.503 mmol,70 mg)合成。將粗產物裝載至裝載器中之約15 g矽膠上。藉由急驟層析法在矽膠上純化(80 g,固體負荷,平衡0% EtOAc/DCM,溶離0% (2 CV)至15% EtOAc/DCM (10 CV))。將含有產物之溶離份於真空中蒸發至乾。得到黃色固體,103 mg (84%產率)。MS (APCI):針對化學式:C 39H 31Cl 2NO 6(M+H)計算值= 680;實測值:680。 1H NMR (400 MHz, TCE) δ 10.37 (s, 1H), 8.62 (d, J = 7.9 Hz, 1H), 8.57 (d, J = 8.3 Hz, 1H), 8.20 (d, J = 2.2 Hz, 1H), 8.04 (d, J = 8.1 Hz, 1H), 7.65 - 7.58 (m, 2H), 7.46 (d, J = 8.6 Hz, 1H), 7.35 (d, J = 8.4 Hz, 1H), 7.08 - 7.02 (m, 2H), 6.85 (s, 2H), 4.38 (t, J = 6.8 Hz, 2H), 4.18 (t, J = 6.0 Hz, 2H), 4.03 (t, J = 6.6 Hz, 2H), 2.28 (p, J = 6.5 Hz, 2H), 1.84 (p, J = 6.7 Hz, 2H), 1.55 - 1.35 (m, 4H), 0.97 (t, J = 7.1 Hz, 3H)。 Compound PLC-50.3 (2,6-dichloro-4-(3-(1,3-dioxo-9-(4-(pentyloxy)phenyl)-1H-𠮿 and[2,1,9-def]isoquinolin-2(3H)-yl)propoxy)benzaldehyde): Compound PLC-50.3 was self-contained in anhydrous DMF (10 mL) in a similar manner to the above procedure The compound PLC-50.2 (0.180 mmol, 119 mg), 2,6-dichloro-4-hydroxybenzaldehyde (0.539 mmol, 103 mg) and K 2 CO 3 (0.503 mmol, 70 mg) was synthesized. The crude product was loaded onto about 15 g of silica gel in the loader. Purified by flash chromatography on silica gel (80 g, solids load, equilibration 0% EtOAc/DCM, eluting 0% (2 CV) to 15% EtOAc/DCM (10 CV)). Fractions containing product were evaporated to dryness in vacuo. Obtained as a yellow solid, 103 mg (84% yield). MS (APCI) : Calcd. for Formula: C39H31Cl2NO6 (M+H) = 680; found : 680. 1 H NMR (400 MHz, TCE) δ 10.37 (s, 1H), 8.62 (d, J = 7.9 Hz, 1H), 8.57 (d, J = 8.3 Hz, 1H), 8.20 (d, J = 2.2 Hz, 1H), 8.04 (d, J = 8.1 Hz, 1H), 7.65 - 7.58 (m, 2H), 7.46 (d, J = 8.6 Hz, 1H), 7.35 (d, J = 8.4 Hz, 1H), 7.08 - 7.02 (m, 2H), 6.85 (s, 2H), 4.38 (t, J = 6.8 Hz, 2H), 4.18 (t, J = 6.0 Hz, 2H), 4.03 (t, J = 6.6 Hz, 2H), 2.28 (p, J = 6.5 Hz, 2H), 1.84 (p, J = 6.7 Hz, 2H), 1.55 - 1.35 (m, 4H), 0.97 (t, J = 7.1 Hz, 3H).

化合物 PLC-50(2-(3-(3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯氧基)丙基)-9-(4-(戊氧基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮):化合物48係以與化合物32相似方式自化合物 PLC-50.3(0.150 mmol,102 mg)、1,4,5,6-四氫苯并[6,7]環庚[1,2-b]吡咯( Ex-7.3,0.315 mmol,58 mg)及TFA (0.25% v/v)在室溫下,然後DDQ (0.255 mmol,58 mg)及2X Et 3N (1.199 mmol,0.17 mL)及BF 3.OEt 2(1.798 mmol,0.22mL)於無水DCM (20 mL)中在室溫下,然後在50℃下合成。將粗製反應混合物裝載至裝載器中之約30 g矽膠上。藉由急驟層析法在矽膠上純化(120 g,固體負荷,平衡及運行0% EtOAc/DCM等濃度)。將含有產物之溶離份於真空中蒸發至乾。得到深紅色固體,127 mg (79%產率)。MS (APCI):針對化學式:C 65H 52BCl 2F 2N 3O 5(M+H)計算值= 1074;實測值:1074。 1H NMR (400 MHz, TCE) δ 8.67 (d, J = 7.9 Hz, 1H), 8.61 (d, J = 8.3 Hz, 1H), 8.20 (d, J = 2.2 Hz, 1H), 8.11 - 8.00 (m, 3H), 7.74 (dd, J = 8.6, 2.1 Hz, 1H), 7.63 - 7.58 (m, 2H), 7.46 (d, J = 8.6 Hz, 1H), 7.41 - 7.33 (m, 5H), 7.33 - 7.26 (m, 2H), 7.04 (d, J = 8.9 Hz, 2H), 7.02 (s, 2H), 6.47 (s, 2H), 4.44 (t, J = 6.9 Hz, 2H), 4.22 (t, J = 6.0 Hz, 2H), 4.03 (t, J = 6.6 Hz, 2H), 2.64 (t, J = 6.7 Hz, 4H), 2.40 - 2.22 (m, 6H), 2.12 - 1.98 (m, 4H), 1.90 - 1.79 (m, 2H), 1.53 - 1.36 (m, 4H), 1.01 - 0.93 (m, 3H)。 Compound PLC-50 (2-(3-(3,5-dichloro-4-(19,19-difluoro-6,7,11,12,13,19-hexahydro-5H-18l4,19l4-benzene And[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']cyclohepta[1',2':4, 5] pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenoxy)propyl)-9-(4-(pentyloxy)phenyl) -1H-𠮿 and[2,1,9-def]isoquinoline-1,3(2H)-dione): Compound 48 was obtained from compound PLC-50.3 (0.150 mmol, 102 mg), 1,4 , 5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-b]pyrrole ( Ex-7.3 , 0.315 mmol, 58 mg) and TFA (0.25% v/v) at room temperature, then DDQ (0.255 mmol, 58 mg) and 2X Et 3 N (1.199 mmol, 0.17 mL) and BF 3 .OEt 2 (1.798 mmol, 0.22 mL) in anhydrous DCM (20 mL) at room temperature, then at 50 °C Synthesize. The crude reaction mixture was loaded onto approximately 30 g of silica gel in the loader. Purified by flash chromatography on silica gel (120 g, solids load, equilibrate and run 0% EtOAc/DCM isocratic). Fractions containing product were evaporated to dryness in vacuo. A dark red solid was obtained, 127 mg (79% yield). MS ( APCI ) : Calcd for Formula: C65H52BCl2F2N3O5 (M+H) = 1074 ; found: 1074. 1 H NMR (400 MHz, TCE) δ 8.67 (d, J = 7.9 Hz, 1H), 8.61 (d, J = 8.3 Hz, 1H), 8.20 (d, J = 2.2 Hz, 1H), 8.11 - 8.00 ( m, 3H), 7.74 (dd, J = 8.6, 2.1 Hz, 1H), 7.63 - 7.58 (m, 2H), 7.46 (d, J = 8.6 Hz, 1H), 7.41 - 7.33 (m, 5H), 7.33 - 7.26 (m, 2H), 7.04 (d, J = 8.9 Hz, 2H), 7.02 (s, 2H), 6.47 (s, 2H), 4.44 (t, J = 6.9 Hz, 2H), 4.22 (t, J = 6.0 Hz, 2H), 4.03 (t, J = 6.6 Hz, 2H), 2.64 (t, J = 6.7 Hz, 4H), 2.40 - 2.22 (m, 6H), 2.12 - 1.98 (m, 4H), 1.90 - 1.79 (m, 2H), 1.53 - 1.36 (m, 4H), 1.01 - 0.93 (m, 3H).

合成化合物 PLC-51化合物 PLC-51.1(6-(2-胺基-4-(第三丁基)苯氧基)-2-(3-羥丙基)-1H-苯并[de]異喹啉-1,3(2H)-二酮):將100 mL 2N圓底燒瓶放入鋁加熱塊中及放入攪拌棒。將該燒瓶安裝翅片冷凝器/氣體適配器及流動控制閥。將系統用氬氣沖洗。向該燒瓶中添加 PLC-26.2(2.559 mmol,925 mg)、3-胺基丙-1-醇(5.119 mmol,0.391 mL)及DMAP (0.768 mmol,94 mg),接著添加200純度乙醇(20 mL)。將反應在氬氣下攪拌及將加熱塊設置為95℃。將反應混合物在此溫度下攪拌2小時,然後冷卻至室溫。將反應混合物用6H HCl (3 mL)中止及用水(約100 mL)稀釋。過濾掉所得沉澱物,用水洗滌。將沉澱物於真空中乾燥,以得到棕黃色固體,定量產率。MS (APCI):針對化學式:C 25H 26N 2O 4(M+H)計算值= 419;實測值:419。 1H NMR (400 MHz, TCE) δ 8.80 (dd, J = 8.4, 1.2 Hz, 1H), 8.67 (dd, J = 7.3, 1.2 Hz, 1H), 8.46 (d, J = 8.3 Hz, 1H), 7.84 (dd, J = 8.4, 7.3 Hz, 1H), 7.02 - 6.92 (m, 3H), 6.87 (dd, J = 8.4, 2.2 Hz, 1H), 4.31 (t, J = 6.2 Hz, 2H), 3.56 (q, J = 5.0 Hz, 2H), 1.97 (p, J = 6.0 Hz, 2H), 1.35 (s, 9H)。 Synthesis of compound PLC-51 : Compound PLC-51.1 (6-(2-amino-4-(tert-butyl)phenoxy)-2-(3-hydroxypropyl)-1H-benzo[de]isoquinoline-1,3 (2H)-diketone): Place a 100 mL 2N round bottom flask in an aluminum heating block and place a stir bar. The flask was fitted with a finned condenser/gas adapter and flow control valve. The system was flushed with argon. To the flask was added PLC-26.2 (2.559 mmol, 925 mg), 3-aminopropan-1-ol (5.119 mmol, 0.391 mL) and DMAP (0.768 mmol, 94 mg), followed by 200 mL of pure ethanol (20 mL ). The reaction was stirred under argon and the heating block was set to 95°C. The reaction mixture was stirred at this temperature for 2 hours, then cooled to room temperature. The reaction mixture was quenched with 6H HCl (3 mL) and diluted with water (ca. 100 mL). The resulting precipitate was filtered off and washed with water. The precipitate was dried in vacuo to afford a tan solid in quantitative yield. MS (APCI ) : Calcd for Formula: C25H26N2O4 ( M+H) = 419; found: 419. 1 H NMR (400 MHz, TCE) δ 8.80 (dd, J = 8.4, 1.2 Hz, 1H), 8.67 (dd, J = 7.3, 1.2 Hz, 1H), 8.46 (d, J = 8.3 Hz, 1H), 7.84 (dd, J = 8.4, 7.3 Hz, 1H), 7.02 - 6.92 (m, 3H), 6.87 (dd, J = 8.4, 2.2 Hz, 1H), 4.31 (t, J = 6.2 Hz, 2H), 3.56 (q, J = 5.0 Hz, 2H), 1.97 (p, J = 6.0 Hz, 2H), 1.35 (s, 9H).

化合物 PLC-51.2(9-(第三丁基)-2-(3-羥丙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮):向40 mL小瓶中放入攪拌棒。向該小瓶中添加NaNO2 (11.291 mmol,779 mg)及水(4 mL)。將小瓶於0℃冰水浴中攪拌。亦向分開40 mL小瓶中放入攪拌棒。向此小瓶中添加化合物 PLC-51.1(1.505 mmol,630 mg)、乙酸(12 mL)及濃HCl (7.527 mmol,mL)。將小瓶在室溫下攪拌幾分鐘,然後放入冰水浴中及在0℃下攪拌1分鐘。歷時10分鐘之時間將NaNO 2之水溶液添加至此小瓶中,同時在0℃下攪拌。將重氮溶液在0℃下攪拌1小時。同時,將250 mL 2N圓底燒瓶安裝翅片冷凝器及添加漏斗及攪拌棒。向燒瓶中添加CuSO 4.5H 2O (10.237 mmol,2.556 g)及水(35 mL)。將溶液在室溫下攪拌。在一小時重氮化終止之前約15分鐘,將硫酸銅溶液加熱至130℃ (加熱塊溫度)。將重氮溶液轉移至添加漏斗中及歷時約15分鐘之時間添加至反應混合物中,同時高速攪拌。將反應混合物再攪拌1分鐘,然後放入室溫水浴中。一旦反應冷卻至室溫,就將產物藉由過濾單離。粗產物為所需醇及乙酸酯之混合物。將粗產物分散於甲醇中及用過量K 2CO 3在60℃下處理,以裂解酯。將反應用水稀釋,過濾掉產物,用水洗滌。將粗產物溶解於DCM中及於真空中蒸發至矽膠上。藉由急驟層析法在矽膠上純化(120 g,固體負荷,平衡0% EtOAc/DCM,溶離0% (2 CV)至75% EtOAc/DCM (20 CV))。將含有產物之溶離份於真空中蒸發至乾。得到黃色固體,379 mg (37%產率)。MS (APCI):針對化學式:C 25H 23NO 4(M+H)計算值= 419;實測值:419。 1H NMR (400 MHz, TCE) δ 8.65 (d, J = 7.8 Hz, 1H), 8.60 (d, J = 8.4 Hz, 1H), 8.07 (d, J = 2.3 Hz, 1H), 8.01 (d, J = 8.0 Hz, 1H), 7.63 (dd, J = 8.7, 2.2 Hz, 1H), 7.37 (d, J = 8.7 Hz, 1H), 7.34 (d, J = 8.3 Hz, 1H), 4.33 (t, J = 6.1 Hz, 2H), 3.57 (q, J = 6.1 Hz, 2H), 3.26 (t, J = 6.9 Hz, 1H), 1.98 (p, J = 5.9 Hz, 2H), 1.44 (s, 9H)。 Compound PLC-51.2 (9-(tert-butyl)-2-(3-hydroxypropyl)-1H-𠮿 And[2,1,9-def]isoquinoline-1,3(2H)-dione): Add a stir bar to a 40 mL vial. To the vial was added NaNO2 (11.291 mmol, 779 mg) and water (4 mL). The vial was stirred in an ice-water bath at 0°C. A stir bar was also placed into a separate 40 mL vial. To this vial was added compound PLC-51.1 (1.505 mmol, 630 mg), acetic acid (12 mL) and concentrated HCl (7.527 mmol, mL). The vial was stirred at room temperature for several minutes, then placed in an ice-water bath and stirred at 0°C for 1 minute. An aqueous solution of NaNO2 was added to the vial over a period of 10 minutes while stirring at 0 °C. The diazonium solution was stirred at 0 °C for 1 hour. At the same time, a 250 mL 2N round bottom flask was installed with a finned condenser, an addition funnel and a stirring bar. To the flask was added CuSO 4 .5H 2 O (10.237 mmol, 2.556 g) and water (35 mL). The solution was stirred at room temperature. The copper sulfate solution was heated to 130°C (heat block temperature) about 15 minutes before the one hour diazotization was terminated. The diazonium solution was transferred to the addition funnel and added to the reaction mixture over a period of about 15 minutes while stirring at high speed. The reaction mixture was stirred for an additional minute, then placed in a room temperature water bath. Once the reaction cooled to room temperature, the product was isolated by filtration. The crude product is a mixture of desired alcohol and acetate. The crude product was dispersed in methanol and treated with excess K2CO3 at 60 °C to cleave the ester. The reaction was diluted with water and the product was filtered off and washed with water. The crude product was dissolved in DCM and evaporated onto silica gel in vacuo. Purified by flash chromatography on silica gel (120 g, solids load, equilibrate 0% EtOAc/DCM, elute 0% (2 CV) to 75% EtOAc/DCM (20 CV)). Fractions containing product were evaporated to dryness in vacuo. Obtained as a yellow solid, 379 mg (37% yield). MS (APCI): Calcd for Formula: C25H23NO4 (M+H) = 419 ; found : 419. 1 H NMR (400 MHz, TCE) δ 8.65 (d, J = 7.8 Hz, 1H), 8.60 (d, J = 8.4 Hz, 1H), 8.07 (d, J = 2.3 Hz, 1H), 8.01 (d, J = 8.0 Hz, 1H), 7.63 (dd, J = 8.7, 2.2 Hz, 1H), 7.37 (d, J = 8.7 Hz, 1H), 7.34 (d, J = 8.3 Hz, 1H), 4.33 (t, J = 6.1 Hz, 2H), 3.57 (q, J = 6.1 Hz, 2H), 3.26 (t, J = 6.9 Hz, 1H), 1.98 (p, J = 5.9 Hz, 2H), 1.44 (s, 9H) .

化合物PLC-51.3 (2-(3-溴丙基)-9-(第三丁基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮):將100 mL 2N圓底燒瓶放入鋁加熱塊中及放入攪拌棒。將燒瓶安裝翅片冷凝器/氣體適配器及流動控制閥。將系統用氬氣沖洗。向該燒瓶中添加 PLC-51.2(0.483 mmol,194 mg)及四溴化碳(0.725 mmol,240 mg),接著無水DCE (20 mL)。將反應混合物在氬氣下在室溫下攪拌及添加三苯基膦(0.725 mmol,190 mg)。將反應混合物在室溫下攪拌30分鐘。將反應混合物裝載至裝載器中之約15 g矽膠上。藉由急驟層析法在矽膠上純化(120 g,固體負荷,平衡0% EtOAc/DCM,溶離0% (2 CV)至10% EtOAc/DCM (20 CV))。將含有產物之溶離份於真空中蒸發至乾。得到黃色固體,149 mg (66%產率)。MS (APCI):針對化學式:C 25H 22BrNO 3(M+H)計算值= 464;實測值:464。 Compound PLC-51.3 (2-(3-bromopropyl)-9-(tert-butyl)-1H-𠮿 And [2,1,9-def]isoquinoline-1,3(2H)-dione): Place a 100 mL 2N round bottom flask in an aluminum heating block and place a stir bar. Install the flask with a finned condenser/gas adapter and flow control valve. The system was flushed with argon. To the flask was added PLC-51.2 (0.483 mmol, 194 mg) and carbon tetrabromide (0.725 mmol, 240 mg), followed by anhydrous DCE (20 mL). The reaction mixture was stirred at room temperature under argon and triphenylphosphine (0.725 mmol, 190 mg) was added. The reaction mixture was stirred at room temperature for 30 minutes. The reaction mixture was loaded onto approximately 15 g of silica gel in the loader. Purified by flash chromatography on silica gel (120 g, solids load, equilibrate 0% EtOAc/DCM, elute 0% (2 CV) to 10% EtOAc/DCM (20 CV)). Fractions containing product were evaporated to dryness in vacuo. Obtained as a yellow solid, 149 mg (66% yield). MS (APCI): Calcd for Formula: C25H22BrNO3 (M+H) = 464; found : 464.

化合物 PLC-51(9-(第三丁基)-2-(3-(3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯氧基)丙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮):化合物 PLC-51係以與上述程序相似方式自含於無水DMF (10 mL)中之化合物 PLC-51.3(0.391 mmol,148 mg)、3,5-二氯-4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)苯酚( PLC-1.3,0.446 mmol,261 mg)及K 2CO 3(0.382 mmol,53 mg)合成。將粗製反應混合物用水稀釋及過濾掉產物。將沉澱物溶解於DCM中及於真空中蒸發至乾。將產物溶解於DCM中,裝載至裝載器中之約20 g矽膠上,及藉由急驟層析法在矽膠上純化(120 g,固體負荷,平衡0% EtOAc/DCM,溶離0% (2 CV)至5% EtOAc/DCM (50 CV))。將含有產物之溶離份於真空中蒸發至乾。得到深紅色固體,153 mg (50%產率)。MS (APCI):針對化學式:C 58H 46BCl 2F 2N 3O 4(M+H)計算值= 968;實測值:968。 1H NMR (400 MHz, TCE) δ 8.67 (d, J = 7.9 Hz, 1H), 8.60 (d, J = 8.3 Hz, 1H), 8.10 - 7.98 (m, 4H), 7.62 (dd, J = 8.8, 2.2 Hz, 1H), 7.40 - 7.25 (m, 8H), 7.02 (s, 2H), 6.48 (s, 2H), 4.43 (t, J = 7.0 Hz, 2H), 4.21 (t, J = 6.0 Hz, 2H), 2.70 - 2.59 (m, 4H), 2.33 (t, J = 6.7 Hz, 6H), 2.12 - 1.98 (m, 4H), 1.44 (s, 9H)。 Compound PLC-51 (9-(tertiary butyl)-2-(3-(3,5-dichloro-4-(19,19-difluoro-6,7,11,12,13,19-hexa Hydrogen-5H-18l4,19l4-Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']cyclohepta [1',2':4,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenoxy)propyl)-1H-𠮿 and[2,1,9-def]isoquinoline-1,3(2H)-dione): Compound PLC-51 was obtained from compound PLC -51 contained in anhydrous DMF (10 mL) in a similar manner to the above procedure. 51.3 (0.391 mmol, 148 mg), 3,5-dichloro-4-(19,19-difluoro-6,7,11,12,13,19-hexahydro-5H-18l4,19l4-benzo[ 3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']cyclohepta[1',2':4,5] Pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)phenol ( PLC-1.3 , 0.446 mmol, 261 mg) and K 2 CO 3 (0.382 mmol, 53 mg )synthesis. The crude reaction mixture was diluted with water and the product was filtered off. The precipitate was dissolved in DCM and evaporated to dryness in vacuo. The product was dissolved in DCM, loaded onto approximately 20 g of silica gel in a loader, and purified by flash chromatography on silica gel (120 g, solids load, equilibration 0% EtOAc/DCM, elution 0% (2 CV ) to 5% EtOAc/DCM (50 CV)). Fractions containing product were evaporated to dryness in vacuo. A dark red solid was obtained, 153 mg (50% yield). MS ( APCI ) : Calcd . for Formula: C58H46BCl2F2N3O4 (M+H) = 968; found: 968 . 1 H NMR (400 MHz, TCE) δ 8.67 (d, J = 7.9 Hz, 1H), 8.60 (d, J = 8.3 Hz, 1H), 8.10 - 7.98 (m, 4H), 7.62 (dd, J = 8.8 , 2.2 Hz, 1H), 7.40 - 7.25 (m, 8H), 7.02 (s, 2H), 6.48 (s, 2H), 4.43 (t, J = 7.0 Hz, 2H), 4.21 (t, J = 6.0 Hz , 2H), 2.70 - 2.59 (m, 4H), 2.33 (t, J = 6.7 Hz, 6H), 2.12 - 1.98 (m, 4H), 1.44 (s, 9H).

合成化合物 PLC-52 化合物 PLC-52.1(5,11-二溴-1H,3H-異𠳭唏并[6,5,4-mna]𠮿-1,3-二酮):向2L 2N圓底燒瓶中放入攪拌棒及安裝長翅片冷凝器。向該燒瓶中添加1H,3H-異𠳭唏并[6,5,4-mna]𠮿-1,3-二酮( Ex-1.3,根據文獻RSC Adv., 2014, 4, 53072-53078合成) (34.688 mmol,10.00 g),接著鄰二氯苯(1000 mL)。將反應混合物在室溫下攪拌及添加Br2 (416.26 mmol,21.3 mL)。將第二個頸塞住及將反應混合物用鋁加熱塊在75℃下對空氣開口加熱歷時週末。將反應混合物冷卻至室溫及過濾掉固體。將濾液用己烷(約20%體積)稀釋及過濾掉第二沉澱物。將此等沉澱物二者於真空中在100℃下乾燥。橙色固體,總計10.866 g (69.9%產率)。二者具有類似LCMS及NMR。MS (APCI):針對化學式:C 18H 6Br 2O 4(M+H)計算值= 445;實測值:445。 1H NMR (400 MHz, TCE) δ 9.47 (dd, J = 8.4, 1.5 Hz, 1H), 8.76 (d, J = 14.2 Hz, 2H), 7.72 - 7.63 (m, 1H), 7.56 (dd, J = 8.3, 1.4 Hz, 1H), 7.46 (ddd, J = 8.5, 6.7, 1.9 Hz, 1H)。 Synthesis of compound PLC-52 : Compound PLC-52.1 (5,11-dibromo-1H,3H-iso[6,5,4-mna]𠮿 -1,3-diketone): Into a 2L 2N round bottom flask was placed a stir bar and fitted with a long-fin condenser. To this flask was added 1H,3H-iso[6,5,4-mna]𠮿 -1,3-Diketone ( Ex-1.3 , synthesized according to literature RSC Adv., 2014, 4, 53072-53078) (34.688 mmol, 10.00 g), followed by o-dichlorobenzene (1000 mL). The reaction mixture was stirred at room temperature and Br2 (416.26 mmol, 21.3 mL) was added. The second neck was plugged and the reaction mixture was heated with an aluminum heating block at 75°C open to air over the weekend. The reaction mixture was cooled to room temperature and the solid was filtered off. The filtrate was diluted with hexane (about 20% by volume) and the second precipitate was filtered off. Both of these precipitates were dried in vacuo at 100°C. Orange solid, 10.866 g in total (69.9% yield). Both have similar LCMS and NMR. MS ( APCI ) : Calcd. for Formula: Ci8H6Br2O4 (M+H) = 445; found : 445. 1 H NMR (400 MHz, TCE) δ 9.47 (dd, J = 8.4, 1.5 Hz, 1H), 8.76 (d, J = 14.2 Hz, 2H), 7.72 - 7.63 (m, 1H), 7.56 (dd, J = 8.3, 1.4 Hz, 1H), 7.46 (ddd, J = 8.5, 6.7, 1.9 Hz, 1H).

化合物 PLC-52.2(2-(4-(5,11-二溴-1,3-二側氧基-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)苯基)乙酸):化合物 PLC-52.2係以與上述程序相似方式自含於無水DMF (65 mL)中之 PLC-52.1(7.000 mmol,3.136 g)、2-(4-胺基苯基)乙酸(14.00 mmol,2.117 g)及DMAP (2.100 mmol,257 mg)在160℃下合成。將粗製反應混合物冷卻至0℃及用6N HCl (約5 mL)中止及用水(至多約350 mL)稀釋。過濾掉沉澱物,用水洗滌。將產物藉由抽吸乾燥及用於下個反應中無需進一步純化。假設100%產率。MS (APCI):針對化學式:C 26H 13Br 2NO 5(M+H)計算值= 578;實測值:578。 Compound PLC-52.2 (2-(4-(5,11-dibromo-1,3-dioxo-1H-𠮿 [2,1,9-def]isoquinolin-2(3H)-yl)phenyl)acetic acid): compound PLC-52.2 was obtained from PLC contained in anhydrous DMF (65 mL) in a similar manner to the above procedure -52.1 (7.000 mmol, 3.136 g), 2-(4-aminophenyl)acetic acid (14.00 mmol, 2.117 g) and DMAP (2.100 mmol, 257 mg) were synthesized at 160°C. The crude reaction mixture was cooled to 0 °C and quenched with 6N HCl (about 5 mL) and diluted with water (up to about 350 mL). The precipitate was filtered off and washed with water. The product was dried by suction and used in the next reaction without further purification. Assuming 100% yield. MS (APCI): Calcd for Formula: C26H13Br2NO5 (M+H) = 578; found : 578.

化合物 PLC-52.3(2-(4-(1,3-二側氧基-5,11-雙(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)苯基)乙酸):化合物 PLC-52.3係自含於THF (/60 mL)、DMF (12 mL)及水(6 mL)中之化合物 PLC-52.2(3.500 mmol,2.034 g)、(4-(三氟甲基)苯基)硼酸(14.00 mmol,2.659 g)、K 2CO 3(19.25 mmol,2.661 g)及Pd(dppf)Cl 2(0.0245 mmol,179 mg)在80℃下在氬氣氛圍下加熱過夜合成。將粗製反應混合物於真空中蒸發至乾,溶於DCM中,及於真空中蒸發至約35 g急驟矽膠上。藉由急驟層析法在矽膠上純化(220 g,平衡0% EtOAc/DCM,溶離0% (10 CV)至15.3% EtOAc/DCM (15.3 CV)至40% EtOAc/DCM (10 CV)至等濃度40% EtOAc/DCM)。EtOAc含有0.1% v/v TFA。將含有產物之溶離份於真空中蒸發至乾。得到棕黃色固體,2.000 g (80.3%來自化合物80.1 (1655-11))。MS (APCI):針對化學式:C 40H 21F 6NO 5(M+H)計算值= 710;實測值:710。 1H NMR (400 MHz, DMSO) δ 12.44 (s, 1H), 8.47 (s, 1H), 8.23 (s, 1H), 8.02 (d, J = 8.1 Hz, 2H), 7.97 - 7.88 (m, 4H), 7.75 (d, J = 8.0 Hz, 2H), 7.49 - 7.37 (m, 3H), 7.31 (d, J = 8.2 Hz, 1H), 7.30 - 7.24 (m, 2H), 7.02 - 6.91 (m, 2H), 3.68 (s, 2H)。 Compound PLC-52.3 (2-(4-(1,3-dioxo-5,11-bis(4-(trifluoromethyl)phenyl)-1H-𠮿 and[2,1,9-def]isoquinolin-2(3H)-yl)phenyl)acetic acid): Compound PLC-52.3 is self-contained in THF (/60 mL), DMF (12 mL) and water ( 6 mL) of compound PLC-52.2 (3.500 mmol, 2.034 g), (4-(trifluoromethyl) phenyl) boronic acid (14.00 mmol, 2.659 g), K 2 CO 3 (19.25 mmol, 2.661 g) and Pd(dppf)Cl 2 (0.0245 mmol, 179 mg) was synthesized by heating at 80°C overnight under argon atmosphere. The crude reaction mixture was evaporated to dryness in vacuo, dissolved in DCM, and evaporated in vacuo onto about 35 g of flash silica gel. Purified by flash chromatography on silica gel (220 g, equilibrated 0% EtOAc/DCM, eluting 0% (10 CV) to 15.3% EtOAc/DCM (15.3 CV) to 40% EtOAc/DCM (10 CV) to etc. Concentration 40% EtOAc/DCM). EtOAc contained 0.1% v/v TFA. Fractions containing product were evaporated to dryness in vacuo. A tan solid was obtained, 2.000 g (80.3% from compound 80.1 (1655-11)). MS (APCI): Calcd . for Formula: C40H21F6NO5 (M+H) = 710; found : 710 . 1 H NMR (400 MHz, DMSO) δ 12.44 (s, 1H), 8.47 (s, 1H), 8.23 (s, 1H), 8.02 (d, J = 8.1 Hz, 2H), 7.97 - 7.88 (m, 4H ), 7.75 (d, J = 8.0 Hz, 2H), 7.49 - 7.37 (m, 3H), 7.31 (d, J = 8.2 Hz, 1H), 7.30 - 7.24 (m, 2H), 7.02 - 6.91 (m, 2H), 3.68 (s, 2H).

化合物 PLC-52.4:向含於8 mL無水DCM及3 mL DMF中之化合物 PLC-29(113 mg,0.1 mmol)之溶液中添加NBS (106 mg,0.6 mmol)。將混合物在60℃下加熱過夜。將所得混合物用100 mL DCM稀釋,用水(2 x 50 mL)洗滌,裝載在矽膠上及藉由急驟層析法使用DCM/EA (0%至10% EA)之溶離劑純化。收集主峰。於移除溶劑及用甲醇研磨後,於過濾及於空氣中乾燥後得到紅棕色固體(80 mg,58%產率)。LCMS (APCI-):針對C 66H 38BBr 3Cl 2F 5N 3O 5計算值:1364.98 (M-);實測值:1365。 Compound PLC-52.4 : To a solution of compound PLC-29 (113 mg, 0.1 mmol) in 8 mL dry DCM and 3 mL DMF was added NBS (106 mg, 0.6 mmol). The mixture was heated at 60 °C overnight. The resulting mixture was diluted with 100 mL of DCM, washed with water (2 x 50 mL), loaded on silica gel and purified by flash chromatography using the eluent of DCM/EA (0% to 10% EA). Collect the main peak. After removal of the solvent and trituration with methanol, a reddish brown solid (80 mg, 58% yield) was obtained after filtration and drying in air. LCMS ( APCI- ) : Calcd . for C66H38BBr3Cl2F5N3O5 : 1364.98 ( M- ); found: 1365.

化合物 PLC-52.5:將含於THF/DMF/水(10 mL/2 mL/1 mL)中之化合物 PLC-52.4(54 mg,0.039 mmol)、4-正丁基苯基硼酸(42 mg,0.236 mmol)、Pd(PPh 3) 4(14 mg,0.012 mmol)及碳酸鉀(32 mg,0.236 mmol)之混合物脫氣及在80℃下加熱6小時。將所得混合物用100 mL DCM稀釋,乾裝載在矽膠上及藉由急驟層析法使用己烷/DCM (0%至50% DCM)之溶離劑純化。收集第一主峰,及移除溶劑,得到呈紅色固體之所需產物(10 mg,30%產率)。LCMS (APCI-):針對C 53H 49BCl 2F 2N 2O計算值:848.33 (M-);實測值:848。 1H NMR (400 MHz, TCE) δ 8.02 (bs, 2H), 7.36 - 7.14 (m, 6H), 6.73 (m, 8H), , 4.42 (s, 1H),2.61 (bs, 4H), 2.39 - 2.31 (m, 4H), 1.86 (s, 8H), 1.37 (p, J = 7.6 Hz, 4H), 1.30 - 1.15 (m, 6H), 0.85 (t, J = 7.3 Hz, 6H)。 Compound PLC-52.5 : Compound PLC-52.4 (54 mg, 0.039 mmol), 4-n-butylphenylboronic acid (42 mg, 0.236 mmol), Pd( PPh3 ) 4 (14 mg, 0.012 mmol) and potassium carbonate (32 mg, 0.236 mmol) was degassed and heated at 80 °C for 6 hours. The resulting mixture was diluted with 100 mL of DCM, dry loaded on silica gel and purified by flash chromatography using the eluent of hexane/DCM (0% to 50% DCM). The first major peak was collected, and the solvent was removed to give the desired product (10 mg, 30% yield) as a red solid. LCMS ( APCI-): Calcd. for C53H49BCl2F2N2O : 848.33 (M-); found: 848. 1 H NMR (400 MHz, TCE) δ 8.02 (bs, 2H), 7.36 - 7.14 (m, 6H), 6.73 (m, 8H), , 4.42 (s, 1H), 2.61 (bs, 4H), 2.39 - 2.31 (m, 4H), 1.86 (s, 8H), 1.37 (p, J = 7.6 Hz, 4H), 1.30 - 1.15 (m, 6H), 0.85 (t, J = 7.3 Hz, 6H).

化合物 PLC-52:將含於5 mL無水DCM中之化合物 PLC-52.5(10 mg,0.012 mmol)、(2-(4-(1,3-二側氧基-5,11-雙(4-(三氟甲基)苯基)-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)苯基)乙酸) (16 mg,0.022 mmol)、DMAP/TsOH (5 mg,0.017 mmol)、DIC (0.05 mL,0.31 mmol)之混合物在室溫下攪拌過夜。將所得混合物裝載在矽膠上及藉由急驟層析法使用己烷/DCM (0%至100% DCM)之溶離劑純化。收集主要所需峰,於移除溶劑及用MeOH研磨後,得到暗棕色固體(10 mg,54%產率)。LCMS (APCI-):針對C 93H 68BCl 2F 8N 3O 5計算值:1539.45 (M-);實測值:1539。 1H NMR (400 MHz, TCE) δ 8.64 (s, 1H), 8.40 (s, 1H), 8.03 (s, 2H), 7.83 (d, J = 8.2 Hz, 2H), 7.81 - 7.74 (m, 4H), 7.59 (d, J = 8.0 Hz, 2H), 7.46 (d, J = 8.2 Hz, 2H), 7.39 - 7.17 (m, 11H), 7.02 (d, J = 8.0 Hz, 1H), 6.95 - 6.50 (m, 10H), 3.78 (s, 2H), 2.62 (s, 4H), 2.41 - 2.30 (m, 4H), 1.87 (s, 8H), 1.41 (p, J = 7.4 Hz, 4H), 1.32 - 1.21 (m, 4H), 0.87 (t, J = 7.3 Hz, 6H)。 Compound PLC-52 : Compound PLC-52.5 (10 mg, 0.012 mmol), (2-(4-(1,3-dioxo-5,11-bis(4- (Trifluoromethyl)phenyl)-1H-𠮿 [2,1,9-def]isoquinolin-2(3H)-yl)phenyl)acetic acid) (16 mg, 0.022 mmol), DMAP/TsOH (5 mg, 0.017 mmol), DIC (0.05 mL, 0.31 mmol) was stirred overnight at room temperature. The resulting mixture was loaded on silica gel and purified by flash chromatography using the eluent of hexane/DCM (0% to 100% DCM). The main desired peak was collected to give a dark brown solid (10 mg, 54% yield) after solvent removal and trituration with MeOH. LCMS ( APCI- ) : Calcd . for C93H68BCl2F8N3O5 : 1539.45 (M-); found: 1539. 1 H NMR (400 MHz, TCE) δ 8.64 (s, 1H), 8.40 (s, 1H), 8.03 (s, 2H), 7.83 (d, J = 8.2 Hz, 2H), 7.81 - 7.74 (m, 4H ), 7.59 (d, J = 8.0 Hz, 2H), 7.46 (d, J = 8.2 Hz, 2H), 7.39 - 7.17 (m, 11H), 7.02 (d, J = 8.0 Hz, 1H), 6.95 - 6.50 (m, 10H), 3.78 (s, 2H), 2.62 (s, 4H), 2.41 - 2.30 (m, 4H), 1.87 (s, 8H), 1.41 (p, J = 7.4 Hz, 4H), 1.32 - 1.21 (m, 4H), 0.87 (t, J = 7.3 Hz, 6H).

合成化合物 PLC-53 化合物 PLC-53.1(9-(6-(2-胺基-4-(第三丁基)苯氧基)-2-(2-羥乙基)-1H-苯并[de]異喹啉-1,3(2H)-二酮):化合物 PLC-53.1係以與上述程序相似方式自 PLC-26.2(8.827 mmol,3.190 g)、乙醇胺(17.65 mmol,1.066 mL)及DMAP (2.648 mmol,324 mg),接著200純度乙醇(70 mL)合成。過濾掉粗沉澱物,溶解於丙酮中,及於真空中蒸發至乾。得到棕黃色固體,2.777 g (78%產率)。MS (APCI):針對C 24H 24N 2O 4(M+H)計算值= 405;實測值:405。 1H NMR (400 MHz, TCE) δ 8.80 (dd, J = 8.4, 1.2 Hz, 1H), 8.67 (dd, J = 7.3, 1.2 Hz, 1H), 8.46 (d, J = 8.3 Hz, 1H), 7.84 (dd, J = 8.4, 7.3 Hz, 1H), 7.02 - 6.92 (m, 3H), 6.87 (dd, J = 8.4, 2.3 Hz, 1H), 4.42 (t, J = 5.2 Hz, 2H), 3.95 (t, J = 5.2 Hz, 2H), 3.74 (s, 2H), 2.39 (s, 1H), 1.35 (s, 9H)。 Synthesis of compound PLC-53 Compound PLC-53.1 (9-(6-(2-amino-4-(tert-butyl)phenoxy)-2-(2-hydroxyethyl)-1H-benzo[de]isoquinoline- 1,3(2H)-diketone): Compound PLC-53.1 was obtained from PLC-26.2 (8.827 mmol, 3.190 g), ethanolamine (17.65 mmol, 1.066 mL) and DMAP (2.648 mmol, 324 mg ), followed by 200 g of ethanol (70 mL). The crude precipitate was filtered off, dissolved in acetone, and evaporated to dryness in vacuo. A tan solid was obtained, 2.777 g (78% yield). MS (APCI): Calcd for C 24 H 24 N 2 O 4 (M+H) = 405; found: 405. 1 H NMR (400 MHz, TCE) δ 8.80 (dd, J = 8.4, 1.2 Hz, 1H), 8.67 ( dd, J = 7.3, 1.2 Hz, 1H), 8.46 (d, J = 8.3 Hz, 1H), 7.84 (dd, J = 8.4, 7.3 Hz, 1H), 7.02 - 6.92 (m, 3H), 6.87 (dd , J = 8.4, 2.3 Hz, 1H), 4.42 (t, J = 5.2 Hz, 2H), 3.95 (t, J = 5.2 Hz, 2H), 3.74 (s, 2H), 2.39 (s, 1H), 1.35 (s, 9H).

化合物 PLC-53.2(9-(第三丁基)-2-(2-羥乙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮):化合物 PLC-53.2係以與上述程序相似方式自化合物 PLC-53.1(6.863 mmol,2.776 g)、NaNO 2(51.475 mmol,3.552 g)、濃HCl (34.317 mmol,2.83 mL)及CuSO 4.5H 2O (46.67 mmol,11.653 g)合成。粗產物為約10%乙酸酯。將其利用K 2CO 3以與上述相同方式裂解。將粗製裂解混合物溶解於丙酮中及蒸發至約20 g矽膠上及放入裝載器中。藉由急驟層析法在矽膠上純化(120 g,固體負荷,平衡0% EtOAc/DCM,溶離(2 CV)至85% EtOAc/DCM (20 CV))。將含有產物之溶離份於真空中蒸發至乾。得到黃色固體,732 mg (27%產率)。MS (APCI):針對化學式:C 24H 21NO 4(M+H)計算值= 388;實測值:388。 Compound PLC-53.2 (9-(tert-butyl)-2-(2-hydroxyethyl)-1H-𠮿 and[2,1,9-def]isoquinoline-1,3(2H)-dione): compound PLC-53.2 was obtained from compound PLC-53.1 (6.863 mmol, 2.776 g), NaNO 2 (51.475 mmol, 3.552 g), concentrated HCl (34.317 mmol, 2.83 mL) and CuSO 4 .5H 2 O (46.67 mmol, 11.653 g). The crude product was about 10% acetate. It was cleaved using K2CO3 in the same manner as above. The crude cleavage mixture was dissolved in acetone and evaporated onto about 20 g of silica gel and placed in a loader. Purified by flash chromatography on silica gel (120 g, solids load, equilibrate 0% EtOAc/DCM, elute (2 CV) to 85% EtOAc/DCM (20 CV)). Fractions containing product were evaporated to dryness in vacuo. Obtained as a yellow solid, 732 mg (27% yield). MS (APCI): Calcd. for Formula: C24H21NO4 (M+H) = 388 ; found : 388.

化合物 PLC-53.3(4-(2-(9-(第三丁基)-1,3-二側氧基-1H-𠮿并[2,1,9-def]異喹啉-2(3H)-基)乙氧基)-2,6-二氯苯甲醛):將化合物 PLC-53.2(0.200 mmol,78 mg)及2,6-二氯-4-羥基苯甲醛(0.260 mmol,50 mg)添加至40 mL螺旋蓋小瓶中,接著添加無水DCE (10 mL)及攪拌棒。將反應混合物在室溫下攪拌及添加DEAD (0.300 mmol,0.137 mL)及PPh 3(0.300 mmol,79 mg)。將反應混合物在室溫下攪拌60分鐘。添加另外DEAD (0.100 mmol,0.046 mL)及PPh 3(0.100 mmol,26 mg)及在室溫下繼續攪拌過夜。將粗製反應混合物裝載至裝載器中之約20 g矽膠上。藉由急驟層析法在矽膠上純化(80 g,固體負荷,平衡0% EtOAc/DCM,溶離0% (2 CV)至10% EtOAc/DCM (15 CV))。MS (APCI):針對化學式:C 31H 23Cl 2NO 5(M+H)計算值= 560;實測值:560。 1H NMR (400 MHz, TCE) δ 10.36 (s, 1H), 8.66 (d, J = 7.9 Hz, 1H), 8.60 (d, J = 8.5 Hz, 1H), 8.06 (d, J = 2.3 Hz, 1H), 8.01 (d, J = 8.0 Hz, 1H), 7.63 (dd, J = 8.7, 2.2 Hz, 1H), 7.37 (d, J = 8.8 Hz, 1H), 7.34 (d, J = 8.4 Hz, 1H), 6.99 (s, 2H), 6.95 (d, J = 14.5 Hz, 1H), 4.64 (t, J = 6.2 Hz, 2H), 4.39 (t, J = 6.2 Hz, 2H), 1.44 (s, 9H)。 Compound PLC-53.3 (4-(2-(9-(tert-butyl)-1,3-two-side oxy-1H-𠮿 and[2,1,9-def]isoquinolin-2(3H)-yl)ethoxy)-2,6-dichlorobenzaldehyde): compound PLC-53.2 (0.200 mmol, 78 mg) and 2 , 6-dichloro-4-hydroxybenzaldehyde (0.260 mmol, 50 mg) was added to a 40 mL screw cap vial, followed by anhydrous DCE (10 mL) and a stir bar. The reaction mixture was stirred at room temperature and DEAD (0.300 mmol, 0.137 mL) and PPh3 (0.300 mmol, 79 mg) were added. The reaction mixture was stirred at room temperature for 60 minutes. Additional DEAD (0.100 mmol, 0.046 mL) and PPh3 (0.100 mmol, 26 mg) were added and stirring was continued at room temperature overnight. The crude reaction mixture was loaded onto approximately 20 g of silica gel in the loader. Purified by flash chromatography on silica gel (80 g, solids load, equilibration 0% EtOAc/DCM, eluting 0% (2 CV) to 10% EtOAc/DCM (15 CV)). MS ( APCI) : Calcd. for Formula: C31H23Cl2NO5 (M+H) = 560; found : 560. 1 H NMR (400 MHz, TCE) δ 10.36 (s, 1H), 8.66 (d, J = 7.9 Hz, 1H), 8.60 (d, J = 8.5 Hz, 1H), 8.06 (d, J = 2.3 Hz, 1H), 8.01 (d, J = 8.0 Hz, 1H), 7.63 (dd, J = 8.7, 2.2 Hz, 1H), 7.37 (d, J = 8.8 Hz, 1H), 7.34 (d, J = 8.4 Hz, 1H), 6.99 (s, 2H), 6.95 (d, J = 14.5 Hz, 1H), 4.64 (t, J = 6.2 Hz, 2H), 4.39 (t, J = 6.2 Hz, 2H), 1.44 (s, 9H).

化合物 PLC-53(9-(第三丁基)-2-(2-(4-(19,19-二氟-6,7,11,12,13,19-六氫-5H-18l4,19l4-苯并[3',4']環庚[1',2':4,5]吡咯并[1,2-c]苯并[3',4']環庚[1',2':4,5]吡咯并[2,1-f][1,3,2]二氮雜硼雜苯-9-基)-3,5-二甲基苯氧基)乙基)-1H-𠮿并[2,1,9-def]異喹啉-1,3(2H)-二酮):化合物 PLC-53係以與化合物32相似方式自化合物53.3 (0.186 mmol,104 mg)、1,4,5,6-四氫苯并[6,7]環庚[1,2-b]吡咯( Ex-7.3,0.371 mmol,68 mg)及pTsOH.H 2O (0.0186 mmol,3.5 mg),然後DDQ (0.241 mmol,55 mg)及2X Et 3N (1.485 mmol,0.210 mL)及BF 3.OEt 2(2.227 mmol,0.280 mL)於無水DCM (20 mL)中在室溫下,然後在50℃下合成。將粗製反應混合物用己烷稀釋,然後裝載至裝載器中之約20 g矽膠上。藉由急驟層析法在矽膠上純化(80 g,固體負荷,平衡0% EtOAc/己烷,溶離0% (2 CV)至75% EtOAc/己烷(30 CV))。將含有產物之溶離份於真空中蒸發至乾。將粗產物研磨及於真空中乾燥。得到深紅色固體,138 mg (78%產率)。MS (APCI):針對化學式:C 59H 50BF 2N 3O 4(M+H)計算值= 954;實測值:954。 1H NMR (400 MHz, TCE) δ 8.70 (d, J = 7.9 Hz, 1H), 8.64 (d, J = 8.4 Hz, 1H), 8.10 - 7.99 (m, 4H), 7.63 (dd, J = 8.7, 2.2 Hz, 1H), 7.42 - 7.32 (m, 6H), 7.32 - 7.24 (m, 2H), 7.14 (s, 2H), 6.43 (s, 2H), 4.70 (t, J = 6.2 Hz, 2H), 4.42 (t, J = 6.3 Hz, 2H), 2.62 (t, J = 6.6 Hz, 4H), 2.30 (s, 4H), 2.11 - 1.96 (m, 4H), 1.44 (s, 9H)。 Compound PLC-53 (9-(tert-butyl)-2-(2-(4-(19,19-difluoro-6,7,11,12,13,19-hexahydro-5H-18l4,19l4 -Benzo[3',4']cyclohepta[1',2':4,5]pyrrolo[1,2-c]benzo[3',4']cyclohepta[1',2': 4,5]pyrrolo[2,1-f][1,3,2]diazaborin-9-yl)-3,5-dimethylphenoxy)ethyl)-1H-𠮿 and[2,1,9-def]isoquinoline-1,3(2H)-dione): Compound PLC-53 was obtained from compound 53.3 (0.186 mmol, 104 mg), 1,4 , 5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-b]pyrrole ( Ex-7.3 , 0.371 mmol, 68 mg) and pTsOH.H 2 O (0.0186 mmol, 3.5 mg), then DDQ (0.241 mmol, 55 mg) and 2X Et 3 N (1.485 mmol, 0.210 mL) and BF 3 .OEt 2 (2.227 mmol, 0.280 mL) in anhydrous DCM (20 mL) at room temperature, then at 50°C Synthesize. The crude reaction mixture was diluted with hexanes and then loaded onto approximately 20 g of silica gel in a loader. Purified by flash chromatography on silica gel (80 g, solids load, equilibrate 0% EtOAc/hexane, elute 0% (2 CV) to 75% EtOAc/hexane (30 CV)). Fractions containing product were evaporated to dryness in vacuo. The crude product was triturated and dried in vacuo. A dark red solid was obtained, 138 mg (78% yield). MS (APCI): Calcd for Formula: C59H50BF2N3O4 ( M + H) = 954; found: 954 . 1 H NMR (400 MHz, TCE) δ 8.70 (d, J = 7.9 Hz, 1H), 8.64 (d, J = 8.4 Hz, 1H), 8.10 - 7.99 (m, 4H), 7.63 (dd, J = 8.7 , 2.2 Hz, 1H), 7.42 - 7.32 (m, 6H), 7.32 - 7.24 (m, 2H), 7.14 (s, 2H), 6.43 (s, 2H), 4.70 (t, J = 6.2 Hz, 2H) , 4.42 (t, J = 6.3 Hz, 2H), 2.62 (t, J = 6.6 Hz, 4H), 2.30 (s, 4H), 2.11 - 1.96 (m, 4H), 1.44 (s, 9H).

實例 10 —— 過濾器層之製造玻璃基板係以實質上下列方式製備。將量測為1-英吋X 1-英吋之1.1 mm厚玻璃基板切成尺寸。然後將玻璃基板用洗滌劑及去離子(DI)水洗滌,用新鮮DI水沖洗,及音波處理約1小時。然後將玻璃浸入異丙醇(IPA)中及音波處理約1小時。然後將玻璃基板浸入丙酮中及音波處理約1小時。然後自丙酮浴移除玻璃及在室溫下用氮氣乾燥。 Example 10 - Fabrication of Filter Layer A glass substrate was prepared in essentially the following manner. A 1.1 mm thick glass substrate measuring 1-inch by 1-inch was cut to size. The glass substrates were then washed with detergent and deionized (DI) water, rinsed with fresh DI water, and sonicated for about 1 hour. The glass was then immersed in isopropanol (IPA) and sonicated for about 1 hour. The glass substrate was then immersed in acetone and sonicated for about 1 hour. The glass was then removed from the acetone bath and dried with nitrogen at room temperature.

製備含於環戊酮(99.9%純)中之聚(甲基丙烯酸甲酯) (PMMA) (藉由GPC平均M.W. 120,000,來自MilliporeSigma, Burlington, MA, USA)共聚物之20重量%溶液。將經製備之共聚物在40℃下攪拌過夜。[PMMA] CAS: 9011-14-7;[環戊酮] CAS: 120-92-3。A 20 wt % solution of poly(methyl methacrylate) (PMMA) (average M.W. 120,000 by GPC, from MilliporeSigma, Burlington, MA, USA) copolymer in cyclopentanone (99.9% pure) was prepared. The prepared copolymer was stirred overnight at 40°C. [PMMA] CAS: 9011-14-7; [Cyclopentanone] CAS: 120-92-3.

將以上製備之20% PMMA溶液(4 g)添加至如上所述於密封容器中製備之3 mg光致發光複合物中及混合約30分鐘。然後將PMMA/發光團溶液在1000 RPM下持續20秒及然後在500 RPM下持續5秒旋塗至經製備之玻璃基板上。所得濕塗層具有約10 µm之厚度。將樣品用鋁箔覆蓋,之後旋塗以保護其免於暴露於光。三個樣品各以此方式各針對發射/FWHM及量子產率經製備。將旋塗樣品於真空烘箱中在80℃下烘烤3小時,以蒸發剩餘溶劑。The 20% PMMA solution prepared above (4 g) was added to the 3 mg photoluminescent complex prepared as described above in a sealed container and mixed for about 30 minutes. The PMMA/luminophore solution was then spin-coated onto the prepared glass substrate at 1000 RPM for 20 seconds and then at 500 RPM for 5 seconds. The resulting wet coating has a thickness of about 10 µm. The samples were covered with aluminum foil prior to spin coating to protect them from exposure to light. Three samples were prepared in this manner each for emission/FWHM and quantum yield. The spin-coated samples were baked in a vacuum oven at 80° C. for 3 hours to evaporate the remaining solvent.

將1-英吋X 1-英吋樣品插入Shimadzu,UV-3600 UV-VIS- NIR分光光度計(Shimadzu Instruments, Inc., Columbia, MD, USA)中。所有裝置操作係於經氮氣填充之手套箱內進行。PLC-1之所得吸收/發射光譜示於 1中,PLC-2之所得吸收/發射光譜示於 2中,及PLC-3之所得吸收/發射光譜示於 3中。 A 1-inch by 1-inch sample was inserted into a Shimadzu, UV-3600 UV-VIS-NIR Spectrophotometer (Shimadzu Instruments, Inc., Columbia, MD, USA). All device manipulations were performed in a nitrogen-filled glove box. The resulting absorption/emission spectrum of PLC-1 is shown in FIG . 1 , that of PLC-2 is shown in FIG. 2 , and that of PLC-3 is shown in FIG. 3 .

如上所述製備之1-英吋X 1-英吋膜樣品之螢光光譜係使用Fluorolog分光光度計(Horiba Scientific, Edison, NJ, USA)利用設置在各自最大吸收波長之激發波長測定。最大發射及FWHM示於表1中。Fluorescence spectra of 1-inch by 1-inch film samples prepared as described above were measured using a Fluorolog spectrophotometer (Horiba Scientific, Edison, NJ, USA) with excitation wavelengths set at the respective maximum absorption wavelengths. The maximum emission and FWHM are shown in Table 1.

如上所述製備之1-英吋X 1-英吋樣品之量子產率係使用Quantarus-QY分光光度計(Hamamatsu Inc., Campbell CA, USA)測定,在各自最大吸收波長下激發。結果報告於表1中。Quantum yields of 1-inch by 1-inch samples prepared as described above were measured using a Quantarus-QY spectrophotometer (Hamamatsu Inc., Campbell CA, USA) excited at the respective maximum absorption wavelength. The results are reported in Table 1.

膜特徵分析(吸收峰波長、FWHM及量子產率)之結果示於下表1中。 1 化合物編號 結構 PMMA 中之吸收 (nm) PMMA 中之發射 (nm) FWHM (nm) QY ( 450 nm ) PLC-1 594 614 35 0.904 PLC-2 592 611 35 0.969 PLC-3 593 615 34 0.937 PLC-4   631 644 28 0.807 PLC-5 644 658 30 0.767 PLC-6 584 602 35 0.888 PLC-7   633 648 32 0.784 PLC-8   581 599 34 0.951 PLC-9   615 628 29 0.809 PLC-10 580 597 34 0.958 PLC-11 631 642 29 0.837 PLC-12 644 656 30 0.751 PLC-13 614 626 28 0.794 PLC-14 633 648 31 0.758 PLC-15 635 643 24 0.862 PLC-16 593 612 36 0.85 PLC-17 644 658 30 0.701 PLC-18 585 602 34 0.873 PLC-19 644 658 30 0.735 PLC-20 593 612 35 0.820 PLC-21 616 626 25 0.861 PLC-22 582 600 37 0.917 PLC-23 592 610 34 0.912 PLC-24 593 615 34 0.924 PLC-25 593 614 34 0.912 PLC-26 593 610 33 0.887 PLC-27 593 611 34 0.894 PLC-28 593 611 33 0.897 PLC-29 592 608 32 0.889 PLC-30 593 611 34 0.907 PLC-31 593 612 35 0.895 PLC-32 593 612 34 0.859 PLC-33 593 612 34 0.909 PLC-34 591 609 33 0.892 PLC-35 591 608 33 0.915 PLC-36 593 612 34 0.909 PLC-37 592 608 33 0.890 PLC-38 591 607 33 0.867 PLC-39 593 610 33 0.903 PLC-40 591 608 34 0.85 PLC-41 591 605 32 0.898 PLC-42 592 610 34 0.869 PLC-43 591 608 34 0.869 PLC-44 592 609 34 0.911 PLC-45 592 612 33 0.877 PLC-46 592 608 33 0.842 PLC-47 592 610 33 0.885 PLC-48 592 612 33 0.864 PLC-49 591 607 36 0.867 PLC-50 591 607 35 0.859 PLC-51 591 606 34 0.857 PLC-52 592 611 35 0.86 PLC-53 592 608 33 0.84 The results of film characteristic analysis (absorption peak wavelength, FWHM and quantum yield) are shown in Table 1 below. Table 1 Compound number structure Absorption in PMMA ( nm) Emission in PMMA ( nm) FWHM (nm) QY ( at 450 nm ) PLC-1 594 614 35 0.904 PLC-2 592 611 35 0.969 PLC-3 593 615 34 0.937 PLC-4 631 644 28 0.807 PLC-5 644 658 30 0.767 PLC-6 584 602 35 0.888 PLC-7 633 648 32 0.784 PLC-8 581 599 34 0.951 PLC-9 615 628 29 0.809 PLC-10 580 597 34 0.958 PLC-11 631 642 29 0.837 PLC-12 644 656 30 0.751 PLC-13 614 626 28 0.794 PLC-14 633 648 31 0.758 PLC-15 635 643 twenty four 0.862 PLC-16 593 612 36 0.85 PLC-17 644 658 30 0.701 PLC-18 585 602 34 0.873 PLC-19 644 658 30 0.735 PLC-20 593 612 35 0.820 PLC-21 616 626 25 0.861 PLC-22 582 600 37 0.917 PLC-23 592 610 34 0.912 PLC-24 593 615 34 0.924 PLC-25 593 614 34 0.912 PLC-26 593 610 33 0.887 PLC-27 593 611 34 0.894 PLC-28 593 611 33 0.897 PLC-29 592 608 32 0.889 PLC-30 593 611 34 0.907 PLC-31 593 612 35 0.895 PLC-32 593 612 34 0.859 PLC-33 593 612 34 0.909 PLC-34 591 609 33 0.892 PLC-35 591 608 33 0.915 PLC-36 593 612 34 0.909 PLC-37 592 608 33 0.890 PLC-38 591 607 33 0.867 PLC-39 593 610 33 0.903 PLC-40 591 608 34 0.85 PLC-41 591 605 32 0.898 PLC-42 592 610 34 0.869 PLC-43 591 608 34 0.869 PLC-44 592 609 34 0.911 PLC-45 592 612 33 0.877 PLC-46 592 608 33 0.842 PLC-47 592 610 33 0.885 PLC-48 592 612 33 0.864 PLC-49 591 607 36 0.867 PLC-50 591 607 35 0.859 PLC-51 591 606 34 0.857 PLC-52 592 611 35 0.86 PLC-53 592 608 33 0.84

相關申請案之交互參照本申請案主張2021年9月27日申請之美國臨時申請案第63/248,863號,及2021年11月12日申請之美國臨時申請案第63/278,944號之優先權,其二者之全文係以引用的方式併入。 CROSS REFERENCE TO RELATED APPLICATIONS This application claims priority to U.S. Provisional Application No. 63/248,863, filed September 27, 2021, and U.S. Provisional Application No. 63/278,944, filed November 12, 2021, Both are incorporated by reference in their entirety.

1為描述光致發光複合物(PLC-1)之一個實施例之吸收及發射光譜的圖。 Figure 1 is a graph depicting the absorption and emission spectra of one example of a photoluminescent complex (PLC-1).

2為描述光致發光複合物(PLC-2)之一個實施例之吸收及發射光譜的圖。 Figure 2 is a graph depicting the absorption and emission spectra of one embodiment of the photoluminescent composite (PLC-2).

3為描述光致發光複合物(PLC-3)之一個實施例之吸收及發射光譜的圖。 Figure 3 is a graph depicting the absorption and emission spectra of one embodiment of the photoluminescent composite (PLC-3).

Claims (17)

一種光致發光複合物,其包含: 藍光吸收供體發色團,其中該供體發色團包含萘醯亞胺衍生物; 連接子複合物;及 環鎖定之硼-二吡咯甲烷(BODIPY)部分; 其中該連接子複合物將具有該萘醯亞胺衍生物之該供體發色團及該環鎖定之BODIPY部分共價連接,其中該萘醯亞胺衍生物吸收第一激發波長之藍光能量及將能量轉移至該環鎖定之BODIPY部分,其中該環鎖定之BODIPY部分發射第二更長波長之光能量,且其中該光致發光複合物具有大於80%之發射量子產率。 A photoluminescent compound comprising: a blue light absorbing donor chromophore, wherein the donor chromophore comprises a naphthyl imide derivative; linker complex; and ring-locked boron-dipyrromethane (BODIPY) moiety; Wherein the linker complex covalently connects the donor chromophore having the naphthyl imide derivative and the ring-locked BODIPY moiety, wherein the naphthyl imide derivative absorbs the blue light energy of the first excitation wavelength and transferring energy to the ring-locked BODIPY moiety, wherein the ring-locked BODIPY moiety emits light energy of a second, longer wavelength, and wherein the photoluminescent composite has an emission quantum yield of greater than 80%. 如請求項1之光致發光複合物,其中該供體發色團之該萘醯亞胺衍生物具有以下通式: ,其中Y為O或S;其中R 7及R 8獨立地為H、經取代或未經取代之芳基、或-CF 3;且其中R 9獨立地為H、經取代或未經取代之芳基、或C 1-C 5烷基。 The photoluminescent compound as claimed in item 1, wherein the naphthyl imide derivative of the donor chromophore has the following general formula: , wherein Y is O or S; wherein R 7 and R 8 are independently H, substituted or unsubstituted aryl, or -CF 3 ; and wherein R 9 is independently H, substituted or unsubstituted Aryl, or C 1 -C 5 alkyl. 如請求項1之光致發光複合物,其中該光致發光複合物具有以下通式: ,其中R 1及R 2獨立地為H、C 1-C 3烷基、或經取代之芳基;其中R 3及R 4獨立地為H、F、Br或-CF 3;其中R 5及R 6獨立地為H、C 1-C 3烷基、鹵化物或C 1-C 3烷氧基;且其中各X獨立地為C 1-C 3烷基或螺環烷基,其中L為該連接子複合物且Z為該供體發色團。 The photoluminescent compound as claimed in item 1, wherein the photoluminescent compound has the following general formula: , wherein R 1 and R 2 are independently H, C 1 -C 3 alkyl, or substituted aryl; wherein R 3 and R 4 are independently H, F, Br or -CF 3 ; wherein R 5 and R 6 is independently H, C 1 -C 3 alkyl, halide, or C 1 -C 3 alkoxy; and wherein each X is independently C 1 -C 3 alkyl or spirocycloalkyl, wherein L is The linker complex and Z is the donor chromophore. 如請求項3之光致發光複合物,其中L為經取代之酯或未經取代之酯。The photoluminescent composite as claimed in item 3, wherein L is a substituted ester or an unsubstituted ester. 如請求項3之光致發光複合物,其中L為經取代之醚或未經取代之醚。The photoluminescent compound as claimed in item 3, wherein L is a substituted ether or an unsubstituted ether. 如請求項1、3或4之光致發光複合物,其中該連接子複合物為未經取代之酯;其中該未經取代之酯包括下列結構中之一者: The photoluminescent complex as claimed in claim 1, 3 or 4, wherein the linker complex is an unsubstituted ester; wherein the unsubstituted ester includes one of the following structures: 如請求項1、3或4之光致發光複合物,其中該連接子複合物為經取代之酯;其中該經取代之酯包括下列結構中之一者: The photoluminescent complex according to claim 1, 3 or 4, wherein the linker complex is a substituted ester; wherein the substituted ester includes one of the following structures: , or . 如請求項1、3或5之光致發光複合物,其中該連接子複合物為未經取代及/或經取代之醚;其中該未經取代及/或經取代之醚包括下列結構中之一者: The photoluminescent complex as claimed in item 1, 3 or 5, wherein the linker complex is an unsubstituted and/or substituted ether; wherein the unsubstituted and/or substituted ether includes one of the following structures one of: 如請求項1、3、4或5之光致發光複合物,其中該光致發光複合物包括下列結構中之一者: (PLC-53),或其任何組合。 The photoluminescent composite according to claim 1, 3, 4 or 5, wherein the photoluminescent composite includes one of the following structures: (PLC-53) , or any combination thereof. 一種色轉換膜,其包含: 透明基板層; 色轉換層,其中該色轉換層包含樹脂基質;及分散於該樹脂基質內之至少一種如請求項1、2、3、4或5之光致發光複合物。 A color conversion film comprising: Transparent substrate layer; A color conversion layer, wherein the color conversion layer comprises a resin matrix; and at least one photoluminescent compound according to claim 1, 2, 3, 4 or 5 dispersed in the resin matrix. 如請求項10之色轉換膜,其進一步包含單態氧淬滅劑。The color conversion film according to claim 10, further comprising a singlet oxygen quencher. 如請求項10之色轉換膜,其進一步包含自由基清除劑。The color conversion film according to claim 10, further comprising a free radical scavenger. 如請求項10之色轉換膜,其中該膜具有介於10 µm與200 µm之間之厚度。The color conversion film as claimed in item 10, wherein the film has a thickness between 10 µm and 200 µm. 如請求項10之色轉換膜,其中該膜吸收約400 nm至約480 nm之波長範圍內之光及發射約590 nm至約650 nm之波長範圍內之光。As claimed in item 10, the color conversion film, wherein the film absorbs light in the wavelength range of about 400 nm to about 480 nm and emits light in the wavelength range of about 590 nm to about 650 nm. 一種製備色轉換膜之方法,該方法包括: 將如請求項1、2、3、4或5之光致發光複合物及黏結劑樹脂溶解於溶劑中;及 將該混合物施覆至透明基板層。 A method of preparing a color conversion film, the method comprising: Dissolving the photoluminescent compound and binder resin according to claim 1, 2, 3, 4 or 5 in a solvent; and The mixture is applied to a transparent substrate layer. 一種背光單元,其包含如請求項10之色轉換膜。A backlight unit comprising the color conversion film according to Claim 10. 一種顯示裝置,其包含如請求項16之背光單元。A display device comprising the backlight unit according to claim 16.
TW111136536A 2021-09-27 2022-09-27 Boron-containing cyclic emissive compounds and color conversion film containing the same TW202330556A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202163248863P 2021-09-27 2021-09-27
US63/248,863 2021-09-27
US202163278944P 2021-11-12 2021-11-12
US63/278,944 2021-11-12

Publications (1)

Publication Number Publication Date
TW202330556A true TW202330556A (en) 2023-08-01

Family

ID=84331527

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111136536A TW202330556A (en) 2021-09-27 2022-09-27 Boron-containing cyclic emissive compounds and color conversion film containing the same

Country Status (3)

Country Link
KR (1) KR20240065040A (en)
TW (1) TW202330556A (en)
WO (1) WO2023049828A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018038138A1 (en) * 2016-08-23 2018-03-01 富士フイルム株式会社 Light-emitting particles, and compound
WO2019044736A1 (en) * 2017-08-28 2019-03-07 静岡県公立大学法人 Detection method and detection probe for colibactin and colibactin-producing bacteria
CN112739794A (en) * 2018-09-11 2021-04-30 巴斯夫欧洲公司 Receiver for optical data communication comprising a luminescent collector
EP4010433A1 (en) * 2019-08-07 2022-06-15 Abbott Laboratories Chemiluminescent compounds for multiplexing

Also Published As

Publication number Publication date
WO2023049828A1 (en) 2023-03-30
KR20240065040A (en) 2024-05-14

Similar Documents

Publication Publication Date Title
Yan et al. A novel coumarin-based red fluorogen with AIE, self-assembly, and TADF properties
JP7451560B2 (en) Boron-containing cyclic luminescent compound and color conversion film containing the same
JP7415034B2 (en) Boron-containing cyclic releasing compound and color conversion film containing the same
TWI823263B (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
JP2024511260A (en) Boron-containing cyclic releasing compound and color conversion film containing the same
TW202330556A (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
TWI764521B (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
Ma et al. Alkyl chains length dependent fluorescence emission and reversible mechanofluorochromism of AIEE-based quinoline derivatives
WO2021202536A1 (en) Improved wavelength conversion film
CN117396580A (en) Boron-containing cyclic light-emitting compound and color conversion film comprising the same
TW202342487A (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
TW202342695A (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
JP7458498B2 (en) Boron-containing cyclic releasing compound and color conversion film containing the same
TW202334720A (en) Wavelength conversion film and display device including the same
TWI831934B (en) Compound, color conversion film comprising same, backlight unit and display apparatus
CN117063288A (en) Boron-containing cyclic light-emitting compound and color conversion film comprising same
Yang et al. Methyl-restricted rotor rotation on the stator produces high-efficiency fluorescence emission: a new strategy to achieve aggregation-induced emission
WO2024081802A1 (en) Wavelength conversion film and display device including the same
WO2024119026A1 (en) Boron-containing cyclic emissive compounds and color conversion film containing the same